<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2013-05-25T13:56:59Z</responseDate><request verb="ListRecords" metadataPrefix="pmc" set="bmcopht">http://www.ncbi.nlm.nih.gov/oai/oai.cgi</request><ListRecords><record><header><identifier>oai:pubmedcentral.nih.gov:31434</identifier><datestamp>2001-05-14</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">31434</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-1-1</article-id>
      <article-id pub-id-type="pmid">11325340</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-1-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report </subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Atypical Herpes simplex keratitis (HSK) presenting as a perforated corneal ulcer with a large infiltrate in a contact lens wearer: multinucleated giant cells in the Giemsa smear offered a clue to the diagnosis</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Athmanathan</surname>
            <given-names>Sreedharan</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>sreedhar@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Pranesh</surname>
            <given-names>Veenashree M</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>sreedhar@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Pasricha</surname>
            <given-names>Gunisha</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>sreedhar@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Garg</surname>
            <given-names>Prashant</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>prashant@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Vemuganti</surname>
            <given-names>Geeta K</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>geetakashyap@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A6" contrib-type="author">
          <name>
            <surname>Sharma</surname>
            <given-names>Savitri</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>savitri@lvpeye.stph.net</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Jhaveri Microbiology Centre, LV Prasad Eye Institute, Banjara Hills, Hyderabad, India</aff>
      <aff id="I2"><label>2</label>Ophthalmic Pathology Division, LV Prasad Eye Institute, Banjara Hills, Hyderabad, India</aff>
      <aff id="I3"><label>3</label>Cornea Services, LV Prasad Eye Institute, Banjara Hills, Hyderabad, India</aff>
      <pub-date pub-type="collection">
        <year>2001</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>4</month>
        <year>2001</year>
      </pub-date>
      <volume>1</volume>
      <fpage>1</fpage>
      <lpage>1</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/1/1"/>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>1</month>
          <year>2001</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>4</month>
          <year>2001</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2001 Athmanathan et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2001</copyright-year>
        <copyright-holder>Athmanathan et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>To report a case of atypical herpes simplex keratitis initially diagnosed as bacterial keratitis, in a contact lens wearer.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Case report of an 18-year-old woman using contact lenses who presented with pain, redness and gradual decrease in vision in the right eye. Examination revealed a paracentral large stromal infiltrate with a central 2-mm perforation. Corneal and conjunctival scrapings were collected for microbiological investigations. Corneal tissue was obtained following penetrating keratoplasty. Corneal scraping revealed no microorganisms. Giemsa stained smear showed multinucleated giant cells. Conjunctival, corneal scrapings and tissue were positive for herpes simplex virus - 1 (HSV) antigen. Corneal tissue was positive for HSV DNA by PCR.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Atypical HSV keratitis can occur in contact lens wearers. A simple investigation like Giemsa stain may offer a clue to the diagnosis.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Herpes simplex keratitis (HSK) often presents either as dendritic or geographic ulcers [<xref ref-type="bibr" rid="B1">1</xref>]. Atypical presentations of HSK have been reported [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. The diagnosis of this condition can pose difficulties if patients present at later stages of the disease, especially when associated with corneal perforation. We report here an unusual case of perforated corneal ulcer with a large infiltrate, caused by HSV-1 in a contact lens wearer, initially diagnosed as bacterial keratitis. A simple investigation such as microscopic examination of Giemsa stained corneal scraping provided a clue to the diagnosis.</p>
    </sec>
    <sec>
      <title>Case Report</title>
      <p>An eighteen-year-old female student presented to us with complaints of pain, redness and gradual decrease in vision in the right eye of 20 days duration. She was treated with 0.3% ciprofloxacin eye drops, by a local ophthalmologist. She had discontinued using the medication prior to presentation to us. She was not treated with steroids at any point of time. She was a myope using daily wear monthly disposable hydrogel contact lenses since eight months which she discontinued wearing with the onset of the present symptoms.</p>
      <p>On examination, her visual acuity was restricted to perception of light and accurate projection of rays in the right eye and 20/20 in the left eye. Slit lamp examination of left eye was within normal limits. The right eye showed congestion of bulbar conjunctiva. Cornea showed a paracentral solitary, large, well circumscribed, full thickness, and yellowish white stromal infiltrate measuring 4.5 mm × 5.5 mm with a central 2-mm perforation. Anterior chamber was shallow (Fig. <xref ref-type="fig" rid="F1">1A</xref>).</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p><bold>Clinical and virological investigations</bold>: <bold>A</bold>. Slit lamp biomicroscopy under optical section of the right eye showing a solitary paracentral, well circumscribed, large, full thickness stromal infiltrate, collapsed anterior chamber and a central area of perforation. X 16. <bold>B</bold>. Giemsa stained corneal scraping showing a multinucleated giant cell with characteristic molding of the nuclei. X 1250. <bold>C</bold>. Conjunctival scraping from lower palpebral conjunctiva showing epithelial cells positive for HSV-1 antigen (Indirect immunoperoxidase, X 500). <bold>D</bold>. Corneal scraping showing many cells positive for HSV-1 antigen (Indirect immunoperoxidase, X 500).</p>
        </caption>
        <graphic xlink:href="1471-2415-1-1-1"/>
      </fig>
      <p>Based on the history and clinical findings a clinical diagnosis of perforated corneal ulcer, probably of bacterial origin (<italic>Pseudomonas</italic> spp.) was made. Corneal scrapings were collected for microscopic examination, bacterial, fungal and acanthamoeba cultures as described elsewhere [<xref ref-type="bibr" rid="B3">3</xref>]. Contact lenses and the cleaning solution were also collected for microbiological investigations. Gram, Giemsa stained smears and the potassium hydroxide preparation of the scraping did not reveal any organisms. However, Giemsa stained smear showed the presence of multinucleated giant cells, with characteristic molding of nuclei (Fig. <xref ref-type="fig" rid="F1">1B</xref>), suggesting infectious keratitis, probably of a viral etiology. Scrapings obtained from the lower palpebral conjunctiva, on the following day (corneal scrapings could not be collected due to the application of tissue adhesive and a bandage contact lens), was positive for HSV-1 antigen (Fig. <xref ref-type="fig" rid="F1">1C</xref>) by an immunoperoxidase assay. Patient was prescribed 3% acyclovir ointment application 5 times daily. None of the cultures yielded any growth.</p>
      <p>She returned to the clinic after a week. On examination, the tissue adhesive and bandage contact lens were dislodged. Repeat corneal scrapings were obtained for microbiological investigations. HSV-1 antigen was detected by an immunoperoxidase assay (Fig. <xref ref-type="fig" rid="F1">1D</xref>) in the repeat corneal scrapings while bacterial and viral cultures (shell vial and conventional tube cultures for HSV-1) were negative.</p>
      <p>Clinical condition did not improve during the subsequent week. Hence, the patient underwent a therapeutic penetrating keratoplasty (PK). Corneal tissue was obtained at PK. She received oral acyclovir 400 mg, 5 times a day and 1% prednisolone acetate eye drops, 6 times a day. Corneal tissue was positive for HSV-1 antigen by immunohistochemistry (Fig. <xref ref-type="fig" rid="F2">2A, B</xref>) and for HSV DNA by PCR (Fig. <xref ref-type="fig" rid="F2">2D</xref>). Histopathological examination of the formalin fixed corneal tissue revealed polymorpho nuclear neutrophils admixed with mononuclear cells, multinucleated giant cells in H &amp; E and PAS (Fig. <xref ref-type="fig" rid="F2">2C</xref>) stained sections. Stromal melting was seen in the central cornea. The visual acuity improved to 20/20. There was no recurrence and the graft was clear (14 months post PK).</p>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p><bold>A. Corneal tissue section showing absence of HSV-1 antigen in the epithelium</bold> (Negative control, Immunohistochemistry, X 500). <bold>B</bold>. Corneal tissue section showing presence of HSV-1 antigen in the epithelium (Immunohistochemistry, X 500). <bold>C</bold>. Corneal tissue section showing a multinucleated giant cell (arrow) (PAS, X 500). <bold>D</bold>. Agarose gel electrophoresis stained with ethidium bromide showing PCR amplified products using primers for a 179 bp sequence of the DNA polymerase gene specific for HSV-1/2. Lane 1: Negative control (NC); Lane 2: Patient's corneal tissue (VI 65/99); Lane 3: Positive control (PC); Lane 4: Molecular weight markers (MW).</p>
        </caption>
        <graphic xlink:href="1471-2415-1-1-2"/>
      </fig>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Clinical diagnosis of atypical HSV keratitis can often be difficult. This case was diagnosed initially as bacterial keratitis considering the rapid progression of the symptoms and a history of contact lens wear. A simple stain like Giemsa revealed the presence of multinucleated giant cells in the corneal scraping. The presence of multinucleated giant cells with characteristic nuclear morphology (molding), may suggest a viral etiology. It may be seen in infections caused by HSV- 1, HSV-2 and VZV. However, this staining technique is not as sensitive as other methods like viral antigen detection, culture or rapid assays like HerpChek . Subsequent virological investigations confirmed the etiology (HSV-1) in this case. Virus cultures were negative probably because the specimens were collected following antiviral therapy.</p>
      <p>We performed the PCR to confirm the presence of HSV DNA, since all viral cultures were negative. PCR for HSV has been shown to be most useful to the clinician in atypical presentations of herpetic ocular disease [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Predisposing factor for an atypical presentation as seen in this case could be due to the contact lens wear, for poor fitting lenses, poor lens hygiene and micro-trauma may all lead to the reactivation of herpetic keratitis.</p>
      <p>It is interesting to note that it is very unusual for a herpes ulcer alone to present with a large yellowish-white infiltrate. Concurrent bacterial infection could have contributed to such a presentation. The possibility of a mixed infection (Bacterial: Herpetic infection) cannot be ruled out entirely in this case since the patient had received topical antibiotics elsewhere before presenting to us. The negative bacterial cultures may be attributed to this finding.</p>
      <p>This case highlights the following: Atypical HSK can present as a perforated corneal ulcer associated with a large infiltrate. A "Low Tech" method like "Giemsa stain" of corneal scraping may offer a clue to the diagnosis. Nevertheless, other tests like viral antigen detection, culture or HerpChek should be done if HSV is specifically suspected. Conjunctival scrapings may be useful for the detection of viral antigen where corneal scrapings cannot be collected. PCR may be useful in the laboratory diagnosis of such an atypical presentation of HSK.</p>
      <p>We believe that diagnosis of such cases would be beneficial in the prompt institution of prophylactic antivirals, especially following penetrating keratoplasty to prevent complications.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/content/backmatter/1471-2415-1-1-b1.pdf"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgement</title>
        <p>We thank the patient for giving us informed consent to publish the details of the case.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koizumi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Adachi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Tei</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Honma</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Dota</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sotozono</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yokoi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Detection of herpes simplex vims DNA in atypical epithelial keratitis using polymerase chain reaction.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1999</year>
          <volume>83</volume>
          <fpage>957</fpage>
          <lpage>960</lpage>
          <pub-id pub-id-type="pmid">10413702</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tei</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Polymerase chain reaction of herpes simplex virus in tear fluid from atypical herpetic epithelial keratitis after penetrating keratoplasty.</article-title>
          <source>Am J Ophthalmol</source>
          <year>1996</year>
          <volume> 122</volume>
          <fpage>732</fpage>
          <lpage>735</lpage>
          <pub-id pub-id-type="pmid">8909218</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kunimoto</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Gopinathan</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Jeevan</surname>
              <given-names>Jyothi</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>GN</given-names>
            </name>
          </person-group>
          <article-title>Microbial keratitis in children.</article-title>
          <source>Ophthalmology</source>
          <year>1998</year>
          <volume> 105</volume>
          <fpage>252</fpage>
          <lpage>257</lpage>
          <pub-id pub-id-type="pmid">9479283</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kowalski</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Romanowski</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Araullo-Cruz</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kinchington</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>A comparison of enzyme immunoassay and polymerase chain reaction with the clinical examination for diagnosing ocular herpetic disease.</article-title>
          <source>Ophthalmology</source>
          <year>1993</year>
          <volume>100</volume>
          <fpage>530</fpage>
          <lpage>533</lpage>
          <pub-id pub-id-type="pmid">8386821</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mietz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cassinotti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Siegl</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kirchhof</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Krieglstein</surname>
              <given-names>GK</given-names>
            </name>
          </person-group>
          <article-title>Detection of herpes simplex virus after penetrating keratoplasty by polymerase chain reaction: Correlation of clinical and laboratory findings.</article-title>
          <source>Graefes Arch Clin Exp Ophthalmol</source>
          <year>1995</year>
          <volume>233</volume>
          <fpage>714</fpage>
          <lpage>716</lpage>
          <pub-id pub-id-type="pmid">8566829</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:35284</identifier><datestamp>2001-07-27</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">35284</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-1-2</article-id>
      <article-id pub-id-type="pmid">11472638</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-1-2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Herpes simplex virus bullous keratitis misdiagnosed as a case of pseudophakic bullous keratopathy with secondary glaucoma: an unusual presentation</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Athmanathan</surname>
            <given-names>Sreedharan</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>sreedhar@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Sridhar</surname>
            <given-names>Mittanamalli S</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>sreedhar@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Anand</surname>
            <given-names>Raj</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>sreedhar@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Mandal</surname>
            <given-names>Anil K</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>mandal@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Rao</surname>
            <given-names>Gullapalli N</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>gnrao@lvpeye.stph.net</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Jhaveri Microbiology Center, Hyderabad Eye Research Foundation, LV Prasad Eye Institute, Hyderabad, India</aff>
      <aff id="I2"><label>2</label>Cornea services, LV Prasad Eye Institute, Hyderabad, India</aff>
      <aff id="I3"><label>3</label>VST Center for Glaucoma Care L.V.Prasad Eye Institute, Hyderabad, India</aff>
      <pub-date pub-type="collection">
        <year>2001</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>3</day>
        <month>7</month>
        <year>2001</year>
      </pub-date>
      <volume>1</volume>
      <fpage>2</fpage>
      <lpage>2</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/1/2"/>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>5</month>
          <year>2001</year>
        </date>
        <date date-type="accepted">
          <day>3</day>
          <month>7</month>
          <year>2001</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2001 Athmanathan et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2001</copyright-year>
        <copyright-holder>Athmanathan et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>To report an unusual case of herpetic bullous keratitis misdiagnosed as a case of pseudophakic bullous keratopathy with secondary glaucoma.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>A retrospective analysis of the case record of a 60-year-old man who had earlier undergone bilateral cataract surgery, was done. He presented with a complaint of decrease in vision in the right eye of 20 days duration. On examination, cornea showed epithelial bullae all over the surface with stromal and epithelial edema. Intraocular pressure was 30 mm of Hg in RE. He was treated with anti-glaucoma medications. Two dendritic lesions were seen in the cornea during a subsequent visit four days later. Virological investigations confirmed a diagnosis of Herpes simplex keratitis. He was treated with topical acyclovir.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>This case highlights the fact that herpes simplex keratitis can present initially as a more diffuse corneal stromal and epithelial edema with epithelial bullae mimicking bullous keratopathy. Herpetic bullous keratitis, although unusual, should be considered in the differential diagnosis under such circumstances.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Herpes simplex keratitis (HSK) is a sight threatening ocular infection and is a leading cause of corneal blindness [<xref ref-type="bibr" rid="B1">1</xref>]. Clinical presentation of HSK is often protean. While a typical and common presentation of HSK is usually a dendritic or geographic ulcer, atypical presentations are not uncommon [<xref ref-type="bibr" rid="B2">2</xref>]. We report here an unusual presentation of HSK. The patient presented to us with bullous keratitis, which was misdiagnosed as a case of pseudophakic bullous keratopathy (PBK) with secondary glaucoma.</p>
    </sec>
    <sec>
      <title>Case Report</title>
      <p>A sixty-year-old male presented to our cornea services with a complaint of progressive diminution of vision, in the right eye, of 20 days duration. There were no other ocular or systemic complaints. He gave a history of having undergone extracapsular cataract extraction with posterior chamber intraocular lens implantation 4.5 years earlier in the RE and phacoemulsification with posterior chamber intraocular lens implantation 2 years earlier in the LE. Surgery and postoperative period were uneventful on both occasions with a final visual acuity of 6/6 in both eyes. On examination, visual acuity in RE was restricted to perception of light with accurate projection of light in all the four quadrants. Conjunctiva was congested and cornea showed epithelial bullae all over the surface with mild to moderate epithelial and stromal edema. Anterior chamber was deep and quiet. Intraocular lens was in place and fundus details were within normal limits. Intraocular pressure in the RE was 30 mm of Hg and LE was 14 mm Hg. A diagnosis of PBK with secondary glaucoma, was made. Patient was immediately treated with intravenous mannitol (350 cc) and a single oral dose of 250 mg acetazolamide, followed by 250 mg three times daily and 0.5% timolol eye drops twice daily for the right eye. Intraocular pressure was 16 mm of Hg following mannitol administration and he was discharged. Patient presented to us four days later. Visual acuity in the RE had improved to counting fingers at 1 m and 6/6 in LE. On examination, cornea showed few epithelial bullae with mild to moderate epithelial and stromal edema. The intraocular pressure in the right eye was 16 mm Hg. Two dendritic lesions were seen (Figure <xref ref-type="fig" rid="F1">1</xref>) in the cornea. A clinical diagnosis of PBK with HSK was made. Corneal scrapings were collected for virological investigations. The patient was treated with 3% acyclovir eye ointment five times daily and cyclopentolate eye drops twice daily for the RE. The patient was lost to follow up.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p><bold>Diffuse illumination of the RE:</bold> Diffuse illumination of the right eye showing two dendritic lesions stained by fluorescein, multiple bullae (arrows) and a diffuse corneal edema.</p>
        </caption>
        <graphic xlink:href="1471-2415-1-2-1"/>
      </fig>
      <p>Papanicolaou stained smear of the corneal scraping showed multinucleated giant cells and intranuclear eosinophilic inclusion (Figure <xref ref-type="fig" rid="F2">2</xref>). HSV-1 antigen was detected in the epithelial cells of the corneal scraping and the smear revealed multinucleated giant cells (Figure <xref ref-type="fig" rid="F3">3</xref>). HSV-1 was isolated in culture and PCR was positive for HSV DNA using primers, which amplified a 179 bp region of the DNA polymerase gene of HSV 1/2.</p>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p><bold>Papanicolaou stain of the corneal scraping:</bold> Corneal scraping showing intranuclear eosinophilic inclusion (arrow) in an epithelial cell (× 500).</p>
        </caption>
        <graphic xlink:href="1471-2415-1-2-2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p><bold>Immunoperoxidase assay of the corneal scraping:</bold> Corneal scraping showing multinucleated giant cells and the presence of HSV-1 antigen (Seen as brown precipitate) (× 500).</p>
        </caption>
        <graphic xlink:href="1471-2415-1-2-3"/>
      </fig>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>This case was initially diagnosed as PBK with secondary glaucoma based on a history of cataract surgery, presence of diffuse corneal stromal and epithelial edema, epithelial bullae and a raised intraocular pressure in the affected eye. The subsequent appearance of typical dendritic lesions and virological investigations confirmed a diagnosis of herpetic bullous keratitis. Further, the present event occurred after 4 years after the cataract surgery. Since corneal latency of HSV has been described [<xref ref-type="bibr" rid="B4">4</xref>], it is perfectly reasonable to assume that herpes rather than the previous endothelial damage caused the whole syndrome.</p>
      <p>The presence of glaucoma possibly suggests HSV trabeculitis in the affected eye. It is difficult to ascertain this finding since we did not perform any investigation. A PCR assay for the detection of HSV DNA using aqueous humor would have provided supporting evidence.</p>
      <p>This event was possibly a syndrome of HSV stromal and epithelial keratitis with trabeculitis, which explains the signs of a diffuse corneal stromal and epithelial edema and an acute rise in the intraocular pressure in the affected eye. The formation of epithelial bullae due to corneal edema could have predisposed the cornea for the development of dendritic ulcers. It has earlier been shown that the presence of corneal epithelial bullae has a statistically significant effect on the rate of ulcer development [<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>This case highlights the fact that HSK can present initially as a more diffuse corneal stromal and epithelial edema with epithelial bullae mimicking bullous keratopathy.</p>
      <p>To the best of our knowledge and based on a MEDLINE search, such a presentation of HSK has not been documented.</p>
      <p>Herpetic bullous keratitis, although unusual, should be considered in the differential diagnosis under such circumstances to prevent further complications and for the prompt institution of specific antiviral therapy.</p>
    </sec>
    <sec>
      <title>Declaration of competing interests</title>
      <p>None declared</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/1/2/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgement</title>
        <p>We thank the patient for giving us informed consent to publish the details of the case.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shimomura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tano</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Detection of herpes simplex virus DNA in human tear film by polymerase chain reaction</article-title>
          <source>Am J Ophthalmol</source>
          <year>1994</year>
          <volume>117</volume>
          <fpage>160</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">8116743</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koizumi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Adachi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Tei</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Honma</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Dota</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sotozono</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yokoi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Detection of herpes simplex virus DNA in atypical epithelial keratitis using polymerase chain reaction</article-title>
          <source>Br J Ophthalmol</source>
          <year>1999</year>
          <volume>83</volume>
          <fpage>957</fpage>
          <lpage>960</lpage>
          <pub-id pub-id-type="pmid">10413702</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luchs</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Rapuano</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Laibson</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Ulcerative keratitis in bullous keratopathy</article-title>
          <source>Ophthalmology</source>
          <year>1997</year>
          <volume>104</volume>
          <fpage>816</fpage>
          <lpage>822</lpage>
          <pub-id pub-id-type="pmid">9160028</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rong</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Pavan-Langston</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Weng</surname>
              <given-names>QP</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cherry</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Dunkel</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>Detection of herpes simplex virus thymidine kinase and latency-associated transcript gene sequences in human herpetic corneas by polymerase chain reaction amplification</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1991</year>
          <volume>32</volume>
          <fpage>1808</fpage>
          <lpage>1815</lpage>
          <pub-id pub-id-type="pmid">1851732</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:57753</identifier><datestamp>2001-10-10</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">57753</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-1-3</article-id>
      <article-id pub-id-type="pmid">11592921</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-1-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Collection of corneal impression cytology directly on a sterile glass slide for the detection of viral antigen: An inexpensive and simple technique for the diagnosis of HSV epithelial keratitis – A pilot study</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Athmanathan</surname>
            <given-names>Sreedharan</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>sreedhar@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Bandlapally</surname>
            <given-names>Sesha Reddy</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>sreedhar@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Rao</surname>
            <given-names>Gullapalli N</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>gnrao@lvpeye.stph.net</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Jhaveri Microbiology Center, Hyderabad Eye Research Foundation, Hyderabad, India</aff>
      <aff id="I2"><label>2</label>Cornea Services L. V. Prasad Eye Institute, L. V. Prasad Marg, Banjara Hills, Hyderabad, India</aff>
      <pub-date pub-type="collection">
        <year>2001</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>9</month>
        <year>2001</year>
      </pub-date>
      <volume>1</volume>
      <fpage>3</fpage>
      <lpage>3</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/1/3"/>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>6</month>
          <year>2001</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>9</month>
          <year>2001</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2001 Athmanathan et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2001</copyright-year>
        <copyright-holder>Athmanathan et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Herpes simplex keratitis (HSK) is a sight threatening ocular infection and occurs worldwide. A prompt laboratory diagnosis is often very useful. Conventional virology techniques are often expensive and time consuming. We describe here a highly economical, simple, rapid and sensitive technique for the collection of impression cytology, for the laboratory diagnosis of HSK.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>Fifteen patients with a clinical diagnosis of HSK (either dendritic or geographic ulcers) and five patients with other corneal infections (Mycotic keratitis, n = 3, Bacterial keratitis, n = 2) were included in the study. Corneal impression cytology specimens were collected using a sterile glass slide with polished edges instead of a membrane, by pressing the surface of one end of the slide firmly, but gently on the corneal lesion. Additionally, corneal scrapings were collected following the impression cytology procedure. Impression cytology and corneal scrapings were stained by an immunoperoxidase or immunofluorescence assay for the detection of HSV-1 antigen using a polyclonal antibody to HSV-1. Corneal scrapings were processed for viral cultures by employing a shell vial assay.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>This simple technique allowed the collection of adequate corneal epithelial cells for the detection of HSV-1 antigen in a majority of the patients. HSV-1 antigen was detected in 12/15 (80%) cases while virus was isolated from 5/15 (33.3%) patients with HSK. All the patients with a clinical diagnosis of HSK (n = 15) were confirmed by virological investigations (viral antigen detection and/or viral cultures). HSV-1 antigen was detected in the impression cytology smears and corneal scrapings in 11/15 (73.3%) and 12/15 (80%) of the patients, respectively (<italic>P</italic> = 1.00). None of the patients in the control group were positive for viral antigen or virus isolation. Minimal background staining was seen in impression cytology smears, while there was some background staining in corneal scrapings stained by the immunoassays.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Collection of impression cytology on a sterile glass slide is a simple, rapid and inexpensive technique for the diagnosis of HSK. Immunological techniques applied on such smears provide virological results within 2-5 hours. This technique could be modified for use in the diagnosis of other external eye diseases, which needs further evaluation.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Herpes Simplex Keratitis (HSK) is a sight threatening ocular infection often caused by HSV-1. It is a leading cause of corneal blindness and occurs worldwide [<xref ref-type="bibr" rid="B1">1</xref>]. HSK usually occurs in its typical form as a dendritic or geographical corneal ulcer. However, there are reports of atypical HSK [<xref ref-type="bibr" rid="B2">2</xref>]. There can be a high degree of overlap between the ocular manifestations of HSV-1 and those of other infections [<xref ref-type="bibr" rid="B3">3</xref>]. A specific and rapid laboratory diagnosis of HSK is essential for the initiation of specific antiviral therapy. Further, complications arising from misdiagnosis and inappropriate treatment can be avoided [<xref ref-type="bibr" rid="B3">3</xref>]. A variety of techniques have been employed for the rapid diagnosis of HSK [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Many of these techniques are expensive, time consuming and may not be available in all settings. Impression cytology has been employed for the rapid diagnosis of superficial viral infections [<xref ref-type="bibr" rid="B6">6</xref>]. It is one of the most preferred techniques in ocular surface sampling in dry eye, keratitis and conjunctivitis [<xref ref-type="bibr" rid="B7">7</xref>]. Conventionally, impression cytology is collected using cellulose acetate filter paper [<xref ref-type="bibr" rid="B8">8</xref>], Biopore membrane [<xref ref-type="bibr" rid="B6">6</xref>] or Nitrocellulose membrane [<xref ref-type="bibr" rid="B9">9</xref>]. These membranes are expensive and may not be available in all laboratories. We describe here an economical, simple and rapid technique for the collection of impression cytology, for the detection of viral antigen.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>Fifteen patients with a clinical diagnosis of HSK (either dendritic or geographic ulcers) and five patients with other corneal infections (Mycotic keratitis, n = 3, Bacterial keratitis, n = 2) were included in the study. Informed consent was obtained from all the patients included in this study and the study conformed to the guidelines stipulated by our institutional research forum. Samples were collected following instillation of a topical anaesthetic (4% Lignocaine hydrochloride or 0.5% Proparacaine hydrochloride). Corneal impression cytology specimens were collected using a sterile glass slide (Blue Star Micro Slides, Polar Industrial Corporation, Bombay, India). These slides are made from selected optically flat micro-glass, the edges are polished (therefore, the edges are not sharp), available in lint free packing and are packed under controlled conditions. The slides were initially washed with distilled water and immersed for 24 h in potassium dichromate-sulphuric acid cleaning solution (This solution was prepared by adding 63 gms of potassium dichromate to 35 ml of distilled water. Concentrated sulphuric acid (1 L) was then added slowly down the sides of the bottle held in an ice bath with intermittent shaking to dissipate the heat generated). Slides were removed and thoroughly washed in tap water, rinsed in distilled water, and air-dried. They were packed in aluminium foil and sterilized by hot air oven for 1 h at 160°C. This method of cleaning slides ensures that the charge of the glass surface is not alkaline and therefore, renders the surface suitable for cell adhesion (an alkaline surface is unsuitable for cell adhesion and is caused by alkaline detergents). Impression cytology smears were obtained by pressing the surface of one end of the slide firmly, but gently on the corneal lesion (Fig. <xref ref-type="fig" rid="F1">1</xref>). A single impression cytology smear was collected from all the patients except in two cases with classical dendritic ulcers and a case of bacterial keratitis, wherein additional smears were collected for Papanicolaou staining. Corneal scrapings were collected from these patients following the impression cytology procedure for the detection of viral antigen [<xref ref-type="bibr" rid="B6">6</xref>] and viral cultures [<xref ref-type="bibr" rid="B5">5</xref>]. Impression cytology specimens and smears made from corneal scrapings were air dried for 30 minutes at room temperature and fixed in acetone for 30 minutes at -20°C. Smears were stained by an immunoperoxidase or immunofluorescence assay for the detection of HSV-1 antigen using a polyclonal antibody to HSV-1, as described elsewhere [<xref ref-type="bibr" rid="B6">6</xref>]. The entire smear was screened for positively stained cells (infected cells) and smears were graded as "Positive" for viral antigen only when &gt;40-50% of the cells/HPF were stained. Viral cultures were performed employing the shell vial assay [<xref ref-type="bibr" rid="B5">5</xref>] using vero/ A 549 or BHK-21 cell line. Corneal scrapings collected from patients with infectious keratitis of non-viral origin were processed for etiological agents as described earlier [<xref ref-type="bibr" rid="B10">10</xref>].</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p><bold>Collection of impression cytology.</bold> Impression cytology being collected From a patient with herpes simplex keratitis, using a sterile glass slide with polished edges.</p>
        </caption>
        <graphic xlink:href="1471-2415-1-3-1"/>
      </fig>
      <p>Statistical analysis was performed on results using a computer assisted statistical program (Epi Info, revision 6.04 b, CDC, USA). Chi square test for proportions (with Yates correction when necessary) was used and <italic>P</italic> value was considered significant if less than 0.05.</p>
    </sec>
    <sec>
      <title>Results</title>
      <p>This simple technique allowed the collection of adequate corneal epithelial cells (10-20 epithelial cells/HPF) for the detection of HSV-1 antigen in a majority of the patients. Most of the smears showed superficial corneal epithelial cells. Some smears showed rounded up corneal epithelial cells. Adequate cells could not be collected in one patient. HSV-1 antigen was detected in 12/15 (80%) cases while virus was isolated from 5/15 (33.3%) patients with HSK. Virus isolation alone was positive in 3/15 patients. All the patients with a clinical diagnosis of HSK (n = 15) were confirmed by virological investigations (viral antigen detection and/or viral cultures).</p>
      <p>HSV-1 antigen was detected in the impression cytology smears (Figs. <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F3">3</xref>) and corneal scrapings (Fig. <xref ref-type="fig" rid="F4">4</xref>) in 11/15 (73.3%) and 12/15 (80%) patients, respectively (<italic>P</italic> = 1.00). All the corneal scraping specimens which were found positive for the presence of viral antigen (n = 12) were also positive by impression cytology (n = 11) except in one case. Adequate cells could not be collected in this case. Minimal background staining was seen in impression cytology smears while there was a disturbing background in corneal scrapings stained by the immunological methods.</p>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p><bold>Detection of HSV-1 antigen.</bold> An impression cytology smear obtained from a patient with HSK showing the presence of corneal epithelial cells positive for viral antigen (arrow). Many antigen negative cells are also seen (arrow head). Note the absence of background staining. Indirect immunoperoxidase assay, × 500.</p>
        </caption>
        <graphic xlink:href="1471-2415-1-3-2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p><bold>Detection of HSV-1 antigen.</bold> An impression cytology smear obtained from a patient with HSK showing the presence of rounded up corneal epithelial cells positive for viral antigen. Infected cells show brilliant apple green fluorescence. Note the absence of background staining. Indirect immunofluorescence assay, × 500.</p>
        </caption>
        <graphic xlink:href="1471-2415-1-3-3"/>
      </fig>
      <fig position="float" id="F4">
        <label>Figure 4</label>
        <caption>
          <p><bold>Detection of HSV-1 antigen.</bold> A smear made from corneal scraping obtained from a patient with HSK showing the presence of corneal epithelial cells positive for viral antigen (cells stained brown). Many antigen negative cells are also seen (cells stained bluish purple). Note the presence of troublesome background staining. Indirect immunoperoxidase assay, × 500.</p>
        </caption>
        <graphic xlink:href="1471-2415-1-3-4"/>
      </fig>
      <p>Papanicolaou stained impression cytology smears showed presence of multinucleated giant cell (Fig. <xref ref-type="fig" rid="F5">5</xref>), koilocytic changes (Fig. <xref ref-type="fig" rid="F6">6</xref>) and inflammatory cells (Fig. <xref ref-type="fig" rid="F7">7</xref>).</p>
      <fig position="float" id="F5">
        <label>Figure 5</label>
        <caption>
          <p><bold>Impression cytology smear stained by Papanicolaou stain.</bold> This specimen was obtained from a patient with a classical dendritic ulcer clinically diagnosed as HSK. Note the presence of a multinucleated giant cell (arrow), × 500.</p>
        </caption>
        <graphic xlink:href="1471-2415-1-3-5"/>
      </fig>
      <fig position="float" id="F6">
        <label>Figure 6</label>
        <caption>
          <p><bold>Impression cytology smear stained by Papanicolaou stain.</bold> Note the presence of koilocytic changes in the epithelial cells. Koilocytic changes like condensed chromatin (arrow) and a perinuclear halo (arrow head) are seen, × 500.</p>
        </caption>
        <graphic xlink:href="1471-2415-1-3-6"/>
      </fig>
      <fig position="float" id="F7">
        <label>Figure 7</label>
        <caption>
          <p><bold>Impression cytology smear stained by Papanicolaou stain.</bold> This specimen was obtained from a patient with bacterial keratitis. Note the presence of superficial epithelial cells and polymorphonuclear neutrophils, × 500.</p>
        </caption>
        <graphic xlink:href="1471-2415-1-3-7"/>
      </fig>
      <p>None of the patients in the control group (non-HSV keratitis) were positive for viral antigen (Fig. <xref ref-type="fig" rid="F8">8</xref>) or virus isolation.</p>
      <fig position="float" id="F8">
        <label>Figure 8</label>
        <caption>
          <p><bold>Detection of HSV-1 antigen.</bold> Impression cytology smear showing corneal epithelial cells from a patient with mycotic keratitis showing the absence of viral antigen. Note the absence of background staining. Indirect immunoperoxidase assay, × 500.</p>
        </caption>
        <graphic xlink:href="1471-2415-1-3-8"/>
      </fig>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Impression cytology is a non-invasive technique for the diagnosis of external eye diseases. It has not been extensively used despite its diagnostic potential because of technical inconvenience in the use of conventional membranes and its non-availability in many settings.</p>
      <p>We have described here a highly economical, simple and rapid technique for the collection of impression cytology for the diagnosis of HSK, by using an ordinary glass slide. Our preliminary data shows that this technique is comparable to collection of corneal scrapings, especially for the detection of viral antigen (11/15 [73.3%] versus 12/15 [80%], <italic>P</italic> = 1.00). The result was not statistically significant.</p>
      <p>Qualitatively, interpretation of antigen detection in impression cytology smears was very easy, since the background staining was virtually negligible. Interpretation of smears stained by the immunofluorescence assay was easier than smears stained by the immunoperoxidase aassay, since the background staining was somewhat lesser in the former. Additional advantage of this technique is that the glass slides are totally devoid of background fluorescence in comparison to cellulose acetate and biopore membranes. The specificity and sensitivity of this technique was 100% and 73.3% respectively and was comparable to that of corneal scrapings (specificity: 100% and sensitivity: 80%), for the detection of viral antigen. Earlier reports using membranes have shown better sensitivity [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. This could be attributed to the inherent property of the membrane devices to which the cells adhere effectively resulting in the collection of a large number of cells[<xref ref-type="bibr" rid="B6">6</xref>]. In contrast, most of the smears made from corneal scrapings which were positive for viral antigen (9/12) showed a troublesome background staining, though the antigen positive cells (virus infected cells) could be identified from uninfected cells.</p>
      <p>Quantitatively, adequate number of cells (10-20 epithelial cells/HPF) could be collected in most of the cases. However, the disadvantage of impression cytology was that in a small proportion of cases (2/15 [13.3%]), the material obtained was inadequate. This may contribute to antigen negativity. Similar findings have been reported by Yagmur et al. These authors have shown that the cell number was inadequate for diagnosis in 21% of the samples observed by impression cytology [<xref ref-type="bibr" rid="B7">7</xref>]. The numbers of cells, which can be collected using a glass slide, are probably small when compared to a membrane. Nevertheless, the results of our preliminary study are encouraging. This may be attributed to the method we have adopted for cleaning the slides, which improves cell adhesion.</p>
      <p>Considering the ease of performance and cost per patient, this technique was very easy to perform and proved to be very economical. The advantage of this technique is that the cells are collected directly onto the slide. Handling the slide for various staining procedures is easy and permanent mounts can be stored conveniently when immunoperoxidase assays are used. It is worthwhile to note that the cost (figures are based on the actual cost of procuring these utilities in a developing country like India) of collecting an impression cytology on a glass slide is approximately $0.01 whereas the cost of a millipore membrane is $2.00.</p>
      <p>The impression cytology smears can be used for other staining procedures like PAP and Giemsa stain. Characteristic features of a viral infection, for example, the presence of multinucleated giant cell (Fig. <xref ref-type="fig" rid="F6">6</xref>), koilocytic changes in epithelial cells (Fig. <xref ref-type="fig" rid="F7">7</xref>) and inflammatory cells (Fig. <xref ref-type="fig" rid="F8">8</xref>), all can be well-delineated in corneal scrapings and impression cytology smears. We have collected impression cytology for such staining procedures in three patients. Further studies are warranted to assess these procedures. Further, impression cytology from other sites like conjunctiva and skin vesicles can be collected by this method, especially for direct staining techniques. This needs further evaluation.</p>
      <p>Based on our preliminary results, the technique we have described may be as useful as collection of impression cytology using Biopore membranes and cellulose acetate papers, as described by other authors[<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. We believe that this procedure is as safe as collection of corneal scraping which is routinely obtained using blade no. 15 on a Bard Parker handle. We did not encounter any difficulty nor untoward incidents during the collection process using the method we have described. It is worthwhile to note that we have used special glass slides with polished edges. Nevertheless, the glass slides can further be modified wherein the square edges can be rounded off. Alternatively, Perspex cover slips can be used for the collection of cells [<xref ref-type="bibr" rid="B12">12</xref>]. However, handling a Perspex cover slip may not be convenient when compared to a glass slide, especially for the collection of corneal impression cytology. This technique can be considered as a suitable alternative procedure where facilities for such devices (Biopore membranes, cellulose acetate paper) are not available. However, our results should be considered with caution, since the sample size is small.</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>In conclusion, collection of impression cytology on a sterile glass slide followed by viral antigen detection is an inexpensive, simple and rapid technique for the diagnosis of HSK. Immunological techniques can be applied on such smears, which can provide virological results within 2-5 hours. This technique could be modified for use in the diagnosis of other external eye diseases and various staining procedures, which needs further evaluation.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>None declared</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/1/3/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>This study was supported by the Hyderabad Eye Research Foundation. The authors thank the patients for participating in this study, and Mr. S. B. N. Chary for assistance in photography.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Shimomura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>yamamoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tano</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Detection of herpes simplex virus DNA in human tear film by polymerase chain reaction.</article-title>
          <source>Am J Ophthalmol</source>
          <year>1994</year>
          <volume>117</volume>
          <fpage>160</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">8116743</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koizumi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Adachi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Adachi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>tei</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Honma</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Dota</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sotozono</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yokoi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Detection of herpes simplex virus DNA in atypical epithelial keratitis using polymerase chain reaction.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1999</year>
          <volume>83</volume>
          <fpage>957</fpage>
          <lpage>960</lpage>
          <pub-id pub-id-type="pmid">10413702</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asbell</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kamenar</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Botone</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Rapid diagnosis of ocular herpes simplex infections.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1995</year>
          <volume>79</volume>
          <fpage>473</fpage>
          <lpage>475</lpage>
          <pub-id pub-id-type="pmid">7612561</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kowalski</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>YJ</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of immunologic tests for the detection of ocular herpes simplex virus.</article-title>
          <source>Ophthalmology</source>
          <year>1989</year>
          <volume>96</volume>
          <fpage>1583</fpage>
          <lpage>1586</lpage>
          <pub-id pub-id-type="pmid">2559384</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walpita</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Darougar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Thaker</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>A rapid and sensitive culture test for detecting herpes simplex virus from the eye.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1985</year>
          <volume>69</volume>
          <fpage>637</fpage>
          <lpage>639</lpage>
          <pub-id pub-id-type="pmid">2994709</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thiel</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bossart</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bernauer</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Improved impression cytology techniques for the immunopathological diagnosis of superficial viral infections.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1997</year>
          <volume>81</volume>
          <fpage>984</fpage>
          <lpage>988</lpage>
          <pub-id pub-id-type="pmid">9505824</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yagmur</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ersoz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ersoz</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Varinli</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Brush technique in ocular surface cytology.</article-title>
          <source>Diagn Cytopathol</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>88</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">9258614</pub-id>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0339(199708)17:2&lt;88::AID-DC2&gt;3.3.CO;2-G</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arora</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Singhvi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Impression debridement of corneal lesions.</article-title>
          <source>Ophthalmology</source>
          <year>1994</year>
          <volume>101</volume>
          <fpage>1935</fpage>
          <lpage>1940</lpage>
          <pub-id pub-id-type="pmid">7997331</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakagawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Takamura</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Araki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Diagnostic impression cytology for herpes simplex keratitis.</article-title>
          <source>Jpn J Ophthalmol</source>
          <year>1993</year>
          <volume>37</volume>
          <fpage>505</fpage>
          <lpage>513</lpage>
          <pub-id pub-id-type="pmid">8145397</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kunimoto</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Gopinathan</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Jeevan</surname>
              <given-names>Jyothi</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>GN</given-names>
            </name>
          </person-group>
          <article-title>Microbial keratitis in children.</article-title>
          <source>Ophthalmology</source>
          <year>1998</year>
          <volume>105</volume>
          <fpage>252</fpage>
          <lpage>257</lpage>
          <pub-id pub-id-type="pmid">9479283</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simon</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pflugfelder</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Murchison</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Atherton</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Comparison of immunocytology to tissue culture for diagnosis of presumed herpes virus dendritic epithelial keratitis.</article-title>
          <source>Ophthalmology</source>
          <year>1992</year>
          <volume>99</volume>
          <fpage>1408</fpage>
          <lpage>1413</lpage>
          <pub-id pub-id-type="pmid">1328982</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirji</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Larke</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Conjunctival impression cytology in contact lens practice.</article-title>
          <source>J Br Contact Lens Assoc</source>
          <year>1981</year>
          <volume>4</volume>
          <fpage>159</fpage>
          <lpage>161</lpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:103667</identifier><datestamp>2002-05-02</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">103667</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-2-1</article-id>
      <article-id pub-id-type="pmid">11934353</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-2-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Lens epithelial cell apoptosis and intracellular Ca<sup>2+</sup> increase in the presence of xanthurenic acid</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Malina</surname>
            <given-names>Halina</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>halina.malina@dkf2.unibe.ch</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Richter</surname>
            <given-names>Christoph</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>richter@bc.biol.ethz.ch</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Frueh</surname>
            <given-names>Beatrice</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>beatrice.frueh@insel.ch</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Hess</surname>
            <given-names>Otto M</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>otto.martin.hess@insel.ch</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Swiss Cardiovascular Research Center, Inselspital, CH-3010 Bern, Switzerland</aff>
      <aff id="I2"><label>2</label>Institute of Biochemistry, Swiss Federal Institute of Technology (ETH), Universitaetstrasse 16, CH-8092 Zuerich, Switzerland</aff>
      <aff id="I3"><label>3</label>Department of Ophthalmology, Inselspital, CH-3010 Bern, Switzerland</aff>
      <pub-date pub-type="collection">
        <year>2002</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>4</month>
        <year>2002</year>
      </pub-date>
      <volume>2</volume>
      <fpage>1</fpage>
      <lpage>1</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/2/1"/>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>12</month>
          <year>2001</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>4</month>
          <year>2002</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2002 Malina et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2002</copyright-year>
        <copyright-holder>Malina et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Xanthurenic acid is an endogenous product of tryptophan degradation by indoleamine 2,3-dioxygenase (IDO). We have previously reported that IDO is present in mammalian lenses, and xanthurenic acid is accumulated in the lenses with aging. Here, we studied the involvement of xanthurenic acid in the human lens epithelial cell physiology.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>Human lens epithelial cells primary cultures were used. Control cells, and cells in the presence of xanthurenic acid grow in the dark. Western blot analysis and immunofluorescence studies were performed.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>In the presence of xanthurenic acid human lens epithelial cells undergo apoptosis-like cell death. In the control cells gelsolin stained the perinuclear region, whereas in the presence of 10 μM xanthurenic acid gelsolin is translocated to the cytoskeleton, but does not lead to cytoskeleton breakdown. In the same condition caspase-3 activation, and DNA fragmentation was observed. At low (5 to 10 μM) of xanthurenic acid concentration, the elongation of the cytoskeleton was associated with migration of mitochondria and cytochrome c release. At higher concentrations xanthurenic acid (20 μM and 40 μM) damaged mitochondria were observed in the perinuclear region, and nuclear DNA cleavage was observed. We observed an induction of calpain Lp 82 and an increase of free Ca<sup>2+</sup> in the cells in a xanthurenic acid concentration-dependent manner.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The results show that xanthurenic acid accumulation in human lens epithelial cells disturbs the normal cell physiology and leads to a cascade of pathological events. Xanthurenic acid induces calpain Lp82 and caspases in the cells growing in the dark and can be involved in senile cataract development.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>The primary cause of senile cataract development is still unclear. To date the involvement of α-crystallin, a molecular chaperone for β- and γ-crystallin, has principally been considered in senile cataract development [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>], the decrease in the chaperone ability of α-crystallin with age being implicated. Xanthurenic acid is produced from a metabolite of tryptophan (3-hydroxy-kynurenine) [<xref ref-type="bibr" rid="B3">3</xref>] in the presence of 2,3-dioxygenase [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. While 3-hydroxykynurenine [<xref ref-type="bibr" rid="B3">3</xref>] is photochemically inert [<xref ref-type="bibr" rid="B8">8</xref>] and serves as a protective UV filter of retina, xanthurenic acid is a photosensitizer [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. Xanthurenic acid accumulates with aging in mammalian lenses [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>] and is involved in the increased fluorescence of the lens with aging [<xref ref-type="bibr" rid="B13">13</xref>]. The glucoside of xanthurenic acid is also present in aged lenses [<xref ref-type="bibr" rid="B14">14</xref>]. Xanthurenic acid is an example of an endogenous ER stressor provoking an accumulation of unfolded proteins which in turn leads to an overexpression of Grp 94 and calreticulin in the lens epithelial cells of young mammals [<xref ref-type="bibr" rid="B15">15</xref>]. We have previously reported that porcine lens epithelial cells in culture respond to xanthurenic acid exposure by an overexpression of stress chaperone proteins, Grp 94 and calreticulin, in [<xref ref-type="bibr" rid="B15">15</xref>]. Here, we report that xanthurenic acid leads to human lens epithelial cells (HuLEC) death associated with caspase-3 activation, intracellular Ca<sup>2+</sup> increase and calpain Lp82 induction. Previously, lens epithelial cell apoptosis was observed in an <italic>in vitro</italic> model of the cataract [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>].</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec>
        <title>Reagents</title>
        <p>We used the following polyclonal antibodies from Santa Cruz Biotechnology Inc. CA, USA:antibody against cytochrome c, secondary antibodies IgG-fluoresceine (FITC)-conjugated. Primary antibody against active caspase-3 p17 was from Promega, Madison, USA. Secondary IgG-Texas Red-conjugated antibodies and Mitotracker CMXRos, DiOC<sub>18</sub>, Calcium Orange™, Hoechst 33342, propidium iodide were from Molecular Probes, Leiden, The Netherlands. Antibody against GPIP1 peptide of gelsolin was prepared as described previously [<xref ref-type="bibr" rid="B24">24</xref>]. Other reagents were from Sigma if not specified. Antibody against calpain Lp82 was from Dr. T. R. Shearer (University of Oregon, Oregon, USA).</p>
      </sec>
      <sec>
        <title>Preparation of human lens epithelial cells primary culture</title>
        <p>Lenses were obtained after transplantation of cornea from 58, 59, and 63 years old donors from Eye Bank University Hospital, Bern. The primary cells cultures were prepared separately from every donor using two lens capsules. The lens capsules from one donor were treated with 1.5 mg/ml of collagenase 1A and 4 overnight at 37°C. Thereafter, 1 ml of MEM medium with 10% FCS was added, and cells were centrifuged for 10 min at 300 g. The supernatant was discarded and the cells were re-suspended in 1.5 ml the growth medium, as described below, for 14 days in one well of 12-well plate. The cells were cultivated in the dark, in Minimal Essential Medium (MEM) with Earle's salts (Gibco BRL). Cells were grown under a humidified atmosphere of 5% CO<sub>2</sub> in air at 37°C in MEM supplemented with 10% fetal bovine serum, penicillin (10 U/ml), streptomycin (10 μg/ml) and fungizone (250 ng/ml). When confluent, they were incubated in MEM or MEM supplemented with xanthurenic acid. A 20 mM stock solution of xanthurenic acid was prepared in 0.5 M NaHCO<sub>3</sub>, and diluted in 0.01 M PBS pH 7.4.</p>
      </sec>
      <sec>
        <title>Cytotoxicity and apoptosis assay</title>
        <p>Cells were observed with differential interference contrast and phase contrast optics on a Zeiss Avionert 405 M inverted microscope, and images recorded with a Matsumoto 3-chip CCD cooled camera with images stored using Adobe Photoshop 4. Cell viability was determined by staining the cells with Hoechst 33342 and propidium iodide (PI) (Juro, Switzerland) using 50 μg/ml of each dye. Fragmented, apoptotic, nuclei were observed with excitation at 350 nm, and necrotic nuclei at 530 nm.</p>
      </sec>
      <sec>
        <title>Cell lysis and immunobloting</title>
        <p>Cells were washed twice with cold 0.01 M PBS, pH 7.4. For Western blotting, cells were lysed in buffer containing 50 mM Tris (pH 8.0), 150 mM NaCl, 1 %Triton X-100, and the following protease inhibitors: 1 mM phenyl-methylsulfonyl fluoride, and leupeptin, aprotinin, and pepstatin, each at 1 μg/ml. The concentration of proteins was calculated from the absorption maximum at 280 nm, as described previously [<xref ref-type="bibr" rid="B15">15</xref>], and the concentration of xanthurenic acid from its absorption maximum at 342 nm (ε<sub>M</sub> 6500). The lysate was centrifuged for 10 min at 14 000 g, and the supernatant was boiled in loading-buffer for 5 min. Proteins (50 μg per lane) were separated by SDS-PAGE containing 10 or 12.5% acrylamide. After transfer to Hybond ECL membrane (Amersham Pharmacia Biotech AB, Uppsala, Sweden) the proteins were probed with the appropriate antibodies. Chemilunimescence ECL system (Amersham Pharmacia Biotech AB, Uppsala, Sweden) was used for the detection of peroxidase-conjugated secondary antibody.</p>
      </sec>
      <sec>
        <title>Immunofluorescence studies</title>
        <p>Cells grown on glass coverslips were fixed for 10 min at room temperature in 4% paraformaldehyde in 0.1 M PIPES, pH 6.8, washed in PBS and permeabilized for 5 min in PIPES containing 0.05% saponin (65 μl per coverslip), washed in PBS, incubated for 10 min in cold aceton for additional fixing and permeabilisation, and again washed in PBS. Cells were incubated for 1.5 hour with the first antibody diluted in PBS containing 1% bovine serum albumine, and after washing incubated for 1.5 hour with the secondary antibody. The coverslips were then washed in PBS and incubated for 10 min with 65 μl of solution containing 1μl of Hoechst 33342 dye (1 mg/ml), washed in PBS, and incubated with Antifade Kits (Molecular Probes, Leiden, The Netherlands) according to the supplier's instruction. Staining of mitochondria was performed using Mitotracker CMXRos, as follows: confluent cells cultures were pre-incubated without or with xanthurenic acid in MEM medium for 72 hours. The medium was removed and replace with medium containing 100 nM Mitotracker CMXRos. After an incubation for 1 hour Mitotracker CMXRos was removed, coverslips were washed twice with PBS, and mounted on the slides using as antioxidative solution 9% w/v of Mowiol (Calbiochem) in 22% glycerol buffered with 0.2 mM Tris/HCl to pH containing 3.5% (w/v) of 1,4-diazabicyclo (2.2.2) octane (Sigma). Membranes were stained using overnight incubation in DiOC<sub>18</sub> at concentration of 12 μM in MEM medium.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Xanthurenic acid activates caspase-3 and translocates gelsolin from the mitochondrial region to the cytoskeleton</title>
        <p>We observed that 10 μM xanthurenic acid in the HuLEC cell culture medium activate caspase-3 (Fig. <xref ref-type="fig" rid="F1">1B</xref>). In the same cells the translocation of gelsolin from perinuclear region to cytoskeleton was observed (Fig. <xref ref-type="fig" rid="F1">1C, 1D</xref>). Previously it was reported that caspase-3 and -9 are associated with mitochondrial membranes [<xref ref-type="bibr" rid="B19">19</xref>]. Gelsolin is the cytoskeletal protein responsible for the disintegration of F actin during apoptosis induced by Fas [<xref ref-type="bibr" rid="B20">20</xref>]. It was also suggested that gelsolin keeps caspases in the inactive state [<xref ref-type="bibr" rid="B21">21</xref>]. We reported previously that gelsolin is abnormally cleaved during apoptosis induced by xanthurenic acid. This abnormal gelsolin cleavage could be a reason of absence of cytoskeleton breakdown in the presence of active caspase-3 (Fig. <xref ref-type="fig" rid="F1">1B, 1D</xref>).</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p>Caspase-3 activation and gelsolin translocation in HuLEC in the presence of xanthurenic acid for 96 hours. Cells stained for active caspase-3 (A, B), and gelsolin (C, D): (A) control cells stained with Hoechst 33342 and for cleaved caspase-3, (B) cells exposed to 10 μM xanthurenic acid and stained for cleaved caspase-3, (C) control cells, (D) in the presence of 10 μM xanthurenic acid.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-1-1"/>
        </fig>
      </sec>
      <sec>
        <title>Xanthurenic acid leads to mitochondrial migration, cytochrome c release, and destruction of mitochondrial structure</title>
        <p>In the control cells mitochondria occupy the perinuclear region (Fig. <xref ref-type="fig" rid="F2">2A</xref>). In the presence of 10 μM xanthurenic acid mitochondrial migration was observed (Fig. <xref ref-type="fig" rid="F2">2B</xref>). However, at higher concentrations (20 and 40 μM) xanthurenic acid led to the destruction of mitochondria. An intrinsic apoptotic pathway is activated by cytochrome c release and apoptosome formation with APAF-1 and ATP [<xref ref-type="bibr" rid="B22">22</xref>]. The apoptosome leads to activation of caspase-9, which activates caspase-3. We observed that in the presence of 10 μM xanthurenic acid cytochrome c was release from mitochondria (Fig. <xref ref-type="fig" rid="F3">3</xref>). APAF-1 is present in the HuLEC and its level is independent from xanthurenic acid concentration (not shown). Thus, release of cytochrome c is responsible for the observed caspase-3 activation, and nucleus cleavage.</p>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p>HuLEC, grown in the presence of xanthurenic acid for 96 hours, stained with Mito-Tracker Red CMXRos: (A) control cells; (B-D) in the presence of xanthurenic acid: (B) 10 μM, (C) 20 μM, (D) 40 μM.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-1-2"/>
        </fig>
        <fig position="float" id="F3">
          <label>Figure 3</label>
          <caption>
            <p>Cytochrome c release in HuLEC grown in the presence of xanthurenic acid for 72 hours. (A) control cells, (B) cells grown in the presence of 10 μM xanthurenic acid.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-1-3"/>
        </fig>
      </sec>
      <sec>
        <title>Mitochondrial damage in the presence of xanthurenic acid is associated with nuclear cleavage</title>
        <p>In control cells about 5 percent are apoptotic (Fig. <xref ref-type="fig" rid="F4">4A</xref>, Fig. <xref ref-type="fig" rid="F5">5</xref>). In the presence of 10 μM xanthurenic acid condensed and/or cleaved nuclei were observed, which a mostly stained only with Hoechst 33342, and not with propidium iodide. This indicated that the observed cell death was apoptotic and not necrotic (Fig. <xref ref-type="fig" rid="F4">4B, 4C</xref>). With concentrations of xanthurenic acid of 20 μM (Fig. <xref ref-type="fig" rid="F4">4D,4E,4F</xref>) and 40 μM (Fig. <xref ref-type="fig" rid="F4">4G,4H,4I</xref>) the destruction of the mitochondrial structure, was associated with nuclear cleavage. Cell death depended on the xanthurenic acid concentration (Fig. <xref ref-type="fig" rid="F5">5</xref>). In the presence of 10 μM xanthurenic acid about 40 percent of cells were dead, and an increase of xanthurenic acid to 20 μM provoked about 70 percent of cell death.</p>
        <fig position="float" id="F4">
          <label>Figure 4</label>
          <caption>
            <p>Nuclear DNA degradation in HuLEC in the presence of xanthurenic acid. (A) control cells stained with Hoechst; (B) cells grown in the presence of 10 μM xanthurenic acid for 96 h and stained with Hoechst; (C) as (B) but stained with Hoechst and propidium iodide; (D-F) cells in the presence of 20 μM xanthurenic acid: (D) stained with Mitotracker, (E) stained with Hoechst, (F) merge of (D and E); (G-I) cells in the presence of 40 μM xanthurenic acid: (G) stained with Mitotracker, (H) stained with Hoechst, (I) merge of (G) and (H).</p>
          </caption>
          <graphic xlink:href="1471-2415-2-1-4"/>
        </fig>
        <fig position="float" id="F5">
          <label>Figure 5</label>
          <caption>
            <p>Apoptotic death of HuLEC in the presence of xanthurenic acid.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-1-5"/>
        </fig>
      </sec>
      <sec>
        <title>Xanthurenic acid leads to damage of the cell membrane</title>
        <p>The cell membranes were stained with DiOC<sub>18</sub> and co-stained with Mito-Tracker Red CMXRos, and the nucleus was stained with Hoechst 33342 (Fig. <xref ref-type="fig" rid="F6">6</xref>). In the control cell mitochondria were in the perinuclear region and the cell membranes were uniformly stained with DiOC<sub>18</sub> (Fig. <xref ref-type="fig" rid="F6">6A,6B,6C</xref>) In the presence of 10 μM xanthurenic acid the mitochondria migrated to the cell periphery and the cell membranes were not uniformly stained (Fig. <xref ref-type="fig" rid="F6">6D,6E,6F</xref>). In the presence of 20 μM of xanthurenic acid the mitochondrial structure was destroyed, nuclear DNA was degraded and membranes were not stained with DiOC<sub>18</sub> (Fig. <xref ref-type="fig" rid="F6">6G,6H,6I</xref>).</p>
        <fig position="float" id="F6">
          <label>Figure 6</label>
          <caption>
            <p>Staining of the mitochondria (Mito-Tracker Red CMXRos), nucleus (Hoechst) and cell membranes (DiOC<sub>18</sub>) in HuLEC grown in the presence of xanthurenic acid for 96 hours: (A-C), control cells: (A) mitochondria, (B) nucleus, (C) membranes; (D-F) with 10 μM xanthurenic acid: (D) mitochondria, (E) membranes, (F) merge of D, E, and nucleus stained by Hoechst; (G-I) with 20 μM xanthurenic acid: (G) mitochondria, (H) merge of (G) and Hoechst staining, (I) membranes</p>
          </caption>
          <graphic xlink:href="1471-2415-2-1-6"/>
        </fig>
      </sec>
      <sec>
        <title>Xanthurenic acid causes an increase of free intracellular Ca<sup>2+</sup> and an induction of the lens calpain Lp82</title>
        <p>Ca<sup>2+</sup> increases are associated with cataract development. We investigated intracellular Ca<sup>2+</sup> by loading the cells with acetometoxyl ester of Calcium Orange™. This dye becomes fluorescent when hydrolysed in the cell by esterases and conjugated with free Ca<sup>2+</sup> Cells were incubated without xanthurenic acid or with xanthurenic acid at concentration of 0.125; 0.25, 0.5; 1; 2; 5, 10, and 20 μM. A presence of xanthurenic acid in the cell culture medium higher then 2 μM provokes an increase of intracellular Ca<sup>2+</sup> in comparison with control. In the presence of xanthurenic acid at concentration of 10 μM and 20 μM an intensive staining with Calcium Orange™ was observed indicating an increase of free Ca<sup>2+</sup> in the cell in a xanthurenic acid concentration-dependent manner (Fig. <xref ref-type="fig" rid="F7">7</xref>).</p>
        <fig position="float" id="F7">
          <label>Figure 7</label>
          <caption>
            <p>Increase of free Ca<sup>2+</sup> in HuLEC after growth in the presence of xanthurenic acid for 96 hours. HuLEC were stained with Calcium Orange™: (A) control cells, (B) in the presence of 10 μM xanthurenic acid, (C) in the presence of 20 μM xanthurenic acid.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-1-7"/>
        </fig>
        <p>The lens specific calpain Lp82 [<xref ref-type="bibr" rid="B23">23</xref>] was not detectable using the Western blot analysis in the lens epithelial cell culture cultivated in the absence of xanthurenic acid (Fig. <xref ref-type="fig" rid="F8">8</xref>, lane 1). In the presence of xanthurenic acid the calpain Lp82 was induced (Fig. <xref ref-type="fig" rid="F8">8</xref>, lanes 2-4).</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Our previous studies in cell culture showed that xanthurenic acid is a potent endogenous pathological substance in retinal pigment epithelium and smooth muscle cells [<xref ref-type="bibr" rid="B24">24</xref>]. In this study, we observed that xanthurenic acid leads to lens epithelial cells death associated with an induction of caspase-3 and calpain Lp82. Apoptosis was observed in models of cataract upon lens treatment with staurosporine, diamide, and ionophore [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. In the selenite cataract model caspase-3 and calpain were induced [<xref ref-type="bibr" rid="B25">25</xref>]. In the normal apoptosis, such as observed with development, cells disappear because of caspase-3-dependent cleavage of DNA and the cytoskeleton [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. The caspase remodeling of the cytoskeleton was indicated as a possible mechanism leading to the aging of lenses [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. Apoptosis is considered as a common cellular basis for non-congenital cataract in mammals [<xref ref-type="bibr" rid="B30">30</xref>]. Recent data indicate that senile cataract is a result of proteolysis of crystalins by calpains [<xref ref-type="bibr" rid="B31">31</xref>]. Calpains are activated by Ca<sup>2+</sup>[<xref ref-type="bibr" rid="B32">32</xref>].</p>
      <p>Previously, it was reported that ER Ca<sup>2+</sup> homeostasis affects the cells' sensitivity to apoptosis [<xref ref-type="bibr" rid="B33">33</xref>]. Lens epithelial cells overloaded by Ca<sup>2+</sup> showed vimentin cleavage and opacification [<xref ref-type="bibr" rid="B34">34</xref>] Thapsigargin, a plant alkaloid, which depletes Ca<sup>2+</sup> from the ER, was used to stop lens epithelial cell growth [<xref ref-type="bibr" rid="B35">35</xref>]. Here, we show that xanthurenic acid, an endogenous molecule, lead to induction of calpain Lp82 and caspase-3 activation. The simultaneus activation of caspase and calpain may lead to an abnormality of apoptosis because calpain cleaves caspases [<xref ref-type="bibr" rid="B36">36</xref>]. The calpain Lp82 is involved in cataract formation in connexin α-3 knockout mice [<xref ref-type="bibr" rid="B37">37</xref>]. The induction of calpain Lp82 leads to the cleavage of crystalins in the lenses and is involved in the senile cataract development [<xref ref-type="bibr" rid="B38">38</xref>]. Xanthurenic acid leads to formation of unfolded proteins [<xref ref-type="bibr" rid="B15">15</xref>].</p>
      <p>An accumulation of unfolded protein can lead to Ca<sup>2+</sup> release from intracellular stores as well to caspase induction [<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. The observed death of the lens epithelial cells has apoptotic characteristics because release of cytochrome c and caspase-3 activation were observed. However, the apoptosis-like process does not lead to a collapse of the cytoskeleton driven by caspase-3 cleaved gelsolin in the presence of Fas-induced apoptosis [<xref ref-type="bibr" rid="B20">20</xref>]. In our study, in the presence of xanthurenic acid cells look normal when observed by the light microscopy. However, when visualized by fluorescence microscopy with Hoechst and propidium iodide a nuclear dysfunction is evident. We have previously reported that xanthurenic acid leads to an abnormal cleavage of gelsolin. The gelsolin stains cytoskeleton of the dead cells. Ca<sup>2+</sup> and bis-phosphatidylinositol (PPI2) regulate, respectively, association and dissociation of gelsolin to actin [<xref ref-type="bibr" rid="B41">41</xref>]. Thus, also the increase in Ca<sup>2+</sup> may play a role in the association of gelsolin to cytoskeleton.</p>
      <p>The mitochondrial damage observed in the presence of xanthurenic acid associated with cytochrome c release could lower energy necessary for the lens enzymes activation observed in senile cataract development.</p>
      <p>In this study we observed that xanthurenic acid accumulation can be an upstream event leading to an induction of the lens proteases: caspase and calpain. An accumulation of xanthurenic acid in the human lenses with aging can change the intracellular Ca<sup>2+</sup> homeostasis. In summary, xanthurenic acid can induce the pathology of the lens epithelial cells without participation of light.</p>
    </sec>
    <sec>
      <title>Author contributions</title>
      <p>All authors contributed equally to realize this work</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>None declared</p>
      <fig position="float" id="F8">
        <label>Figure 8</label>
        <caption>
          <p>Induction of calpain Lp82 in HuLEC growing 24 hours in controlled cells (lane-1) and in the presence of 1,2,4 mM xanthurenic acid (lanes-2,3,4, repectively).</p>
        </caption>
        <graphic xlink:href="1471-2415-2-1-8"/>
      </fig>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/2/1/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>This work was supported by grant awarded to H. Z. M. by the Swiss National Foundation (32-59183.99) and MSE-Pharmaceutika GMBH, Bad Homburg, Germany. We thank Dr. T. R. Shearer for the kind gift of the antibody against calpain Lp82, Mr. R. Fischer and Mrs A. Marrero Nodarse for cell culture facilities, and Mrs D. Zuercher for lens epithelial cell culture preparation.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andley</surname>
              <given-names>UP</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wawrousek</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Fleming</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Bassnett</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Differential protective activity of alpha A- and alphaB-crystallin in lens epithelial cells.</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>36823</fpage>
          <lpage>36831</lpage>
          <pub-id pub-id-type="pmid">10967101</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.M004233200</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horwitz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>QL</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bova</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Lens alpha-crystallin: chaperone-like properties.</article-title>
          <source>Methods Enzymol</source>
          <year>1998</year>
          <volume>290</volume>
          <fpage>365</fpage>
          <lpage>383</lpage>
          <pub-id pub-id-type="pmid">9534176</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Heyningen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Assay of fluorescent glucosides in human lens.</article-title>
          <source>Exp Eye Res</source>
          <year>1973</year>
          <volume>15</volume>
          <fpage>121</fpage>
          <lpage>126</lpage>
          <pub-id pub-id-type="pmid">4683836</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ozaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Byrne</surname>
              <given-names>GI</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Borden</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects.</article-title>
          <source>Experientia</source>
          <year>1989</year>
          <volume>45</volume>
          <fpage>535</fpage>
          <lpage>541</lpage>
          <pub-id pub-id-type="pmid">2472288</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malina</surname>
              <given-names>HZ</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>XD</given-names>
            </name>
          </person-group>
          <article-title>Indoleamine 2,3-dioxygenase activity in the aqueous humor, iris/ciliary body, and retina of the bovine eye.</article-title>
          <source>Graefes Arch Clin Exp Ophthalmol</source>
          <year>1993</year>
          <volume>231</volume>
          <fpage>482</fpage>
          <lpage>486</lpage>
          <pub-id pub-id-type="pmid">8224949</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malina</surname>
              <given-names>HZ</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>XD</given-names>
            </name>
          </person-group>
          <article-title>Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye.</article-title>
          <source>Graefes Arch Clin Exp Ophthalmol</source>
          <year>1996</year>
          <volume>234</volume>
          <fpage>457</fpage>
          <lpage>462</lpage>
          <pub-id pub-id-type="pmid">8817290</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takikawa</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Littlejohn</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Truscott</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Indoleamine 2,3-dioxygenase in the human lens, the first enzyme in the synthesis of UV filters.</article-title>
          <source>Exp Eye Res</source>
          <year>2001</year>
          <volume>72</volume>
          <fpage>271</fpage>
          <lpage>277</lpage>
          <pub-id pub-id-type="pmid">11180976</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.2000.0951</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dillon</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Photophysics and photobiology of the eye.</article-title>
          <source>J Photochem Photobiol B: Biol</source>
          <year>1991</year>
          <volume>10</volume>
          <fpage>23</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1016/1011-1344(91)80209-Z</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Finley</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Patat</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Schey</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
          <article-title>Photooxidation of lens proteins with xanthurenic acid: a putative chromophore for cataractogenesis.</article-title>
          <source>Photochem Photobiol</source>
          <year>2001</year>
          <volume>74</volume>
          <fpage>740</fpage>
          <lpage>744</lpage>
          <pub-id pub-id-type="pmid">11723804</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Wishart</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chignell</surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Photochemical studies on xanthurenic acid.</article-title>
          <source>Photochem Photobiol</source>
          <year>2000</year>
          <volume>72</volume>
          <fpage>467</fpage>
          <lpage>471</lpage>
          <pub-id pub-id-type="pmid">11045716</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malina</surname>
              <given-names>HZ</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>XD</given-names>
            </name>
          </person-group>
          <article-title>Deamination of 3-hydroxykynurenine in bovine lenses: a possible mechanism of cataract formation in general.</article-title>
          <source>Graefes Arch Clin Exp Ophthalmol</source>
          <year>1995</year>
          <volume>233</volume>
          <fpage>38</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">7721122</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malina</surname>
              <given-names>HZ</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>XD</given-names>
            </name>
          </person-group>
          <article-title>Xanthurenic acid derivative formation in the lens is responsible for senile cataract in humans.</article-title>
          <source>Graefes Arch Clin Exp Ophthalmol</source>
          <year>1996</year>
          <volume>234</volume>
          <fpage>723</fpage>
          <lpage>730</lpage>
          <pub-id pub-id-type="pmid">8986443</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malina</surname>
              <given-names>HZ</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>XD</given-names>
            </name>
          </person-group>
          <article-title>3-hydroxykynurenine transamination leads to the formation of the fluorescent substances in human lenses.</article-title>
          <source>Eur J Ophthalmol</source>
          <year>1996</year>
          <volume>6</volume>
          <fpage>250</fpage>
          <lpage>256</lpage>
          <pub-id pub-id-type="pmid">8908429</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shirao</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ando</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shirao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Balasubramanian</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Identification of a novel fluorophore, xanthurenic acid 8-O-β-D-glucoside in human brunescent cataract.</article-title>
          <source>Exp Eye Res</source>
          <year>2001</year>
          <volume>73</volume>
          <fpage>421</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="pmid">11825015</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.2001.1051</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malina</surname>
              <given-names>HZ</given-names>
            </name>
          </person-group>
          <article-title>Xanthurenic acid provokes formation of unfolded proteins in endoplasmic reticulum of the lens epithelial cells.</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1999</year>
          <volume>265</volume>
          <fpage>600</fpage>
          <lpage>605</lpage>
          <pub-id pub-id-type="pmid">10558916</pub-id>
          <pub-id pub-id-type="doi">10.1006/bbrc.1999.1716</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andersson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sjostrand</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Honarvar</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Karlsson</surname>
              <given-names>JO</given-names>
            </name>
          </person-group>
          <article-title>Caspase and proteasome activity during staurosporin-induced apoptosis in lens epithelial cells.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>2623</fpage>
          <lpage>2632</lpage>
          <pub-id pub-id-type="pmid">10937575</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azuma</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shearer</surname>
              <given-names>TR</given-names>
            </name>
          </person-group>
          <article-title>Involvement of calpain in diamide-induced cataract in cultured lenses.</article-title>
          <source>FEBS Lett</source>
          <year>1992</year>
          <volume>307</volume>
          <fpage>313</fpage>
          <lpage>317</lpage>
          <pub-id pub-id-type="pmid">1644187</pub-id>
          <pub-id pub-id-type="doi">10.1016/0014-5793(92)80703-J</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanderson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Marcantonio</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Calcium ionophore induced proteolysis and cataract: inhibition by cell permeable calpain antagonists.</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1996</year>
          <volume>218</volume>
          <fpage>893</fpage>
          <lpage>901</lpage>
          <pub-id pub-id-type="pmid">8579611</pub-id>
          <pub-id pub-id-type="doi">10.1006/bbrc.1996.0159</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Susin</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Lorenzo</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Zamzami</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Marzo</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Larochette</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mitochondrial release of caspase-2 and -9 during the apoptotic process.</article-title>
          <source>J Exp Med</source>
          <year>1999</year>
          <volume>189</volume>
          <fpage>381</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="pmid">9892620</pub-id>
          <pub-id pub-id-type="doi">10.1084/jem.189.2.381</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kothakota</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Azuma</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Reinhard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Klippel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis.</article-title>
          <source>Science</source>
          <year>1997</year>
          <volume>278</volume>
          <fpage>294</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="pmid">9323209</pub-id>
          <pub-id pub-id-type="doi">10.1126/science.278.5336.294</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azuma</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Koths</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Flanagan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kwiatkowski</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic progression.</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>3761</fpage>
          <lpage>3766</lpage>
          <pub-id pub-id-type="pmid">10660524</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.275.6.3761</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zou</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9.</article-title>
          <source>J Biol Chem</source>
          <year>1999</year>
          <volume>274</volume>
          <fpage>11549</fpage>
          <lpage>11556</lpage>
          <pub-id pub-id-type="pmid">10206961</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.274.17.11549</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fukiage</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shih</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Azuma</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shearer</surname>
              <given-names>TR</given-names>
            </name>
          </person-group>
          <article-title>Decreased sensitivity of lens-specific calpain Lp82 to calpastatin inhibitor.</article-title>
          <source>Exp Eye Res</source>
          <year>1999</year>
          <volume>69</volume>
          <fpage>155</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="pmid">10433852</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.1998.0686</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malina</surname>
              <given-names>HZ</given-names>
            </name>
            <name>
              <surname>Richter</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mehl</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hess</surname>
              <given-names>OM</given-names>
            </name>
          </person-group>
          <article-title>Pathological apoptosis by xanthurenic acid, a tryptophan metabolite: activation of cell caspases but not cytoskeleton breakdown.</article-title>
          <source>BMC Physiol</source>
          <year>2001</year>
          <volume>1</volume>
          <fpage>7</fpage>
          <pub-id pub-id-type="pmid">11459518</pub-id>
          <pub-id pub-id-type="doi">10.1186/1472-6793-1-7</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tamada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fukiage</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Azuma</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Shearer</surname>
              <given-names>TR</given-names>
            </name>
          </person-group>
          <article-title>Evidence for apoptosis in the selenite rat model of cataract.</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>300</fpage>
          <lpage>306</lpage>
          <pub-id pub-id-type="pmid">10964662</pub-id>
          <pub-id pub-id-type="doi">10.1006/bbrc.2000.3298</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Enari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sakahira</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yokoyama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Okawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Iwamatsu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD.</article-title>
          <source>Nature</source>
          <year>1998</year>
          <volume>391</volume>
          <fpage>43</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">9422506</pub-id>
          <pub-id pub-id-type="doi">10.1038/34112</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geng</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Azuma</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>JX</given-names>
            </name>
            <name>
              <surname>Hartwig</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Muszynski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Q</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines.</article-title>
          <source>Eur J Cell Biol</source>
          <year>1998</year>
          <volume>77</volume>
          <fpage>294</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="pmid">9930654</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kilic</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Trevithick</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Modelling cortical cataractogenesis. XXIX. Calpain proteolysis of lens fodrin in cataract.</article-title>
          <source>Biochem Mol Biol Int</source>
          <year>1998</year>
          <volume>45</volume>
          <fpage>963</fpage>
          <lpage>978</lpage>
          <pub-id pub-id-type="pmid">9739461</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Morrow</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Fowler</surname>
              <given-names>VM</given-names>
            </name>
          </person-group>
          <article-title>Caspase remodeling of the spectrin membrane skeleton during lens development and aging.</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>20735</fpage>
          <lpage>20742</lpage>
          <pub-id pub-id-type="pmid">11278555</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.M009723200</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Kuszak</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Dunn</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>GM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lens epithelial cell apoptosis appears to be a common cellular basis for non-congenital cataract development in humans and animals.</article-title>
          <source>J Cell Biol</source>
          <year>1995</year>
          <volume>130</volume>
          <fpage>169</fpage>
          <lpage>181</lpage>
          <pub-id pub-id-type="pmid">7790371</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>David</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Azuma</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shearer</surname>
              <given-names>TR</given-names>
            </name>
          </person-group>
          <article-title>Cataract and the acceleration of calpain-induced beta-crystallin insolubilization occurring during normal maturation of rat lens.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1994</year>
          <volume>35</volume>
          <fpage>785</fpage>
          <lpage>793</lpage>
          <pub-id pub-id-type="pmid">8125740</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strobi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fernandez-Catalan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Masumoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium.</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>588</fpage>
          <lpage>592</lpage>
          <pub-id pub-id-type="pmid">10639123</pub-id>
          <pub-id pub-id-type="doi">10.1073/pnas.97.2.588</pub-id>
        </citation>
      </ref>
      <ref id="B33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bossy-Wetzel</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fadel</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Lozyk</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Goping</surname>
              <given-names>IS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Changes in endoplasmic reticulum luminal environment affect cell sensitivity to apoptosis.</article-title>
          <source>J Cell Biol</source>
          <year>2000</year>
          <volume>150</volume>
          <fpage>731</fpage>
          <lpage>740</lpage>
          <pub-id pub-id-type="pmid">10952999</pub-id>
          <pub-id pub-id-type="doi">10.1083/jcb.150.4.731</pub-id>
        </citation>
      </ref>
      <ref id="B34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanderson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Marcantonio</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>A human lens model of cortical cataract: Ca2+-induced protein loss, vimentin cleavage and opacification.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>2255</fpage>
          <lpage>2261</lpage>
          <pub-id pub-id-type="pmid">10892870</pub-id>
        </citation>
      </ref>
      <ref id="B35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wormstone</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Marcantonio</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>Thapsigargin-coated intraocular lenses inhibit human lens cell growth.</article-title>
          <source>Nat Med</source>
          <year>1997</year>
          <volume>3</volume>
          <fpage>1026</fpage>
          <lpage>1028</lpage>
          <pub-id pub-id-type="pmid">9288732</pub-id>
        </citation>
      </ref>
      <ref id="B36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chua</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases.</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>5131</fpage>
          <lpage>5135</lpage>
          <pub-id pub-id-type="pmid">10671558</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.275.7.5131</pub-id>
        </citation>
      </ref>
      <ref id="B37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baruch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Greenbaum</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Gilula</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>NM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Defining a Link between Gap Junction Communication, Proteolysis, and Cataract Formation.</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>28999</fpage>
          <lpage>29006</lpage>
          <pub-id pub-id-type="pmid">11395508</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.M103628200</pub-id>
        </citation>
      </ref>
      <ref id="B38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shearer</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shih</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hata</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fukiage</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lp82 calpain during rat lens maturation and cataract formation.</article-title>
          <source>Curr Eye Res</source>
          <year>1998</year>
          <volume>17</volume>
          <fpage>1037</fpage>
          <lpage>1043</lpage>
          <pub-id pub-id-type="pmid">9846621</pub-id>
          <pub-id pub-id-type="doi">10.1076/ceyr.17.11.1037.5232</pub-id>
        </citation>
      </ref>
      <ref id="B39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Posmantur</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nadimpalli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nath</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mohan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nixon</surname>
              <given-names>RA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis.</article-title>
          <source>Arch Biochem Biophys</source>
          <year>1998</year>
          <volume>356</volume>
          <fpage>187</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="pmid">9705209</pub-id>
          <pub-id pub-id-type="doi">10.1006/abbi.1998.0748</pub-id>
        </citation>
      </ref>
      <ref id="B40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoneda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Imaizumi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Oono</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yui</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gomi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Katayama</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress.</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>13935</fpage>
          <lpage>13940</lpage>
          <pub-id pub-id-type="pmid">11278723</pub-id>
        </citation>
      </ref>
      <ref id="B41">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>HQ</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mejillano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>Gelsolin, a multifunctional actin regulatory protein.</article-title>
          <source>J Biol Chem</source>
          <year>1999</year>
          <volume>274</volume>
          <fpage>33179</fpage>
          <lpage>33182</lpage>
          <pub-id pub-id-type="pmid">10559185</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.274.47.33179</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:107746</identifier><datestamp>2002-05-09</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">107746</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-2-2</article-id>
      <article-id pub-id-type="pmid">11950394</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-2-2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The significance of opthalmologic evaluation in the early diagnosis of inborn errors of metabolism: the Cretan experience</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Tsagaraki</surname>
            <given-names>Daria P</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>dotopto@med.uoc.gr</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Evangeliou</surname>
            <given-names>Athanasios E</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>evangeli@med.uoc.gr</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Tsilimbaris</surname>
            <given-names>Miltiadis</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>tsilimb@med.uoc.gr</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Spilioti</surname>
            <given-names>Martha G</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>evangeli@med.uoc.gr</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Mihailidou</surname>
            <given-names>Eleni P</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>miheni@med.uoc.gr</email>
        </contrib>
        <contrib id="A6" contrib-type="author">
          <name>
            <surname>Lionis</surname>
            <given-names>Christos</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>lionis@med.uoc.gr</email>
        </contrib>
        <contrib id="A7" contrib-type="author">
          <name>
            <surname>Pallikaris</surname>
            <given-names>Ioannis</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>pallikar@med.uoc.gr</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Opthalmology, School of Medicine, University Hospital of Crete Medical School, Crete, Greece</aff>
      <aff id="I2"><label>2</label>Department of Pediatrics Pediatrics, School of Medicine, University Hospital of Crete Medical School, Crete, Greece</aff>
      <aff id="I3"><label>3</label>Department of Neurology, School of Medicine, University Hospital of Crete Medical School, Crete, Greece</aff>
      <aff id="I4"><label>4</label>Clinic of Social and Family Medicine, School of Medicine, University Hospital of Crete Medical School, Crete, Greece</aff>
      <pub-date pub-type="collection">
        <year>2002</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>4</month>
        <year>2002</year>
      </pub-date>
      <volume>2</volume>
      <fpage>2</fpage>
      <lpage>2</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/2/2"/>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>10</month>
          <year>2001</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>4</month>
          <year>2002</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2002 Tsagaraki et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2002</copyright-year>
        <copyright-holder>Tsagaraki et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>The Inborn Errors of Metabolism (IEM) are far from the rare systemic diseases that mainly affect the neural tissue. There are very few written reports on ocular findings in subjects with IEM, thus it was interesting to study the frequency of ocular findings in the studied population and explore their contribution to the early diagnosis of IEM.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>Our study involved the evaluation of IEM suspected cases, which had been identified in a rural population in Crete, Greece. Over a period of 3 years, 125 patients, who fulfilled the inclusion criteria of this study, were examined. Analytical physical examination, detailed laboratory investigation as well as a thorough ocular examination were made.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>A diagnosis of IEM was established in 23 of the 125 patients (18.4%). Ten (43.5%) of the diagnosed IEM had ocular findings, while 8 of them (34.8%) had findings which were specific for the diagnosed diseases. One patient diagnosed with glycogenosis type 1b presented a rare finding. Of the 102 non-diagnosed patients, 53 (51.96 %) presented various ophthalmic findings, some of which could be related to a metabolic disease and therefore may be very helpful in the future.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The ocular investigation can be extremely useful for raising the suspicion and the establishment of an early diagnosis of IEM. It could also add new findings related to these diseases. The early management of the ocular symptoms can improve the quality of life to these patients.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Until a few years ago, metabolic diseases, were thought to be controversial entities with exotic names, only a few people were involved in their research. The fact that the majority of these diseases were considered incurable reduced the interest of their investigation. However, recently the situation has changed dramatically and metabolic diseases have received serious attention and considerable progress has been made in prevention and therapeutic management. It is now clear that metabolic diseases are far from rare. The incidence of metabolic diseases in North America and in Central and Northern Europe is 1:5000.</p>
      <p>Metabolic diseases mainly affect the neural tissue, but may also affect others such as the heart, liver, kidneys, blood and eyes. The ocular symptoms and signs are found in a large number of these diseases [<xref ref-type="bibr" rid="B4">4</xref>]. They frequently represent an already allocated symptom of a systemic disorder. The ocular finding can rarely be so characteristic as to render itself the key to the diagnosis, as for example in Wilson's disease [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>].</p>
      <p>A pilot study has been implemented in rural Crete and its first results and experiences have been reported in a recent publication [<xref ref-type="bibr" rid="B7">7</xref>]. There are very few written reports on ocular findings in subjects with inborn errors of metabolism (IEM), thus it was interesting to study the frequency of ocular findings in the studied population and explore their contribution to the early diagnosis of IEM.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>Our pilot study was carried out during the period from January of 1997 to January 2000. The predominant source of the study's data was derived from the eight Primary Health Care Centres in rural Crete, which accounts for 225,000 inhabitants, and are taking part in the activities of the Cretan Primary Healthcare Network [<xref ref-type="bibr" rid="B7">7</xref>]. An invitation was extended to all of the primary care physicians of these Health Centres, of which eight medical doctors participated in an intensive educational programme for IEM and their early diagnosis. A checklist with specific illness conditions, symptoms and clinical signs was drawn up (see <xref ref-type="supplementary-material" rid="S1">additional file 1</xref>). Primary care physicians checked the presence of at least one condition, sign or symptom in all children or adults who visited the participating Health Centres and who had been symptomatic since childhood and were not related to other conditions. They referred all eligible subjects to the Department of Child Care at the University Hospital of Heraklion, Crete. Three of children who had examined at the Department of Ophthalmology at the University Hospital of Heraklion had fulfilled the inclusion criteria were added in our study sample. A full and analytical physical examination as well as a detailed laboratory investigation was made in this department. Patients with history of perinatal asphyxia, infection, injury or tumor of the central nervous system were excluded of the study. An ophthalmologic evaluation was part of this assessment. The ophthalmologic evaluation included the following:</p>
      <p>(1) Case History (Personal and Family). (2) Visual acuity measurements for near and/or distant vision. In selecting the method of estimation of visual acuity we took into consideration factors such as age, existence of mental retardation, and collaboration of the patient. (3) Color Perception (using the Ishihara Isochromatic Cards). (4) Pupil reflexes (direct and indirect). (5) Near reflex. (6) Orthoptic evaluation including conjugate eye movements; cover-uncover test; cover-test and prism cover test where it was necessary. (7) Examination for presence of nystagmus. (8) Slit lamp examination of the anterior segment of the eye. (9) Retinoscopy. (10) Indirect ophthalmoscopy. (11) Photography when applicable.</p>
      <p>The ocular investigation was performed every year on each patient included in the study.</p>
    </sec>
    <sec>
      <title>Results</title>
      <p>During the 3-year period the study involved the examination of 125 subjects which fulfilled the inclusion criteria of this study. There were 75 males (60%) and 50 females (40%). The ages were between 0 to 30 years. The mean age of the examined patients was 6.34 (S.D: ± 5.75) years. Of the 125 subjects examined, a diagnosis of IEM was established in 23 (18.4%). Subsequently 63 (50.4%) had ocular findings.</p>
      <p>From the 23 diagnosed patients, 10 (43.5%) had ocular findings, and 8 of these (34.8%) had findings specific for the diagnosed diseases (see <xref ref-type="supplementary-material" rid="S2">additional file 2</xref>). In one patient diagnosed with glycogenosis type 1b a rare finding of large preretinal spherical deposits near the ora serrata was documented. These deposits probably consisted of glycogen and/or triglycerides. To the best of our knowledge, this finding has not previously been reported in any publication.</p>
      <p>Thirteen (56.5%) of the diagnosed patients had no ocular findings (5 patients with organic acidurias, 2 with glycogenosis type la, 2 b-oxidation defects, one with lysosomal disorder, one mitochondriopathy and two with aminoacid disorders).</p>
      <p>From the 102 non-diagnosed patients 40 (39.21%) had no ocular findings and 9 (8.82%) had only a very low refractive error (-2.0D to + 2.0D). Fifty – three (51.96 %) undiagnosed patients presented various ophthalmic findings that are shown in (see <xref ref-type="supplementary-material" rid="S3">additional file 3</xref>)</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>This study attempted to show the significance of the ocular investigation in the early diagnosis and management of IEM. It is known that IEM affect vision because of the damage to the brain, visual pathways and other eye structures such as the lens, the cornea and the retina. The existence of the ocular finding was critical for the suspicion of the disease and the definitive diagnosis in several of the diagnosed patients (18.4%). Of the 23 diagnosed patients, 10 (43, 47%) presented ocular symptoms (<italic>Table 2</italic>). In 4 patients (with Canavan's disease, metachromatic leucodysrtophy and adrenoleucodystrophy) the suspicion of the disease was set because of the other clinical symptoms in spite of the fact that atrophy of the optic nerve was a specific finding [<xref ref-type="bibr" rid="B8">8</xref>]. In 8 (34,78%) of the 10 diagnosed patients the ocular symptoms were specific for the underlying disease. This means that 80% (8/10) of the patients diagnosed with ocular symptoms had specific ocular findings for the diagnosed disease.</p>
      <p>The diagnosis of IEM represents one of the most difficult aspects of medicine and their differential diagnosis from perinatal lesions is not always easy. In this case, the ocular findings can be of great value in directing the diagnosis to a specific disease. This was the case with one of our patients with Niemman-Pick type C who had a very slow progression. It was the ocular findings (vertical gaze paresis, doll's eye movements and retinitis pigmentosa) which led to the suspicion of the diagnosis [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B11">11</xref>].</p>
      <p>In the cases of the patients with Kearns-Sayre syndrome, mannosidosis and Lowe's syndrome the ocular findings were characteristic for the disease and contributed to the fast diagnosis of the underlying disease. The patient with the Kearns-Sayre syndrome exhibited the typical triad of progressive external ophthalmoplegia, retinal pigmentary degeneration, and heart block [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. The patient with Mannosidosis presented a progressively developing wheel-like cataract and optic disk pallor [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>] which was probably related to demyelination and associated gliosis involving the parieto-occipital white matter [<xref ref-type="bibr" rid="B17">17</xref>]. The patients mother was at the first trimester of her 2<sup>nd</sup> pregnancy. Prenatal screening was ordered which revealed the some diagnosis in the fetus [<xref ref-type="bibr" rid="B18">18</xref>]. The patient in Lowe's syndrome (oculocerebrorenal syndrome) presented congenital discoid cataracts [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>], miosis, congenital glaucoma [<xref ref-type="bibr" rid="B21">21</xref>]. The mother had flake like opacities of the lenses, a typical finding in a female carrier [<xref ref-type="bibr" rid="B22">22</xref>]. The child was treated for cataracts, and glaucoma. Currently, he is under topical therapy with a b-blocker.</p>
      <p>In biotinidase deficiency, strabismus is a non-specific ocular finding. However, it is described in 30% of the patients in various research studies [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>].</p>
      <p>The case of a patient with glycogenosis type 1b is of interest. This patient presented large preretinal spherical deposits near the ora serrata, probably consisting of glycogen and/or triglycerides. This patient was under no therapeutic scheme until the age of 25. Three years later in a new fundus examination the large preretinal deposits were absorbed and replaced with small drussen-like preretinal deposits. These new deposits were mainly concentrated in the peripheral retina of the inferior nasal quadrant of each eye. Our ocular finding in glycogenosis type 1b may be correlated with ocular findings reported by other authors for this disease. [<xref ref-type="bibr" rid="B25">25</xref>].</p>
      <p>It is an interesting fact that although 18.4% were finally diagnosed, but ocular findings existed in 50.4% of them.</p>
      <p>The findings in undiagnosed patients were notable. A high percentage of ocular findings were documented for these patients (51.96%) A tight surveillance of the undiagnosed patients is important as some of these findings may be related to a metabolic disease, the existence of which can not be established at the present time although it is certain that some of these findings should be very helpful in the future.</p>
      <p>The high percentage of ocular findings (43.47% in the diagnosed and 51.96% in the undiagnosed patients) in both diagnosed and undiagnosed patients is indicative of the significant involvement of the eye in problems raising a suspicion of an IEM disease. The ocular evaluation of these patients seems to be obligatory.</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>The results of this study demonstrate that a thorough ophthalmologic examination can be extremely useful for the pediatricians and the neurologist concerning the diagnosis of metabolic neurogenetic diseases. For the establishment of the diagnosis, the collaboration of various institutes is usually necessary in some cases the diagnosis can be facilitated by the ophthalmologic findings. Moreover, there are cases where an ophthalmologic examination is the main examination that leads to the early recognition of these diseases. Finally, the amelioration of the ocular symptoms can offer a better quality of life to those patients.</p>
    </sec>
    <sec>
      <title>Competing Interests</title>
      <p>None declared.</p>
    </sec>
    <sec>
      <title>Author controibutions</title>
      <p><bold>Dr Tsagaraki Daria and Dr Evangeliou Athanasios</bold> had primary responsibility for protocol development, patient screening, enrolment, outcome assessment, preliminary data analysis and writing of the manuscript. <bold>Dr Tsilibaris Miltiadis, Dr Spilioti Martha and Dr Lionis Christos</bold> participated in the development of protocol and analytic framework of the study and contributed to the writing of the manuscript. <bold>Dr Michailidou Eleni</bold> was responsible for patient screening and <bold>Dr Pallicaris Ioannis</bold> supervised the design and execution of the study and contributed to the writing of the manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/2/2/prepub"/>
      </p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="S1">
        <caption>
          <title>Additional file 1</title>
        </caption>
        <media xlink:href="1471-2415-2-2-S1.xls" mimetype="application" mime-subtype="vnd.ms-excel">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S2">
        <caption>
          <title>Additional file 2</title>
        </caption>
        <media xlink:href="1471-2415-2-2-S2.xls" mimetype="application" mime-subtype="vnd.ms-excel">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S3">
        <caption>
          <title>Additional file 3</title>
        </caption>
        <media xlink:href="1471-2415-2-2-S3.xls" mimetype="application" mime-subtype="vnd.ms-excel">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Applegarth</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Toone</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Lowry</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>Incidence of inborn errors of metabolism in British Columbia, 1969–1996.</article-title>
          <source>Pediatrics</source>
          <year>2000</year>
          <volume>105</volume>
          <fpage>e10</fpage>
          <pub-id pub-id-type="pmid">10617747</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zakiah</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ashikin</surname>
              <given-names>YN</given-names>
            </name>
            <name>
              <surname>Aisiah</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Ismail</surname>
              <given-names>HI</given-names>
            </name>
          </person-group>
          <article-title>Inborn errors of metabolic diseases in Malaysia: a preliminary report of maple syrup urine diseases for 1993: Southeast Asian</article-title>
          <source>J Trop Med Pubic health</source>
          <year>1995</year>
          <volume>26</volume>
          <fpage>134</fpage>
          <lpage>136</lpage>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Widhalm</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>25 years Austrian screening program for inborn errors of metabolism at the Vienna University.</article-title>
          <source>Wien Klin Wochenschr,</source>
          <year>1992</year>
          <volume>104</volume>
          <fpage>510</fpage>
          <lpage>513</lpage>
          <pub-id pub-id-type="pmid">1413809</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iwata</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kaiser-Kupfer</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>Ocular manifestations of metabolic disorders.</article-title>
          <source>Curr Opin Ophthalmol</source>
          <year>1994</year>
          <volume>5</volume>
          <fpage>79</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">10150832</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sheinberg</surname>
              <given-names>IH</given-names>
            </name>
            <name>
              <surname>Sternlich</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Smith LH</surname>
            </name>
          </person-group>
          <article-title>Wilson's Disease.</article-title>
          <source>In Major Problems in Internal Medicine</source>
          <year>1984</year>
          <volume>23</volume>
          <edition>1</edition>
          <publisher-name>Philadelphia: Saunders</publisher-name>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Golldberg</surname>
              <given-names>MF.</given-names>
            </name>
            <name>
              <surname>Von Noorden</surname>
              <given-names>GK</given-names>
            </name>
          </person-group>
          <article-title>Ophthalmologic Findings in Wilson's Hepatolenticular Degeneration,</article-title>
          <source>Arch Ophthalmol</source>
          <year>1968</year>
          <volume>75</volume>
          <fpage>162</fpage>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evangeliou</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lionis</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Michailidou</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Selective screening for inborn errors of metabolism: the primary care-based model in rural Crete.</article-title>
          <source>J Inherit Metab Dis</source>
          <year>2001</year>
          <volume>24</volume>
          <fpage>877</fpage>
          <lpage>880</lpage>
          <pub-id pub-id-type="pmid">11916324</pub-id>
          <pub-id pub-id-type="doi">10.1023/A:1013904627537</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Menke's</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Menke's J</surname>
            </name>
          </person-group>
          <article-title>Diffuse cerebral degenerative diseases; Diseases with Degeneration Affecting Primarily White matter.</article-title>
          <source>In Child Neurology</source>
          <year>1985</year>
          <edition>3</edition>
          <publisher-name>Philadelphia : Lea &amp; Fabiger</publisher-name>
          <fpage>150</fpage>
          <lpage>156</lpage>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turpin</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Goas</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Masson</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Type C Niemann-Pick disease: supranuclear ophthalmoplegia associated with deficient biosynthesis of cholesterol esters.</article-title>
          <source>Rev Neurol (Paris)</source>
          <year>1991</year>
          <volume>147</volume>
          <fpage>28</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">2014379</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fink</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Filling-Katz</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Sokol</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical spectrum of Niemann-Pick disease type C.</article-title>
          <source>Neurology</source>
          <year>1989</year>
          <volume>39</volume>
          <fpage>1040</fpage>
          <lpage>1049</lpage>
          <pub-id pub-id-type="pmid">2761697</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palmer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Maumenee</surname>
              <given-names>IH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Niemann-Pick disease type C. Ocular histopathologic and electron microscopic studies.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1985</year>
          <volume>103</volume>
          <fpage>817</fpage>
          <lpage>822</lpage>
          <pub-id pub-id-type="pmid">4004622</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gross-J</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schatz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>HR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Kearns-Sayre syndrome: a case report and review.</article-title>
          <source>Eur J Ophthalmol</source>
          <year>1992</year>
          <volume>2</volume>
          <fpage>15</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">1638160</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKechnie</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Retinal pathology in the Kearns-Sayre syndrome.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1985</year>
          <volume>69</volume>
          <fpage>63</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="pmid">3965031</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mullie</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Harding</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Petty</surname>
              <given-names>RK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The retinal manifestations of mitochondrial myopathy. A study of 22 cases.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1985</year>
          <volume>103</volume>
          <fpage>1825</fpage>
          <lpage>1830</lpage>
          <pub-id pub-id-type="pmid">4074172</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Aguire</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stamm</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Haskins</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jezyk</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Goldberg's</surname>
            </name>
          </person-group>
          <article-title>Animal Models of Metabolic Eye Diseases. Defects in Glycoproteins Degradation. Mannosidosis.</article-title>
          <source>In Genetic and Metabolic Eye Diseases</source>
          <year>1986</year>
          <edition>2</edition>
          <publisher-name>Boston: Little Brown and co.</publisher-name>
          <fpage>152</fpage>
          <lpage>157</lpage>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alroy</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bachrach</surname>
              <given-names>A</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Thalhammer</surname>
              <given-names>JG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical, neurophysiological, biochemical and morphological features of eyes in Persian cats with mannosidosis.</article-title>
          <source>Virchows Arch B Cell Pathol Incl Mol Pathol</source>
          <year>1991</year>
          <volume>60</volume>
          <fpage>173</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="pmid">1679268</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dietemann</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Filippi de la Palavesa</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Tranchant</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MRI findings in mannosidosis.</article-title>
          <source>Neuroradiology</source>
          <year>1990</year>
          <volume>32</volume>
          <fpage>485</fpage>
          <lpage>487</lpage>
          <pub-id pub-id-type="pmid">2287376</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petushkova</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <article-title>First-trimester diagnosis of an unusual case of alpha-mannosidosis.</article-title>
          <source>Prenat Diagn</source>
          <year>1991</year>
          <volume>11</volume>
          <fpage>279</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">1832757</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Endres</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>YS</given-names>
            </name>
          </person-group>
          <article-title>Cataract and metabolic disease.</article-title>
          <source>J Inherit Metab Dis</source>
          <year>1990</year>
          <volume>13</volume>
          <fpage>509</fpage>
          <lpage>516</lpage>
          <pub-id pub-id-type="pmid">2122117</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tripathi</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Cibis</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Tripathi</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Pathogenesis of cataracts in patients with Lowe's syndrome.</article-title>
          <source>Ophthalmology</source>
          <year>1986</year>
          <volume>93</volume>
          <fpage>1046</fpage>
          <lpage>1051</lpage>
          <pub-id pub-id-type="pmid">3763153</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ginsberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bove</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Fogelson</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Pathological features of the eye in the oculocerebrorenal (Lowe) syndrome.</article-title>
          <source>J Pediatr Ophthalmol Strabismus</source>
          <year>1981</year>
          <volume>18</volume>
          <fpage>16</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">7264855</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koniszewski</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Root</surname>
              <given-names>HD</given-names>
            </name>
          </person-group>
          <article-title>The Lyon effect of the lens: findings in the carriers of X chromosome-linked cataract and in Lowe syndrome.</article-title>
          <source>Klin Monatsbl Augenheilkd</source>
          <year>1985</year>
          <volume>187</volume>
          <fpage>525</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">4094364</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Campana</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Valentini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Legnaioli</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>Ocular aspects in biotinidase deficiency. Clinical and genetic original studies.</article-title>
          <source>Ophthalmic Paediatr Genet</source>
          <year>1987</year>
          <volume>8</volume>
          <fpage>125</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="pmid">3658339</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salbert</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Astruc</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Ophthalmologic findings in biotinidase deficiency.</article-title>
          <source>Ophthalmologica</source>
          <year>1993</year>
          <volume>206</volume>
          <fpage>177</fpage>
          <lpage>181</lpage>
          <pub-id pub-id-type="pmid">8278163</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tamai</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Ocular changes of glycogen storage disease type I.</article-title>
          <source>Ophthalmologica</source>
          <year>1995</year>
          <volume>209</volume>
          <fpage>92</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="pmid">7746653</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:113264</identifier><datestamp>2002-05-23</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">113264</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-2-3</article-id>
      <article-id pub-id-type="pmid">11983023</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-2-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Comparison of an immortalized human corneal epithelial cell line with Vero cells in the isolation of Herpes simplex virus-1 for the laboratory diagnosis of Herpes simplex keratitis</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Athmanathan</surname>
            <given-names>Sreedharan</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>sreedhar@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>B Reddy</surname>
            <given-names>Sesha</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>sreedhar@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Nutheti</surname>
            <given-names>Rishita</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>rishita@lvpeye.stph.net</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Rao</surname>
            <given-names>Gullapalli N</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>gnrao@lvpeye.stph.net</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Jhaveri Microbiology Center, Prof. Brien Holden Eye Research Center, Hyderabad Eye Research Foundation, L. V. Prasad Eye Institute, L. V. Prasad Marg, Banjara Hills, Hyderabad, India</aff>
      <aff id="I2"><label>2</label>International Centre for Advancement of Rural Eye care, L. V. Prasad Eye Institute, L. V. Prasad Marg, Banjara Hills, Hyderabad, India</aff>
      <aff id="I3"><label>3</label>Cornea services, L. V. Prasad Eye Institute, L. V. Prasad Marg, Banjara Hills, Hyderabad, India</aff>
      <pub-date pub-type="collection">
        <year>2002</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>4</month>
        <year>2002</year>
      </pub-date>
      <volume>2</volume>
      <fpage>3</fpage>
      <lpage>3</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/2/3"/>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>11</month>
          <year>2001</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>4</month>
          <year>2002</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2002 Athmanathan et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2002</copyright-year>
        <copyright-holder>Athmanathan et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Herpes simplex keratitis (HSK) is a sight threatening ocular infection often requiring a specific and prompt laboratory diagnosis. Isolation of Herpes simplex virus (HSV-1) in culture provides the most reliable and specific method and is considered as the "Gold Standard" in the laboratory diagnosis of HSK in spite of its low sensitivity. Using "cell lines of corneal origin" for virus isolation may be beneficial under such circumstances, since these cells have been shown to be excellent substrates for the growth of HSV-1 isolated from the cornea. We report a comparative study of a novel human corneal epithelial cell line (HCE) and the Vero cell line in the isolation of HSV-1 from corneal scrapings employing a shell vial assay.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>Corneal scrapings were obtained from 17 patients with a clinical diagnosis of HSK. All the cases were confirmed by virological investigations (PCR and viral antigen detection positive, n = 15, PCR positive, n = 1, Viral antigen positive, n = 1). Scrapings obtained from 10 patients with infectious keratitis of non-viral origin were included as controls. All the scrapings were simultaneously inoculated into shell vials of HCE and Vero cells. Cultures were terminated at 24 h post-infection. Isolation of HSV-1 was confirmed using an indirect immunofluorescence/ immunoperoxidase assay.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Virus could be isolated using both or either of the cell lines in 10/17 (58.82%) patients with HSK. HSV-1 was isolated from 10/ 17 (58.82%) and 4/17(23.52%) specimens in HCE and Vero cells, respectively (P = 0.036). None of the controls yielded HSV-1. While all the 10 (100%) strains were isolated in HCE, Vero yielded only 4/10 (40%) strains in the shell vial culture (<italic>P</italic> = 0.014).</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>HCE showed a statistically significant difference in the virus isolation rate with respect to Vero cells. HCE may be an excellent alternative cell line for the isolation of HSV-1, especially from corneal scrapings, for the laboratory diagnosis of HSK.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Herpes simplex keratitis (HSK), a leading cause of corneal blindness, is a sight threatening ocular infection often requiring a specific and prompt laboratory diagnosis [<xref ref-type="bibr" rid="B1">1</xref>]. A variety of techniques have been employed for the rapid diagnosis of HSK [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B5">5</xref>]. Isolation of Herpes simplex virus-1(HSV-1) in culture provides the most reliable and specific method and is considered as the "Gold Standard" in the laboratory diagnosis of HSK. However, the sensitivity of this technique has been found to be low [<xref ref-type="bibr" rid="B6">6</xref>]. The reasons for this low sensitivity, especially for the isolation of HSV-1 from corneal scrapings, may be attributed to the sensitivity of the cell line used and the small volume of the specimen available. A number of cell lines are currently being used for the rapid isolation of HSV-1 in cell culture including primary rabbit kidney cells, human fetal foreskin fibroblasts, human embryonic lung fibroblasts and Vero [<xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>A recent study has reported that isolates derived from herpetic keratitis grow better in corneal epithelial cells and rabbit corneal epithelial cells may be more suitable for isolating HSV from the cornea [<xref ref-type="bibr" rid="B8">8</xref>]. Therefore, we performed a prospective study comparing the efficacy of a recently described novel immortalized human corneal epithelial cell line [<xref ref-type="bibr" rid="B9">9</xref>] and Vero cells in the isolation of HSV-1 from corneal scrapings obtained from patients with HSK.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Specimens</title>
        <p>Corneal scrapings were obtained following informed consent, from 17 patients with a clinical diagnosis of HSK. All the cases were confirmed by virological investigations (PCR and Viral antigen detection positive, n = 15, PCR positive, n = 1, Viral antigen positive, n = 1). Scrapings obtained from 10 patients with infectious keratitis of non-viral origin (Bacterial keratitis: n = 4, Mycotic keratitis: n = 3, Acanthamoeba keratitis: n = 1, Keratitis due to Nocardia <italic>spp</italic>: n = 1, and Mycobacterium <italic>spp</italic>: n = 1), were included as controls. Specimens were transferred to a vial containing 1 ml of viral transport medium (VTM), transported to the virology laboratory immediately and frozen at -70° C until they were processed for virus cultures.</p>
      </sec>
      <sec>
        <title>Cell lines</title>
        <p>HSV-1 was isolated employing a shell vial assay. HCE (fig. <xref ref-type="fig" rid="F1">1</xref>) (Kind gift from Dr. Araki-Sasaki, K., Osaka University Medical School, Osaka, Japan) and Vero (National facility for animal tissue and cell cultures, Pune, Maharashtra, India) shell vials were prepared as per standard protocols. The HCE cell line has been established by immortalizing primary cultured human corneal epithelial cells (obtained from a donor cornea) with a recombinant SV40-adenovirus vector and cloned three times to obtain a continuously growing cell line. This cell line has been shown to have properties similar to normal human corneal epithelial cells [<xref ref-type="bibr" rid="B9">9</xref>]. HCE cells were grown using the supplemented hormonal epithelial medium (SHEM) consisting of equal volumes of MEM and Ham's nutrient mixture F-12 supplemented with 5% (vol./vol.) heat inactivated fetal bovine serum (FBS), 5 μg/ml insulin, 0.1 μg/ml Cholera toxin, 10 ng/ml human epidermal growth factor, 0.5% dimethyl sulfoxide and 40 μg/ml gentamicin. All the reagents were obtained from Sigma, St. Louis MO. Vero cells were grown using MEM supplemented with 5% FBS.</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p><bold>Monolayer of HCE</bold>. Shell vial culture, Phase contrast microscopy, × 100.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-3-1"/>
        </fig>
      </sec>
      <sec>
        <title>Suitability and susceptibility of HCE for the isolation of HSV-1 by a shell vial assay and tube culture</title>
        <p>The HCE was assessed for its suceptibility to HSV-1 and its suitability for the isolation of HSV-1 by a shell vial assay and conventional tube culture, since such aspects of this cell line have not been described earlier. Briefly, a strain of HSV-1 (HSV-1, McIntyre, ATCC, V-539, Vero culture supernatant, 100 PFU in 500 μl) was inoculated into a shell vial and tube culture of HCE. The tube cultures were observed for the evidence of cytopathic effect (CPE) everyday for 4 days. Shell vial cultures were examined the next day (12–16 h) following the day of specimen inoculation. Shell vial and tube cultures were terminated and the cells harvested at 24 h and 96 h post-infection, respectively. HSV-1 isolation was confirmed using an indirect immunofluorescence/ immunoperoxidase assay.</p>
      </sec>
      <sec>
        <title>Shell vial cultures using clinical specimens</title>
        <p>For the shell vial cultures, specimens collected in VTM were thawed, vortexed vigorously for 30 seconds and an equal volume (0.5 ml/ vial) of the sample was inoculated into a vial of HCE and Vero cells. The vials were then centrifuged at 700 × <italic>g</italic> for 1 hour at room temperature and were incubated at 36°C for 1 hour for adsorption. The supernatant was discarded and 1 ml of maintenance medium (SHEM Supplemented with 1% FBS for HCE and MEM with 1% FBS for Vero cells) was added. The vials were incubated for 24 hours at 36°C. Based on our suceptibility assay results, routine examination of the cell cultures were done the next day (12–16 h) following the day of specimen inoculation, for any evidence of CPE. Cultures were terminated at 24 h post-infection. Isolation of HSV-1 was confirmed employing an indirect immunofluorescence assay using a polyclonal antibody to HSV-1 (Dako, Capinteria, LA). Two types of positivity were observed: qualitative (presence of cells with specific fluorescence) and quantitative (number of infectious foci (IF) present in each shell vial), as described previously [<xref ref-type="bibr" rid="B10">10</xref>].</p>
        <p>Statistical analysis was performed on results using a computer assisted statistical program (Epi Info, Version 6.04 b, CDC, USA). Chi square test for proportions (with Yates correction when required) was used. All <italic>P</italic> value were considered significant if less than 0.05.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Susceptibility of HCE to HSV-1 and its suitability for the isolation of HSV-1</title>
        <p>The HCE was found to be suceptible to HSV-1 as determined by both the shell vial and tube cultures. Cytopathic effect (CPE) (fig. <xref ref-type="fig" rid="F2">2</xref>) was seen in the tube cultures at 48 h (&gt;50% of the cells were refractile, showed rounding and ballooning). Shell vial culture showed such changes in few cells (&lt; 10%) at 12–16 h post-infection. Nevertheless, both the cultures showed the presence of infected cells as determined by the Immunofluorescence/ Immunoperoxidase assay (figs. <xref ref-type="fig" rid="F3">3</xref>,<xref ref-type="fig" rid="F4">4</xref>) suggesting that the HCE was suitable for use in the shell vial assay and tube cultures, for the isolation of HSV-1.</p>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p><bold>HCE showing CPE</bold>. Conventional tube culture, Phase contrast microscopy, × 100.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-3-2"/>
        </fig>
        <fig position="float" id="F3">
          <label>Figure 3</label>
          <caption>
            <p><bold>HSV-1 (McIntyre) infected HCE</bold>. Note the virus-infected cells showing apple green fluorescence. Uninfected cells are stained red due to the counterstain. Indirect immunofluorescence assay, × 400.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-3-3"/>
        </fig>
        <fig position="float" id="F4">
          <label>Figure 4</label>
          <caption>
            <p><bold>HSV-1(McIntyre) infected HCE</bold>. Virus infected cells are stained brown. Uninfected cells are stained blue due to the counterstain. Indirect immunoperoxidase assay, × 500.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-3-4"/>
        </fig>
      </sec>
      <sec>
        <title>Shell vial cultures using clinical specimens</title>
        <p>Virus could be isolated using both or either of the cell lines from 10/17 (58.82%) specimens collected from patients with HSK (figs. <xref ref-type="fig" rid="F5">5</xref>,<xref ref-type="fig" rid="F6">6</xref>,<xref ref-type="fig" rid="F7">7</xref>,<xref ref-type="fig" rid="F8">8</xref>). None of the controls yielded HSV-1. HSV-1 was isolated from 10/ 17 (58.82%) and 4/17(23.52%) specimens obtained from patients with HSK in HCE and Vero cells, respectively (P = 0.036) (Table <xref ref-type="table" rid="T1">1</xref>). The sensitivity, specificity, PPV and NPV are shown in Table <xref ref-type="table" rid="T1">1</xref>. While all the 10 (100%) strains were isolated in HCE, Vero yielded only 4/10 (40%) strains in the shell vial culture (<italic>P</italic> = 0.014) (Table <xref ref-type="table" rid="T2">2</xref>). The HCE showed a statistically significant difference in the virus isolation rate with respect to Vero cells. An unexpected finding in this study was that two of the specimens inoculated into the HCE showed CPE during routine examination of cultures at 12 h and 16 h, respectively (fig. <xref ref-type="fig" rid="F5">5</xref>). Such an observation was not seen in Vero cells.</p>
        <fig position="float" id="F5">
          <label>Figure 5</label>
          <caption>
            <p><bold>HCE inoculated with a clinical specimen showing CPE at 12 h in the shell vial assay</bold>. Note the presence of some rounded and refractile cells on the cover slip. The edge of the cover slip is also seen. Phase contrast microscopy, × 40.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-3-5"/>
        </fig>
        <fig position="float" id="F6">
          <label>Figure 6</label>
          <caption>
            <p><bold>HCE inoculated with a low viral load clinical specimen positive for HSV-1</bold>. Note the presence of very few infected cells showing apple green fluorescence. Indirect immunofluorescence assay, × 250.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-3-6"/>
        </fig>
        <fig position="float" id="F7">
          <label>Figure 7</label>
          <caption>
            <p><bold>HCE inoculated with a low viral load clinical specimen positive for HSV-1</bold>. Note the presence of very few infected cells, which are stained brown. Indirect immunoperoxidase assay, × 500.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-3-7"/>
        </fig>
        <fig position="float" id="F8">
          <label>Figure 8</label>
          <caption>
            <p><bold>HCE inoculated with a high viral load clinical specimen positive for HSV-1</bold>. Note the presence of many infected cells showing apple green fluorescence. Indirect immunofluorescence assay, × 125.</p>
          </caption>
          <graphic xlink:href="1471-2415-2-3-8"/>
        </fig>
        <table-wrap position="float" id="T1">
          <label>Table 1</label>
          <caption>
            <p>Qualitative results of HSV-1 isolation in HCE and Vero cells (n = 27, Cases: 17 [true positives], Controls: 10 [true negatives])</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td align="left">Cell line</td>
                <td align="center">True + ves</td>
                <td align="center">True - ves</td>
                <td align="center">Sensitivity(%)</td>
                <td align="center">Specificity(%)</td>
                <td align="center">PPV(%)</td>
                <td align="center">NPV(%)</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">HCE + ve</td>
                <td align="center">10</td>
                <td align="center">0</td>
                <td align="center">58.82</td>
                <td align="center">100</td>
                <td align="center">100</td>
                <td align="center">58.82</td>
              </tr>
              <tr>
                <td align="left">HCE - ve</td>
                <td align="center">7</td>
                <td align="center">10</td>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">Vero + ve</td>
                <td align="center">4</td>
                <td align="center">0</td>
                <td align="center">23.52</td>
                <td align="center">100</td>
                <td align="center">100</td>
                <td align="center">43.47</td>
              </tr>
              <tr>
                <td align="left">Vero - ve</td>
                <td align="center">13</td>
                <td align="center">10</td>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <table-wrap position="float" id="T2">
          <label>Table 2</label>
          <caption>
            <p>Details of HSV-1 isolation in HCE and Vero cells (n = 10)</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td align="left">Cell line</td>
                <td align="center">No. of strains isolated</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">HSV-1 isolated in HCE and Vero</td>
                <td align="center">4</td>
              </tr>
              <tr>
                <td align="left">HSV-1 isolated in HCE only</td>
                <td align="center">6</td>
              </tr>
              <tr>
                <td align="left">HSV-1 isolated in Vero only</td>
                <td align="center">0</td>
              </tr>
              <tr>
                <td align="left">Total no. of strains isolated</td>
                <td align="center">10</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Considering the quantitative analysis (Table <xref ref-type="table" rid="T3">3</xref>), HCE performed better than Vero cells, based on the number of IF present in the monolayers. HSV-1 was isolated in both the cell lines (3/ 3), when the viral load was high (&gt; 20 IF). In contrast, HCE yielded more number of isolations (7/7) than Vero (1/7) when the viral load was relatively low (&lt; 20 IF) (<italic>P</italic> = 0.0069, Table <xref ref-type="table" rid="T3">3</xref>). It is interesting to note that the virus could not be isolated in vero cells when the viral load was very low (&lt; 10 IF) while there were 4 isolations in HCE (Table <xref ref-type="table" rid="T3">3</xref>).</p>
        <table-wrap position="float" id="T3">
          <label>Table 3</label>
          <caption>
            <p>Quantitative results of HSV-1 isolation in HCE and Vero based on number of IF present in each shell vial.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td align="left">No. of IF</td>
                <td align="left" colspan="2">No. (%) of samples in cell line</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td/>
                <td align="left">HCE</td>
                <td align="left">Vero</td>
              </tr>
              <tr>
                <td colspan="3">
                  <hr/>
                </td>
              </tr>
              <tr>
                <td align="left">1–10</td>
                <td align="left">4 (100)</td>
                <td align="left">0 (0)</td>
              </tr>
              <tr>
                <td align="left">11–20</td>
                <td align="left">3 (100)</td>
                <td align="left">1 (33.3)</td>
              </tr>
              <tr>
                <td align="left">&gt; 20</td>
                <td align="left">3 (100)</td>
                <td align="left">3 (100)</td>
              </tr>
              <tr>
                <td align="left">Total</td>
                <td align="left">10 (100)</td>
                <td align="left">4 (40)</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>This study was performed to assess the relative sensitivity of a recently described HCE and the Vero cells based on an earlier observation that corneal epithelial cells may be more suitable for the isolation of HSV from the cornea [<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>Vero cells were chosen for comparison since our earlier observations over a two-year period (unpublished data) suggested that this cell line performs better than HEp2/ BHK-21/ HeLa or A549 in the isolation of HSV-1 from patients with HSK. We employed the shell vial assay since this technique has been shown to be a rapid and sensitive method for the isolation of HSV [<xref ref-type="bibr" rid="B11">11</xref>] and adenovirus [<xref ref-type="bibr" rid="B12">12</xref>] from ocular specimens when compared to the conventional tube cultures.</p>
      <p>Assays done to determine the performance characteristics of HCE show that this cell line is susceptible to HSV-1 and suitable for the isolation of the virus from corneal scrapings in a shell vial assay.</p>
      <p>Our results show that the HCE is superior to Vero in the isolation of HSV-1, both in the qualitative and quantitative analysis. Considering the qualitative analysis, it is interesting to note that HCE yielded the maximum number of isolations. There were no cases where HSV-1 was isolated only in Vero cells (Table <xref ref-type="table" rid="T2">2</xref>), which suggests the increased sensitivity of the HCE. While there was a statistically significant difference in the sensitivity of these two cell lines for virus isolation, the specificity and PPV were very good (100 %, Table <xref ref-type="table" rid="T1">1</xref>). However, the low NPV of both the cell lines (Table <xref ref-type="table" rid="T1">1</xref>) suggests that there is a need for better cell lines, especially for the isolation of virus from corneal scrapings. Further, it is worthwhile to note that CPE can be observed in HCE earlier than in conventional tube cultures, in some specimens, as seen in this study. Such specimens can be processed for imunofluorescence/ immunoperoxidase assay immediately leading to a "reduced turn around time" of reporting the results.</p>
      <p>Analysis of the quantitative results showed that HCE had the greatest sensitivity irrespective of the viral load, while vero had similar sensitivity to that of HCE only when the load was high (Table <xref ref-type="table" rid="T3">3</xref>). HCE proved to be very beneficial, especially when the viral load was low (&lt; 10 IF) (Table <xref ref-type="table" rid="T3">3</xref>).</p>
      <p>It is obvious from the results that HSV-1 can be more often isolated in HCE than Vero. This has been shown both by qualitative and quantitative analysis.</p>
      <p>In general, the isolation rates of HSV-1 in cultures from corneal specimens have been low [<xref ref-type="bibr" rid="B6">6</xref>], irrespective of the cell line used. Our earlier report showed a similar trend wherein we could isolate HSV-1 in Vero cells only in 5/15 (33.3%) specimens obtained from patients with HSK [<xref ref-type="bibr" rid="B13">13</xref>]. This study demonstrates that using HCE can further increase the virus isolation rate.</p>
      <p>The rate of isolation of HSV-1 from corneal scrapings has increased from 33.3% to 58.82% in our laboratory employing the HCE, as seen in this study. We have used an inoculum size of 0.5 ml of the specimen in our study. It has earlier been shown that increasing the inoculum size of the specimen can further increase the sensitivity of the shell vial assay [<xref ref-type="bibr" rid="B14">14</xref>]. Such studies are being done at our laboratory.</p>
      <p>We have shown the superiority of HCE over Vero cells in the isolation of HSV-1 from corneal scrapings for the laboratory diagnosis of HSK, in this preliminary study. However, the results should be interpreted with caution, since the sample size is small. Further studies are warranted using an adequate sample size. Such a study is being pursued in our laboratory.</p>
      <p>To the best of our knowledge based on a "MEDLINE" search, this is the first report of the HCE being used for the isolation of HSV-1 in a shell vial assay for the laboratory diagnosis of HSK. We believe that the inclusion of this cell line, when available, in the routine culture protocols of ocular virology laboratories would result in a significant increase in the diagnostic yield.</p>
    </sec>
    <sec>
      <title>Commercial interests</title>
      <p>None declared</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/2/3/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>This study was supported by the Hyderabad Eye Research Foundation, Hyderabad, India.</p>
        <p>We thank all the patients for participation in this study, Dr. Prashant Garg, Dr. Nibaran Gangopadhyay for the clinical evaluation and collection of corneal scrapings from the patients with HSK and Mr. S. B. N Chary for excellent photography.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Shimomura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>yamamoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tano</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Detection of herpes simplex virus DNA in human tear film by polymerase chain reaction.</article-title>
          <source>Am J Ophthalmol</source>
          <year>1994</year>
          <volume>117</volume>
          <fpage>160</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">8116743</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Espy</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Uhl</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Thorvilson</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Wold</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>TF</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis of herpes simplex virus infection in the clinical laboratory by Light Cycler PCR.</article-title>
          <source>J Clin Microbiol</source>
          <year>2000</year>
          <volume>38</volume>
          <fpage>795</fpage>
          <lpage>799</lpage>
          <pub-id pub-id-type="pmid">10655387</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kowalski</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>YJ</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of immunologic tests for the detection of ocular herpes simplex virus.</article-title>
          <source>Ophthalmology</source>
          <year>1989</year>
          <volume>96</volume>
          <fpage>1583</fpage>
          <lpage>1586</lpage>
          <pub-id pub-id-type="pmid">2559384</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thiel</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bossart</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bernauer</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Improved impression cytology techniques for the immunopathological diagnosis of superficial viral infections.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1997</year>
          <volume>81</volume>
          <fpage>984</fpage>
          <lpage>988</lpage>
          <pub-id pub-id-type="pmid">9505824</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asbell</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kamenar</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Botone</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Rapid diagnosis of ocular herpes simplex infections.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1995</year>
          <volume>79</volume>
          <fpage>473</fpage>
          <lpage>475</lpage>
          <pub-id pub-id-type="pmid">7612561</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaye</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bonshek</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Maseruka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Grinfeld</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tullo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Easty</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Human herpes viruses in the cornea.</article-title>
          <source>Br J Ophthalmol</source>
          <year>2000</year>
          <volume>84</volume>
          <fpage>563</fpage>
          <lpage>571</lpage>
          <pub-id pub-id-type="pmid">10837377</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.84.6.563</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buthod</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Schindler</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>HW</given-names>
            </name>
          </person-group>
          <article-title>Determination of cell line suitability for rapid isolation of herpes simplex virus.</article-title>
          <source>J Virol Methods</source>
          <year>1987</year>
          <volume>18</volume>
          <fpage>37</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="pmid">2826519</pub-id>
          <pub-id pub-id-type="doi">10.1016/0166-0934(87)90108-X</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mori</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shimomura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Susceptibility of cultured rabbit corneal epithelial cells to various herpes simplex virus isolates.</article-title>
          <source>Jpn J Ophthalmol</source>
          <year>1996</year>
          <volume>40</volume>
          <fpage>367</fpage>
          <lpage>370</lpage>
          <pub-id pub-id-type="pmid">8988426</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Araki-Sasaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohashi</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Sasabe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tano</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Handa</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>An SV40 immortalized human corneal epithelial cell line and its characteriaztion.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1995</year>
          <volume>36</volume>
          <fpage>614</fpage>
          <lpage>621</lpage>
          <pub-id pub-id-type="pmid">7534282</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reina</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fernandez-Baca</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Blanco</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Munar</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Comparison of Madin-Darby canine kidney cells (MDCK) with a green monkey continuous cell line (Vero) and human embryonated cells (MRC-5) in the isolation of Influenza A virus from nasopharyngeal aspirates by shell vial culture.</article-title>
          <source>J Clin Microbiol</source>
          <year>1999</year>
          <volume>35</volume>
          <fpage>1900</fpage>
          <lpage>1901</lpage>
          <pub-id pub-id-type="pmid">9196221</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walpita</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Darougar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Thaker</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>A rapid and sensitive culture test for detecting herpes simplex virus from the eye.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1985</year>
          <volume>69</volume>
          <fpage>637</fpage>
          <lpage>639</lpage>
          <pub-id pub-id-type="pmid">2994709</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kowalski</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Karenchak</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Romanowski</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>YJ</given-names>
            </name>
            <collab>the community Ophthalomologists of Pittsburg, Pennsylvania</collab>
          </person-group>
          <article-title>Evaluation of the shell vial technique for the detection of ocular adenovirus.</article-title>
          <source>Ophthalmology</source>
          <year>1999</year>
          <volume>106</volume>
          <fpage>1324</fpage>
          <lpage>1327</lpage>
          <pub-id pub-id-type="pmid">10406615</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(99)00718-6</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Athmanathan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sesha Reddy</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>GN</given-names>
            </name>
          </person-group>
          <article-title>Collection of impression cytology directly on a sterile glass slide for the detection of viral antigen: An inexpensive and simple technique for the diagnosis of HSV epithelial keratitis – A pilot study.</article-title>
          <source>BMC Ophthalmology</source>
          <year>2001</year>
          <volume>1</volume>
          <fpage>3</fpage>
          <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/1/3"/>
          <pub-id pub-id-type="pmid">11592921</pub-id>
          <pub-id pub-id-type="doi">10.1186/1471-2415-1-3</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>FB</given-names>
            </name>
            <name>
              <surname>Visick</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>A rapid culture alternative to the shell vial method for the detection of herpes simplex virus.</article-title>
          <source>Diag Microbiol Infect Dis</source>
          <year>1992</year>
          <volume>15</volume>
          <fpage>673</fpage>
          <lpage>678</lpage>
          <pub-id pub-id-type="doi">10.1016/0732-8893(92)90070-A</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:138814</identifier><datestamp>2002-12-19</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">138814</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-2-4</article-id>
      <article-id pub-id-type="pmid">12489986</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-2-4</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Changes in the tear proteins of diabetic patients</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Grus</surname>
            <given-names>F H</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>f@grus.de</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Sabuncuo</surname>
            <given-names>P</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>100024.1664@csi.com</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Dick</surname>
            <given-names>H B</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>100024.1664@csi.com</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Augustin</surname>
            <given-names>A J</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>100024.1664@csi.com</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Pfeiffer</surname>
            <given-names>N</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>100024.1664@csi.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Dept. of Ophthalmology, University of Mainz, Germany</aff>
      <aff id="I2"><label>2</label>Dept. of Ophthalmology, Staedt. Klinikum, Karlsruhe, Germany</aff>
      <pub-date pub-type="collection">
        <year>2002</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>10</month>
        <year>2002</year>
      </pub-date>
      <volume>2</volume>
      <fpage>4</fpage>
      <lpage>4</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/2/4"/>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>6</month>
          <year>2002</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>10</month>
          <year>2002</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2002 Grus et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2002</copyright-year>
        <copyright-holder>Grus et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Previous studies have shown a significant increase in tear protein peaks in the tears of diabetic patients suffering from dry eye. The aim of this study was to analyze the tear protein patterns from patients with diabetes mellitus who do not suffer from ocular surface diseases (DIA).</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>A total of 515 patients were examined in this study (255 healthy subjects (controls) and 260 patients suffering from diabetes mellitus). Tear proteins were separated by sodium-dodecyl-sulfate polyacrylamide gel electrophoresis. After digital image analysis densitometric data files were created and subsequently used for multivariate statistical procedures.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>A significant increase in the number of peaks was detected in diabetic patients compared to controls (P &lt; 0.0003). The analysis of discriminance revealed a highly significant discrimination between diabetic patients and controls (Wilks lambda: 0.27; P &lt; 0.000001). Furthermore, a significant difference in the protein pattern of diabetic patients could be detected between those suffering from dry eye or not (P &lt; 0.002). The changes in protein patterns of diabetic patients increased with the duration of the diabetic disease. In diabetic patients with a disease duration longer than 10 years the changes were significantly more expressed than in patients with a shorter diabetic history (P &lt; 0.003) and in healthy subjects (P &lt; 0.0001).</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The tear protein patterns of diabetic patients are very different in the number and intensity of spots from those of healthy subjects. Furthermore, it could be demonstrated that the differences found in the tear patterns of diabetic patients are not equal to those found in previous studies in patients suffering from dry-eye disease. The alterations in the diabetic tears were correlated with the duration of the diabetic disease. With longer disease, history changes in the tear protein patterns increased. With the course of the disease some protein peaks appeared that are not present in healthy persons. Our study shows that the analysis of electrophoretic tear protein patterns is a new non-invasive approach in the early diagnosis and analysis of the pathogenesis of diabetes induced ocular surface disease.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>In previous studies changes in tear protein patterns of diabetic patients suffering from dry-eye disease could be found [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. The occurrence of the dry eye disease and other ocular surface diseases is increased in diabetic patients [<xref ref-type="bibr" rid="B4">4</xref>].</p>
      <p>The dry eye syndrome has a very high frequency of occurrence in the industrial word. In the United States, 1 of 5 people, i.e. 59 millions of patients, suffer from symptoms of this disease (Eagle Vision, Yankelovich und Partners, 1997), and the number of dry eye patients has been doubled since the last ten years [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. Dry eye patients typically suffer from discomfort, burning, irritation, photophobia, blurred vision, and have an increased risk of corneal infection and resulting irreversible tissue damages [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. This is mostly caused by aqueous, mucin or lipid deficiencies in tears.</p>
      <p>Until today, no causative treatment of the disease is available. Patients are symptomatically treated with lubricant eye drops.</p>
      <p>Worldwide about 100 millions of people suffer from Diabetes mellitus [<xref ref-type="bibr" rid="B11">11</xref>]. Diabetes is a systemic disease with multiple severe very known related disorders such as the diabetic angiopathy, polyneuropathy, and nephropathy. Many ocular complications such as the inflammation of lids, acute orbital infections, cataract, and the diabetic retinopathy are known to be associated with diabetes mellitus and many of them may lead to blindness. Moreover, the risk of cataract is 2–4 times greater than in healthy people [<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. In diabetic patients a significantly increased corneal thickness [<xref ref-type="bibr" rid="B16">16</xref>] and a decreased corneal sensitivity [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B20">20</xref>] was demonstrated. Interestingly, the severity of the dry eye disease correlates with the severity of the diabetic retinopathy [<xref ref-type="bibr" rid="B21">21</xref>], which represents a main reason for blindness in diabetic patients.</p>
      <p>The tear film quantity (Schirmer test=basal secretory test, BST) is decreased in diabetic patients [<xref ref-type="bibr" rid="B22">22</xref>]. In this study, we attempt to investigate the changes in the composition of tears in diabetic patients compared to healthy subjects.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Patients</title>
        <p>Tears of 515 patients were collected without touching the lid margins and eye lashes of the patients, 255 control persons (controls) and 260 diabetic patients (DIA). Informed consent was obtained from all patients participating in this study. All diabetic patients were diabetic type II with a known diabetic history. The tear volume of approximately 5 μl was sampled with a 5 μl glass capillary and stored at -80°C until use. The basis secretory test (BST) was performed and the patient's history was taken. Each patient was asked for his subjective symptoms like burning, itching, foreign body sensation, dryness, and photophobia. For all diabetic patients, it was determined if they suffer from dry-eye disease. The initial clinical diagnosis of dry eye was based on the BST value. Patients with values BST &lt; 11/5' were classified as dry eye (DIDRY= diabetic patients suffering from dry eye; DICTRL= diabetic patients without dry eye symptoms).</p>
      </sec>
      <sec>
        <title>Biochemical procedures</title>
        <sec>
          <title>Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE)</title>
          <p>Tear samples were centrifuged at 12000 g for 3 to 5 min. 0.5 μl of each tear sample were diluted with 2.5 μl sample buffer (62.5 mM Tris, pH 6.8, 5% (v/v) 2-mercaptoethanol, 10% (w/v) saccharose, 2% SDS, 0.005 % bromphenolblue). The tear proteins were separated by SDS-PAGE (sodium-dodecyl-sulfate polyacrylamide gel-electrophoresis) on discontinuous slab-gels ([<xref ref-type="bibr" rid="B23">23</xref>], stacking gel: 125 mM Tris, pH 6.8, 0.1 % (w/v) SDS; separating gel: 375 mM Tris, pH 8.8, 0.1 % SDS, electrode buffer: 192 mM glycine, 25 mM Tris, pH 8.3, 0.1% SDS (MultiGel-Long, Biometra, Germany). Molecular weights were estimated using marker proteins (BioRad, Munich, Germany, molecular weight standards "broad range"). The electrophoretic separations were stained by the standard Coomassie-Blue procedure [<xref ref-type="bibr" rid="B24">24</xref>].</p>
        </sec>
        <sec>
          <title>Digital image analysis</title>
          <p>The data was acquired using the video documentation system BioDocAnalyze (Biometra, Göttingen, Germany).</p>
          <p>All lanes were defined by start, end, and their width. For each particular Rf-region (relative mobility), a gray value was calculated by averaging the values within that width of the lane. For each electrophoretic lane, a densitometric data file was created by showing the gray-intensity values versus the Rf values. BioDocAnalyze evaluates height, area, and molecular weight, Rf value (relative mobility), etc., for all peaks in all lanes. The separated proteins could be identified by comparing the relative mobilities of unknown proteins of a sample to the relative mobilities of known proteins in the molecular weight standard (Broad Range, BioRad, Munich).</p>
        </sec>
      </sec>
      <sec>
        <title>Statistical procedure</title>
        <p>For each electrophoretic lane a data vector was created and the Rf range, i.e., Rf = 0 through Rf = 1, was divided into 70 different classes. Every variable of the data vector thus represents 1/70 of the complete Rf-range. For all peaks of each electrophoretic lane it was calculated into which particular Rf-class this peak falls. The volume of that peak was added to the corresponding variable of this Rf-class in the data vector of this electrophoretic lane. From these data vectors, a multivariate analysis of discriminance was performed. This analysis of discriminance not only tests the zero hypothesis that mean data vectors of the different groups derive from a multivariate normally distributed population, but also shows which of the various groups are statistically different. Based on this, discriminant function analysis can be used to determine which variables (Rf ranges) caused the mean value comparison to become significant or which variables can discriminate between groups. Additionally, the analysis allows classification of electrophoretic patterns; it can be used to test whether an individual protein pattern is similar to the pattern of a particular known group or to which of several group patterns it shows the greatest similarity. This calculation procedure has been described in detail elsewhere [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. The statistical calculations were performed by STATISTICA™ (Ver 5.5, Statsoft, Tulsa, USA).</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <p>There were no age- or gender-related statistical differences between patients with diabetes and control subjects.</p>
      <p>In the electrophoretic separations, the known main protein peaks could be detected (Fig. <xref ref-type="fig" rid="F1">1</xref>). The quantitative analysis of the volume of the 5 main protein peaks (lactoferrin, sIgA, albumin, lipocalin, and lysozyme) revealed no statistical significant difference between the clinical groups (healthy persons and patients suffering from diabetes mellitus; p &gt; 0.05).</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Densitograph and photograph of an electrophoretic lane of the DRY group. Scanner units are plotted vs. the Rf-values (relative mobility). 1: lactoferrin and sIgA (secretory IgA), 2: albumin, 3: heavy chain of sIgA, 4: alpha sIgA, 5: lipocalin, formerly called tear specific prae albumin (TSPA), and 6: lysozyme.</p>
        </caption>
        <graphic xlink:href="1471-2415-2-4-1"/>
      </fig>
      <p>However, a significant increase in the number of peaks could be detected in diabetic patients compared to controls (P &lt; 0.0003; Fig. <xref ref-type="fig" rid="F2">2</xref>).</p>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>Mean number of peaks (± SE) in the tears of diabetic patients (DICTRL), diabetic patients suffering from dry-eye disease (DIDRY), and healthy volunteers (CTRL). The number of peaks was significantly higher in DIA, and DIDRY compared to CTRL (P &lt; 0.05).</p>
        </caption>
        <graphic xlink:href="1471-2415-2-4-2"/>
      </fig>
      <p>A complete electrophoretic pattern analysis was performed – represented by the data vector derived from the densitographic data. The multivariate analysis of discriminance revealed a highly significant discrimination between diabetic patients and controls (Wilks lambda: 0.27; P &lt; 0.000001).</p>
      <p>For each diabetic patient, a BST was performed. According to the results of this test, 140 of the diabetic patients suffered from dry-eye (DIDRY) and 120 of them did not (DICTRL). The protein patterns of DIDRY and DICTRL were compared and a significant difference in the protein pattern and number of peaks of diabetic patients could be detected between those suffering from dry eye disease or not (P &lt; 0.002).</p>
      <p>To investigate the correlation between the changes in protein patterns and the duration of the diabetic disease, the diabetic patients were subgrouped between those, who had a known diabetic history longer than 10 years (DIA2) or shorter (DIA1).</p>
      <p>The changes in the protein patterns of diabetic patients increased with the duration of the diabetic disease. In diabetic patients with a disease duration longer than 10 years the alterations in protein patterns were significantly more expressed than in patients with a shorter diabetic history (P &lt; 0.003). Furthermore, the changes were more pronounced in DIA2 compared to healthy subjects (P &lt; 0.0001) (Fig. <xref ref-type="fig" rid="F3">3</xref>). A correlation analysis (spearman rank correlation test) revealed a r<sup>2</sup>-value of 0.9 (p &lt; 0.03).</p>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>The mean canonical roots (± SE) derived from the analysis of discriminance of tear protein patterns were plotted for three groups: normal controls, diabetic patients with a disease duration longer than ten years (DIA2) and shorter (DIA1). The figure illustrates the power of discriminance between the groups: the closer the bars are to each other, the more similar are the tear protein patterns of the electrophoretic separations of these groups.</p>
        </caption>
        <graphic xlink:href="1471-2415-2-4-3"/>
      </fig>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>In previous studies a significant difference in the tear protein patterns of patients suffering from dry eye, diabetic patients suffering from dry eye, and healthy volunteers could be demonstrated [<xref ref-type="bibr" rid="B3">3</xref>]. This was done by means of one-dimensional electrophoretical separations of the tear proteins.</p>
      <p>In the present study, the electrophoretic patterns from tear proteins of non-diabetic and diabetic patients were analyzed and compared to controls. The main protein peaks, lactoferrin, lysozyme, lipocalin, and albumin were detected and quantified. No statistical significant difference between the main protein peaks of the groups could be found. However, the number of peaks was significantly increased in the tear protein pattern of diabetics. By including all peaks of the electrophoretic separations in the comparison, the multivariate approach could demonstrate a significant difference between both groups (diabetics and healthy volunteers). Thus, this must be due to changes in tear protein patterns, e.g. the development of new protein peaks, not only by slight differences between the concentrations of the main protein peaks. The most important differences in protein patterns were found in the molecular weight range of 30–50 kDa. We could not identify one single peak that was consistent in all patients. However, an increase of peaks in that molecular weight range was highly specific.</p>
      <p>Those "new" proteins, which do not exist in healthy subjects, could play a role in the pathogenesis of the diabetic disease and/or the development of eye-related complications of the diabetic disease. The present study demonstrates that changes in protein patterns are strongly correlated with the duration of the diabetic disease. The longer the disease duration, the more changes were expressed. Thus, it is promising to evaluate the use of these proteins as early-onset or follow-up marker of the diabetic disease. Further study has to prove if the differences in tear proteins found in this study have a prognostic value for the development of diabetic retinopathy. The differences found might not be caused by the diabetes itself, but by the trophic or autonomic disturbances common to that condition. However, an increased knowledge about the protein changes found in this study could be helpful, e.g., for identifying diabetics at risk of becoming blind.</p>
      <p>It is still not clear why diabetic patients develop dry eyes more often than healthy subjects [<xref ref-type="bibr" rid="B27">27</xref>]. One possible explanation could be an exocrine dysfunction of the main lacrimal gland in patients with diabetes mellitus or perhaps the development of additional unknown proteins in the tear fluids. Another cause could be the reduction of stimulatory signals from the ocular surface to the lacrimal gland as consequence of the reduced corneal sensation and the influence on regulatory systems.</p>
      <p>However, this study could prove that the tear protein patterns of diabetics are different from those diabetic patients who suffer additionally from the dry-eye disease. These changes were clearly distinguishable from each other. Thus, it can be excluded that the method used to determine the changes in protein pattern just recognizes in general any changes as significant. In this study, the tear composition of diabetics was found to be changed in comparison to other diabetic patients suffering additionally from an ocular surface disease that is already known to have an influence on the protein patterns in tears [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>This preliminary study could clearly and surprisingly demonstrate that there are marked alterations in the diabetic tear protein patterns. Further studies will evaluate whether the changes in the tear protein patterns of the diabetic patients can be used as a new non-invasive diagnostic tool. Furthermore, identifying these proteins could contribute to learn more about the pathogenesis of diabetic related ocular surface disease.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>None declared.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>PS carried out the biochemical procedures. FHG conceived of the study and was responsible for the study design and computer analysis. BHD, AJA, and NP was involved in study design, discussion of the results and work with patients included in that study.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/2/4/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grus</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Augustin</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Evangelou</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Toth-Sagi</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Analysis of tear-protein patterns as a diagnostic tool for the detection of dry-eyes in diabetic and non-diabetic dry-eye patients.</article-title>
          <source>Eur J Ophthalmol</source>
          <year>1998</year>
          <volume>8</volume>
          <fpage>90</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">9673477</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grus</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Augustin</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Analysis of tear protein patterns by a neural network as a diagnostical tool for the detection of dry eyes.</article-title>
          <source>Electrophoresis</source>
          <year>1999</year>
          <volume>20</volume>
          <fpage>875</fpage>
          <lpage>880</lpage>
          <pub-id pub-id-type="pmid">10344262</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grus</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Augustin</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Toth-Sagi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Evangelou</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Schmitz</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Analysis of tear protein patterns by means of HPLC.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1998</year>
          <volume>39</volume>
          <fpage>536</fpage>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramos-Remus</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Suarez-Almazor</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Performance of online biomedical databases in rheumatology.</article-title>
          <source>Clin Exp Rheumatol</source>
          <year>1994</year>
          <volume>12</volume>
          <fpage>375</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">7955600</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schein</surname>
              <given-names>OD</given-names>
            </name>
            <name>
              <surname>Munoz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Tielsch</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Bandeen-Roche</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of dry eye among the elderly.</article-title>
          <source>Am J Ophthalmol</source>
          <year>1997</year>
          <volume>124</volume>
          <fpage>723</fpage>
          <lpage>728</lpage>
          <pub-id pub-id-type="pmid">9402817</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bjerrum</surname>
              <given-names>KB</given-names>
            </name>
          </person-group>
          <article-title>The ratio of albumin to lactoferrin in tear fluid as a diagnostic tool in primary Sjogren's syndrome.</article-title>
          <source>Acta Ophtahlmol Scand</source>
          <year>1997</year>
          <volume>75</volume>
          <fpage>281</fpage>
          <lpage>286</lpage>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Damato</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Allan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1994</year>
          <volume>68</volume>
          <fpage>674</fpage>
          <lpage>680</lpage>
          <pub-id pub-id-type="pmid">6331845</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hikichi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fukui</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Course of vitreomacular traction syndrome.</article-title>
          <source>Graefes Arch Clin Exp Ophthalmol</source>
          <year>1995</year>
          <volume>233</volume>
          <fpage>555</fpage>
          <lpage>558</lpage>
          <pub-id pub-id-type="pmid">8543205</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lemp</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes.</article-title>
          <source>CLAO</source>
          <year>1995</year>
          <volume>21</volume>
          <fpage>221</fpage>
          <lpage>232</lpage>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubniewski</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Posterior infectious crystalline keratopathy with Staphylococcus epidermidis.</article-title>
          <source>Ophthalmology Clinics of North America</source>
          <year>1990</year>
          <volume>3</volume>
          <fpage>575</fpage>
          <lpage>594</lpage>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="other">
          <article-title>Deutscher Diabetiker Bund e.V.</article-title>
          <year>2000</year>
          <ext-link ext-link-type="uri" xlink:href="http://www.diabetikerbund.de"/>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ederer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hiller</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Senile lens changes and diabetes in two population studies.</article-title>
          <source>Am J Ophthalmol</source>
          <year>1981</year>
          <volume>91</volume>
          <fpage>381</fpage>
          <pub-id pub-id-type="pmid">7211996</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nielsen</surname>
              <given-names>NV</given-names>
            </name>
            <name>
              <surname>Vinding</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The prevalence of cataract in insulin-independent and noninsulin-dependent diabetes mellitus.</article-title>
          <source>Acta Ophthalmol</source>
          <year>1984</year>
          <volume>62</volume>
          <fpage>595</fpage>
          <pub-id pub-id-type="pmid">6385608</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skaika</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Prchal</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>The effect of diabetes mellitus and diabetic therapy on cataract formation.</article-title>
          <source>Ophthalmology</source>
          <year>1981</year>
          <volume>88</volume>
          <fpage>117</fpage>
          <pub-id pub-id-type="pmid">7231895</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>BEK</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of cataracts in a population-based study of persons with diabetes mellitus.</article-title>
          <source>Ophthalmology</source>
          <year>1985</year>
          <volume>92</volume>
          <fpage>1191</fpage>
          <pub-id pub-id-type="pmid">4058882</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Desai</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Lavingia</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Cornea thickness and tear glucose levels in diabetes mellitus and normal persons.</article-title>
          <source>Indian J Ophthalmol</source>
          <year>1987</year>
          <volume>35</volume>
          <fpage>130</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">3508761</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Awasthi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sarbhai</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Maheshwari</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
          <article-title>Corneal sensations in diabetes mellitus.</article-title>
          <source>Transactions of the International Congress (Paris)</source>
          <year>1974</year>
          <volume>1</volume>
          <fpage>402</fpage>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rogell</surname>
              <given-names>GD</given-names>
            </name>
          </person-group>
          <article-title>Corneal hypesthesia and retinopathy in diabetes mellitus.</article-title>
          <source>Ophthalmology</source>
          <year>1980</year>
          <volume>87</volume>
          <fpage>229</fpage>
          <pub-id pub-id-type="pmid">7191550</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>ED</given-names>
            </name>
          </person-group>
          <article-title>Corneal sensitivity in diabetics.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1974</year>
          <volume>91</volume>
          <fpage>174</fpage>
          <pub-id pub-id-type="pmid">4814962</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scullica</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Proto</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Rilievi clinici e statistici sulla sensibilita corneale nei diabetici.</article-title>
          <source>Boll Ocul</source>
          <year>1965</year>
          <volume>44</volume>
          <fpage>944</fpage>
          <pub-id pub-id-type="pmid">5884905</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nepp</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Abela</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Polzer</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Derbolav</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wedrich</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Is there a correlation between the severity of diabetic retinopathy and keratoconjunctivitis sicca.</article-title>
          <source>Cornea</source>
          <year>2000</year>
          <volume>19</volume>
          <fpage>487</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">10928764</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dogru</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Katakami</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Masanori</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Tear function and ocular surface changes in noninsulin depetendent diabetes mellitus.</article-title>
          <year>2001</year>
          <volume>108</volume>
          <fpage>586</fpage>
          <lpage>592</lpage>
          <pub-id pub-id-type="pmid">11237914</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laemmli</surname>
              <given-names>UK</given-names>
            </name>
          </person-group>
          <article-title>Cleavage of structural proteins during the assembly of head of bacteriophage T4.</article-title>
          <source>Nature</source>
          <year>1970</year>
          <volume>227</volume>
          <fpage>680</fpage>
          <lpage>685</lpage>
          <pub-id pub-id-type="pmid">5432063</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harlow</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lane</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Antibodies, a laboratory manual.</article-title>
          <source>Cold Spring Harbor Laboratory</source>
          <year>1988</year>
          <volume>649</volume>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmermann</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Grus</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Dux</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Multivariate statistical comparison of autoantibody repertoires (Western-blots) by discriminant analysis.</article-title>
          <source>Electrophoresis</source>
          <year>1995</year>
          <volume>16</volume>
          <fpage>941</fpage>
          <lpage>947</lpage>
          <pub-id pub-id-type="pmid">7498140</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grus</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Augustin</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Toth-Sagi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Autoantibody repertoires in animals with lens-induced uveitis after different therapies using megablot technique: A Comparison.</article-title>
          <source>Adv Ther</source>
          <year>1997</year>
          <volume>14</volume>
          <fpage>8</fpage>
          <lpage>13</lpage>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seifart</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Strempel</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>The dry eye and diabetes mellitus.</article-title>
          <source>Opthalmologe</source>
          <year>1994</year>
          <volume>91</volume>
          <fpage>235</fpage>
          <lpage>9</lpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:140319</identifier><datestamp>2003-02-04</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">140319</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-3-1</article-id>
      <article-id pub-id-type="pmid">12515578</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-3-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Analysis of nuclear fiber cell compaction in transparent and cataractous diabetic human lenses by scanning electron microscopy</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Freel</surname>
            <given-names>Christopher D</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>cfreel@med.unc.edu</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Al-Ghoul</surname>
            <given-names>Kristin J</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>Kristin_J_Al-Ghoul@rush.edu</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Kuszak</surname>
            <given-names>Jer R</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>jkuszak@rush.edu</email>
        </contrib>
        <contrib id="A4" corresp="yes" contrib-type="author">
          <name>
            <surname>Costello</surname>
            <given-names>M Joseph</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>mjc@med.unc.edu</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Cell and Developmental Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA</aff>
      <aff id="I2"><label>2</label>Department of Anatomy, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL, USA</aff>
      <aff id="I3"><label>3</label>Department of Ophthalmology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL, USA</aff>
      <aff id="I4"><label>4</label>Department of Pathology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL, USA</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>1</month>
        <year>2003</year>
      </pub-date>
      <volume>3</volume>
      <fpage>1</fpage>
      <lpage>1</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/1"/>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>10</month>
          <year>2002</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>1</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2003 Freel et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Freel et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Compaction of human ocular lens fiber cells as a function of both aging and cataractogenesis has been demonstrated previously using scanning electron microscopy. The purpose of this investigation is to quantify morphological differences in the inner nuclear regions of cataractous and non-cataractous human lenses from individuals with diabetes. The hypothesis is that, even in the presence of the osmotic stress caused by diabetes, compaction rather than swelling occurs in the nucleus of diabetic lenses.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>Transparent and nuclear cataractous lenses from diabetic patients were examined by scanning electron microscopy (SEM). Measurements of the fetal nuclear (FN) elliptical angles (anterior and posterior), embryonic nuclear (EN) anterior-posterior (A-P) axial thickness, and the number of EN fiber cell membrane folds over 20 μm were compared.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Diabetic lenses with nuclear cataract exhibited smaller FN elliptical angles, smaller EN axial thicknesses, and larger numbers of EN compaction folds than their non-cataractous diabetic counterparts.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>As in non-diabetic lenses, the inner nuclei of cataractous lenses from diabetics were significantly more compacted than those of non-cataractous diabetics. Little difference between diabetic and non-diabetic compaction levels was found, suggesting that diabetes does not affect the degree of compaction. However, consistent with previous proposals, diabetes does appear to accelerate the formation of cataracts that are similar to age-related nuclear cataracts in non-diabetics. We conclude that as scattering increases in the diabetic lens with cataract formation, fiber cell compaction is significant.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>The normal human ocular lens exhibits a steady increase in size due to growth throughout life, harboring some the oldest cells in the body [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. Overall, from birth to 65 years of age, the human lens will increase 63% in equatorial diameter, while increasing only 22% in A-P axial thickness [<xref ref-type="bibr" rid="B4">4</xref>]. Cell growth dramatically influences the contours of the anterior and posterior lens surfaces, but is not the sole factor affecting lens form.</p>
      <p>Previous studies investigating the hydration of transparent human lenses revealed an age-related dependence between water content and lens region [<xref ref-type="bibr" rid="B5">5</xref>]. With advancing age, the human lens cortex shows a slight increase in water composition (+0.0087%/year), whereas the nucleus decreases its total water content (-0.077%/year), setting up a gradient of hydration [<xref ref-type="bibr" rid="B5">5</xref>]. Studies of human diabetic lenses have revealed greater total water content in comparison to transparent, non-diabetic lenses, with swelling reported to extend into the adult and perhaps the fetal nuclei [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. The result is a characteristically larger lens in comparison to transparent, age-matched, non-diabetic lenses. Previous documentation by Scheimpflug analysis demonstrated that the annual expansion rate of the lenticular A-P length is accelerated 70% in early-onset diabetics [<xref ref-type="bibr" rid="B8">8</xref>]. Steepening of the anterior and posterior surface curvatures was detected but little difference in lens nuclear size was found. The osmotic imbalance observed in the diabetic lens may be responsible for the pronounced influx of water into the epithelial and cortical areas, swelling and damaging the cells [<xref ref-type="bibr" rid="B9">9</xref>].</p>
      <p>In our previous morphological study of non-diabetic aging human lenses by SEM it was concluded that the innermost nuclear fibers of the human lens significantly decrease in size and change shape with age and cataractogenesis [<xref ref-type="bibr" rid="B4">4</xref>], a process termed compaction. In concordance with previous investigations [<xref ref-type="bibr" rid="B10">10</xref>], it was found that the rate of lens compaction was not constant over time, and that the majority of compaction was observed before middle age. Changes in the A-P length of the embryonic nucleus impact the curvature angles of the inner fetal nuclear fibers at the equator, possibly affecting the overall lenticular form. Employing transmission electron microscopy (TEM) in an additional study [<xref ref-type="bibr" rid="B9">9</xref>], extensive fiber cell damage was noted in the outer adult nucleus of late-onset diabetic cataractous lenses, with minimal morphological disturbances in the inner nuclei.</p>
      <p>In this study, SEM was used to search for evidence of osmotic swelling and/or fiber cell compaction in the nucleus of non-cataractous and clinically diagnosed nuclear cataractous human lenses from persons with diabetes. Due to the manner in which we receive our specimens, the nature and medical history of the donors' diabetes are unknown. This study aims to compare the transparent lenses of diabetic patients to those of with nuclear cataract, without conclusions based on disease type or treatment. For further comparisons, previously documented non-diabetic compaction data was utilized [<xref ref-type="bibr" rid="B4">4</xref>].</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Specimens</title>
        <p>Six diabetic human lenses, 69 to 73 years of age, were obtained from the National Disease and Research Interchange (Philadelphia, PA). Lenses were enucleated and placed in primary fixative (detailed below) between 4 to 6 hours post mortem. Specimens were shipped by overnight courier at room temperature to our laboratories for further processing. IRB requirements do not allow the distribution of detailed patient information; age, gender, and the diabetic state of the tissue are known, but the type and treatment of diabetes remains unknown. Lenses with obvious nuclear scattering, history of cataract, or cortical or posterior subcapsular scattering were excluded from the study. The transparency of each lens was evaluated on a backlit calibrated reticle. Transparent lenses caused little distortion of the underlying grid.</p>
        <p>Six human nuclear cataractous lens nuclei from patients with diabetes, ranging in age from 54 to 61 years, were obtained following extracapsular extraction from Duke Eye Center (Durham, NC). These lenses exhibited significant nuclear light scattering diagnosed as cataract by slit lamp, and warranted removal by an ophthalmologist (grade 2–4 on a 0–4 scale [<xref ref-type="bibr" rid="B11">11</xref>]). The extractions were performed by the same surgeon using consistent techniques. Nuclei were transported to our laboratories in vials with gauze moistened with balanced salt solution at room temperature and were placed in primary fixative within 4 hours of extraction. As in the case of the non-cataractous diabetic lenses, detailed information concerning the diabetic type, disease duration, and treatment was not distributed. Potential variations in morphology between post mortem and surgically extracted lenses were minimized by using identical preparation techniques. All donated lenses had no history of laser or intraocular surgery, and were obtained according to the tenets of the Declaration of Helsinki.</p>
      </sec>
      <sec>
        <title>Sample preparation</title>
        <p>Lenses were preserved in a primary fixative of 10% buffered formalin (in 0.1 M phosphate buffer, pH 7.2) for 24 hours at room temperature with slight agitation [<xref ref-type="bibr" rid="B12">12</xref>]. This was followed by five days of fixation in an osmotically balanced solution of 2.5% gluteraldehyde in 0.12 M sodium cacodylate buffer (pH 7.2) at room temperature with daily fix exchanges. Each lens was washed overnight in 0.2 M sodium cacodylate and the nuclei dissected as previously described [<xref ref-type="bibr" rid="B13">13</xref>]. In brief, a 4 mm trephine was used to extract the core of the lens around the optic axis. The anterior and posterior disks of tissue overlying the inner nuclei were removed with forceps, and the process repeated until the distinct Y-suture pattern could be resolved on the lens surface (indicative of the FN). Each lens core was split along the optic axis with forceps (Fig. <xref ref-type="fig" rid="F1">1</xref>) and post-fixed in 1% aqueous osmium tetroxide for 24 hours at 4°C. Following several washes in 0.2 M sodium cacodylate buffer, the lens portions were dehydrated in a graded ethanol series. Samples were critical point dried in liquid CO<sub>2 </sub>using the Balzers CPD 010 (Balzers Instruments, Liechtenstein), mounted on aluminum stubs, and sputter coated with gold/palladium using the Polaron SEM Coating Unit E5100 (Thermo VG Scientific, Beverly, MA). Specimens were examined on a JEOL 820 scanning electron microscope (JEOL USA, Peabody, MA) at magnifications ranging from 40–2500 X. Stereo images were taken with 12° of tilt.</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p><bold>Splitting of the lens inner nuclei. </bold>Splitting of the lens inner nuclei. Following coring and peeling, the resulting lens nuclei were split in half using two pairs of EM grade forceps. The lens is gently grasped from the anterior and posterior with the tines parallel to one of the Y-suture arms (A). Each pair of forceps is externally rotated, splitting the lens through the optic axis (B). The resulting halves reveal the surfaces of the embryonic and inner fetal nuclear fibers, permitting the measurement process (C; adapted from [<xref ref-type="bibr" rid="B1">1</xref>]).</p>
          </caption>
          <graphic xlink:href="1471-2415-3-1-1"/>
        </fig>
      </sec>
      <sec>
        <title>Morphometry</title>
        <p>To detect differences in the extent of compaction between transparent and cataractous diabetic lenses, some of the same analysis procedures outlined in our previous SEM compaction study were used [<xref ref-type="bibr" rid="B4">4</xref>]. In brief, each sample was oriented with the features of interest perpendicular to the viewing angle (0° tilt). This orientation is very important due to aberrant measurements that can occur when the tissue is viewed at an angle. To confirm the proper viewing angle, tilt series and stereo imaging were utilized. Representative micrographs were carefully chosen for the measurement process. Computer-assisted measurements (using Adobe Photoshop 6.0, Adobe Systems Inc., San Jose, CA; NIH Image 1.62, US National Institutes of Health, <ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/nih-image/"/>) were made from scanned SEM micrograph negatives investigating four parameters (magnifications are in parentheses): 1. anterior ellipsoid angle of fetal nuclear fibers (40–60 X), 2. posterior ellipsoid angle of fetal nuclear fibers (40–60 X), 3. embryonic nuclear polar axis length (200–400 X), and 4. average number of embryonic nuclear fiber compaction folds over a 20 μm distance (2000 X).</p>
        <p>Anterior and posterior ellipsoid angles were measured 1 mm from the center of the EN along the equatorial axis. Computer generated ellipses were mapped to the FN fiber cell(s) at this distance in both directions. A table of ellipsoid axis ratios generated from the measurements of ellipse templates of varying degrees and axial lengths (Alvin &amp; Company Inc., Windsor, CT) was used to determine the anterior and posterior angles for each sample. The axial length measurements of the EN were made along the optical axis from the initiation of the fetal suture planes at the anterior and posterior poles. To determine the mean number of membrane compaction folds on the surface of EN fiber cells over a 20 μm distance, five to ten measurements per sample were compiled and averaged. Due to the variation in separation planes from sample to sample, it was not always possible to measure every parameter in each lens.</p>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <p>Lenses were compiled into transparent diabetic or nuclear cataractous diabetic groups for statistical analysis. Limited knowledge of the multiple population distributions comprising each group, and the relatively small sample sizes [<xref ref-type="bibr" rid="B15">15</xref>], could undermine the power of most standard parametric statistical tests. For these reasons, the two-sided non-parametric Mann-Whitney <italic>U</italic>-test was chosen for the comparisons. Any significant results of these tests were interpreted as trends between the groups. Descriptive statistics were calculated using StatView (v. 5.0.1, SAS Institute, Inc., Cary, NC; Table <xref ref-type="table" rid="T1">1</xref>), and <italic>p</italic>-values less than 0.05 were considered significant. Non-diabetic lens measurements from our previous study were included for additional comparisons [<xref ref-type="bibr" rid="B4">4</xref>].</p>
        <table-wrap position="float" id="T1">
          <label>Table 1</label>
          <caption>
            <p>Morphometric summary and descriptive statistics</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td/>
                <td align="center" colspan="3">Aged transparent lenses [<xref ref-type="bibr" rid="B4">4</xref>]</td>
                <td align="center" colspan="3">Age-related nuclear cataracts [<xref ref-type="bibr" rid="B4">4</xref>]</td>
                <td align="center" colspan="3">Transparent diabetic lenses</td>
                <td align="center" colspan="3">Diabetic lenses with nuclear cataract</td>
              </tr>
              <tr>
                <td/>
                <td colspan="12">
                  <hr/>
                </td>
              </tr>
              <tr>
                <td align="left">Parameter</td>
                <td align="center">mean ± <italic>s</italic></td>
                <td align="center">Median (Minimum and Maximum)</td>
                <td align="center">
                  <italic>n</italic>
                </td>
                <td align="center">mean ± <italic>s</italic></td>
                <td align="center">Median (Minimum and Maximum)</td>
                <td align="center">
                  <italic>n</italic>
                </td>
                <td align="center">mean ± <italic>s</italic></td>
                <td align="center">Median (Minimum and Maximum)</td>
                <td align="center">
                  <italic>n</italic>
                </td>
                <td align="center">mean ± <italic>s</italic></td>
                <td align="center">Median (Minimum and Maximum)</td>
                <td align="center">
                  <italic>n</italic>
                </td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Anterior FN Elliptical Angles (°)</td>
                <td align="center">25 ± 2</td>
                <td align="center">25 (23,29)</td>
                <td align="center">13</td>
                <td align="center">22 ± 3</td>
                <td align="center">23 (18,26)</td>
                <td align="center">8</td>
                <td align="center">26 ± 1</td>
                <td align="center">26 (25,27)</td>
                <td align="center">6</td>
                <td align="center">23 ± 2</td>
                <td align="center">23 (22,26)</td>
                <td align="center">5</td>
              </tr>
              <tr>
                <td align="left">Posterior FN Elliptical Angles (°)</td>
                <td align="center">27 ± 2</td>
                <td align="center">27 (25,30)</td>
                <td align="center">13</td>
                <td align="center">24 ± 3</td>
                <td align="center">25 (20,28)</td>
                <td align="center">8</td>
                <td align="center">28 ± 1</td>
                <td align="center">28 (27,29)</td>
                <td align="center">6</td>
                <td align="center">25 ± 1</td>
                <td align="center">25 (24,27)</td>
                <td align="center">5</td>
              </tr>
              <tr>
                <td align="left">EN A-P Axis Length (μm)</td>
                <td align="center">141 ± 12</td>
                <td align="center">140 (120,160)</td>
                <td align="center">9</td>
                <td align="center">123 ± 9</td>
                <td align="center">125 (110,132)</td>
                <td align="center">6</td>
                <td align="center">138 ± 10</td>
                <td align="center">134 (131,158)</td>
                <td align="center">6</td>
                <td align="center">125 ± 6</td>
                <td align="center">123 (120,134)</td>
                <td align="center">5</td>
              </tr>
              <tr>
                <td align="left"># EN Fiber Folds/20 μm</td>
                <td align="center">5.40 ± 1.19</td>
                <td align="center">5.31 (2.75,6.67)</td>
                <td align="center">9</td>
                <td align="center">6.26 ± 0.48</td>
                <td align="center">6.11 (5.83,7.06)</td>
                <td align="center">6</td>
                <td align="center">6.53 ± 0.23</td>
                <td align="center">6.50 (6.33,6.89)</td>
                <td align="center">5</td>
                <td align="center">6.95 ± 0.29</td>
                <td align="center">7.05 (6.48,7.22)</td>
                <td align="center">5</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Morphological changes in diabetics with cataracts</title>
        <p>Examination of the peeled and split lens nuclei by SEM revealed an ideal and reproducible dissection procedure for the exposure of FN and EN fibers along their length near the mid-sagittal plane. Unlike the cells of the outer nuclei and cortex, as described by TEM [<xref ref-type="bibr" rid="B9">9</xref>], no noticeable cell damage could be detected by SEM at low magnification in the diabetic fetal and embryonic nuclei. As in non-diabetic tissues, little morphological difference could be resolved by superficial observation between transparent and cataractous diabetic lenses [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. Detailed analysis at higher magnifications, however, demonstrated the differences between specimens. A summary of the morphometric data is given in Table <xref ref-type="table" rid="T1">1</xref>.</p>
        <p>Low magnification micrographs facilitated measurement of the FN elliptical angles in the transparent diabetic (Fig. <xref ref-type="fig" rid="F2">2A</xref>) and cataractous diabetic (Fig. <xref ref-type="fig" rid="F2">2B</xref>) lenses. Due to the differences in anterior and posterior curvatures in the human lens, two ellipses of different sizes are mapped to each. Transparent lenses displayed an average anterior fetal elliptical angle of 26° while the cataracts averaged 23°, a decrease of 12%. Similarly, the average posterior FN angle was 11% smaller in diabetic nuclei compared to transparent tissue (28° to 25°, respectively). Medium magnification analysis allowed the entire EN to be viewed, with its centrally located fibers and lack of suture planes. On the average, the transparent diabetic lenses (Fig. <xref ref-type="fig" rid="F3">3A</xref>) exhibited an EN A-P axis length of 138 μm while the cataracts averaged 125 μm, a 9% decrease (Fig. <xref ref-type="fig" rid="F3">3B</xref>). At high magnification, the surface topography of the EN fibers is easily visualized, facilitating quantification of the membrane fiber folds of the cell surfaces (Fig. <xref ref-type="fig" rid="F4">4</xref>, arrows). Transparent diabetic lenses (Fig. <xref ref-type="fig" rid="F4">4A</xref>) had 6% fewer fiber folds per 20 μm than the diabetics with nuclear cataract (Fig. <xref ref-type="fig" rid="F4">4B</xref>; 6.53 to 6.95, respectively).</p>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p><bold>Anterior and posterior fetal nuclear elliptical angle measurements. </bold>From the center of the embryonic nucleus (black square), a 1 mm distance (white vertical line) is measured along the equatorial axis, and the fetal fiber(s) at this point is traced (black dots) anteriorly (<italic>a</italic>) and posteriorly (<italic>p</italic>) for a short distance. Transparent diabetic lenses (A) exhibited an average anterior fetal elliptical angle of 26° and posterior average of 28°. The anterior fetal elliptical angle of nuclear cataractous diabetic lenses (B) averaged 23° (a decrease of 12% from the transparent diabetics) and 25° for the posterior (an 11% decrease).</p>
          </caption>
          <graphic xlink:href="1471-2415-3-1-2"/>
        </fig>
        <fig position="float" id="F3">
          <label>Figure 3</label>
          <caption>
            <p><bold>Anterior-posterior axial length measurements. </bold>Measurements were made from the initiation of the fetal suture planes at the anterior and posterior poles. Transparent diabetic lenses (A) averaged 138 μm in length, while the cataractous diabetic lenses (B) exhibited an average of 125 μm, a 9% decrease.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-1-3"/>
        </fig>
        <fig position="float" id="F4">
          <label>Figure 4</label>
          <caption>
            <p><bold>Average count of embryonic nuclear fiber folds per 20 microns. </bold>Folds of membrane (arrows) on the surface of embryonic nuclear fibers were counted from peak to peak over a 20 μm distance. Transparent diabetic lenses (A) averaged 6.53 folds per 20 μm, while the cataractous diabetics (B) had a mean of 6.95 folds, an increase of 6%.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-1-4"/>
        </fig>
        <p>To better appreciate the three-dimensional nature of the fiber cells of the inner lens nuclei and their surface characteristics, stereo images have been included (Fig. <xref ref-type="fig" rid="F5">5</xref>).</p>
        <fig position="float" id="F5">
          <label>Figure 5</label>
          <caption>
            <p><bold>Stereo imaging of a cataractous diabetic lens nucleus at increasing magnification. </bold>(A) Stereo pair of the fetal and embryonic nuclei. The asterisks designate the anterior and posterior fetal Y-suture planes. (B) Stereo pair of inner nuclear cells. Note the numerous membrane compaction folds (arrows) along the flat face of each fiber cell. (C) Stereo pair of inner nuclear fiber cells at high magnification. Note the intricate furrowed membrane domains (white arrow) on the surfaces of each cell and the interlocking edge processes (black arrow) at the cellular junctions. The scale bar is 10 μm in each image.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-1-5"/>
        </fig>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <sec>
          <title>Comparisons between transparent and nuclear cataractous diabetic lenses</title>
          <p>Statistical analysis indicated significant differences in the measurements between transparent and nuclear cataractous diabetic lenses in all four of the examined parameters (Table <xref ref-type="table" rid="T2">2</xref>).</p>
          <table-wrap position="float" id="T2">
            <label>Table 2</label>
            <caption>
              <p>Mann-Whitney p-values</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <td align="left">Parameter</td>
                  <td align="center">Transparent diabetic lenses vs. Diabetic lenses with nuclear cataract</td>
                  <td align="center">Aged transparent lenses [<xref ref-type="bibr" rid="B4">4</xref>] vs. Age-related nuclear cataracts [<xref ref-type="bibr" rid="B4">4</xref>]</td>
                  <td align="center">Aged transparent lenses [<xref ref-type="bibr" rid="B4">4</xref>] vs. Transparent diabetic lenses</td>
                  <td align="center">Age-related nuclear cataracts [<xref ref-type="bibr" rid="B4">4</xref>] vs. Diabetic lenses with nuclear cataract</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Anterior FN Elliptical Angles</td>
                  <td align="center">0.033</td>
                  <td align="center">0.010</td>
                  <td align="center">0.449</td>
                  <td align="center">0.600</td>
                </tr>
                <tr>
                  <td align="left">Posterior FN Elliptical Angles</td>
                  <td align="center">0.011</td>
                  <td align="center">0.045</td>
                  <td align="center">0.472</td>
                  <td align="center">0.877</td>
                </tr>
                <tr>
                  <td align="left">EN A-P Axis Length</td>
                  <td align="center">0.027</td>
                  <td align="center">0.008</td>
                  <td align="center">0.344</td>
                  <td align="center">0.855</td>
                </tr>
                <tr>
                  <td align="left"># EN Fiber Folds/20 μm</td>
                  <td align="center">0.047</td>
                  <td align="center">0.113</td>
                  <td align="center">0.070</td>
                  <td align="center">0.045</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec>
          <title>Comparisons between diabetic and non-diabetic lenses</title>
          <p>To detect any changes in compaction due to diabetes itself, morphometric data from non-diabetic aged transparent human lenses (ages 59–81) and non-diabetic age-related nuclear cataracts (ages 55–81) were utilized for additional statistical comparisons [<xref ref-type="bibr" rid="B4">4</xref>]. Parameter measurement comparisons between transparent non-diabetic lenses and those from transparent diabetics did not reveal any statistically significant differences between the groups (Table <xref ref-type="table" rid="T2">2</xref>). The average anterior FN elliptical angles of the transparent diabetic lenses were 4% larger than that of non-diabetic transparent lenses (<italic>p </italic>= 0.449), and the posterior angles were also 4% larger (<italic>p </italic>= 0.472). The diabetics displayed an average EN A-P axis length that was 2% smaller than the non-diabetics (<italic>p </italic>= 0.344), with 17% more EN fiber folds per 20 μm (<italic>p </italic>= 0.070). A comparison of non-diabetic age-related nuclear cataractous lenses and nuclear cataracts from diabetic patients yielded insignificantly small differences in three of the four parameters tested (Table <xref ref-type="table" rid="T2">2</xref>). Both the average anterior and posterior FN elliptical angles of the cataractous diabetic nuclei were 4% larger than those of the age-related cataract (<italic>p </italic>= 0.600 and 0.877, respectively). The age-related cataractous lenses revealed an average EN A-P axis length that was only 2% smaller than in the diabetics with cataract (<italic>p </italic>= 0.855), with 11% fewer EN fiber folds per 20 μm (<italic>p </italic>= 0.045).</p>
        </sec>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Comparisons of transparent diabetic and diabetic lenses with nuclear cataract yielded statistically significant differences in each measured parameter, indicating a detectable and real difference in inner nuclear size between the groups. Based on the strengths of the statistical tests used, these results should be interpreted as trends between the tissues. As observed in non-diabetic aged transparent and age-related human cataractous lenses, it appears that nuclear fiber cell compaction is responsible for these differences.</p>
      <p>It should be noted that any study that utilizes tissue processing for electron microscopy is subject to potential morphological artifacts due to fixation. Every effort has been made in this study to minimize the potential occurrences of such artifacts by utilizing proven preservation methods for lens tissue [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. It is possible that the processing may dehydrate the presbyopic lens nuclei; however, the potential structural changes may occur on too small a scale to significantly affect the gross measurements made here.</p>
      <p>To relate these variations in compaction to diabetes and/or cataractogenesis, statistical testing was performed using previously collected non-diabetic data. In Brown and Hungerford's review of the size of the lens in ocular disease he comments that the rise in overall lens growth rate observed in the diabetic lens can be almost entirely attributed to increased cortical thickness, with relatively insignificant width changes in the nucleus [<xref ref-type="bibr" rid="B19">19</xref>]. Later postulations concerning the mechanism of this growth included increased fiber formation, enlarged fiber cell volume, and decreased nuclear compaction [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. Parameter comparisons of transparent aged human lenses to those of diabetics did not yield statistically significant results, indicating little difference in average nuclear compaction between the tissues. Our previous study demonstrated a 12% average decrease in elliptical angle and A-P axis measurements between aged transparent lenses and those of age-related nuclear cataracts [<xref ref-type="bibr" rid="B4">4</xref>]; this is roughly the same amount of change reported here between transparent and nuclear cataractous diabetic lenses (11% decrease). This suggests that the compaction changes observed in this study are not necessarily a direct effect of diabetes itself, but are perhaps due to morphological changes in the nuclei undergoing cataractogenesis. The role that diabetes does appear to play, however, involves the onset age of cataract. Though we cannot deduce the age of cataract onset in our samples, we do know the age at which the cataract was considered advanced and removed by an ophthalmologist. In our comparisons, the average age for the age-related nuclear cataract group was 70 years [<xref ref-type="bibr" rid="B4">4</xref>] whereas that for the cataractous diabetic group in this study was only 55 years old. These results suggest an age-related acceleration of cataract formation in persons with diabetes. Several population studies have documented a link between diabetes and senile cataract formation in persons aged 65 years and younger [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B26">26</xref>]. Conversely, a number of studies have shown little association of nuclear cataracts with diabetes [<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B29">29</xref>]. Though this relationship continues to be debated, as are the underlying physiological mechanisms, premature opacification may occur due to an increased susceptibility to oxidative damage.</p>
      <p>Although the exact details concerning the cause of compaction remain unknown, some features of the multifactorial process are understood. The morphological changes described in the inner nuclear areas are a direct result of the change in A-P axis length. This change in length has an observable effect on the reduction of both anterior and posterior FN elliptical angles, and manifests itself in the EN as accordion-like membrane folds along the straight fibers. This phenomenon suggests a loss of cytoplasmic water and a decrease in nuclear cytoplasmic osmolarity [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. The tendency of lens proteins to self-associate and the release of bound water to the bulk water pool can lead to greater cellular dehydration [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. The end result is a decrease in cell volume without the loss of cell surface area, producing an EN with measurably shorter fiber cells with increased membrane complexity.</p>
      <p>In conclusion, this study is in agreement with our earlier finding that nuclear fiber cell compaction in the lens is a normal and measurable process with advancing age; the process of cataractogenesis appears to have a profound effect on the extent and severity of compaction in the nucleus. The osmotic swelling of the cortex in typical diabetic lenses is not matched by comparable water uptake in the nucleus; in fact, compaction occurs in similar fashion to that observed in non-diabetic lenses. Diabetes may elicit an increased compaction rate as well as an earlier onset of cataract formation, though there may be multiple mechanisms of action dependent on disease type, duration, or treatment strategy. Further investigations employing a broad population of samples with extensive medical histories will yield additional, more conclusive results about the relationship of diabetes and nuclear cataract.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>None declared.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>CDF and KJA were responsible for tissue preparation, SEM examination, morphometric measurements, and data analysis. CDF drafted the manuscript. JRK and MJC conceived of the study, and participated in its design and coordination.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/1/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>The authors would like to thank Dr. Craig Fowler of the Duke Eye Center, Durham, NC, for providing the extracapsular cataracts. The technical assistance of Mr. Hal Mekeel and Mr. Layne Novak are also gratefully acknowledged. This research was supported by NIH-NEI grants EY-08148 (MJC), EY-05722 (Duke), and EY-06642 (JRK) and the Louise C. Norton Trust, Chicago, IL.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>JR</surname>
              <given-names>Kuszak</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>HG</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Albert DM, Jakobiec FA</surname>
            </name>
          </person-group>
          <article-title>Embryology and anatomy of the lens.</article-title>
          <source>Principles and practice of ophthalmology: basic sciences</source>
          <year>1994</year>
          <publisher-name>Philadelphia, W.B. Saunders Company</publisher-name>
          <fpage>82</fpage>
          <lpage>96</lpage>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Al-Ghoul</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Lane</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Kuszak</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Costello</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Morphology of the normal human lens.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1996</year>
          <volume>37</volume>
          <fpage>1396</fpage>
          <lpage>1410</lpage>
          <pub-id pub-id-type="pmid">8641842</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kuszak</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Al-Ghoul</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Costello</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Tasman WT, Jaeger EA</surname>
            </name>
          </person-group>
          <article-title>Pathology of age-related human cataracts.</article-title>
          <source>Duane's Clinical Ophthalmology</source>
          <year>1998</year>
          <volume>71B</volume>
          <publisher-name>Philadelphia, Lippincott Williams &amp; Wilkins</publisher-name>
          <fpage>1</fpage>
          <lpage>14</lpage>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Ghoul</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Nordgren</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Kuszak</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Freel</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Costello</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kuszak</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Structural evidence of human nuclear fiber compaction as a function of ageing and cataractogenesis.</article-title>
          <source>Exp Eye Res</source>
          <year>2001</year>
          <volume>72</volume>
          <fpage>199</fpage>
          <lpage>214</lpage>
          <pub-id pub-id-type="pmid">11180969</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.2000.0937</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lahm</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Bettelheim</surname>
              <given-names>FA</given-names>
            </name>
          </person-group>
          <article-title>Age dependence of freezable and nonfreezable water content of normal human lenses.</article-title>
          <source>Invest Ophthamol Vis Sci</source>
          <year>1985</year>
          <volume>26</volume>
          <fpage>1162</fpage>
          <lpage>1165</lpage>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bettelheim</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Do changes in the hydration of the diabetic human lens precede cataract formation?</article-title>
          <source>Res Commun Mol Pathol Pharmacol</source>
          <year>1998</year>
          <volume>102</volume>
          <fpage>3</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">9920342</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>LI</given-names>
            </name>
            <name>
              <surname>Barnett</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Miglior</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Eagon</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Brady</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Proton magnetic resonance imaging of the ocular lens.</article-title>
          <source>Exp Eye Res</source>
          <year>1987</year>
          <volume>45</volume>
          <fpage>875</fpage>
          <lpage>882</lpage>
          <pub-id pub-id-type="pmid">3428403</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sparrow</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Bron</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>NAP</given-names>
            </name>
            <name>
              <surname>Neil</surname>
              <given-names>HAW</given-names>
            </name>
          </person-group>
          <article-title>Biometry of the crystalline lens in early-onset diabetes.</article-title>
          <source>Br J Ophthamol</source>
          <year>1990</year>
          <volume>74</volume>
          <fpage>654</fpage>
          <lpage>660</lpage>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Ghoul</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Costello</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Morphological changes in human nuclear cataracts of late-onset diabetics.</article-title>
          <source>Exp Eye Res</source>
          <year>1993</year>
          <volume>57</volume>
          <fpage>469</fpage>
          <lpage>486</lpage>
          <pub-id pub-id-type="pmid">8282033</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.1993.1149</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>NAP</given-names>
            </name>
            <name>
              <surname>Sparrow</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Bron</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Central compaction in the process of lens growth as indicated by lamellar cataract.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1988</year>
          <volume>72</volume>
          <fpage>538</fpage>
          <lpage>544</lpage>
          <pub-id pub-id-type="pmid">3415946</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chylack</surname>
              <given-names>LT</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Tung</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Classification of human senile cataractous changes by the American Cooperative Cataract Research Group.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1983</year>
          <volume>24</volume>
          <fpage>424</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="pmid">6832915</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuszak</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Ennesser</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Bertram</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Imherr-McMannis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jones-Rufer</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Weinstein</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>The contribution of cell-to-cell fusion to the ordered structure of the crystalline lens.</article-title>
          <source>Lens Eye Toxic Res</source>
          <year>1989</year>
          <volume>6</volume>
          <fpage>639</fpage>
          <lpage>673</lpage>
          <pub-id pub-id-type="pmid">2487276</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuszak</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Ennesser</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Umlas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Macsai-Kaplan</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Weinstein RS</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>The ultrastructure of fiber cells in primate lenses: a model for studying membrane senescence.</article-title>
          <source>J Ultrastruct Mol Struct Res</source>
          <year>1988</year>
          <volume>100</volume>
          <fpage>60</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">3209860</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kuszak</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>HG</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Albert DM, Jakobiec FA</surname>
            </name>
          </person-group>
          <article-title>Embryology and anatomy of the lens.</article-title>
          <source>Principles and practice of ophthalmology: basic sciences</source>
          <year>1994</year>
          <publisher-name>Philadelphia, W.B. Saunders Company</publisher-name>
          <fpage>82</fpage>
          <lpage>96</lpage>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Vingrys</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Small samples: does size matter?</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>1411</fpage>
          <lpage>1413</lpage>
          <pub-id pub-id-type="pmid">11381039</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costello</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Oliver</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Cobo</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Cellular architecture in age-related human nuclear cataracts.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1992</year>
          <volume>33</volume>
          <fpage>3202</fpage>
          <lpage>3227</lpage>
          <pub-id pub-id-type="pmid">1399425</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Ghoul</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Costello</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Fiber cell morphology and cytoplasmic texture in cataractous and normal human lens nuclei.</article-title>
          <source>Curr Eye Res</source>
          <year>1996</year>
          <volume>15</volume>
          <fpage>533</fpage>
          <lpage>542</lpage>
          <pub-id pub-id-type="pmid">8670754</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Ghoul</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Lane</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Fowler</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Costello</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Distribution and type of morphological damage in human nuclear age-related cataracts.</article-title>
          <source>Exp Eye Res</source>
          <year>1996</year>
          <volume>62</volume>
          <fpage>237</fpage>
          <lpage>251</lpage>
          <pub-id pub-id-type="pmid">8690033</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.1996.0029</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>NAP</given-names>
            </name>
            <name>
              <surname>Hungerford</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The influence of the size of the lens in ocular disease.</article-title>
          <source>Trans Ophthalmol Soc UK</source>
          <year>1982</year>
          <volume>102</volume>
          <fpage>359</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="pmid">6964281</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bron</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Sparrow</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Harding</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Blakytny</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The lens in diabetes.</article-title>
          <source>Eye</source>
          <year>1993</year>
          <volume>7</volume>
          <fpage>260</fpage>
          <lpage>275</lpage>
          <pub-id pub-id-type="pmid">7607346</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kirwan</surname>
              <given-names>EOG</given-names>
            </name>
          </person-group>
          <article-title>Diabetic cataract.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1993</year>
          <volume>17</volume>
          <fpage>346</fpage>
          <lpage>351</lpage>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Brien</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Molsberry</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Diabetic cataract: incidence and morphology in 126 young diabetic patients.</article-title>
          <source>JAMA</source>
          <year>1934</year>
          <volume>103</volume>
          <fpage>892</fpage>
          <lpage>897</lpage>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hiller</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Senile cataract extraction and diabetes.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1976</year>
          <volume>60</volume>
          <fpage>283</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">1276117</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Caird</surname>
              <given-names>FI</given-names>
            </name>
            <name>
              <surname>Pirie</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ransell</surname>
              <given-names>TG</given-names>
            </name>
          </person-group>
          <article-title>Diabetes and the eye.</article-title>
          <source>Oxford: Blackwell Scientific Publishing</source>
          <year>1969</year>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ederer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hiller</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Senile lens changes and diabetes in two population studies.</article-title>
          <source>Am J Ophthalmol</source>
          <year>1981</year>
          <volume>91</volume>
          <fpage>381</fpage>
          <lpage>395</lpage>
          <pub-id pub-id-type="pmid">7211996</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kreines</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rowe</surname>
              <given-names>KW</given-names>
            </name>
          </person-group>
          <article-title>Cataracts and adult diabetes.</article-title>
          <source>Ohio Med J</source>
          <year>1979</year>
          <volume>75</volume>
          <fpage>782</fpage>
          <lpage>786</lpage>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Rosenthal</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Munoz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Newland</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Abbey</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Emmett</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Effects of ultraviolet radiation on cataract formation.</article-title>
          <source>N Engl J Med</source>
          <year>1988</year>
          <volume>319</volume>
          <fpage>1429</fpage>
          <lpage>1433</lpage>
          <pub-id pub-id-type="pmid">3185661</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Collman</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Shore</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Shy</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Checkoway</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Luria</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Sunlight and other risk factors for cataracts: an epidemiologic study.</article-title>
          <source>Am J Public Health</source>
          <year>1988</year>
          <volume>78</volume>
          <fpage>1459</fpage>
          <lpage>1462</lpage>
          <pub-id pub-id-type="pmid">3177720</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dolezal</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Perkins</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>Sunlight, skin sensitivity, and cataract.</article-title>
          <source>Am J Epidemiol</source>
          <year>1989</year>
          <volume>129</volume>
          <fpage>559</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="pmid">2916549</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tardieu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Veretout</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Krop</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Slingsby</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Protein interactions in the calf eye lens: interactions between beta-crystallins are repulsive whereas in gamma-crystallins they are attractive.</article-title>
          <source>Eur Biophys J</source>
          <year>1992</year>
          <volume>21</volume>
          <fpage>1</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">1516556</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kenworthy</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Magid</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Oliver</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Mcintosh</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title>Colloid osmotic pressure of steer alpha- and beta-crystallins: possible functional roles for lens crystalline distribution and structural diversity.</article-title>
          <source>Exp Eye Res</source>
          <year>1994</year>
          <volume>59</volume>
          <fpage>11</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">7835391</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.1994.1077</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Racz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tompa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pocsik</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Confirmation of lens hydration by Raman spectroscopy.</article-title>
          <source>Exp Eye Res</source>
          <year>1979</year>
          <volume>50</volume>
          <fpage>129</fpage>
          <lpage>135</lpage>
          <pub-id pub-id-type="pmid">446557</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:140320</identifier><datestamp>2003-02-04</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">140320</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-3-2</article-id>
      <article-id pub-id-type="pmid">12515585</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-3-2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The effect of ketotifen on inflammatory markers in allergic conjunctivitis: an open, uncontrolled study</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Martín</surname>
            <given-names>Andrea P</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>amartin@bioclin.fcq.unc.edu.ar</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Urrets-Zavalia</surname>
            <given-names>Julio</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>jauz@arnet.com.ar</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Berra</surname>
            <given-names>Alejandro</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>hserra@bioclin.fcq.unc.edu.ar</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Mariani</surname>
            <given-names>Ana Lía</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>almariani@arnet.com.ar</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Gallino</surname>
            <given-names>Norberto</given-names>
          </name>
          <xref ref-type="aff" rid="I5">5</xref>
          <email>hprivadoalergia@arnet.com.ar</email>
        </contrib>
        <contrib id="A6" contrib-type="author">
          <name>
            <surname>Demel</surname>
            <given-names>Eduardo Gomez</given-names>
          </name>
          <xref ref-type="aff" rid="I6">6</xref>
          <email>oftalmologia_h_priv@cordoba.com.ar</email>
        </contrib>
        <contrib id="A7" contrib-type="author">
          <name>
            <surname>Gagliardi</surname>
            <given-names>Julio</given-names>
          </name>
          <xref ref-type="aff" rid="I5">5</xref>
          <email>hprivadoalergia@arnet.com.ar</email>
        </contrib>
        <contrib id="A8" contrib-type="author">
          <name>
            <surname>Baena-Cagnani</surname>
            <given-names>Carlos E</given-names>
          </name>
          <xref ref-type="aff" rid="I7">7</xref>
          <email>baena@powernet.net.ar</email>
        </contrib>
        <contrib id="A9" contrib-type="author">
          <name>
            <surname>Urrets-Zavalia</surname>
            <given-names>Enrique</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I8">8</xref>
          <email>jauz@arnet.com.ar</email>
        </contrib>
        <contrib id="A10" corresp="yes" contrib-type="author">
          <name>
            <surname>M Serra</surname>
            <given-names>Horacio</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I8">8</xref>
          <email>hserra@bioclin.fcq.unc.edu.ar</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Inmunología, Dpto. Bioquímica Clínica, Facultad Ciencias Químicas, Universidad Nacional de Córdoba, Argentina</aff>
      <aff id="I2"><label>2</label>Servicio de Oftalmología, Clínica Reina Fabiola. Córdoba, Argentina</aff>
      <aff id="I3"><label>3</label>Dpto. de Patología, Facultad Medicina, Universidad de Buenos Aires, Argentina</aff>
      <aff id="I4"><label>4</label>Inmunología, Universidad Nacional de Misiones, Argentina</aff>
      <aff id="I5"><label>5</label>Servicio de Alergia e Inmunología, Hospital Privado. Córdoba, Argentina</aff>
      <aff id="I6"><label>6</label>Servicio de Oftalmología, Hospital Privado. Córdoba, Argentina</aff>
      <aff id="I7"><label>7</label>Servicio de Pediatría, Hospital Infantil Municipal. Córdoba, Argentina</aff>
      <aff id="I8"><label>8</label>These authors contributed equally to this work</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>1</month>
        <year>2003</year>
      </pub-date>
      <volume>3</volume>
      <fpage>2</fpage>
      <lpage>2</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/2"/>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>9</month>
          <year>2002</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>1</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2003 Martín et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Martín et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>The efficacy and safety of ketotifen eye drop treatment in allergic conjunctivitis (AC) management is perfectly known by several studies, but the mechanism of action at the biochemical levels is poorly understood so we decided to perform an open, uncontrolled study in order to investigate the effect of the topical administration of ketotifen fumarate 0.05% on biochemical markers of inflammation on conjunctival cells in patients with AC.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>Nineteen patients with symptoms and signs of AC (itching, discharge, burning, redness, increase in the watery discharge, swelling and follicles) and with a history of allergy were prescribed with two daily instillation of one drop of eyewash ketotifen fumarate 0,05% in both eyes during thirty days. They were studied by measuring clinical and immunologic parameters.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Ketotifen fumarate treatment significantly reduced the total symptoms and signs score for each patient as well as each symptoms and signs at all time points compared with day 0 (p &lt; 0.0001 and p &lt; 0.016, respectively). Although the percentage of HLA-DR+ epithelial cells diminished only in 58% of patients, the numbers of CD29+ and eotaxin+ epithelial cells dropped significantly in 68% and 73 % of them (p &lt; 0.0062 and &lt;0.0082, respectively) as a consequence of the treatment. In 9 out of 19 patients a simultaneous decrease in the percentage of epithelial cells positive for CD29 and eotaxin was observed.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Ketotifen besides the well-known effect in reducing signs and symptoms of AC significantly diminished production of eotaxin and expression of CD29 by epithelial cells in patients with seasonal AC.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Allergic conjunctivitis (AC) is an ocular surface inflammatory disease that affects approximately 25% of the general population [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>] and has a significant impact on the social and economic aspects of life. It can appear alone or associated with other allergic diseases, especially allergic rhinitis. AC is an immunopathological disease which the number of mast cells in the substantia propria increase, and also the epithelium becomes densely infiltrated [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Activation of mast cells by IgE bound-receptor crosslinking by allergens promotes the release of several mediators such as histamine, prostaglandins, leukotrienes, tryptase and cytokines, all of them responsible for the symptoms of AC and the inflammatory changes in conjunctival cells [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>Conjunctival epithelial cells (EC) play an important proinflammatory role in chronic ocular allergic diseases, the expression profile levels of different cellular adhesion molecules and surface inflammatory antigens have been reported in normal and altered human conjunctival epithelium [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>]. Recent results have demonstrated that expression of ICAM-1 may allow EC to recruit, retain and locally concentrate leukocytes and the presence of HLA-DR raises the question of conjunctival EC antigen presentation [<xref ref-type="bibr" rid="B12">12</xref>].</p>
      <p>Although the level of expression of CD29 (the common chain of the beta 1 integrins) on normal conjunctival ECs is already known [<xref ref-type="bibr" rid="B10">10</xref>], there is not information about changes in its expression during AC. In addition, different epithelial cytokines/chemokines, which are upregulated actively, participate in allergic inflammation [<xref ref-type="bibr" rid="B13">13</xref>]. Among those chemokines eotaxin not only play an important role in eosinophilic recruiting and in damaging the tissue, but also maintain this type of immune response [<xref ref-type="bibr" rid="B14">14</xref>].</p>
      <p>AC can be treated with local anti-allergic agents such as antihistamines, either alone or in combination with alpha-adrenergic agents and mast cell stabilizers [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. Ketotifen fumarate is derived from cyproheptadine, a serotonin and histamine antagonist [<xref ref-type="bibr" rid="B19">19</xref>]. The efficacy and safety of this drug treatment in AC management is well known [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>] and its clinical use has also been widely studied in relation to bronchial asthma where have been demonstrated that ketotifen treatment significantly decreased EG2+ activated eosinophils, CD3+ and CD4+ T cells in the bronchial mucosa and inhibit the expression of E-selectin and ICAM-1 on vascular endothelial cells [<xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B24">24</xref>].</p>
      <p>The effects of different H1 antihistamines on ICAM-1 expression have been extensively studied [<xref ref-type="bibr" rid="B24">24</xref>-<xref ref-type="bibr" rid="B29">29</xref>], but since there is not too much information about the effects of ketotifen on expression of CD29, HLA-DR and eotaxin on conjunctival EC during AC, we performed an open, uncontrolled study on patients with AC to investigat the effect of this drug on clinical features and those markers of inflammation.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Human subjects</title>
        <p>Nineteen subjects (8 males and 11 females, between 6 and 63 years) with seasonal AC [<xref ref-type="bibr" rid="B30">30</xref>] and with a history of allergy (allergic conjunctivitis, hay fever, asthmatic bronchitis and dermatitis) who visited the Department of Ophthalmology, Hospital Privado, Córdoba, Argentina, during the spring season were evaluated. Those patients were diagnosed as previously described [<xref ref-type="bibr" rid="B31">31</xref>] based on positive allergen-skin prick test, IgE in tears, conjunctival eosinophils, and symptoms and signs such as itching, discharge, burning, redness, increase in the watery discharge, swelling and presence of follicles. At day 0 they had normal levels of secretory IgA and lisozime and did neither suffer from other eye disorder, nor had they experienced any ophthalmologic treatment in the two previous weeks to their enrollment. The use of contact lenses was suspended for seventy two hours before and during the whole study. All subjects gave informed consent and the study was approved by the ethics committee of the Hospital Privado.</p>
        <p>Each patient was prescribed with two daily instillations of one drop of eyewash ketotifen fumarate 0,05% in both eyes, during thirty days.</p>
      </sec>
      <sec>
        <title>Ocular status assessment</title>
        <p>Different symptoms (itching, tearing, burning, redness) and signs (watery discharge increase, swelling, presence of follicles) of allergic conjunctivitis were evaluated at their enrollment (day zero) and at different times after starting treatment (7, 15 and 30 days). Symptoms and signs were classified in four stages: 0-Absent; 1-Mild; 2-Moderate and 3-Severe. The total symptoms and signs score (TSSS) for each subject were obtained adding the values of each symptoms and signs divided by the total number of them.</p>
      </sec>
      <sec>
        <title>Immunological studies</title>
        <p>Samples of conjunctival scrapings were collected from both eyes of all patients treated on days 0 and 30 using a disposable plastic scoop (Rhino probe™). The EC obtained were suspended in 20% AB human serum – PBS and incubated with anti-CD29 (beta chain of beta 1 integrin) RD1 (COULTER), anti-HLA-DR FITC (Becton Dickinson), and anti-CD45 (Leukocyte common antigen) PerCP (Becton Dickinson) monoclonal antibodies (mAb), or isotopic antibody controls (Becton Dickinson) for 45 min on ice. Another fraction of the EC was incubated with anti-eotaxin (CCL11) mAb (6H9, kindly provided by LeukoSite Inc., Cambridge, MA) diluted with Triton 2%-PBS (Sigma) for 1 hour at 37°C, then it was incubated with goat anti-mouse IgG FITC (SIGMA) antibody for 30 min on ice and finally with anti-CD45 PerCP (Becton Dickinson) mAb, or isotopic antibody controls (Becton Dickinson) for 45 min on ice. The samples were properly washed and fixed with paraformaldehyde 1% and analyzed on a flow cytometer (Cytoron Absolute), equipped with an argon laser emitting at 488 nm. Analytical gates were set to discard cell debris and CD45+ cells. The number of antigen-positive EC was then obtained from a quadrant graphic paper representing mean fluorescence intensities (MFI) on a 3-decade logarithmic amplifier. The upper limit of intensity of fluorescence from the control antibody was regarded as positivity threshold for the tested antibodies. For each sample, 1.000–5.000 EC were analyzed.</p>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <p>Variability of the parameters studied was analyzed with Wilcoxon matched-pairs signed-rank test. For all tests, p ≤ 0,05 was considered significant.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <p>After 7 days of treatment, 53% of patients showed improvements of their symptoms and signs (p &lt; 0.0001). With continued treatment through day 14, symptoms control was achieved in 76% of patients (p &lt; 0.0001). Moreover, administration of 0,05% ketotifen eye drops for thirty days significantly (p &lt; 0.0001) reduced the TSSS for each patient (Figure <xref ref-type="fig" rid="F1">1</xref>) between days 0 and 30.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p><bold>Variation of total score of symptoms and signs for each patient with ketotifen treatment. </bold>The differences between time points were analyzed by Wilcoxon signed-rank test (*, p &lt; 0.0001, day 0 vs 7, 15 and 30; and 7 vs 30; **, p &lt; 0.0002, day 7 vs 15; ***, p &lt; 0.0008 day 15 vs 30).</p>
        </caption>
        <graphic xlink:href="1471-2415-3-2-1"/>
      </fig>
      <p>Treatment with this drug has clinical effect on burning, watery discharge, and swelling, particularly, at the end of the treatment. Every other symptom were significantly reduced (p &lt; 0.016) at any time of clinical evaluation (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p><bold>Variation of total score of symptoms and signs with ketotifen treatment. </bold>The differences between time points were analyzed by Wilcoxon signed-rank test (*, p &lt; 0.016, day 0 vs 7, 15 and 30; day 7 vs 30, and day 15 vs 30; **, p &lt; 0.031, day 7 vs 15).</p>
        </caption>
        <graphic xlink:href="1471-2415-3-2-2"/>
      </fig>
      <p>The effect of the treatment was also studied on the expression of different molecules on CD45 negative cells (EC) by FACS. It is worth to note that cells studied which were obtained by conjunctival scraping never contain more than 3 % of CD45 + cells (data not shown).</p>
      <p>When the expression of HLA-DR, CD29 and eotaxin on EC was evaluated after the treatment we found a drop in the percentage of those positive EC in 58%, 68% and 73% of patients, respectively. Although the variation in percentage of HLA-DR+ EC was not significant, the percentage of CD29+ and eotaxin + EC significantly decreased (p &lt; 0.0062 and &lt;0.0082, respectively) at the end of the treatment (Table <xref ref-type="table" rid="T1">1</xref>). In 9/19 patients a simultaneous drop in EC positive for CD29 and eotaxin was observed. Figure <xref ref-type="fig" rid="F3">3</xref> shows a representative case from this group of patients.</p>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p><bold>HLA-DR, CD29 and eotaxin expression by EC from patients with AC before and after the treatment with ketotifen fumarate 0.05%. </bold>Data show one representative case from nine patients who had a simultaneous drop in CD29+ and eotaxin+ EC.</p>
        </caption>
        <graphic xlink:href="1471-2415-3-2-3"/>
      </fig>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Percentage of positive EC before and after the treatment with ketotifen fumarate 0.05%.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="center">Patients</td>
              <td align="center" colspan="2">HLA-DR positive cells*</td>
              <td align="center" colspan="2">CD29 positive cells*</td>
              <td align="center" colspan="2">Eotaxin positive cells*</td>
            </tr>
            <tr>
              <td/>
              <td colspan="6">
                <hr/>
              </td>
            </tr>
            <tr>
              <td/>
              <td align="center">Day 0</td>
              <td align="center">Day 30</td>
              <td align="center">Day 0</td>
              <td align="center">Day 30</td>
              <td align="center">Day 0</td>
              <td align="center">Day 30</td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="center">1</td>
              <td align="center">60</td>
              <td align="center">30</td>
              <td align="center">82</td>
              <td align="center">38</td>
              <td align="center">69</td>
              <td align="center">52</td>
            </tr>
            <tr>
              <td align="center">2</td>
              <td align="center">18</td>
              <td align="center">31</td>
              <td align="center">67</td>
              <td align="center">34</td>
              <td align="center">81</td>
              <td align="center">66</td>
            </tr>
            <tr>
              <td align="center">3</td>
              <td align="center">50</td>
              <td align="center">34</td>
              <td align="center">86</td>
              <td align="center">70</td>
              <td align="center">75</td>
              <td align="center">64</td>
            </tr>
            <tr>
              <td align="center">4</td>
              <td align="center">46</td>
              <td align="center">30</td>
              <td align="center">59</td>
              <td align="center">27</td>
              <td align="center">83</td>
              <td align="center">69</td>
            </tr>
            <tr>
              <td align="center">5</td>
              <td align="center">10</td>
              <td align="center">65</td>
              <td align="center">61</td>
              <td align="center">50</td>
              <td align="center">86</td>
              <td align="center">64</td>
            </tr>
            <tr>
              <td align="center">6</td>
              <td align="center">45</td>
              <td align="center">80</td>
              <td align="center">81</td>
              <td align="center">73</td>
              <td align="center">85</td>
              <td align="center">84</td>
            </tr>
            <tr>
              <td align="center">7</td>
              <td align="center">12</td>
              <td align="center">55</td>
              <td align="center">78</td>
              <td align="center">45</td>
              <td align="center">98</td>
              <td align="center">72</td>
            </tr>
            <tr>
              <td align="center">8</td>
              <td align="center">75</td>
              <td align="center">32</td>
              <td align="center">85</td>
              <td align="center">25</td>
              <td align="center">94</td>
              <td align="center">83</td>
            </tr>
            <tr>
              <td align="center">9</td>
              <td align="center">91</td>
              <td align="center">19</td>
              <td align="center">65</td>
              <td align="center">51</td>
              <td align="center">93</td>
              <td align="center">70</td>
            </tr>
            <tr>
              <td align="center">10</td>
              <td align="center">32</td>
              <td align="center">70</td>
              <td align="center">36</td>
              <td align="center">54</td>
              <td align="center">51</td>
              <td align="center">66</td>
            </tr>
            <tr>
              <td align="center">11</td>
              <td align="center">21</td>
              <td align="center">11</td>
              <td align="center">64</td>
              <td align="center">13</td>
              <td align="center">68</td>
              <td align="center">82</td>
            </tr>
            <tr>
              <td align="center">12</td>
              <td align="center">24</td>
              <td align="center">27</td>
              <td align="center">22</td>
              <td align="center">23</td>
              <td align="center">74</td>
              <td align="center">60</td>
            </tr>
            <tr>
              <td align="center">13</td>
              <td align="center">20</td>
              <td align="center">12</td>
              <td align="center">17</td>
              <td align="center">24</td>
              <td align="center">76</td>
              <td align="center">65</td>
            </tr>
            <tr>
              <td align="center">14</td>
              <td align="center">62</td>
              <td align="center">31</td>
              <td align="center">81</td>
              <td align="center">37</td>
              <td align="center">63</td>
              <td align="center">72</td>
            </tr>
            <tr>
              <td align="center">15</td>
              <td align="center">55</td>
              <td align="center">72</td>
              <td align="center">54</td>
              <td align="center">83</td>
              <td align="center">77</td>
              <td align="center">57</td>
            </tr>
            <tr>
              <td align="center">16</td>
              <td align="center">82</td>
              <td align="center">41</td>
              <td align="center">91</td>
              <td align="center">41</td>
              <td align="center">81</td>
              <td align="center">89</td>
            </tr>
            <tr>
              <td align="center">17</td>
              <td align="center">80</td>
              <td align="center">3</td>
              <td align="center">75</td>
              <td align="center">80</td>
              <td align="center">84</td>
              <td align="center">72</td>
            </tr>
            <tr>
              <td align="center">18</td>
              <td align="center">67</td>
              <td align="center">11</td>
              <td align="center">81</td>
              <td align="center">48</td>
              <td align="center">79</td>
              <td align="center">84</td>
            </tr>
            <tr>
              <td align="center">19</td>
              <td align="center">17</td>
              <td align="center">63</td>
              <td align="center">42</td>
              <td align="center">45</td>
              <td align="center">76</td>
              <td align="center">56</td>
            </tr>
            <tr>
              <td align="center">
                <bold>Media</bold>
              </td>
              <td align="center">
                <bold>46</bold>
              </td>
              <td align="center">
                <bold>38</bold>
              </td>
              <td align="center">
                <bold>64</bold>
              </td>
              <td align="center">
                <bold>45</bold>
              </td>
              <td align="center">
                <bold>79</bold>
              </td>
              <td align="center">
                <bold>70</bold>
              </td>
            </tr>
            <tr>
              <td align="center">
                <bold>SD</bold>
              </td>
              <td align="center">
                <bold>26</bold>
              </td>
              <td align="center">
                <bold>23</bold>
              </td>
              <td align="center">
                <bold>22</bold>
              </td>
              <td align="center">
                <bold>19</bold>
              </td>
              <td align="center">
                <bold>11</bold>
              </td>
              <td align="center">
                <bold>10</bold>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>* See Methods.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>We did not find any correlation between variations in mean fluorescent intensity and percentage of positive EC for these markers before and after the treatment.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>AC is a common, prevalent, and clinically significant IgE mediate hypersensitivity response in which signs and symptoms associated with the progression from early to late phase reaction start four to eight hours after challenge and persist up to 24 hours. The clinical reaction is accompanied by a significant recruitment of inflammatory cells (mainly neutrophils) in tears 20 minutes after challenge, and eosinophils and lymphocytes 6 to 24 hours after challenge [<xref ref-type="bibr" rid="B32">32</xref>]. In the chronic and more severe forms of AC, other mechanisms and cells contribute to a more complex clinical profile [<xref ref-type="bibr" rid="B33">33</xref>]. In addition, the mast cell is considered to play a pivotal role in causing signs and symptoms since Bacon AS et al found increased levels of histamine, tryptase, PGD2, and leukotriene C4 in the tears of patients with Seasonal Allergic Conjunctivitis after conjunctival allergen challenge [<xref ref-type="bibr" rid="B34">34</xref>].</p>
      <p>It is now becoming clear that EC may be viewed as active participants in the regulation of inflammation and leukocyte behavior. EC from a number of mucosal sites have been shown to be capable of: 1) expressing adhesion molecules like ICAM-1 (CD54) or beta 1 integrin (CD29), which are important for leukocyte emigration into tissue; 2) expressing MHC class II molecules and 3) synthesizing and releasing prostaglandins and leukotrienes which attract and activate leukocytes and 4) producing a variety of pro-inflammatory cytokines and chemokines. The adhesion molecules expressed on EC not only allow interactions between cells and cells with matrix but also they might be involved in intracellular signals [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B35">35</xref>-<xref ref-type="bibr" rid="B37">37</xref>].</p>
      <p>Although we did not found significant variations in the percentage of HLA-DR+ EC before and after treatment, the majority of patients exhibited a significant decrease in the percentage of CD29+ cells suggesting that the expression of these molecules are controlled by different mechanisms.</p>
      <p>Eotaxin, a CC chemokine, is a potent and selective eosinophil chemoattractant to the site of inflammation but also plays an important role in damaging tissue by its capacity to induce the release of reactive oxygen species [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. It has been previously demonstrated that eotaxin mRNA and protein are constitutively expressed by bronchial and nasal epithelium from normal individuals and increased within the airways of asthmatic individuals, and in nasal biopsy specimens from individuals with allergic rhinitis. In addition eotaxin immunoreactivity was found in macrophages, eosinophils, T cells, mast cells, and neutrophils, suggesting that this chemokine is an important mediator in the physiological and pathological trafficking of eosinophils [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>].</p>
      <p>It has been reported that in EC from normal conjunctival biopsies there is a weak cytoplasmic expression of eotaxin [<xref ref-type="bibr" rid="B13">13</xref>]. In our study we found a strong expression of eotaxin on EC from patients with AC which decrease significantly after treatment with ketotifen.</p>
      <p>Current therapy of ocular allergic disease focuses on allergen elimination, modulation of the immune system and pharmacological inhibition of the chemical mediators involved in the immune response. The most commonly used therapeutic option is the pharmacological inhibition of chemical mediators. Mast cells stabilizers and antihistamines are two of the most commonly used group of therapeutic agents; they stabilize the mast cell membranes by preventing calcium influx across the mast cell membranes, thereby preventing mast cell degranulation and mediator release and the new antihistamines have been demonstrated to be capable of affecting several phenomena of the allergic inflammation, including mediator release, cellular activation and adhesion molecule expression [<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. Among these drugs, ketotifen fumarate, attenuated the local allergic reaction in patients with AC [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>] and the efficacy and safety of this drug in AC management has also been shown in human conjunctival allergen challenge model [<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>].</p>
      <p>Here, we corroborated the effectiveness of ketotifen fumarate in decreasing the symptoms and signs of AC in the majority of patients, but more importantly we showed that this drug even though was not effected in reducing the expression of HLA-DR on EC, it significantly decreased the percentage of CD29+ and eotaxin+ EC.</p>
      <p>The mechanism of action by which this drug produce this effects are probably related to the decrease amounts of inflammatory cytokines/chemokines released by effector cells at the conjunctival level. Clearly, additional studies are needed to fully understand the complex mechanisms of the anti-inflammatory effect of Ketotifen fumarate in patients with AC.</p>
    </sec>
    <sec>
      <title>List of abbreviations</title>
      <p>AC = Allergic Conjunctivitis.</p>
      <p>EC = Epithelial cells.</p>
      <p>TSSS = Total symptoms and signs score.</p>
      <p>mAb = Monoclonal antibody.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>None declared.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p><bold>Martín AP</bold>: collected conjunctival scrapings and carried out immunofluorescence studies, performed the statistical analysis and drafted the manuscript.</p>
      <p><bold>Urrets-Zavalia J</bold>: performed the ophthalmological evaluation of the patients with AC.</p>
      <p><bold>Berra A</bold>: performed conjunctival cytology studies and quantification of tear IgE.</p>
      <p><bold>Mariani AL</bold>: carried out the quantification of serum IgE, secretory IgA and lisozime.</p>
      <p><bold>Gallino N</bold>: carried out the prick tets and clinical evaluation of the patients with AC.</p>
      <p><bold>Gomez Demel E</bold>: performed the ophthalmological evaluation of the patients with AC.</p>
      <p><bold>Gagliardi J</bold>: carried out the prick tets and clinical evaluation of the patientswith AC.</p>
      <p><bold>Baena-Cagnani CE</bold>: carried out the prick tets and clinical evaluation of the patientswith AC.</p>
      <p><bold>Urrets-Zavalia E</bold>: conceived of the study, and participated in its design and coordination.</p>
      <p><bold>Serra, HM</bold>: conceived of the study, and participated in its design and coordination.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/2/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>We wish to thank the excellent technical assistance of Yanina Eberhard and Pablo Romagnoli.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A</surname>
              <given-names>Solomon</given-names>
            </name>
            <name>
              <surname>Pe'er</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Levi-Schaffer</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies.</article-title>
          <source>Curr Opin Allergy Clin Immunol</source>
          <year>2001</year>
          <volume>1</volume>
          <fpage>477</fpage>
          <lpage>482</lpage>
          <pub-id pub-id-type="pmid">11964730</pub-id>
          <pub-id pub-id-type="doi">10.1097/01.all.0000011063.28808.cc</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bielory</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Update on Ocular Allergy Treatment.</article-title>
          <source>Expert Opin Pharmacother</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>541</fpage>
          <lpage>553</lpage>
          <pub-id pub-id-type="pmid">11996633</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abelson</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Garofalo</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Differential diagnosis of ocular disorders.</article-title>
          <source>Ann Allergy</source>
          <year>1993</year>
          <volume>70</volume>
          <fpage>95</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="pmid">8430929</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacLeod</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Baddeley</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Holgate</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>McGill</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Roche</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva.</article-title>
          <source>Clin Exp Allergy</source>
          <year>1997</year>
          <volume>27</volume>
          <fpage>1328</fpage>
          <lpage>1334</lpage>
          <pub-id pub-id-type="pmid">9420138</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1365-2222.1997.1600959.x</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Irani</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Bielory</surname>
            </name>
          </person-group>
          <article-title>Ocular mast cells and mediators in ocular allergy.</article-title>
          <source>Immunology and allergy clinics of North America</source>
          <year>1997</year>
          <publisher-name>Philadelphia, WB Saunders</publisher-name>
          <fpage>1</fpage>
          <lpage>13</lpage>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacDonald</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Histamine-releasing factor.</article-title>
          <source>Curr Opin Immunol</source>
          <year>1996</year>
          <volume>8</volume>
          <fpage>778</fpage>
          <lpage>783</lpage>
          <pub-id pub-id-type="pmid">8994855</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0952-7915(96)80004-5</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Desreumaux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Capron</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Eosinophils in allergic reactions.</article-title>
          <source>Curr Opin Immunol</source>
          <year>1996</year>
          <volume>8</volume>
          <fpage>790</fpage>
          <lpage>795</lpage>
          <pub-id pub-id-type="pmid">8994857</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0952-7915(96)80006-9</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>MacLeod</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Baddeley</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Bacon</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>McGill</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Holgate</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>WR</surname>
              <given-names>Roche</given-names>
            </name>
          </person-group>
          <article-title>Seasonal allergic conjunctivitis is accompanied by increase mast cell numbers in the absence of leukocyte infiltration.</article-title>
          <source>Clin Exp Allergy</source>
          <year>1997</year>
          <volume>27</volume>
          <fpage>1060</fpage>
          <lpage>1066</lpage>
          <pub-id pub-id-type="pmid">9678838</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fujihara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tsuboda</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Flow cytometric analysis of surface antigens on human conjunctival epithelial cells.</article-title>
          <source>Ophthalmic Res</source>
          <year>1997</year>
          <volume>29</volume>
          <fpage>103</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="pmid">9154536</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Avunduk</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Avunduk</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Dayioglu</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Centinkaya</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Flow cytometric tear analysis in patients with chronic allergic conjunctivitis.</article-title>
          <source>Jpn J Ophthalmol</source>
          <year>1997</year>
          <volume>41</volume>
          <fpage>67</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">9152806</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0021-5155(97)00012-9</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vorkauf</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Duncker</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nolle</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sterry</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Adhesion molecules in normal human conjunctiva. An immunohistological study using monoclonal antibodies.</article-title>
          <source>Graefes Arch Clin Exp Ophthalmol</source>
          <year>1993</year>
          <volume>231</volume>
          <fpage>323</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="pmid">8339947</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hingorani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Calder</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Buckley</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Lightman</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The Role of Conjunctival Epithelial Cells in Chronic Ocular Allergic Disease.</article-title>
          <source>Exp Eye Res</source>
          <year>1998</year>
          <volume>67</volume>
          <fpage>491</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="pmid">9878210</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.1998.0528</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abu El-Asrar</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Struyf</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Al-Kharashi</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Missotten</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Van Damme</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Geboes</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Chemokines in the limbal form of vernal keratoconjunctivitis</article-title>
          <source>Br J Ophthalmol</source>
          <year>2000</year>
          <volume>84</volume>
          <fpage>1360</fpage>
          <lpage>1366</lpage>
          <pub-id pub-id-type="pmid">11090473</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.84.12.1360</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garcia-Zepeda</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Rothenberg</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Ownbey</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Celestin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Leder</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Luster</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.</article-title>
          <source>Nat Med</source>
          <year>1996</year>
          <volume>2</volume>
          <fpage>449</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="pmid">8597956</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abelson</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Allansmith</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Friedlaender</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Effect of topically applied ocular decongestant and antihistamine.</article-title>
          <source>Am J Ophthalmol</source>
          <year>1980</year>
          <volume>90</volume>
          <fpage>254</fpage>
          <lpage>257</lpage>
          <pub-id pub-id-type="pmid">7425039</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naclerio</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Optimizing treatment options.</article-title>
          <source>Clin Exp Allergy</source>
          <year>1998</year>
          <volume>28</volume>
          <fpage>54</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">9988437</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1365-2222.1998.0280s6054.x</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joss</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title>Seasonal allergic conjunctivitis: overview and treatment update.</article-title>
          <source>J Am Osteopath Assoc</source>
          <year>1999</year>
          <volume>99</volume>
          <fpage>S13</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">10478515</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedlaender</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>The current and future therapy of allergic conjunctivitis.</article-title>
          <source>Curr Opin Ophthalmol</source>
          <year>1998</year>
          <volume>9</volume>
          <fpage>54</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">10387470</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grant</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Goa</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Fitton</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sorkin Ketotifen</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders.</article-title>
          <source>Drugs</source>
          <year>1990</year>
          <volume>40</volume>
          <fpage>412</fpage>
          <lpage>448</lpage>
          <pub-id pub-id-type="pmid">2226222</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mimura</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Clinical efficacy and optimal concentration of ketotifen ophthalmic solution on allergic conjunctivitis and vernal conjunctivitis.</article-title>
          <source>J Clinical Ther Med</source>
          <year>1989</year>
          <volume>5</volume>
          <fpage>709</fpage>
          <lpage>721</lpage>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aguilar</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate.</article-title>
          <source>Acta Ophthalmol Scand Suppl</source>
          <year>2000</year>
          <volume>230</volume>
          <fpage>52</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">11057352</pub-id>
          <pub-id pub-id-type="doi">10.1034/j.1600-0420.2000.078s230052.x</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kabra</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Pandey</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Seth</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Ketotifen for asthma in children aged 5 to 15 years: a randomised placebo-controlled trial.</article-title>
          <source>Ann Allergy Asthma Immunol</source>
          <year>2000</year>
          <volume>85</volume>
          <fpage>46</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">10923604</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoshino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sim</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Tomioka</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A comparative study of the effects of ketotifen, disodium cromoglycate, and beclomethasone dipropionate on bronchial mucosa and asthma symptoms in patients with atopic asthma.</article-title>
          <source>Respir Med</source>
          <year>1998</year>
          <volume>92</volume>
          <fpage>942</fpage>
          <lpage>950</lpage>
          <pub-id pub-id-type="pmid">10070568</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miki</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kusano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ohta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hanai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Otoshi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Masaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ohmori</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells.</article-title>
          <source>Cell Immunol</source>
          <year>1996</year>
          <volume>171</volume>
          <fpage>285</fpage>
          <lpage>288</lpage>
          <pub-id pub-id-type="pmid">8806799</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciprandi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Buscaglia</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pesce</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Passalacqua</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rihoux</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Bagnasco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Canonica</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge.</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>1995</year>
          <volume>95</volume>
          <fpage>612</fpage>
          <lpage>621</lpage>
          <pub-id pub-id-type="pmid">7531732</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bagnasco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Canonica</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Influence of H1-receptor antagonists on adhesion molecules and cellular traffic.</article-title>
          <source>Allergy</source>
          <year>1995</year>
          <volume>50</volume>
          <fpage>17</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">7645677</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciprandi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Buscaglia</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pronzato</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Benvenuti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cavalli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bruzzone</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Canonica</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Oxatomide reduces inflammatory events induced by allergen-specific conjunctival challenge.</article-title>
          <source>Ann Allergy Asthma Immunol</source>
          <year>1995</year>
          <volume>75</volume>
          <fpage>446</fpage>
          <lpage>452</lpage>
          <pub-id pub-id-type="pmid">7583868</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciprandi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pronzato</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ricca</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Varese</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Del Giacco</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Canonica</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy.</article-title>
          <source>Clin Exp Allergy</source>
          <year>1995</year>
          <volume>25</volume>
          <fpage>871</fpage>
          <lpage>878</lpage>
          <pub-id pub-id-type="pmid">8564726</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vignola</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Crampette</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mondain</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sauvere</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Czarlewski</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bousquet</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells.</article-title>
          <source>Allergy</source>
          <year>1995</year>
          <volume>50</volume>
          <fpage>200</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="pmid">7677235</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedlaender</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Conjunctivitis of Allergic origin: Clinical presentation and differential diagnosis.</article-title>
          <source>Surv Ophthalmol</source>
          <year>1993</year>
          <volume>38</volume>
          <fpage>105</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="pmid">8236003</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martín</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gagliardi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gomez Demel</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Berra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gallino</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Daraio</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Copello</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Urrets-Zavalia</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mariani</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Urrets-Zavalia</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Serra</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Toward the best diagnosis of allergic conjunctivitis.</article-title>
          <source>Archivos de Alergia e Inmunología Clínica</source>
          <year>2001</year>
          <volume>32</volume>
          <fpage>16</fpage>
          <lpage>25</lpage>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ghinelli</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>The Early and Late Phase of the Ocular Allergic Reaction.</article-title>
          <source>Acta Ophthalmol Scand</source>
          <year>2000</year>
          <volume>78</volume>
          <fpage>41</fpage>
          <pub-id pub-id-type="doi">10.1034/j.1600-0420.2000.078s230041.x</pub-id>
        </citation>
      </ref>
      <ref id="B33">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Abelson</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Udell</surname>
              <given-names>IJ</given-names>
            </name>
          </person-group>
          <article-title>Allergic and toxic reactions.</article-title>
          <source>Principles and Practice of Ophtalmology: Clinical Practice</source>
          <year>1994</year>
          <publisher-name>Philadelphia: WB Saunders Company</publisher-name>
          <fpage>77</fpage>
          <lpage>100</lpage>
        </citation>
      </ref>
      <ref id="B34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bacon</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Ahluwalia</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Irani</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Holgate</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Church</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>McGill</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <article-title>Tear and conjunctival changes during the allergen-induced early and late phase responses.</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>2000</year>
          <volume>106</volume>
          <fpage>948</fpage>
          <lpage>954</lpage>
          <pub-id pub-id-type="pmid">11080719</pub-id>
          <pub-id pub-id-type="doi">10.1067/mai.2000.110930</pub-id>
        </citation>
      </ref>
      <ref id="B35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abu El-Asrar</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Geboes</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Al-Kharashi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Al-Mansouri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Missotten</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Geboes</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Adhesion molecules in vernal keratoconjunctivitis.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1997</year>
          <volume>81</volume>
          <fpage>1099</fpage>
          <lpage>1106</lpage>
          <pub-id pub-id-type="pmid">9497473</pub-id>
        </citation>
      </ref>
      <ref id="B36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bacon</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>McGill</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Baddeley</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lightman</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Holgate</surname>
              <given-names>ST</given-names>
            </name>
          </person-group>
          <article-title>Adhesion molecules and relationship to leukocyte levels in allergic eye disease.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1998</year>
          <volume>39</volume>
          <fpage>322</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="pmid">9477989</pub-id>
        </citation>
      </ref>
      <ref id="B37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciprandi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Buscaglia</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pesce</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bagnasco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Canonica</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Allergic subjects express intercellular adhesion molecule-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge.</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>1993</year>
          <volume>91</volume>
          <fpage>783</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="pmid">8095941</pub-id>
        </citation>
      </ref>
      <ref id="B38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jose</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Griffiths-Johnson</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Moqbel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Totty</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Truong</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Hsuan</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title>Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.</article-title>
          <source>J Exp Med</source>
          <year>1994</year>
          <volume>179</volume>
          <fpage>881</fpage>
          <lpage>887</lpage>
          <pub-id pub-id-type="pmid">7509365</pub-id>
        </citation>
      </ref>
      <ref id="B39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elsner</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hochstetter</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kimmig</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kapp</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Human eotaxin represents a potent activator of the respiratory burst of human eosinophils.</article-title>
          <source>Eur J Immunol</source>
          <year>1996</year>
          <volume>26</volume>
          <fpage>1919</fpage>
          <lpage>1915</lpage>
          <pub-id pub-id-type="pmid">8765040</pub-id>
        </citation>
      </ref>
      <ref id="B40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Minshall</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Miotto</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shimbara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Luster</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hogg</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Hamid</surname>
              <given-names>QA</given-names>
            </name>
          </person-group>
          <article-title>Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals.</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>1999</year>
          <volume>103</volume>
          <fpage>476</fpage>
          <lpage>483</lpage>
          <pub-id pub-id-type="pmid">10069883</pub-id>
        </citation>
      </ref>
      <ref id="B41">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minshall</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Cameron</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lavigne</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Hamilos</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Garcia-Zepada</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Rothenberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Luster</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Hamid</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title>Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis.</article-title>
          <source>Am J Respir Cell Mol Biol</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>683</fpage>
          <lpage>690</lpage>
          <pub-id pub-id-type="pmid">9409555</pub-id>
        </citation>
      </ref>
      <ref id="B42">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abelson</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Schaefer</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Conjunctivitis of allergic origin: Immunologic mechanims and current approaches to therapy.</article-title>
          <source>Surv Ophthalmol</source>
          <year>1993</year>
          <volume>38</volume>
          <fpage>115</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="pmid">7901917</pub-id>
        </citation>
      </ref>
      <ref id="B43">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciprandi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Passalacqua</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Canonica</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Effects of H1 antihistamines on adhesion molecules: a possible rationale for long-term treatment.</article-title>
          <source>Clin Exp Allergy</source>
          <year>1999</year>
          <volume>29</volume>
          <fpage>49</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">10444212</pub-id>
        </citation>
      </ref>
      <ref id="B44">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berdy</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Spangler</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Bensch</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Berdy</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Brusatti</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model.</article-title>
          <source>Clin Ther</source>
          <year>2000</year>
          <volume>22</volume>
          <fpage>826</fpage>
          <lpage>833</lpage>
          <pub-id pub-id-type="pmid">10945509</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0149-2918(00)80055-7</pub-id>
        </citation>
      </ref>
      <ref id="B45">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D'Arienzo</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Leonardi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bensch</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model.</article-title>
          <source>Clin Ther</source>
          <year>2002</year>
          <volume>24</volume>
          <fpage>409</fpage>
          <lpage>416</lpage>
          <pub-id pub-id-type="pmid">11952024</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0149-2918(02)85042-1</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:149350</identifier><datestamp>2003-02-25</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">149350</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-3-3</article-id>
      <article-id pub-id-type="pmid">12546709</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-3-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Morphological characterization of the AlphaA- and AlphaB-crystallin double knockout mouse lens</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Boyle</surname>
            <given-names>Daniel L</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>dboyle@ksu.edu</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Takemoto</surname>
            <given-names>Larry</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>takemlj@ksu.edu</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Brady</surname>
            <given-names>James P</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>james.brady@pharma.novartis.com</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Wawrousek</surname>
            <given-names>Eric F</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>ericw@helix.nih.gov</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Kansas State University, Division of Biology, Ackert Hall, Manhattan, KS, USA</aff>
      <aff id="I2"><label>2</label>Ocular Gene Therapy, Genetic Therapy, Inc., 9 W Watikins Mill Rd, Gaithersburg, MD, USA</aff>
      <aff id="I3"><label>3</label>Lab of Molecular &amp; Dev Biology, National Eye Institute, NIH, 6 Center Drive MSC 2730, Bethesda, MD, USA</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>1</month>
        <year>2003</year>
      </pub-date>
      <volume>3</volume>
      <fpage>3</fpage>
      <lpage>3</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/3"/>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>12</month>
          <year>2002</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>1</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2003 Boyle et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Boyle et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>One approach to resolving some of the <italic>in vivo </italic>functions of alpha-crystallin is to generate animal models where one or both of the alpha-crystallin gene products have been eliminated. In the single alpha-crystallin knockout mice, the remaining alpha-crystallin may fully or partially compensate for some of the functions of the missing protein, especially in the lens, where both alphaA and alphaB are normally expressed at high levels. The purpose of this study was to characterize gross lenticular morphology in normal mice and mice with the targeted disruption of alphaA- and alphaB-crystallin genes (alphaA/BKO).</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>Lenses from 129SvEvTac mice and alphaA/BKO mice were examined by standard scanning electron microscopy and confocal microscopy methodologies.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Equatorial and axial (sagittal) dimensions of lenses for alphaA/BKO mice were significantly smaller than age-matched wild type lenses. No posterior sutures or fiber cells extending to the posterior capsule of the lens were found in alphaA/BKO lenses. Ectopical nucleic acid staining was observed in the posterior subcapsular region of 5 wk and anterior subcapsular cortex of 54 wk alphaA/BKO lenses. Gross morphological differences were also observed in the equatorial/bow, posterior and anterior regions of lenses from alphaA/BKO mice as compared to wild mice.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>These results indicated that both alphaA- and alphaB-crystallin are necessary for proper fiber cell formation, and that the absence of alpha-crystallin can lead to cataract formation.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Alpha-Crystallin is comprised of two polypeptides, alphaA-crystallin (alphaA) and alphaB-crystallin (alphaB), which share 55% amino acid sequence homology [<xref ref-type="bibr" rid="B1">1</xref>]. They are the most abundant proteins in lens fiber cells [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>] and exist as heteroaggregates of approximately 800 kDa that can undergo inter-aggregate subunit exchange [<xref ref-type="bibr" rid="B4">4</xref>]. The expression of these two proteins in the lens epithelium, however, is not uniform throughout different regions of the anterior epithelium. AlphaB expression is detected in central epithelium and increases from the central to elongation zones, where epithelial cells differentiate into fiber cells. AlphaA, however, is not detected in the central epithelium. The relative proportion of alphaA and alphaB changes from a molar ratio of 1:3 in the pericentral and germative zones to a molar ratio of 3:1 in the elongation zone and fiber cells [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. These differences in the relative proportions of alphaA and alphaB within the lens suggest different functions for the two subunits in the developing lens.</p>
      <p>Prior to the 1990's, alpha-crystallin was thought to be a structural protein whose major cellular function was to produce a dense solution necessary for the refraction of light in the lens. During the early 1990's, alpha-crystallin was shown to act as a molecular chaperone, binding to partially denatured proteins, both <italic>in vitro </italic>[<xref ref-type="bibr" rid="B5">5</xref>] and probably <italic>in vivo </italic>[<xref ref-type="bibr" rid="B6">6</xref>], to inhibit further denaturation and aggregation of lens proteins. AlphaA and alphaB were also shown to have sequence homology with several other proteins that are members of the small heat shock protein (hsp) family [<xref ref-type="bibr" rid="B7">7</xref>]. Moreover, expression of alpha-crystallin, particularly alphaB, was shown to not be restricted to the lens. AlphaB was found to be expressed at significant levels in a variety of nonlenticular tissues, while alphaA has only been detected in small amounts in a few other tissues such as retina, spleen and thymus [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. Collectively, these findings have challenged the dogma that alpha-crystallin is purely a structural protein necessary for light refraction, and have led to the realization that alpha-crystallin may have a variety of biological functions in the lens.</p>
      <p>A much broader scope of cellular functions of alpha-crystallin in lens is inferred from <italic>in vitro </italic>observations. Both alphaA and alphaB can bind specifically to actin, <italic>in vitro </italic>[<xref ref-type="bibr" rid="B13">13</xref>] and <italic>in vivo </italic>[<xref ref-type="bibr" rid="B14">14</xref>]. Although actin filament formation has been shown to be necessary for differentiation of lens epithelial cells [<xref ref-type="bibr" rid="B15">15</xref>], the significance of alpha-crystallin's interaction with actin in differentiation is not known. In the lens, alpha-crystallin also associates with type III intermediate filament proteins and the beaded filament proteins CP49 and CP115, and correct beaded filament assembly has been shown depend on the presence of alpha-crystallin [<xref ref-type="bibr" rid="B16">16</xref>]. Beaded filament mRNA levels are greatly increased in differentiating lens epithelium and have been suggested as a pan-specific marker for lens fiber development [<xref ref-type="bibr" rid="B17">17</xref>]. Alpha-crystallin has also been shown to interact directly with DNA [<xref ref-type="bibr" rid="B18">18</xref>]. In transfected CHO cells, alphaB has also been shown to ectopically localize to interphase nuclei, suggesting a role for this protein in the nucleus [<xref ref-type="bibr" rid="B19">19</xref>]. A nuclear role for alphaB in the lens was supported by the findings that a subset of lens epithelial cells derived from alphaB knockout mice demonstrated hyperproliferation and genomic instability [<xref ref-type="bibr" rid="B20">20</xref>]. In addition, the administration of exogenous alpha-crystallin to primary bovine lens epithelial cell cultures resulted in the formation of lentoid bodies, consistent with a role for these proteins in lens differentiation [<xref ref-type="bibr" rid="B21">21</xref>]. These findings indicate that alpha-crystallin may have a multitude of <italic>in vivo </italic>functions.</p>
      <p>One approach to resolving some of the <italic>in vivo </italic>functions of alpha-crystallin is to generate animal models where one or both of the alpha-crystallin gene products have been eliminated. Brady et al. [<xref ref-type="bibr" rid="B22">22</xref>] demonstrated, by targeted disruption of the mouse alphaA gene, that this protein was essential for the maintenance of lens transparency, possibly by maintaining the solubility of alphaB, or associated proteins, in the lens. These lenses were also reported to be smaller in equatorial and light axial dimensions than age matched wild type lens. It was not possible using the techniques employed in the study to determine if the smaller lenses were due to reduced volume or number of fiber cells. Targeted disruption of the mouse alphaB gene resulted in lenses similar in size to aged-matched wild type lens. Moreover, no cataract formation was observed in the alphaB knockout lenses. These animals have muscle cell abnormalities, severe postural anomalies, selective muscle degeneration, and shorter life spans compared to normal controls [<xref ref-type="bibr" rid="B23">23</xref>].</p>
      <p>In the single alpha-crystallin knockout mice, the remaining alpha-crystallin may fully or partially compensate for some of the functions of the missing protein, especially in the lens, where both alphaA and alphaB are normally expressed at high levels. The objectives of the current report were to characterize gross morphology of young (5 wk) and old (54 wk) mouse lenses with targeted disruption of both the alphaA and alphaB genes, in comparison to age matched wild type lenses, using scanning electron microscopy (SEM) and confocal microscopy, to elucidate the possible functions of alpha-crystallin in the lens. The results indicate that alpha-crystallin is necessary for proper fiber cell formation and resulting lens transparency.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Lenses</title>
        <p>The wild type mouse strain used in this study was the 129SvEvTac mouse. Lenses examined were from 5(8 lenses), 46(8 lenses) and 72(6 lenses) wk old mice.</p>
        <p>AlphaA/BKO was generated by cross breeding alphaAKO-127 [<xref ref-type="bibr" rid="B22">22</xref>] and alphaBKO-168 mice [<xref ref-type="bibr" rid="B23">23</xref>], also in a 129Sv background. These mice also lack the HSPB2 gene product [<xref ref-type="bibr" rid="B23">23</xref>]. Lenses examined were from 5 wk (6 lenses) and 54 wk (16 lenses) old mice. All animals were treated in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research.</p>
        <p>Immediately after euthanizing animals, eyes were enucleated. A scalpel blade was then used to make a small incision into the anterior chamber near the equator and then both eyes from individual animals were immersed in 5 ml fixative (2% (w/v) paraformaldehyde and 2% glutaraldehyde (v/v) in 0.1 M sodium cacodylate buffer, pH 7.2). Eyes were fixed for at least 24 hr at room temperature (RT) prior to dissection of the lenses. At this time, equatorial and axial dimensions of lenses and gross lenticular appearance were recorded. Statistical analyses on data consisted of Student's t-test, means and standard deviation, using the statistical software package StatMost (Dataxiom Software Inc., Los Angeles, CA).</p>
      </sec>
      <sec>
        <title>Confocal microscopy</title>
        <p>Lenses were vibratome sectioned into 100–200 μm thick sections along the optical (anterior to posterior) or equatorial axes. Thick sections were fixed in 2% (w/v) paraformaldehyde and 2% glutaraldehyde (v/v) in 0.1 M sodium cacodylate buffer pH 7.2 at RT for 24 hrs then washed several times in Tris buffered saline (0.5 M Tris, 150 mM NaCl, pH 7.4). To visualize lipid membranes, sections were stained with 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate ('DiI';DiIC<sub>18</sub>; Molecular Probes) as previously described [<xref ref-type="bibr" rid="B24">24</xref>]. Sections were then washed several times with Tris buffered saline, and nucleic acids were stained by incubating sections in TBS containing 1 μM SYTOX Green (Molecular Probes) for 10 min at RT followed by several washes with TBS prior to confocal imaging.</p>
        <p>Lens sections were viewed on a Zeiss laser scanning confocal microscope model LSM 410 equipped with an Axiovert 100 inverted microscope, an Argon-Krypton 488/568/647 laser, a KP line selection filter, a FT 488/568 Dichroic beam splitter, a FT 560 Dichroic beam splitter, a LP 590 emission filter for viewing DiI, a BP 515–540 emission filter for viewing SYTOX green, and the software package LSM 3.993.</p>
      </sec>
      <sec>
        <title>Scanning electron microscopy</title>
        <p>Lenses bisected along the optical axes were immersion fixed in 2% (w/v) paraformaldehyde and 2% glutaraldehyde (v/v) in 0.1 M sodium cacodylate buffer pH 7.2 at RT for 24 hrs. Samples were then washed several times with distilled water and postfixed in 1% (v/v) aqueous osmium tetroxide at RT for 1 hr. Lens halves were dehydrated in an ascending ethanol series from 50–100 %. Once lens halves were in 100% ethanol, they were critical point dried in carbon dioxide in a Samdri-790B (Tousimis Research Corp., Rockville, MD). Critical point dried lens halves were secured on aluminum stubs with double sided tape. Mounted specimens were then sputter coated with gold and viewed on a Hitachi S-3500N scanning electron microscope (Tokyo, Japan) at 1–5 kV. This microscope is equipped with Hitachi's patented "Dual-Bias" which allows extremely high emission currents at acceleration voltages of 5 kV and lower.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <p>Equatorial and axial (sagittal) dimensions of lenses, and gross lenticular appearance, were recorded (Table <xref ref-type="table" rid="T1">1</xref>). AlphaA/BKO lenses at 5 wks of age were significantly smaller (p &lt; 0.05), both equatorially and axially, than 5 wk old wild type lenses and remain smaller throughout life. Fifty-four wk old alphaA/BKO lenses were much smaller than similarly aged normal lenses, and were similar in size to 5 wk old wild type lenses. Both the 5 wk old wild type lenses and the 54 wk old alphaA/BKO lenses were significantly smaller (p &lt; 0.01) than the 46 or 72 wk old wild type lenses. AlphaA/BKO lenses at 5 wks of age exhibited vacuoles at the equatorial region (Figure <xref ref-type="fig" rid="F1">1A</xref> see arrows) and an area of slight light scatter at the posterior subcapsular regions (Figure <xref ref-type="fig" rid="F1">1B</xref> see arrowheads). By 54 wks of age, alphaA/BKO lenses exhibited dense cortical and nuclear cataracts (Figure <xref ref-type="fig" rid="F1">1C</xref>). No posterior sutures were observed in any of the alphaA/BKO lenses examined. All wild type lenses were transparent upon removal from the eye (Figure <xref ref-type="fig" rid="F1">1D,1E</xref> and <xref ref-type="fig" rid="F1">1F</xref>) and had well defined posterior sutures.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Light micrographs of lenses dissected from fixed eyes of alphaA/BKO (A-C) and wild type (D-F) mice. All micrographs were generated using a 4 × /0.10 objective on a Zeiss LSM 410 using transmitted light mode. Images in (A&amp;B) were enlarged compared to images (C-F) (see scale bars). For all micrographs except (B) the objective focal point was set at the equatorial plane of the lens, while (B) was set at the posterior pole of the lens. (A&amp;B) Representative micrographs of lenses from 5 wk alphaA/BKO mice, showing changes in the equatorial (A) and posterior sub capsular (B) regions. (C) Representative micrograph of 54 wk alphaA/BKO mouse lens showing dense whole lens cataract. (D-F) Representative clear lenses from 5 wk (D), 46 wk (E), and wk 72 (F) wild type mice. Arrows (A) indicate vacuoles in the equatorial region of a representative 5 wk alphaA/BKO lens. The arrowheads (B) indicate an area of minor light scattering deep to the posterior capsule in a representative 5 wk alphaA/BKO lens.</p>
        </caption>
        <graphic xlink:href="1471-2415-3-3-1"/>
      </fig>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Dimensions and gross lenticular appearance of lenses.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="center">Lenses</td>
              <td align="center">Sample size (n)</td>
              <td align="center" colspan="2">Mean +/- standard deviation</td>
              <td align="center">Gross lenticular appearance</td>
            </tr>
            <tr>
              <td/>
              <td/>
              <td colspan="2">
                <hr/>
              </td>
              <td/>
            </tr>
            <tr>
              <td/>
              <td/>
              <td align="center">Axial diameter mm</td>
              <td align="center">Equatorial diameter mm</td>
              <td/>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="center">5 wk alphaA/BKO</td>
              <td align="center">6</td>
              <td align="center">1.3567 +/-0.0321</td>
              <td align="center">1.55+/-0.0458</td>
              <td align="center">Equatorial and posterior subcapsular light scattering</td>
            </tr>
            <tr>
              <td align="center">54 wk alphaA/BKO</td>
              <td align="center">6</td>
              <td align="center">1.78+/-0.0516</td>
              <td align="center">1.87+/-0.0837</td>
              <td align="center">Dense whole lens cataract</td>
            </tr>
            <tr>
              <td align="center">5 wk wild type</td>
              <td align="center">6</td>
              <td align="center">1.8625+/-0.0585</td>
              <td align="center">1.905+/-0.087</td>
              <td align="center">clear</td>
            </tr>
            <tr>
              <td align="center">46 wk wild type</td>
              <td align="center">6</td>
              <td align="center">2.2075+/-0.0929</td>
              <td align="center">2.3775+/-0.015</td>
              <td align="center">clear</td>
            </tr>
            <tr>
              <td align="center">72 wk wild type</td>
              <td align="center">6</td>
              <td align="center">2.5633+/-0.0252</td>
              <td align="center">2.4567+/-0.0058</td>
              <td align="center">clear</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Examination of mid-axial sections stained with DiI and SYTOX green revealed unique differences in gross morphology and nucleic acid staining between alphaA/BKO lenses and wild type lenses (Figure <xref ref-type="fig" rid="F2">2</xref>). In five week old alphaA/BKO lenses, Sytox green stained nuclei (green) in the anterior epithelium, equatorial/bow, and posterior subcapsular regions (Figure <xref ref-type="fig" rid="F2">2A</xref>). Cell nuclei localized to the equatorial/bow region were disorganized as compared to wild type. There were enlarged extracellular spaces between cells in the equatorial/bow region in 5 wk old alphaA/BKO lenses. Fifty-four wk old alphaA/BKO lenses (Figure <xref ref-type="fig" rid="F2">2B</xref>) did not stain for nucleic acid in the posterior subcapsular region, however, the entire anterior subcapsular lens region stained for nucleic acid (refer to Figure <xref ref-type="fig" rid="F3">3I</xref> for high magnification/resolution image of this area). A defined equatorial/bow region was not observed in these older lenses, and fiber cells extending to the posterior capsule of the lens were not found. Disorganized cellular material capped the anterior region of the embryonic/fetal nucleus, and a distinctive indentation of the lens mass at the equatorial region was apparent in mid-axial sections as well as whole lenses. In alphaA/BKO lenses the embryonic/fetal nucleus (primary lens fibers) had migrated posteriorly and appeared to be in contact with the posterior capsule. In 5 wk, 46 wk or 72 wk old wild type lenses (Figure <xref ref-type="fig" rid="F2">2C,2D</xref> and <xref ref-type="fig" rid="F2">2E</xref>), however, there was no posterior or anterior subcapsular nucleic acid staining and the embryonic-fetal nucleus was centrally located, not in contact with the posterior capsule.</p>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>Representative confocal optical sections taken from mid-axial vibratome sections of alphaA/BKO (A&amp;B) and wild type (C-E) lenses. All optical sections were generated using a 4 × /0.10 objective on a Zeiss LSM 410. The red color represents DiI staining (membrane), while the green color represents SYTOX green staining (DNA). (A&amp;B) were taken from 5 wk and 54 wk alphaA/BKO lenses, respectively. (C-E) were taken from 5 wk, 46 wk, and 72 wk wild type lenses, respectively. The arrowheads indicate representative anterior epithelial nuclei stained with SYTOX green.</p>
        </caption>
        <graphic xlink:href="1471-2415-3-3-2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>Representative confocal optical sections from alphaA/BKO (A-J) and wild type (K-T) lenses. All optical sections were generated using a 63 × /1.4 objective on a Zeiss LSM 410. The red color represents DiI staining (membrane), while the green color represents SYTOX green staining (DNA). (A-E) are from 5 wk alphaA/BKO lenses. (F-J) are from 54 wk alphaA/BKO lenses. (K-O) are from 5 wk wild type lenses. (P-T) are from 46 wk wild type lenses. (A, F, K, and P) are anterior central cortex and epithelium. (B, G, L, and Q) are equatorial bow region. (C, H, M, and R) are embryonic/fetal nucleus. (D, I, N, and S) are deep anterior cortex. (E, J, O, and T) are posterior subcapsular region. (*) indicates areas devoid of cellular material (B and G). Arrow indicates posterior suture (O). Arrowheads indicate representative nuclei stained with SYTOX green (A, B, E, F, G, I, K, L, P, and Q).</p>
        </caption>
        <graphic xlink:href="1471-2415-3-3-3"/>
      </fig>
      <p>At higher magnification, examination of sections stained with DiI and SYTOX green revealed ultrastructural differences between alphaA/BKO lenses and wild type lenses (Figure <xref ref-type="fig" rid="F3">3</xref>). Anterior epithelial staining in 5 wk old alphaA/BKO (Figure <xref ref-type="fig" rid="F3">3A</xref>) and 5 wk old wild type lenses were similar (Figure <xref ref-type="fig" rid="F3">3K</xref>) with respect to nuclear staining with SYTOX green. However, some differences in 54 wk old alphaA/BKO lenses (Figure <xref ref-type="fig" rid="F3">3F</xref>) were observed in the central anterior epithelium compared to 5 wk (Figure <xref ref-type="fig" rid="F3">3K</xref>), 46 wk (Figure <xref ref-type="fig" rid="F3">3P</xref>), and 72 wk (data not shown) wild type lenses. These differences included changes in central epithelial nuclear staining, nuclear shape and epithelial thickness and continuity. Superficial and deep anterior cortical staining was grossly different between alphaA/BKO (Figure <xref ref-type="fig" rid="F3">3A,3D,3F</xref> and <xref ref-type="fig" rid="F3">3I</xref>) and wild type lenses (Figure <xref ref-type="fig" rid="F3">3K,3N,3P</xref> and <xref ref-type="fig" rid="F3">3S</xref>). In 5 and 54 wk old alphaA/BKO lenses, superficial and deep anterior cortical regions, stained for lipid membranes, did not reveal any patterns typical of fiber cells cut in cross-section or longitudinal section. In 5 wk alphaA/BKO lenses there was a high density of stained membranes per unit area throughout the cortex, with no nucleic acid staining in these regions. In 54 wk alphaA/BKO lenses, large, irregularly shaped cells were observed, interspersed among regions of high membrane staining density per unit area. These large objects were not vacuoles, because examination of the interior of these structures by transmitted and reflected light microscopy showed that the membranes encompassed cellular material (data not shown). In addition, nucleic acid staining was observed (Figure <xref ref-type="fig" rid="F3">3F</xref> and <xref ref-type="fig" rid="F3">3I</xref>) within many of these cells exhibiting large cross-sectional profiles. In the wild type lenses, typical cross-sectional patterns of fiber cells organized in radial columns were observed (Figure <xref ref-type="fig" rid="F3">3K,3N,3P</xref> and <xref ref-type="fig" rid="F3">3S</xref>).</p>
      <p>Ultrastructural differences at the equatorial/bow region were also observed between alphaA/BKO lenses (Figure <xref ref-type="fig" rid="F3">3B</xref> and <xref ref-type="fig" rid="F3">3G</xref>) and wild type lenses (Figure <xref ref-type="fig" rid="F3">3L</xref> and <xref ref-type="fig" rid="F3">3Q</xref>). In contrast to wild type lenses (Figure <xref ref-type="fig" rid="F3">3L</xref> and <xref ref-type="fig" rid="F3">3Q</xref>), the alphaA/BKO lenses (Figure <xref ref-type="fig" rid="F3">3B</xref> and <xref ref-type="fig" rid="F3">3G</xref>) contained large areas devoid of cellular material, their nuclei were not limited to a well defined equatorial/bow region, and ordered radial columns of elongating fiber cells extending from the posterior capsule to the anterior epithelium were not observed. In addition to the equatorial region, ultrastructural differences between alphaA/BKO lenses (Figure <xref ref-type="fig" rid="F3">3C</xref> and <xref ref-type="fig" rid="F3">3H</xref>) and wild type lenses (Figure <xref ref-type="fig" rid="F3">3M</xref> and <xref ref-type="fig" rid="F3">3R</xref>) were observed in fiber cells of the embryonic and fetal nucleus. In 5 wk alphaA/BKO lenses (Figure <xref ref-type="fig" rid="F3">3C</xref>), a greater variation in cross sectional diameter was observed, with cell diameters ranging from less than 2 microns up to approximately 25 microns, compared to the 5 wk and 46 wk wild type lenses, whose diameters ranged from less than 2 microns up to approximately 10 microns (Figure <xref ref-type="fig" rid="F3">3M</xref> and <xref ref-type="fig" rid="F3">3R</xref>). At 54 wk, these cells in the alphaA/BKO lenses were larger in cross sectional diameter than wild type, and exhibited a much greater variation in the cross sectional size and cell shape.</p>
      <p>Cells adjacent to the posterior capsule of 5 wk alphaA/BKO lenses (Figure <xref ref-type="fig" rid="F3">3E</xref>) exhibited nucleic acid staining, were small and non-elongated, with numerous membrane projections., These were, however, not observed in 54 wk alphaA/BKO lenses. In 5 wk alphaA/BKO lenses, deep to the posterior capsule, larger diameter cells, similar to those observed in the embryonic/fetal nucleus were observed (data not shown). Fiber cells of similar dimension and appearance to embryonic/fetal nuclear fibers were seen at the posterior capsule in 54 wk alphaA/BKO lenses (Figure <xref ref-type="fig" rid="F3">3J</xref>). In both 5 and 54 wk alphaA/BKO lenses, no posterior sutures could be found in any axial or equatorial vibratome sections examined. Posterior sutures were readily found in vibratome sections of wild type lenses (Figure <xref ref-type="fig" rid="F3">3O</xref>, arrow). Fiber cells attached to the posterior capsule and extending anteriorly were observed in 5 wk (Figure <xref ref-type="fig" rid="F3">3O</xref>), 46 wk (Figure <xref ref-type="fig" rid="F3">3T</xref>) and 72 wk (data not shown) wild type lenses.</p>
      <p>SEM confirmed many of the observations made by confocal microscopy. In the equatorial/bow region, a disorganized array of relatively small irregular shaped cells were observed in 5 wk (Figure <xref ref-type="fig" rid="F4">4A</xref>) and 54 wk (Figure <xref ref-type="fig" rid="F4">4D</xref>) alphaA/BKO lenses, while elongated fiber cells organized into radial columns, with ball and socket interdigitations, were observed in 5 wk (Figure <xref ref-type="fig" rid="F4">4G</xref>), 46 wk (Figure <xref ref-type="fig" rid="F4">4J</xref>) and 72 wk (data not shown) wild type lenses. In the anterior cortical region of 5 wk alphaA/BKO lenses, radial columns of cells with numerous cell surface projections were observed (Figure <xref ref-type="fig" rid="F4">4B</xref>), but these radial columns were no longer present at 54 weeks of age (Figure <xref ref-type="fig" rid="F4">4E</xref>). In these older lenses, irregularly shaped, convoluted cells, with no recognizable pattern of organization, were present. In contrast, radial columns of elongated fiber cells of uniform size and shape, with ball and socket interdigitations, were present in the anterior cortical region of 5 wk (Figure <xref ref-type="fig" rid="F4">4H</xref>), 46 wk (Figure <xref ref-type="fig" rid="F4">4K</xref>) and 72 week (data not shown) wild type lenses. The posterior subcapsular regions of 5 wk (Figure <xref ref-type="fig" rid="F4">4C</xref>) and 54 wk (Figure <xref ref-type="fig" rid="F4">4F</xref>) alphaA/BKO lenses were filled with irregularly shaped cells with numerous cell surface projections. In the fetal/embryonic nucleus, elongated fiber cells with numerous long, finger-like projections and furrowed membranes were evident (not shown). No elongated cells extending from the bow region to the posterior capsule of alphaA/BKO lenses were observed. In contrast, radial columns of elongated fiber cells of uniform size and shape containing ball and socket interdigitations were observed in the posterior subcapsular region in 5 wk (Figure <xref ref-type="fig" rid="F4">4I</xref>), 46 wk (Figure <xref ref-type="fig" rid="F4">4L</xref>) and 72 wk (data not shown) wild type lenses, and fiber cells in contact with the posterior capsule could be traced back to the equatorial bow region and anterior epithelium.</p>
      <fig position="float" id="F4">
        <label>Figure 4</label>
        <caption>
          <p>Representative scanning electron micrographs of alphaA/BKO (A-F) and wild type (G-L) lenses. (A-C) Representative images from 5 wk alphaA/BKO lenses. (D-F) Representative images from 54 wk alphaA/BKO lenses. (G-I) Representative images from 5 wk wild type lenses. (J-L) Representative images from 46 wk wild type lenses. (A, D, G, and J) Equatorial/bow region. (B, E, H, and K) Anterior cortex. C, (F, I, and L) Posterior subcapsular region.</p>
        </caption>
        <graphic xlink:href="1471-2415-3-3-4"/>
      </fig>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>One approach to resolving some of the <italic>in vivo </italic>functions of alpha-crystallin is to generate animal models where one or both of the alpha-crystallin gene products have been eliminated. Brady et al. [<xref ref-type="bibr" rid="B22">22</xref>] demonstrated, by targeted disruption of the mouse alphaA gene, that this protein was essential for the maintenance of lens transparency, possibly by maintaining the solubility of alphaB, or associated proteins, in the lens. These lenses were also reported to be smaller in equatorial and axial dimensions than age matched wild type lens, which was very similar to that which was observed with the double knockout lens. Targeted disruption of the mouse alphaB gene, however, resulted in lenses similar in size to aged-matched wild type lens with no cataracts reported [<xref ref-type="bibr" rid="B23">23</xref>]. This indicates that alphaA may play a greater role in maintaining the transparency of the lens then alphaB. In the single alpha-crystallin knockout mice, the remaining alpha-crystallin may fully or partially compensate for some of the functions of the missing protein, especially in the lens, where both alphaA and alphaB are normally expressed at high levels. This was supported by the morphological observation made in this study of no posterior sutures or fiber cells extending to the posterior capsule of the lens, ectopically staining nucleic acids in the posterior subcapsular region of 5 wk and anterior subcapsular cortex of 54 wk, gross morphological differences in the equatorial/bow, posterior and anterior regions of lenses from alphaA/BKO mice as compared to wild mice. None of these morphological differences have been reported in the single alphaA or alphaB knockout mice. It must be noted, however, that the alphaA/BKO mice also lack the HSPB2 gene product [<xref ref-type="bibr" rid="B23">23</xref>] and the contribution of this protein to normal lens morphology and functions should not be overlooked. Future studies should address the possible functions of HSPB2 in normal lens.</p>
      <p>The results of the current study support the hypothesis that alpha-crystallin plays an active role in the differentiation and growth of lens fiber cells. Normal differentiation of lens fiber cells consists of a progression from a simple cuboidal epithelial cell, containing a nucleus and a minimal numbers of organelles, to a stratified layer of elongated fiber-like cells, devoid of nuclei and organelles. Differentiation of epithelial cells occurs in the equatorial/bow region of the lens, where epithelial cells begin to elongate and differentiate into fiber cells of uniform cellular shape, arranged in radial columns of cells extending from the anterior epithelium to the posterior capsule. This process did not appear to have proceeded normally in lenses lacking alphaA and alphaB. The morphological observations presented in this study demonstrate that fiber cells in lenses lacking alphaA and alphaB fail to elongate symmetrically from the bow region and therefore do not establish the typical "onion skin" conformation in which cells extend from the anterior epithelium to the posterior capsule. Additionally, in lenses from 54 wk alphaA/BKO lenses, there was a persistence of cell nuclei in deeper cortical regions, and ectopic cell nuclei were present in large numbers in the anterior central cortex. At 5 wks of age cell nuclei were present, adjacent to the posterior capsule. These morphological observations are consistent with a defect in the normal differentiation pathway of lens epithelial cells into fiber cells.</p>
      <p>It is unlikely that these alterations in alphaA/BKO mouse lenses result from increased susceptibility of these lenses to light-induced damage in the absence of the molecular chaperone protection afforded by alphaA and alphaB in normal lenses. With the normal time of eye opening at approximately 14 days after birth, the 5 wk old mice had their eyes open and lenses exposed to light for only about 3 weeks prior to morphological analysis. Moreover, these animals had been exposed to only animal facility fluorescent lighting and were protected from UV light by plastic cages. If lack of protection from light-induced damage was the major factor affecting the changes in these lenses, then the bulk of the damage should have resided along the visual axis, particularly in the central anterior epithelium and subcapsular cortex in the 5 wk lenses, but this was not the case. In these lenses, gross morphological changes were apparent in the equatorial and posterior subcapsular regions. These changes included posterior subcapsular nucleic acid staining, absence of posterior sutures, and small irregularly shaped cells, not arranged in any discernable pattern, in the equatorial/bow region. Systemic stress factors crossing the blood/aqueous barrier might explain some morphological changes at the equatorial region, but this would not explain nucleic acid staining in the posterior subcapsular region. In the 5 wk alphaA/BKO lenses, nucleic acid staining in the posterior subcapsular region is consistent with either anterior epithelial cells migrating aberrantly to the posterior pole, or primary fiber cells failing to fully differentiate by 5 wks of age. These two possibilities could not be differentiated in the methods employed, and were beyond the objectives of the current study. Future studies are being designed to address which of these two processes might explain nucleic acid staining in the posterior subcapsular region. Staining in this region was not observed in older alphaA/BKO lenses, suggesting that this pattern was transient. The fate of the nucleic acid-containing cells in the posterior capsular region of younger lenses is not known at this time, nor is the morphology of earlier stage lenses. Future studies with defined objectives to address the development and progression of morphological changes seen in this study are being designed. The morphological differences in alphaA/BKO lenses, compared to age matched wild type lenses, were consistent with the hypothesis that alpha-crystallin plays an active role in the differentiation and growth of lens fiber cells. In addition, it was clearly evident that alpha-crystallin is necessary for lens transparency.</p>
      <p>The final biological event in a lens epithelial cell's life is the transformation from an epithelial cell into a fiber cell, which occurs at the equatorial/bow region of the lens. The newly forming fiber cell continues to differentiate in the cortex until a mature fiber cell devoid of organelles with suture formation at the ends of the cell is formed. This entire process from epithelial cell to mature fiber cell is defined as lens differentiation. The precise spatial and temporal expression of the crystallin proteins in the developing lens may not be simply a consequence of the differentiation process, but instead may play an important, if not essential, role in the differentiation process itself. The results of the current study support this hypothesis.</p>
      <p>The exact <italic>in vivo </italic>molecular mechanisms, by which alpha-crystallin might influence lens epithelial cell differentiation, and maintenance of lens transparency, remain to be determined. AlphaA and alphaB are members of the shsp family [<xref ref-type="bibr" rid="B7">7</xref>]. Previous studies have shown that the alpha-crystallin possesses molecular chaperone activity, binding to partially denatured proteins, both <italic>in vitro </italic>[<xref ref-type="bibr" rid="B5">5</xref>] and probably <italic>in vivo </italic>[<xref ref-type="bibr" rid="B6">6</xref>], to inhibit further denaturation. Although this property may be a major contributor to the maintenance of lens clarity, the early changes in the alphaA/BKO lenses indicate a much broader cellular function for alpha-crystallin. Stress proteins have been shown to be expressed in non-stressed cells during development and differentiation [<xref ref-type="bibr" rid="B25">25</xref>]. Hsps were shown to be expressed during the differentiation of mammalian osteoblasts and promelocytic leukemia cells [<xref ref-type="bibr" rid="B26">26</xref>]. In addition, hsp expression has been shown to accompany growth arrest in human B lymphocytes [<xref ref-type="bibr" rid="B27">27</xref>] and macrophage differentiation of HL 60 cells [<xref ref-type="bibr" rid="B28">28</xref>]. During myogenic differentiation, mRNA for alphaB increases in conjunction with the induction of mRNA for myogenin, the earliest known event in myogenesis [<xref ref-type="bibr" rid="B29">29</xref>]. The addition of exogenous alpha-crystallin to primary bovine lens epithelium was shown to induce rapid changes in cell shape, leading to the formation of lentoid bodies [<xref ref-type="bibr" rid="B21">21</xref>]. These studies strongly suggest that the hsp family of proteins has other functions in addition to protecting proteins and cells during stress.</p>
      <p>Alpha-crystallin may play a functional role in the cell nucleus and may have a role in regulating the cell cycle. Several heat shock proteins have been found in cell nuclei in the absence of stress [<xref ref-type="bibr" rid="B30">30</xref>], and alpha-crystallin has been shown to interact directly with DNA [<xref ref-type="bibr" rid="B18">18</xref>]. AlphaB, expressed in transfected CHO cells, has been shown to ectopically localize to interphase nuclei, suggesting a regulatory role for this protein in the nucleus [<xref ref-type="bibr" rid="B19">19</xref>]. A subset of immortalized lens epithelial cells from alphaBKO mice have been shown to hyperproliferate [<xref ref-type="bibr" rid="B20">20</xref>] suggesting that alphaB may be important in maintaining genomic stability. In lens epithelium derived from alphaAKO lenses, cell growth rates were reported to be 50% lower compared to wild type [<xref ref-type="bibr" rid="B31">31</xref>], suggesting a role for alphaA in regulating the cell cycle. All of these findings raise many questions as to the possible role(s) of alpha-crystallin in the nucleus and in cell cycle regulation during differentiation. In the current study, the observation of a disorganized pattern of nuclei localized to the equatorial bow region of alphaA/BKO lenses, and nucleic acid staining of structures throughout the anterior cortex of 54 wk alphaA/BKO lenses, is consistent with a role for alpha-crystallin in the nucleus.</p>
      <p>There is extensive evidence from previous studies demonstrating that alpha-crystallin plays a role in the cytoskeletal organization. Both alphaA and alphaB can bind specifically to actin, both <italic>in vitro </italic>[<xref ref-type="bibr" rid="B13">13</xref>] and <italic>in vivo </italic>[<xref ref-type="bibr" rid="B14">14</xref>]. Actin filament formation has been shown to be necessary for the differentiation of lens epithelial cells [<xref ref-type="bibr" rid="B15">15</xref>], however, the significance of alpha-crystallin interaction with actin in differentiation is not known. In the lens, alpha-crystallin also forms a complex with type III intermediate filament proteins and the lens-specific beaded filament proteins CP49 and CP115, which may be critical for proper filament assembly [<xref ref-type="bibr" rid="B16">16</xref>]. Beaded filament mRNA levels increase greatly in differentiating lens epithelial cells, and have been suggested as a pan-specific marker for lens fiber cells [<xref ref-type="bibr" rid="B17">17</xref>]. It is therefore possible that increased synthesis of alpha-crystallin in epithelial cells early in the differentiation process may have profound effects upon the cytoskeleton, which in turn may profoundly affect cell shape and migration. The lack of cellar organization and uniform cell shape at the equatorial region observed in alphaA/BKO lenses supports this hypothesis. Studies are currently underway to characterize cytoskeletal organization in the alphaA/BKO lens.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>None declared</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>DLB conceived and designed the study, carried out sample preparation, confocal microscopy, scanning electron microscopy, statistical analysis, and drafted the manuscript. JPB assisted in the production of the Alpha/BKO mice. EFW assisted in the production of the AlphaA/BKO mice, experimental design, and initial fixation of samples. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/3/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>This research was supported in part by a NIH Grant for Vision Research EY02932 awarded to LT.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bloemendal</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The vertebrate eye lens.</article-title>
          <source>Science</source>
          <year>1977</year>
          <volume>197</volume>
          <fpage>127</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">877544</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Rafferty</surname>
              <given-names>NS</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Harry Maisel</surname>
            </name>
          </person-group>
          <article-title>Lens morphology.</article-title>
          <source>The Ocular Lens: structure, function and pathology</source>
          <year>1985</year>
          <publisher-name>Marcel Dekker, Inc</publisher-name>
          <fpage>51</fpage>
          <lpage>53</lpage>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vermorken</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Hilderink</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>van de Ven</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Bloemendal</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Lens differentiation. Crystallin synthesis in isolated epithelia from calf lenses.</article-title>
          <source>J Cell Biol</source>
          <year>1978</year>
          <volume>76</volume>
          <fpage>175</fpage>
          <lpage>183</lpage>
          <pub-id pub-id-type="pmid">618891</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horwitz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bova</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Haley</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>Lens alpha-crystallin: function and structure.</article-title>
          <source>Eye</source>
          <year>1999</year>
          <volume>Pt 13</volume>
          <fpage>403</fpage>
          <lpage>408</lpage>
          <pub-id pub-id-type="pmid">10627817</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horwitz</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Alpha crystallins can function as a molecular chaperone.</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1992</year>
          <volume>89</volume>
          <fpage>10449</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">1438232</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boyle</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Takemoto</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the alpha-gamma and alpha-beta complex: Evidence for in vivo functional role of alpha-crystallin as a molecular chaperone.</article-title>
          <source>Exp Eye Res</source>
          <year>1994</year>
          <volume>58</volume>
          <fpage>9</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="pmid">8157104</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.1994.1190</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DeJong</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Leunissen</surname>
              <given-names>JAM</given-names>
            </name>
            <name>
              <surname>Voorter</surname>
              <given-names>CEM</given-names>
            </name>
          </person-group>
          <article-title>Evolution of alpha crystallin/small heat-shock protein family.</article-title>
          <source>Mol Biol Evol</source>
          <year>1993</year>
          <volume>10</volume>
          <fpage>103</fpage>
          <lpage>126</lpage>
          <pub-id pub-id-type="pmid">8450753</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kato</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shinohara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Inaguma</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Morishita</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Asano</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Copurification of small heat shock protein with alphaB-crystallin from human skeletal muscle.</article-title>
          <source>J Biol Chem</source>
          <year>1992</year>
          <volume>267</volume>
          <fpage>7718</fpage>
          <lpage>7725</lpage>
          <pub-id pub-id-type="pmid">1560006</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Srinivasan</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Nagineni</surname>
              <given-names>CN</given-names>
            </name>
            <name>
              <surname>Bhat</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>Alpha A-crystallin is expressed in non-ocular tissues.</article-title>
          <source>J Biol Chem</source>
          <year>1992</year>
          <volume>267</volume>
          <fpage>23337</fpage>
          <lpage>23341</lpage>
          <pub-id pub-id-type="pmid">1429679</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deretic</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Aebersold</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Morrison</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Papermaster</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>AlphaA- and alphaB-crystallin in retina. Association wit post-Golgi compartment of frog retinal photoreceptors.</article-title>
          <source>J Biol Chem</source>
          <year>1994</year>
          <volume>269</volume>
          <fpage>16853</fpage>
          <lpage>16861</lpage>
          <pub-id pub-id-type="pmid">8207008</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dubin</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Wawrousek</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Piatigorsky</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Expression of the murine alphaB-crystallin gene is not restricted to the lens.</article-title>
          <source>Mol Cell Biol</source>
          <year>1989</year>
          <volume>9</volume>
          <fpage>1083</fpage>
          <lpage>1091</lpage>
          <pub-id pub-id-type="pmid">2725488</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhat</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Nagineni</surname>
              <given-names>CN</given-names>
            </name>
          </person-group>
          <article-title>AlphaB subunit of lens-specific protein alpha-crystallin is present in other ocular and non-ocular tissues.</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1989</year>
          <volume>158</volume>
          <fpage>319</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="pmid">2912453</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gopalakrishnan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Boyle</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Takemoto</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Association of actin with alpha crystallin.</article-title>
          <source>Trans Kans Acad Sci</source>
          <year>1993</year>
          <volume>96</volume>
          <fpage>7</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">11537714</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DelVecchio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mac Elroy</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rosser</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Church</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Association of alpha crystallin with actin in cultured lens cells.</article-title>
          <source>Curr Eye Res</source>
          <year>1984</year>
          <volume>3</volume>
          <fpage>1213</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">6386347</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mousa</surname>
              <given-names>GY</given-names>
            </name>
            <name>
              <surname>Trevithick</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Differentiation of rat lens epithelial cells in culture II. Effects of cytochalasins B and D on actin organization and differentiation.</article-title>
          <source>Develop Biol</source>
          <year>1977</year>
          <volume>60</volume>
          <fpage>14</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">561720</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carter</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hutchenson</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Quinlan</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>In vitro studies on the assembly properties of the lens proteins C49, CP115: Coassembly with alpha-crystallin but not with vimentin.</article-title>
          <source>Exp Eye Res</source>
          <year>1995</year>
          <volume>60</volume>
          <fpage>181</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">7781747</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ireland</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sandilands</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Poosch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kasper</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Graw</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Maisel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Prescott</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Hutcheson</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Goebel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Quinlan</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Up-regulation of novel intermediate filament proteins in primary fiber cells: and indicator of all vertebrate lens fiber differentiation?</article-title>
          <source>Anatom Rec</source>
          <year>2000</year>
          <volume>258</volume>
          <fpage>25</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0185(20000101)258:1&lt;25::AID-AR3&gt;3.0.CO;2-C</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pietrowski</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Durante</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Liebstein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schmitt-John</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Graw</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>alpha-crystallins are involved in specific interactions with murine gamma-D/E/F-crystallin encoding gene.</article-title>
          <source>Gene</source>
          <year>1994</year>
          <volume>144</volume>
          <fpage>171</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="pmid">8039702</pub-id>
          <pub-id pub-id-type="doi">10.1016/0378-1119(94)90375-1</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhat</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Hale</surname>
              <given-names>IL</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Elghanayan</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Ectopic expression of alpha B-crystallin in Chinese hamster ovary cells suggests a nuclear role for this protein.</article-title>
          <source>Euro J Cell Biol</source>
          <year>1999</year>
          <volume>78</volume>
          <fpage>143</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="pmid">10099937</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andley</surname>
              <given-names>UP</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wawrousek</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Brady</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Bassnett</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fleming</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
          <article-title>Lens epithelial cells derived from alphaB-crystallin knockout mice demonstrate hyperproliferation and genomic instability.</article-title>
          <source>FASEB J</source>
          <year>2001</year>
          <volume>15</volume>
          <fpage>221</fpage>
          <lpage>229</lpage>
          <pub-id pub-id-type="pmid">11149910</pub-id>
          <pub-id pub-id-type="doi">10.1096/fj.00-0296com</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boyle</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Takemoto</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>A possible role for alpha-crystallins in lens epithelial cell differentiation.</article-title>
          <source>Mol Vis</source>
          <year>2000</year>
          <volume>6</volume>
          <fpage>63</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">10811949</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brady</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Garland</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Duglas-Tabor</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Robison</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Groome</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wawrousek</surname>
              <given-names>EF</given-names>
            </name>
          </person-group>
          <article-title>Targeted disruption of the mouse alphaA-crystallin gene induces cataract and cytoplasmic inclusion bodies containing the small heat shock protein alphaB-crystallin.</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1997</year>
          <volume>94</volume>
          <fpage>884</fpage>
          <lpage>889</lpage>
          <pub-id pub-id-type="pmid">9023351</pub-id>
          <pub-id pub-id-type="doi">10.1073/pnas.94.3.884</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brady</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Garland</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Tamm</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Giblin</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Wawrouskek</surname>
              <given-names>EF</given-names>
            </name>
          </person-group>
          <article-title>B-crystallin is lens development and muscle integrity: A gene knockout approach.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>2924</fpage>
          <lpage>2034</lpage>
          <pub-id pub-id-type="pmid">11687538</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boyle</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Takemoto</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <article-title>Confocal microscopy of human lens membranes in aged normal and nuclear cataracts.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1997</year>
          <volume>38</volume>
          <fpage>2826</fpage>
          <lpage>2832</lpage>
          <pub-id pub-id-type="pmid">9418736</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arrigo</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Expression of stress genes during development.</article-title>
          <source>Neuropathol Appl Neurobiol</source>
          <year>1995</year>
          <volume>21</volume>
          <fpage>488</fpage>
          <lpage>491</lpage>
          <pub-id pub-id-type="pmid">8745237</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shakoori</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Oberdorf</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Owen</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Expression of heat shock genes during differentiation of mammalian osteoblasts and promelocytic leukemia cells.</article-title>
          <source>J Cell Biochem</source>
          <year>1992</year>
          <volume>48</volume>
          <fpage>277</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="pmid">1400614</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spector</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Samson</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gribben</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Urba</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Welch</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Nadler</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Growth arrest of human B lymphocytes is accompanied by induction of low molecular weight mammalian heat shock protein (hsp 28).</article-title>
          <source>J Immunol</source>
          <year>1992</year>
          <volume>148</volume>
          <fpage>1668</fpage>
          <lpage>1673</lpage>
          <pub-id pub-id-type="pmid">1541812</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spector</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Samson</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Nadler</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Arrigo</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Heat shock protein is a unique marker of growth arrest during macrophage differentiation of HL, 60 cells.</article-title>
          <source>J Cell Physiol</source>
          <year>1993</year>
          <volume>156</volume>
          <fpage>619</fpage>
          <lpage>625</lpage>
          <pub-id pub-id-type="pmid">8360264</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugiyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kishikawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Akutsu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hirose</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Waye</surname>
              <given-names>MMY</given-names>
            </name>
            <name>
              <surname>Tsui</surname>
              <given-names>SKW</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Muscle develops a specific form of small heat shock protein complex composed of MKBP/HSPB2 and HSPB3 during myogenic differentiation.</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>1095</fpage>
          <lpage>1114</lpage>
          <pub-id pub-id-type="pmid">10625651</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.275.2.1095</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Csermely</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schnauzer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Szanto</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Signaling and transport through the nuclear membrane.</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1995</year>
          <volume>1241</volume>
          <fpage>425</fpage>
          <lpage>452</lpage>
          <pub-id pub-id-type="pmid">8547304</pub-id>
          <pub-id pub-id-type="doi">10.1016/0304-4157(95)00015-1</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andley</surname>
              <given-names>UP</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wawrousek</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Bassnett</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The molecular chaperone alphaA-crystallin enhances lens epithelial cell growth and resistance to UVA stress.</article-title>
          <source>J Biol Chem</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>31252</fpage>
          <lpage>31261</lpage>
          <pub-id pub-id-type="pmid">9813033</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.273.47.31252</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:151685</identifier><datestamp>2003-03-20</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">151685</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-3-4</article-id>
      <article-id pub-id-type="pmid">12597779</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-3-4</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The PALM Technique: histological findings of masked phototherapeutic keratectomy on rabbit corneas</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Katsanevaki</surname>
            <given-names>Vikentia J</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>vikatsan@med.uoc.gr</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Ginis</surname>
            <given-names>Harilaos S</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>ginis@med.uoc.gr</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Naoumidi</surname>
            <given-names>Irini I</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>maoumidis@hotmail.com</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Pallikaris</surname>
            <given-names>Ioannis G</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>pallikar@her.forthnet.gr</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>University of Crete, Medical School, Vardinoyannion Eye Institute of Crete, Heraklion, Crete, Greece</aff>
      <aff id="I2"><label>2</label>University Hospital of Crete, Department of Ophthalmology, Heraklion Greece</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>2</month>
        <year>2003</year>
      </pub-date>
      <volume>3</volume>
      <fpage>4</fpage>
      <lpage>4</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/4"/>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>12</month>
          <year>2002</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>2</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2003 Katsanevaki et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Katsanevaki et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>To compare the corneal healing response between conventional and phototherapeutic keratectomy through a masking agent, in rabbit corneas.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>24 adult rabbits underwent phototherapeutic keratectomy. Animals were divided in two groups: 12 received photoablation through a masking agent (PALM gel) and the remaining 12 received conventional phototherapeutic keratectomy of equal depth and served as control. Light and transmission electron microscopy was performed in specimens of both groups obtained: immediately after, four hours, one week, one, three and six months after treatment.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Reepitheliazation was complete within five days in all eyes. Light and transmission electron microscopy did not reveal any differences of the healing process in the experimental eyes compared to the controls.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Photoablation through the PALM technique did not result any evident alterations of the reepithelisation and stromal healing process.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>corneal healing</kwd>
        <kwd>gel</kwd>
        <kwd>masking</kwd>
        <kwd>PALM</kwd>
        <kwd>phototherapeutic</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>The excimer laser ablation is currently widely used primarily to correct refractive errors by altering the anterior curvature of the cornea. Due to its potential for accurate ablation of anterior stromal corneal lesions its initial clinical utilization was removal of diseased corneal tissue in a procedure called photo therapeutic keratectomy (PTK). In 1985 Serdareviz et al proposed the first therapeutic use of the excimer laser to treat an experimental Candida infectious keratitis [<xref ref-type="bibr" rid="B1">1</xref>]. Despite the lack of controlled clinical trials comparing PTK with other treatment modalities such as superficial keratectomy or lamellar keratoplasty, the US Food and Drug Administration (FDA) identified PTK as an alternative therapeutic approach for the treatment of superficial corneal and epithelial membrane dystrophies, irregular corneal surfaces and corneal scars and opacities.</p>
      <p>The major inherent obstacle of PTK for the management of corneal surface irregularities is that through photoablation these irregularities are reproduced deeper within the stroma.</p>
      <p>Masking techniques refer to photorefractive procedures utilizing various masking means or so called modulators to protect flatter corneal areas while steeper areas are excised with the excimer laser.</p>
      <p>Kornmehl et al [<xref ref-type="bibr" rid="B2">2</xref>] have shown that an ideal masking agent should have moderate viscosity (between that of saline and 1% carboxymethylcellulose) and concluded that very viscous fluids would not cover irregular surfaces uniformly whereas fluids of inadequate viscosity would run off quickly exposing both peaks and valleys thus resulting in irregular surfaces after ablation.</p>
      <p>Numerous previous investigators have used different masking agents as methylcellulose [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>] and sodium hyaluronate [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>] at various concentrations or performed transepithelial (so that the epithelium acts as a natural masking agent) treatments [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>] and reported the beneficial effect of masked PTK. Fasano et al [<xref ref-type="bibr" rid="B3">3</xref>] reported that the ideal masking agent should have the same ablation rate to that of the cornea, be biocompatible and adhere well to the cornea.</p>
      <p>These properties have been met with the use of collagen solutions as modulators. Their applicability as masking agents for corneal photoablation was examined in experimental models of animal and cadaver eyes (Scott et al: Collagen modulator fluids for use during photoablation keratectomy: ARVO 1992, Margaritis et al. Properties of a new two component gel material as an aid in PRK corneal remodeling: ARVO 1994) [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>] as well as in limited clinical trials of partially sighted eyes (Pallikaris et al: Photoablated lenticular modulator PALM technique: A report of ten cases: ARVO 1998) [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>].</p>
      <p>Photo-Ablatable Lenticular Modulator (PALM) technique refers to the use of a modified collagen gel solution for the photorefractive correction of corneal surface irregularities [<xref ref-type="bibr" rid="B14">14</xref>]. The PALM gel similarly to other collagen modulators [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B15">15</xref>] is thermo reversible. The gel is in liquid state when heated to solidify to a firm gel as its temperature lowers. Its use for masking purposes requires its application onto the corneal stoma at a temperature of 49°C where it can be molded to form a stable lenticule that serves as the final masking agent.</p>
      <p>At temperatures of 40° to 53°C, the collagen individual fibril bonds are broken and the collagen denatures to its parent gelatinous form. When the tissue temperature drops to below 40°C, these bonds can reunite with possible rearrangement of the matrix but without any cellular damage [<xref ref-type="bibr" rid="B16">16</xref>]. Under this consideration the thermal contact of the 49°C preheated PALM gel onto the bare corneal stroma for the in situ molding of the lenticule, would not be expected to induce any irreversible changes of the corneal collagen chains. However its sequential use as masking agent for PTK could affect the laser-tissue interaction and probably the corneal healing response to irradiation.</p>
      <p>In the current study we examined the possible implication of the PALM gel when used as described above, to the corneal wound healing on rabbit corneas.</p>
      <p>We examined the reepithelization process of 12 rabbit eyes after PTK through PALM gel lenticules formed in situ. We used a moving slit delivery system in a 5 mm ablation zone confined by means of a metal iris diaphragm. An equal group of rabbit eyes received conventional PTK of the same depth and treatment zone and served as control.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>The PALM gel as a masking agent</title>
        <p>The gel used, as modulator is a soluble mixture of purified type A gelatin from porcine skin and a polysaccharide, type III carrageenan K in nanopure water [<xref ref-type="bibr" rid="B17">17</xref>]. Both components are commercially available for laboratory use (Sigma Chemical Co, St Louis, Mo).</p>
        <p>Being thermoreversible, the gel can be stored at room temperature in solid form. When heated to 49°C it liquefies to a high viscosity fluid that solidifies within minutes when exposed to room temperature. When still in liquid form the gel can be molded by means of a rigid contact lens to form a stable lenticule that its upper surface will reproduce the inner surface of the molding lens.</p>
        <p>If the lenticule is molded in situ onto the cornea its bottom surface will fill any corneal surface irregularity. As shown by testing on freshly excised porcine corneas (fig. <xref ref-type="fig" rid="F1">1</xref>) the mixture for the preparation of the gel is conditioned so that its solid form to have the same ablation to that of the cornea [<xref ref-type="bibr" rid="B13">13</xref>]. The full removal of the lenticule with photoablation in PTK mode would be expected to reproduce the lenticule's upper surface onto the surface of the cornea. Selecting the appropriate inner radius of curvature of the molding lens, the upper surface of the formed lenticule can be of variable curvature. Instillation of 100 μm of the preheated liquid solution [<xref ref-type="bibr" rid="B18">18</xref>] on the corneal surface requires 4 minutes for the lenticule to acquire the mechanical stiffness required to withstand the stress induced by the lens removal, at room temperature of 25°C. After this time the lens mold is removed and the lenticule is ablated through with irradiation in PTK mode. An effective amount of fluorescein in the lenticule mixture provides the surgeon visual feedback for the ablation progress. Fluorescence fades as soon as the lenticule is fully removed.</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p>Ablation rate of the gel was examined on irregular porcine cornea developed by means of 60 microns deep phototherapeutic keratectomy through a metal grid. The irregular cornea created was fully covered with PALM gel. Half of the cornea was ablated until the gel was fully removed. Ablation resulted in smooth cornea. Microphotograph. Original magnification ×</p>
          </caption>
          <graphic xlink:href="1471-2415-3-4-1"/>
        </fig>
      </sec>
      <sec>
        <title>Surgical procedure</title>
        <p>A total of 24 adult New Zealand white rabbits (average weight 4–5 Kg) were anaesthetized by intramuscular injection of ketamine hydrochloride (40 mg/kg) and xylazine hydrochloride (7 mg/kg) mixture. All experimental procedures were carried out in accordance with the Guiding Principles in the Care and Use of Animals (DHEW Publication, NIH 80–23) and were approved from the University's of Crete ethics committee.</p>
        <p>One drop of 0.5% proparacaine hydrochloride (Alcon, Ft Worth, TX) was instilled into each eye and the corneas were deepithelized with the use of a rotating brush. We treated one eye of each animal. 12 were treated with PTK through PALM gel (experimental eyes) and the remaining 12 received conventional treatment and served as controls. The laser system used in all eyes was the Aesculap Meditec Mel 60 (Karl-Zeiss, Jena, Germany), with laser fluence of 180 mJ/cm<sup>2 </sup>pulse rate at 20 Hz, in PTK mode.</p>
        <p>Experimental eyes received PTK through PALM gel lenticules formed in situ onto deepithelized corneas as described above. In order to shorten the time of the surgical procedures we obtained the thinner possible lenticules using as molds the "best fitting" contact lenses for each operative eye. Molds used in the current study had inner radii of curvature ranging from 8.25 to 9 mm. After the removal of the mold, an iris diaphragm having an inner aperture of 5 mm was centrated over the pupil onto the upper surface of the lenticule to define the ablation zone. The gel lenticules were ablated through with irradiation in PTK mode. As soon as fluorescence faded each experimental eye received an additional 60-micron deep PTK.</p>
        <p>The control eyes were submitted to a phototherapeutic keratectomy of 5 mm diameter ablation zone (confined by the same iris diaphragm), depth of 60 μm, on deepithelised cornea without the use of any masking agent.</p>
      </sec>
      <sec>
        <title>Postoperative care</title>
        <p>Postoperative treatment of all treated eyes included daily application of combined tobramycin (0.3%), dexamethasone (0.1%) ointment (Alcon Ft Worth, TX) until reepithelisation was complete. No topical steroids were used subsequently in the study.</p>
        <p>The reepithelization process was examined daily with staining of the epithelial defect area using 2% fluorescein dye and a hand held slit-lamp. Corneal clarity was recorded using a predetermined 5-scale grading of haze [<xref ref-type="bibr" rid="B19">19</xref>].</p>
        <p>Two animals of each group (experimental and control) were sacrificed with an overdose of penthobarbital sodium through the marginal ear vein at each of the following postoperative intervals: immediately after treatment, 4 hours after treatment, 1 week and at one, three and six postoperative months.</p>
      </sec>
      <sec>
        <title>Histology processing</title>
        <p>Immediately after enucleation the eyes were fixed using 2.5% gludaraldehyde in 0.1 mol/l cacodylate buffer (pH 7.4). After short prefixation the corneas were excised and placed in the same fresh fixative overnight. The tissue samples were post fixated in 2% osmium tetroxide in 0.1 M cacodylate buffer (Ph 7.4) for 2 hours at 4°C, dehydrated in a series of alcohol and propylene oxide and embedded in epoxy resin.</p>
        <p>1-μm sections were stained with trichrome stain and were processed for light microscopic examination whereas ultra thin sections were stained with uranyl acetate and lead citrate and were examined with transmit ion electron microscopy.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Clinical course</title>
        <p>Reepithelisation was complete (no epithelial defect was observed with fluorescein staining) within five days in all treated eyes (within 3 days in two control and one experimental eye, 4 days in three experimental and one control eye and on the fifth postoperative day to the rest of the treated eyes). No persistent defects or recurrent erosions were recorded.</p>
        <p>Corneal haze was evident from the first week in all treated eyes ranging from grade 1 to grade 2.</p>
        <p>Corneal haze reached its maximum on the first postoperative month ranging from grade 2 to 3 (grade 3 in one experimental eye).</p>
        <p>All treated eyes were clear or had minimal haze by the third month (grade 1 in one experimental and two control eyes), which was resolved in all eyes by the sixth postoperative month.</p>
      </sec>
      <sec>
        <title>Histology</title>
        <p>In the specimens taken immediately after treatment, the surface of corneal stroma was covered by a pseudomembrane typical after excimer laser. The control group didn't demonstrate any difference in pseudomembrane thickness or regularity in comparison to the experiment. The most typical corneal morphology is demonstrated in fig <xref ref-type="fig" rid="F2">2</xref>. The appearance of collagen fibrils and stromal keratocytes was close to normal in both groups of specimens.</p>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p>Experimental cornea. Immediately after the procedure, the pseudomembrane (arrowheads) that was formed during ablation, has local thickness irregularities. cf – collagen fibers Electron microphotograph. Original magnification × 6600.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-4-2"/>
        </fig>
        <p>4 hours after irradiation, the distribution of collagen fibers under the ablated area was irregular due to the occurrence of corneal edema. Isolated macrophages were observed on the stromal surface. Keratocytes situated within the 20–40 μm of the upper stroma, demonstrated various pathological changes including cytoplasm vacuolization and blebbing, with formation of cellular fragments (fig <xref ref-type="fig" rid="F3">3</xref>). Keratocytes located deeper than 40 μm under ablated stromal surface did not demonstrate any noticeable morphological alterations. We observed no differences in the type, degree and extent of the pathological changes of keratocytes under the ablated surface between the control and experimental specimens. In the endothelial corneal layer, both inside and outside the ablation area, we didn't observe any morphological abnormalities, neither in the experimental nor in the control groups. The nuclear chromatin, abundant mitochondria, reticulum and coated vesicles, had normal appearance. The cells preserved their apical junctional complexes and well developed intercellular gap junctions.</p>
        <fig position="float" id="F3">
          <label>Figure 3</label>
          <caption>
            <p>Experimental cornea 4 hours after the procedure. Macrophages (M) appear on the corneal surface covered by pseudomembrane (arrows). Abnormal keratocyte (AK) with vacuolized cytoplasm (asterisk), blebbing (big arrowheads) and cytoplasmic fragments surrounded by cell's membrane (small arrowheads). Deeper in the cornea, a normal keratocyte (NK) may be seen, whose cytoplasmic and nuclear structures are typical for corneal stroma. Electron microphotograph. Original magnification × 3300.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-4-3"/>
        </fig>
        <p>In the specimens obtained 1 week after the procedure, the epithelium covering the stroma in the ablated zone demonstrated mild hyperplasia. The typical desmosomal contacts between the basal cells, which are very characteristic for the intact stromal epithelium, were rather rare (fig <xref ref-type="fig" rid="F4">4</xref>). However, adhesive contacts with significant resemblance with zonula adherens were observed. The morphological appearance of the regenerating basement membrane that was removed during the procedure, corresponded to the initial phases of its reconstruction: formation of characteristic amorphous layer of extracellular matrix was evident in some contact zones of the epithelial cells with stroma. In some places this layer had focal discontinuities or duplication. Typical hemidesmosomes were not present. However, few small sized hemidesmosomes with low electron density of cytoplasmic plaque were observed. The presence of these immature hemidesmosomes was considered as an evidence of adhesive contacts' reconstruction between the epithelium and the basement membrane. At this stage, inflammatory cells infiltration was rarely observed in all obtained specimens. The anterior stroma beneath the treatment zone consisted of newly synthesized extracellular matrix with collagen fibers of irregular size and distribution, as well as few amorphous inclusions and "empty" spaces giving this layer a "foamy" appearance. The thickness of this locally discontinued "foam" layer did not exceed 3–4 μm. The corneal endothelium of the 1 week specimens of both groups had normal appearance. A discontinuous layer of an electron dense substance was observed beneath the boarder between the endothelial layer and Descemet's membrane (fig <xref ref-type="fig" rid="F5">5</xref>).</p>
        <fig position="float" id="F4">
          <label>Figure 4</label>
          <caption>
            <p>Experimental cornea 1 week after the procedure. In the anterior stroma under the epithelium, appearance of chaotically distributed collagen fibers is observed (between the arrows), as well as of amorphous inclusions strictly under the basal parts of epithelial cells (arrowheads), and of small "empty" spaces in the extracellular matrix (asterisk). Original magnification × 3300.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-4-4"/>
        </fig>
        <fig position="float" id="F5">
          <label>Figure 5</label>
          <caption>
            <p>Experimental cornea 1 week after the procedure. The cells of corneal endothelium demonstrate normal appearance of cell structures and intercellular contacts. Under the endothelial layer, the Descemet's membrane has a discontinuous layer of an electrondense substance (big arrowheads). m – mitochondria AC – apical junctional complex N – nucleus Original magnification × 3300.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-4-5"/>
        </fig>
        <p>One month postoperatively, no epithelial irregularities were observed (fig <xref ref-type="fig" rid="F6">6</xref>). The desmosomes between epithelial cells, as well as the hemidesmosomes between the basal epithelial cells and the basal lamina, were more frequently observed and although irregularly distributed, their morphology was close to the normal structure of contacts of the intact epithelium. The irregular distribution of hemidesmosomes can be justified by their concurrent reconstruction with the basal lamina formation. The thickness of the "foam" layer mostly consisted of activated fibroblasts, achieved its maximum (10–15 μm) by this interval. The deeper corneal layers demonstrated exquisitely regular structure (fig <xref ref-type="fig" rid="F7">7</xref>).</p>
        <fig position="float" id="F6">
          <label>Figure 6</label>
          <caption>
            <p>Experimental cornea. Light microphotograph of the ablation zone 1 month after the procedure. The epithelial layer (E) covering the stroma has normal appearance, with the possible exception of minor thickness variations. The anterior stroma (AS) under the epithelium may be distinguished by a big number of cell elements (fibroblasts); the structure of extracellular matrix in the subepithelial stroma differs significantly from that of extracellular matrix of deeper layers. Note the absence of inflammatory cells in the subepithelial stroma. Original magnification × 130.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-4-6"/>
        </fig>
        <fig position="float" id="F7">
          <label>Figure 7</label>
          <caption>
            <p>Experimental cornea 1 month after the procedure. Adhesive contacts between epithelial cells are represented by normal desmosomes typical for corneal epithelial layer (big arrowheads). Hemidesmosomes (small arrrows) between basal epithelial cells and basement membrane are distributed extremely irregularly (compare zones I and II). The foamy layer (between big arrows) is significantly thicker in comparison to 1-week post-op specimens. Numerous activated fibroblasts (AF) are observed within this layer. Electron microphotograph. Original magnification × 3300.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-4-7"/>
        </fig>
        <p>Three months postoperatively, the epithelium covering the ablation zone exceeded normal thickness only in very few locations (fig <xref ref-type="fig" rid="F8">8</xref>). The morphology of epithelial cells, the number of layers and the intercellular contacts were close to normal. The structure of the epithelial basal lamina was also appeared close to normal: lamina densa and lamina lucida were well distinguishable with rare branching and duplication. The hemidesmosomes were regularly distributed, and had normal morphology. The thin (2–3 μm) layer of anterior stroma beneath the treatment zone was close to normal, with rare exceptions of aggregations of electron dense substance, few irregularly located collagen fibres with small variations of their diameter (fig <xref ref-type="fig" rid="F9">9</xref>). The deeper stromal layers had normal architecture, with no signs of scarring, inflammatory infiltration or deformation, neither in the experimental nor in the control specimens.</p>
        <fig position="float" id="F8">
          <label>Figure 8</label>
          <caption>
            <p>Experimental cornea 3 months after the procedure. Light microscopy of the ablation zone. The border of the ablation zone is indicated by a big arrowhead. The epithelium (E) in the ablated zone (to the left of the arrowhead) has local thickness irregularities. However, the cells have mostly normal appearance. No signs of inflammatory reaction. The "foamy" layer in the stroma (S) is practically indistinguishable in light microphotographs. Original magnification × 130.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-4-8"/>
        </fig>
        <fig position="float" id="F9">
          <label>Figure 9</label>
          <caption>
            <p>Experimental cornea 3 months after the procedure. The basal part of epithelial cells demonstrates well-developed adhesive contacts. Hemidesmosomes (HD) have normal structure and regular distribution along basal lamina. The thickness and electron density of lamina densa (LD) and lamina lucida (LL) have returned back to normal values. The layer of anterior stroma (AS) contains aggregations of electrondense substance (arrowheads). The fibers of this layer have attained more regular distribution in comparison to 1-month post-op specimens. Electron microphotograph. Original magnification × 10 000.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-4-9"/>
        </fig>
        <p>Six months postoperatively, we didn't find any significant morphological difference compared to the three-month interval obtained specimens, neither in the experimental nor in the control group.</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Application of a heated agent on denuded cornea or even ablation through a chemical agent could affect laser-tissue interaction, corneal reepithelization or stromal healing response after photo ablation.</p>
      <p>We used rabbits to examine the probable effect of the PALM gel if used as a masking agent for PTK since stromal healing is very similar in rabbits and humans [<xref ref-type="bibr" rid="B20">20</xref>].</p>
      <p>The healing course proved similar in the experimental and control eyes. No specimens obtained at any postoperative interval had any sign of necrosis or macrophages infiltration.</p>
      <p>The simultaneous reepithelization as well as the similar histological findings between experimental specimens and controls is indicative of negligible gel's impact on corneal healing response. The newly synthesized extracellular matrix presented as foam layer at the early specimens is a common finding reported after photo refractive keratectomy or even simple epithelial scrape injury in a number of previous studies [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B24">24</xref>] and is supposed to manifest the healing response of rabbit corneas [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B24">24</xref>].</p>
      <p>The epithelial hyperplasia observed on the seventh postoperative day was more intense than that reported in the literature [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. The possibility of the gel's implication to this response is minimized since it was also observed in the control eyes. We assume that this finding is related to the ablation profile of our treatments (a rather deep keratectomy with sharp edges), which would justify an intense epithelial healing response [<xref ref-type="bibr" rid="B26">26</xref>].</p>
      <p>The extrusion of electron dense fibro-granular material into the descemet's membrane is also a common finding observed in a number of previous studies [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B29">29</xref>] and has been attributed to acoustic shock waves by irradiation [<xref ref-type="bibr" rid="B24">24</xref>] or the distraction of the epithelial integrity after trauma [<xref ref-type="bibr" rid="B29">29</xref>]. The presence of this finding in only one of our specimens may be related to the homogenous and smooth removal of the corneal epithelium with the rotating brush.</p>
      <p>In conclusion the use of the PALM gel did not seem to seriously affect the healing process after PTK on rabbit corneas as compared to controls. A larger number of animals would allow for statistical analysis of pathologic findings such as activated fibroblasts by depth and thickness of newly formed extracellular matrix between experimental and control eyes. Furthermore, tenascin and fibronectin staining of the specimens would allow for better understanding of the corneal healing process.</p>
      <p>The use of new generation laser systems that offer phototherapeutic ablation mode with transition zones are expected to minimize epithelial hyperplasia and corneal stroma healing response. The major remaining drawback of the PALM as well as of similar PTK techniques [<xref ref-type="bibr" rid="B15">15</xref>] in order to obtain an optimal refractive result is the accurate centration and placement of the molding lens for the proper formation of the lenticule before irradiation.</p>
    </sec>
    <sec>
      <title>Competing Interests</title>
      <p>Authors Ioannis G Pallikaris and Harilaos S Ginis are patent holders and have proprietary interest in PALM technique. The rest of the authors have no proprietary interest.</p>
    </sec>
    <sec>
      <title>Acknowledgements</title>
      <p>The study was supported by a research grant (August 1999) from the LASIK Institute (LASIK Institute, 750 Washington Street, box 450, Boston Massachusetts 02111, USA).</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/4/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Serdareviz</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Darrell</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Krueger</surname>
              <given-names>RR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Excimer laser therapy for experimental Candida Keratitis.</article-title>
          <source>Am J Ophthalmol</source>
          <year>1985</year>
          <volume>99</volume>
          <fpage>534</fpage>
          <lpage>538</lpage>
          <pub-id pub-id-type="pmid">4003487</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kornmehl</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Steinert</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Puliafito</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>A comparative study of masking fluids for excimer laser phototherapeutic keratectomy.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1991</year>
          <volume>109</volume>
          <fpage>860</fpage>
          <lpage>863</lpage>
          <pub-id pub-id-type="pmid">2043076</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fasano</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Moreira</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mc Donnel</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Sinbawy</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Excimer laser smoothing with a re producible model of anterior corneal surface irregularity.</article-title>
          <source>Ophthalmology</source>
          <year>1991</year>
          <volume>98</volume>
          <fpage>1782</fpage>
          <lpage>1785</lpage>
          <pub-id pub-id-type="pmid">1775310</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gartry</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kerr Muir</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maarshall</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Excimer laser treatment of corneal surface pathology a laboratory and clinical study.</article-title>
          <source>Br J Ophthalmol</source>
          <year>1991</year>
          <volume>75</volume>
          <fpage>258</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="pmid">1817467</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fagerholm</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fitzimmmons</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Orndhal</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phototherapeutic keratectomy: long term results in 166 eyes.</article-title>
          <source>Refract Corneal Surg</source>
          <year>1993</year>
          <volume>9</volume>
          <fpage>S76</fpage>
          <lpage>S81</lpage>
          <pub-id pub-id-type="pmid">8499385</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hersh</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Spinak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Garrana</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Phototherapeutic keratectomy: Strategies and results in 12 eyes.</article-title>
          <source>Refract Corneal Surg</source>
          <year>1993</year>
          <volume>9</volume>
          <fpage>S90</fpage>
          <lpage>S95</lpage>
          <pub-id pub-id-type="pmid">8499388</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alio</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Belda</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Shalaby</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Correction of irregular astigmatism with excimer laser assisted by sodium hyaluronate.</article-title>
          <source>Ophthalmology</source>
          <year>2001</year>
          <volume>108</volume>
          <fpage>1246</fpage>
          <lpage>1260</lpage>
          <pub-id pub-id-type="pmid">11425683</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(01)00602-9</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dogru</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Katakami</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yamanka</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Refractive changes after excimer laser phototherapeutic keratectomy.</article-title>
          <source>J Cataract Refract Surg</source>
          <year>2001</year>
          <volume>27</volume>
          <fpage>686</fpage>
          <lpage>692</lpage>
          <pub-id pub-id-type="pmid">11377896</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0886-3350(01)00802-1</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mc Donnel</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Seiler</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Phototherapeutic keratectomy for Reis-Buckler's corneal dystrophy.</article-title>
          <source>Refract Corneal Surg</source>
          <year>1992</year>
          <volume>8</volume>
          <fpage>306</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="pmid">1390411</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Talamo</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Wagoner</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SY</given-names>
            </name>
          </person-group>
          <article-title>Management of ablation decentration following excimer photorefractive keratectomy.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1995</year>
          <volume>113</volume>
          <fpage>706</fpage>
          <lpage>707</lpage>
          <pub-id pub-id-type="pmid">7786205</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Englanoff</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Kolahdouz-Isfahani</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Moreira</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cheung</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Nimni</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Trockel</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Mc Donnel</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>In situ collagen mold as an aid in excimer laser superficial keratectomy.</article-title>
          <source>Ophthalmology</source>
          <year>1992</year>
          <volume>99</volume>
          <fpage>1201</fpage>
          <lpage>1208</lpage>
          <pub-id pub-id-type="pmid">1513572</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Vore</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Nordquist</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Eifferman</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Rapidly polymerized collagen gel as a smoothing agent in excimer laser photoablation.</article-title>
          <source>J Refract Surg</source>
          <year>1995</year>
          <volume>11</volume>
          <fpage>50</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">7641050</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stevens</surname>
              <given-names>SX</given-names>
            </name>
            <name>
              <surname>Bowyer</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Sanchez-Thorin</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Rowsy</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>The BioMask for treatment of corneal surface irregularities with excimer Laser phototherapeutic keratectomy.</article-title>
          <source>Cornea</source>
          <year>1999</year>
          <volume>18</volume>
          <fpage>155</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">10090360</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pallikaris</surname>
              <given-names>IG</given-names>
            </name>
            <name>
              <surname>Katsanevaki</surname>
              <given-names>VJ</given-names>
            </name>
            <name>
              <surname>Ginis</surname>
              <given-names>HS</given-names>
            </name>
          </person-group>
          <article-title>The PALM technique as an alternative to Customized Ablation.</article-title>
          <source>Seminars in Ophthalmology</source>
          <year>2000</year>
          <volume>15</volume>
          <fpage>160</fpage>
          <lpage>169</lpage>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kremer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Aronsky</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bowyer</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>SX</given-names>
            </name>
          </person-group>
          <article-title>Treatment of corneal surface irregularities using BioMask as an adjunct to excimer laser phototherapeutic keratectomy.</article-title>
          <source>Cornea</source>
          <year>2002</year>
          <volume>21</volume>
          <fpage>28</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">11805503</pub-id>
          <pub-id pub-id-type="doi">10.1097/00003226-200201000-00007</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Ohshiro</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Galderhead</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Ohshiro T, Galderhead RG</surname>
            </name>
          </person-group>
          <article-title>Reversible and irreversible photobioreactions.</article-title>
          <source>Low level laser therapy: A practical introduction</source>
          <year>1988</year>
          <publisher-name>John Willey &amp; sons Ltd</publisher-name>
          <fpage>25</fpage>
          <lpage>26</lpage>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Pallikaris</surname>
              <given-names>IG</given-names>
            </name>
          </person-group>
          <article-title>inventor: Photoablatable Lenticular Modulator:US Patent 09/139,368.</article-title>
          <comment>1998 August 25</comment>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Pallikaris</surname>
              <given-names>IG</given-names>
            </name>
            <name>
              <surname>Ginis</surname>
              <given-names>HS</given-names>
            </name>
          </person-group>
          <article-title>inventors: Device for the shaping of a substance on the surface of the cornea.</article-title>
          <source>PCT/1B01/01088</source>
          <comment>April 20 2001</comment>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fantes</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Warring</surname>
              <given-names>GO</given-names>
              <suffix>III</suffix>
            </name>
            <name>
              <surname>Pouliquen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Salvodelli</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Wound healing after excimer laser keratomileusis (photorefractive keratetomy) in monkeys.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1990</year>
          <volume>108</volume>
          <fpage>665</fpage>
          <lpage>675</lpage>
          <pub-id pub-id-type="pmid">2334323</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Talamo</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Gollamudi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>De la Cruiz</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Filatov</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Stark</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1991</year>
          <volume>109</volume>
          <fpage>1141</fpage>
          <lpage>1146</lpage>
          <pub-id pub-id-type="pmid">1907822</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanna</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Pouliquen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Waring</surname>
              <given-names>GO</given-names>
              <suffix>III</suffix>
            </name>
            <name>
              <surname>Salvodelli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cotter</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Morton</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Menache</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Corneal stromal wound healing in rabbits after excimer laser surface ablation.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1989</year>
          <volume>107</volume>
          <fpage>895</fpage>
          <lpage>901</lpage>
          <pub-id pub-id-type="pmid">2730408</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amm</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wetzel</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Winter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Uthof</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Duncker</surname>
              <given-names>GIW</given-names>
            </name>
          </person-group>
          <article-title>Histopathological comparison of photorefractive keratectomy and laser in situ keratomileusis in rabbits.</article-title>
          <source>J Refract Surg</source>
          <year>1996</year>
          <volume>12</volume>
          <fpage>758</fpage>
          <lpage>766</lpage>
          <pub-id pub-id-type="pmid">8970022</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilson</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>Molecular cell biology for the refractive corneal surgeon: Programmed cell death and wound healing.</article-title>
          <source>J Refract Surg</source>
          <year>1997</year>
          <volume>13</volume>
          <fpage>171</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="pmid">9109075</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Histopathology of corneal wound healing after photorefractive keratectomy in rabbit eyes.</article-title>
          <source>J Refract Surg</source>
          <year>1998</year>
          <volume>14</volume>
          <fpage>S209</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">9571556</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Del Pero</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Gigstad</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>A refractive and histopathologic study of excimer laser keratectomy in primates.</article-title>
          <source>Am J Ophthalmol</source>
          <year>1990</year>
          <volume>109</volume>
          <fpage>419</fpage>
          <pub-id pub-id-type="pmid">2330944</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heitzman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Binder</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Kassar</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Nordan</surname>
              <given-names>ST</given-names>
            </name>
          </person-group>
          <article-title>The correction of high myopia with the excimer laser.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1993</year>
          <volume>111</volume>
          <fpage>1627</fpage>
          <lpage>1634</lpage>
          <pub-id pub-id-type="pmid">8155032</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Seiler</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fantes</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Waring</surname>
              <given-names>GO</given-names>
              <suffix>III</suffix>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Warring GO III</surname>
            </name>
          </person-group>
          <article-title>Laser corneal surgery.</article-title>
          <source>Refractive keratectomy for myopia and astigmatism</source>
          <year>1992</year>
          <publisher-name>St Louis Mo: Mosby year book Inc</publisher-name>
          <fpage>669</fpage>
          <lpage>745</lpage>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Krueger</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Binder</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>McDonnel</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Salz JJ</surname>
            </name>
          </person-group>
          <article-title>The effects of excimer laser photoablation of the cornea.</article-title>
          <source>Corneal laser surgery</source>
          <year>1995</year>
          <publisher-name>St Louis Mo: Mosby year book Inc</publisher-name>
          <fpage>11</fpage>
          <lpage>44</lpage>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sano</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Itoh</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tsuneoka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ohki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sakabe</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kitahara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Changes in descemet membrane and endothelium after corneal epithelial abrasion alone and with photorefractive keratectomy in rabbits.</article-title>
          <source>Arch Ophthalmol</source>
          <year>1996</year>
          <volume>114</volume>
          <fpage>1105</fpage>
          <lpage>1108</lpage>
          <pub-id pub-id-type="pmid">8790097</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:153521</identifier><datestamp>2003-04-19</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">153521</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-3-5</article-id>
      <article-id pub-id-type="pmid">12659653</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-3-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: Prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ<sub>2</sub></article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Garg</surname>
            <given-names>Tarun K</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>gargtarunk@uams.edu</email>
        </contrib>
        <contrib id="A2" corresp="yes" contrib-type="author">
          <name>
            <surname>Chang</surname>
            <given-names>Jason Y</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>changjasony@uams.edu</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Departments of Anatomy &amp; Neurobiology University of Arkansas for Medical Sciences Little Rock, AR 72205, USA</aff>
      <aff id="I2"><label>2</label>Ophthalmology University of Arkansas for Medical Sciences Little Rock, AR 72205, USA</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2003</year>
      </pub-date>
      <volume>3</volume>
      <fpage>5</fpage>
      <lpage>5</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/5"/>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>9</month>
          <year>2002</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>3</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2003 Garg and Chang; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Garg and Chang; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>The retina, which is exposed to both sunlight and very high levels of oxygen, is exceptionally rich in polyunsaturated fatty acids, which makes it a favorable environment for the generation of reactive oxygen species. The cytotoxic effects of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) induced oxidative stress on retinal pigment epithelium were characterized in this study.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>The MTT cell viability assay, Texas-Red phalloidin staining, immunohistochemistry and Western blot analysis were used to assess the effects of oxidative stress on primary human retinal pigment epithelial cell cultures and the ARPE-19 cell line.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>The treatment of retinal pigment epithelial cells with H<sub>2</sub>O<sub>2 </sub>caused a dose-dependent decrease of cellular viability, which was preceded by a significant cytoskeletal rearrangement, activation of the Extracellular signal-Regulated Kinase, lipid peroxidation and nuclear condensation. This cell death was prevented partially by the prostaglandin derivative, 15d-PGJ<sub>2 </sub>and by the protein kinase inhibitor, AG126.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>15d-PGJ<sub>2 </sub>and AG126 may be useful pharmacological tools in the future capable of preventing oxidative stress induced RPE cell death in human ocular diseases.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>The retina, which is exposed to both sunlight and very high levels of oxygen, is exceptionally rich in polyunsaturated fatty acids, which makes it a favorable environment for the generation of reactive oxygen species. For example, retinal pigment epithelium (RPE) generates a number of reactive oxygen species when illuminated with light [<xref ref-type="bibr" rid="B1">1</xref>]. Furthermore, phagocytosis of photoreceptor outer segments by RPE causes an increase in intracellular [<xref ref-type="bibr" rid="B2">2</xref>] and extracellular H<sub>2</sub>O<sub>2 </sub>generation [<xref ref-type="bibr" rid="B3">3</xref>]. Oxidative stress has been suggested as the cause of a number of retinal pathological conditions [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>].</p>
      <p>A number of <italic>in vitro </italic>studies have attempted to characterize the effect of oxidative stress on RPE. Depending on the experimental conditions, treatment of RPE with H<sub>2</sub>O<sub>2 </sub>can cause an alteration of cellular functions [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>] or cell death [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. Cytotoxic levels of H<sub>2</sub>O<sub>2 </sub>can cause significant mitochondrial [<xref ref-type="bibr" rid="B10">10</xref>] and genomic [<xref ref-type="bibr" rid="B11">11</xref>] DNA damage in RPE simulating the features of programmed cell death [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. Studies from other cell types indicate that early cellular events following H<sub>2</sub>O<sub>2 </sub>treatment include morphological alterations and actin re-organization [<xref ref-type="bibr" rid="B13">13</xref>]. In addition, activation of the ERK (p42/44, Extracellular signal-Regulated Kinase) MAP kinases (Mitogen-Activated Protein kinases) can occur within minutes following cellular oxidative stress. Depending on the cell type examined, inhibition of the ERK activity can either prevent [<xref ref-type="bibr" rid="B14">14</xref>] or enhance H<sub>2</sub>O<sub>2</sub>-induced cell death [<xref ref-type="bibr" rid="B15">15</xref>]. The involvement of actin re-organization and ERK activation has not been examined in RPE under oxidative stress.</p>
      <p>Lipid peroxidation products, such as 4-hydroxynonenal (4-HNE), have attracted considerable attention because of their potential involvement in aging and in a number of neuropathological conditions [<xref ref-type="bibr" rid="B16">16</xref>]. 4-HNE was implicated in the etiology of some pathological conditions in the eye. For example, levels of 4-HNE increased significantly in the vitreous of patients with proliferative vitreoretinopathy compared with controls [<xref ref-type="bibr" rid="B17">17</xref>]. Further, 4-HNE forms a stable adduct with rhodopsin in the photoreceptor, which may interfere with its functions [<xref ref-type="bibr" rid="B18">18</xref>]. 4-HNE even causes cataracts in cultured rat lens [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. Whether oxidative stress on RPE can cause accumulation of cellular HNE-protein adducts remains unknown.</p>
      <p>Peroxisome proliferator-activated receptors (PPARs) belong to a group of nuclear receptors that include steroid, retinoid, thyroid hormone receptors and others [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>]. There are three types of PPARs: PPARα is expressed predominantly in the liver, heart, kidney, brown adipose and stomach mucosa, and is important for lipid catabolism. PPARγ is found in adipose tissues and is important for adipogenesis. PPARβ is found in most tissues, but its role is less well defined. RPE cells express all three forms of PPARs but PPARβ is the dominant isoform [<xref ref-type="bibr" rid="B24">24</xref>]. There is a 10-fold induction of PPARγ mRNA that reaches a peak at 4-hour after phagocytosis of photoreceptor outer segments. The levels of either PPARα mRNA or PPARβ mRNA are not altered under the same conditions. Increases in PPARγ in RPE cells may be important for handling the lipids generated during the phagocytosis of photoreceptor outer segments [<xref ref-type="bibr" rid="B24">24</xref>]. Since RPE cells generate large amounts of H<sub>2</sub>O<sub>2 </sub>during the phagocytosis of photoreceptor outer segments, there is a possibility that activation of PPARγ may assist in defending the oxidative stress associated with phagocytosis.</p>
      <p>This study was designed to examine morphological alterations in RPE during oxidative stress, the involvement of ERK MAP kinase and 4-HNE and to test the hypothesis that PPARγ activation can prevent oxidative damage on RPE cells. The human RPE cell line, ARPE-19, and primary cultures of adult human RPE were used in this study. ARPE-19 is a spontaneous occurring, non-transformed RPE cell line which expresses RPE specific markers (such as CRALBP and RPE65) and exhibits morphological polarization and tight junctions similar to native RPE [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>].</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec sec-type="materials">
        <title>Materials</title>
        <p>WY14643, 15d-PGJ<sub>2</sub>, azelaoyl PAF and ciglitazone were purchased from Cayman (Ann Arbor, MI). LY 171883 was purchased from Alexis Biochemicals (San Diego, CA). AG126 and PD98059 were purchased from Calbiochem (San Diego, CA). Hydrogen peroxide and other pharmacological and general biochemical reagents were purchased from Sigma (St. Louis, MO) unless otherwise stated.</p>
      </sec>
      <sec>
        <title>Cell cultures</title>
        <p><italic>ARPE-19 </italic>cells [<xref ref-type="bibr" rid="B25">25</xref>] were obtained from the American Type Culture Collection and grown in DMEM/F12 containing 10% heat-inactivated fetal bovine serum and 2.5 mM glutamine. <italic>Human primary RPE cultures </italic>were established from donor eyes obtained from the Arkansas Lions Eye Bank &amp; Laboratory. The globe was sectioned at the ora serrata, and the lens and vitreous body were removed. The eye cup was then filled with 4% dispase (prepared in DMEM) containing 1× antibiotic-antimycotic reagents (final concentrations: 100 units/ml Penicillin G, 100 μg/ml Streptomycin and 0.25 μg/ml Amphotericin B) and incubated in a 37°C incubator with 5% CO<sub>2 </sub>for ~30 minutes. RPE cells were then removed under a dissecting microscope, dissociated by trituration using a Pasteur pipette, and then plated on poly-L-lysine (25 mg/liter in water) coated 35-cm<sup>2 </sup>culture dishes. The cell population was then expanded by sequentially subculturing into 25-cm<sup>2 </sup>tissue culture flasks, then to 75-cm<sup>2 </sup>tissue culture flasks. Cells of passages #3–#6 were used for this study. The culture medium consisted of 10% heat-inactivated fetal bovine serum, 2.5 mM glutamine and 1× antibiotic-antimycotic reagents in DMEM.</p>
      </sec>
      <sec>
        <title>Cell viability</title>
        <p>Cells were plated in 96-well plates (human primary RPE: 10,000 cells/well, ARPE-19: 15,000–20,000 cells/well, unless otherwise stated) overnight, fed with serum-free medium or treated with testing agents (prepared in serum-free medium) the next day followed by H<sub>2</sub>O<sub>2 </sub>treatment for a day, then the viability from each treatment was determined by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay [<xref ref-type="bibr" rid="B27">27</xref>]. Culture medium was removed after treatment and then 100 μl MTT solution (100 μg/ml prepared in DMEM) was added to each well. The cultures were incubated at 37°C for one hour in a tissue culture incubator. The MTT solution was then removed and the cells in each well were lysed by the addition of 100 μl dimethyl sulfoxide. The plate was placed on a shaker for one hour at room temperature to complete the lysing process, then the optical density of each well was measured by a 96-well plate reader with a filter setting at 570 nm (reference filter setting was 630 nm). When a pharmacological agent was used in the experiment, the MTT reading from cultures treated with that agent alone was used as 100% cellular viability.</p>
      </sec>
      <sec>
        <title>Actin staining</title>
        <p>This was performed as described by Carter et al. [<xref ref-type="bibr" rid="B28">28</xref>]. Cells grown on coverslips were treated with H<sub>2</sub>O<sub>2 </sub>for various period of time as indicated in figure legends, washed three times with phosphate-buffered saline (PBS), then fixed for 10 minutes with 3.7% formaldehyde (prepared in PBS). The cultures were then washed three times with PBS, extracted with -20°C acetone for 5 minutes followed by three washes with PBS. Each culture was then stained with Texas Red-phalloidin (Molecular Probes, Eugene, OR) prepared in PBS containing 1% bovine serum albumin for 20 minutes at room temperature in a lightproof box. The cultures were then washed three times with water, mounted with GEL/MOUNT (Biomedia, Foster City, CA). The slides were examined under a Nikon microscope Eclipse E600 (Nikon Instruments Inc., Melville, NY). Cells were photographed digitally at a fixed exposure time by using a Photometrics CoolSNAP fx camera (Roper Scientific, Inc., Tucson, AZ) and the software MetaVue, Meta Imaging Series 4.5 (Universal Imaging Corporation, Downingtown, PA).</p>
      </sec>
      <sec>
        <title>Immunohistochemical and immunofluorescent staining</title>
        <p>Cultures grown on coverslips were used in this set of experiments. Phospho-ERK was detected by mouse anti-phospho-ERK antibody (Santa Cruz Biotechnology, Santa Cruz, CA, used at 1:1500) and the Vectastain ABC kit (Vector Lab., Burlingame, CA) with diaminobenzidine as the chromogen. Cellular 4-HNE protein adducts were detected by rabbit anti-4-HNE antibodies (Calbiochem, San Diego, CA, used at 1:250) followed by anti-rabbit secondary antibody labeled with FITC (Dako Corporation, Carpinteria, CA). The cultures were then mounted with GEL/MOUNT. The slides were examined under Nikon microscope Eclipse E600 (Nikon Instruments Inc., Melville, NY). Cells were photographed at fixed exposure time with Nikon digital still camera DXM 1200 (Nikon Instruments Inc., Melville, NY) and the software Nikon ACT-1 version 2.11 (Nikon Corporation, Tokyo, Japan).</p>
      </sec>
      <sec>
        <title>Nuclear staining</title>
        <p>Cells grown on coverslips were treated with H<sub>2</sub>O<sub>2 </sub>for various periods of time as indicated in figure legends, fixed for 10 minutes with 3.7% formaldehyde (prepared in PBS), stained with 1 μg/ml bisbenzimide solution (Hoechst 33258, Sigma, St. Louis, MO) for 10 minutes at room temperature, mounted with GEL/MOUNT, then observed under a fluorescent microscope as described in the previous section.</p>
      </sec>
      <sec>
        <title>Western blot analysis</title>
        <p>RPE cells were plated in T-150 flasks overnight, fed with serum-free medium for a day, then treated with H<sub>2</sub>O<sub>2 </sub>as indicated in figure legends. For sample preparation, cultures were detached with a scraper in PBS then centrifuged. The cell pellets were suspended in 150–300 μl ice-cold RIPA lysis buffer (1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS in PBS, 0.5 mM Phenylmethylsulfonyl fluoride (PMSF), 0.02 mg/ml Aprotinin, 1 mM Na<sub>3</sub>VO<sub>4</sub>) and incubated for 30 min on ice. Each sample was further homogenized by passage through a 21-gauge needle followed by an addition of 10 μl PMSF (stock solution: 50 mM). The samples were then incubated for 30 min on ice and subsequently centrifuged at 14,000 RPM for 20 min at 4°C. The supernatant from each sample was collected and an aliquot was taken for protein concentration determination by Micro BCA Protein Assay Reagent Kit (Pierce, Rockford, IL). Protein samples were stored at -70°C until ready for electrophoretic analysis. Equal amounts of protein samples (20 μg/well) were heated at 95°C for 6 min then loaded onto 1% SDS, 10% polyacrylamide gels. BenchMark pre-stained protein ladder (Invitrogen life technologies, Carlsbad, California) was used as molecular weight standards. Following electrophoretic separation, the proteins were transferred to nitrocellulose membranes. Equal loading and appropriate transfer of each lane was confirmed by staining the membrane with the Ponceau S solution (Sigma, St. Louis, MO). Membranes were blocked in 5% nonfat dried milk for one hour, washed in 10 mM Tris-buffered saline (pH 7.5) containing 0.1% Tween-20 (TBST) and probed with primary antibody overnight at 4°C. Membranes were washed with TBST and then incubated for 1 hour at room temperature with a secondary antibody followed by washing three times with TBST, immersed in ECL Plus western blotting detection system (Amersham Pharmacia Biotech, Buckinghamshire, England) for 1 min and then exposed to Kodak X-ray film (Rochester, NY). The films were analyzed by densitometry using a ChemiImager 5500 imaging system with AlphaEaseFC software (Alpha Innotech Corporation, San Leandro, CA). Results, expressed as percentage of control, from replicate experiments were pooled and averaged. The primary antibodies used in this set of experiments were from Santa Cruz (anti-ERK 1/2, used at 1:5000; anti-phospho-ERK, used at 1:1000; anti-PPARγ, used at 1:2000) or from Calbiochem (anti-4-HNE, used at 1:2,000).</p>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <p>Unless otherwise stated, results of cell viability experiments were pooled from 12 replicate samples derived from 3 independent experiments, and expressed as mean ± SEM. Statistical analyses were performed by analysis of variance (one-way ANOVA) followed by the Bonferroni test to determine the significance of difference.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Cytotoxicity of H<sub>2</sub>O<sub>2 </sub>toward primary human RPE and ARPE-19 cells</title>
        <p>Initial experiments analyzing the cytotoxic effect of oxidative stress on primary cultures of human RPE cells indicated that H<sub>2</sub>O<sub>2 </sub>at 1 mM or less did not affect cellular viability. Higher concentrations caused a sharp decrease of viability in human RPE such that a 24-hour treatment of cells with 1.2 mM H<sub>2</sub>O<sub>2 </sub>lowered the viability to 13% of controls (Fig. <xref ref-type="fig" rid="F1">1A</xref>, squares). This concentration lowered the viability of human RPE to 62% after a 4-hour treatment (Fig. <xref ref-type="fig" rid="F1">1A</xref>, circles).</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p>Cytotoxicity of H<sub>2</sub>O<sub>2 </sub>on human RPE cells. Fig. <xref ref-type="fig" rid="F1">1A</xref>: Primary human RPE cells were plated in 96-well plate, fed with serum-free medium the next day, then treated with H<sub>2</sub>O<sub>2 </sub>for 4 hours (circles) or 24 hours (squares). Fig. <xref ref-type="fig" rid="F1">1B</xref>: ARPE-19 cells were plated in 96-well plate, fed with serum-free medium the next day, then treated with H<sub>2</sub>O<sub>2 </sub>for 4 hours (circles) or 24 hours (squares). Fig. <xref ref-type="fig" rid="F1">1C</xref>: ARPE-19 cells were plated with a density of 10,000 cells/well, 20,000 cells/well or 40,000 cells/well in 96-well plates, fed with serum-free medium the next day, then treated with H<sub>2</sub>O<sub>2 </sub>for 24 hours. The viability of each treatment was determined by the MTT assay. Cultures at a density of 40,000 cells/well were 100% confluent.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-5-1"/>
        </fig>
        <p>In a set of analogous experiments, ARPE-19 cells treated with various concentrations of H<sub>2</sub>O<sub>2 </sub>for 4 hours or 24 hours showed that a 4-hour treatment with 1 mM H<sub>2</sub>O<sub>2 </sub>did not affect viability. An increase of H<sub>2</sub>O<sub>2 </sub>concentrations beyond 1 mM decreased viability such as 2 mM H<sub>2</sub>O<sub>2 </sub>decreased the viability to 46% of controls in 4 hours (Fig. <xref ref-type="fig" rid="F1">1B</xref>, circles). Treatment of cells with H<sub>2</sub>O<sub>2 </sub>for 24 hours caused a dose-dependent decrease of viability with a LD<sub>50 </sub>of ~1.35 mM (Fig. <xref ref-type="fig" rid="F1">1B</xref>, squares).</p>
        <p>H<sub>2</sub>O<sub>2 </sub>induced cytotoxicity in RPE cells appears to be affected by the density of cells in cultures [<xref ref-type="bibr" rid="B29">29</xref>]. To study this phenomenon, ARPE-19 cells plated in 96-well plates with densities of 10,000, 20,000 or 40,000 cells/well were subjected to H<sub>2</sub>O<sub>2 </sub>treatment. Cells grown in a high-density culture were indeed more resistant to H<sub>2</sub>O<sub>2 </sub>as compared to those grown in a low-density culture (Fig. <xref ref-type="fig" rid="F1">1C</xref>). For example, H<sub>2</sub>O<sub>2 </sub>at 1.4 mM reduced cellular viability to 11%, 49% or 94% of control in cultures with 10,000, 20,000 or 40,000 cells/well, respectively.</p>
      </sec>
      <sec>
        <title>H<sub>2</sub>O<sub>2 </sub>induced morphological alterations and formation of 4-HNE-adducts</title>
        <p>To analyze morphological changes of RPE cells treated with a cytotoxic concentration of H<sub>2</sub>O<sub>2</sub>, ARPE-19 cells were treated with 1.5 mM H<sub>2</sub>O<sub>2 </sub>for various periods of time and then processed for actin staining. Without H<sub>2</sub>O<sub>2 </sub>treatment, stress fibers appeared thin and diffuse in control cells (Fig. <xref ref-type="fig" rid="F2">2A</xref>, arrow). At 15-min after treatment, these cells appeared to round up and significant ruffling occurred at the edge of their plasma membrane (Fig. <xref ref-type="fig" rid="F2">2B</xref>, arrows). Overall thickening of stress fibers occurred at two hours after treatment in addition to the membrane ruffling (Fig. <xref ref-type="fig" rid="F2">2C</xref>, arrows). Additional morphological changes after 4 hours of H<sub>2</sub>O<sub>2 </sub>treatment (Fig. <xref ref-type="fig" rid="F2">2D,2E,2F</xref>) included distinctive dense bands at the periphery of some cells (Fig. <xref ref-type="fig" rid="F2">2D</xref>, arrows), peri-nuclear staining of actin fibers in other cells (which made the nuclei prominent, Fig. <xref ref-type="fig" rid="F2">2E</xref>, arrows) and microspikes (Fig. <xref ref-type="fig" rid="F2">2F</xref>, arrow) on the cell surface of some cells.</p>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p>Reorganization of actin fibers caused by oxidative stress. ARPE-19 cells were treated with 1.5 mM H<sub>2</sub>O<sub>2 </sub>then processed for actin stain as described in the Methods. Fig. <xref ref-type="fig" rid="F2">2A</xref>: untreated; Fig. <xref ref-type="fig" rid="F2">2B</xref>: 15-min; Fig. <xref ref-type="fig" rid="F2">2C</xref>: 2-hour; Figs. <xref ref-type="fig" rid="F2">2D,2E</xref> and <xref ref-type="fig" rid="F2">2F</xref>: 4-hour after treatment. See text for detailed discussion of the results. Scale bar in Fig. <xref ref-type="fig" rid="F2">2F</xref>: 50 μm.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-5-2"/>
        </fig>
        <p>Subsequent experiments with immunofluorescent staining indicated that 1.5 mM H<sub>2</sub>O<sub>2 </sub>treatment of ARPE-19 cells for 4 hours led to the formation of 4-HNE protein adducts both in the cytoplasm and nucleus, presumably as a result of lipid-peroxidation (Fig. <xref ref-type="fig" rid="F3">3A,3B</xref>). Various protein bands on Western blots were positive for anti-HNE antibody reactivity, further intensified as a result of H<sub>2</sub>O<sub>2 </sub>treatment (Fig <xref ref-type="fig" rid="F3">3C</xref>). Densitometry measurements were performed to estimate the collective increase of band intensity in each lane between 39 Kd and 87 Kd. Results derived from a total of six independent experiments indicated that treatment of cells with 0.5, 1, 1.5 or 2 mM H<sub>2</sub>O<sub>2 </sub>caused an increase of intensity to 2.5-, 3.1-, 3.7- or 7.1-fold of control, respectively.</p>
        <fig position="float" id="F3">
          <label>Figure 3</label>
          <caption>
            <p>H<sub>2</sub>O<sub>2 </sub>induced lipid peroxidation in RPE. ARPE-19 cells were treated with 1.5 mM H<sub>2</sub>O<sub>2 </sub>for 4 hours then processed for immunofluorescent staining using antibodies against 4-HNE. Fig. <xref ref-type="fig" rid="F3">3A</xref>: untreated cells. Scale bar: 50 μm. Fig. <xref ref-type="fig" rid="F3">3B</xref>: H<sub>2</sub>O<sub>2 </sub>treated cells. Note the overall enhanced staining in nucleus and cytoplasm. Fig. <xref ref-type="fig" rid="F3">3C</xref>: ARPE-19 cells were treated with various concentrations (0.5, 1, 1.5, 2 mM) of H<sub>2</sub>O<sub>2 </sub>for 24 hours then processed for Western blot analysis using anti-4-HNE antibodies. These polyclonal antibodies recognize cysteine-, histidine- and lysine-4-HNE Michael adducts. This is a representative result from 6 similar experiments.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-5-3"/>
        </fig>
        <p>Though there was significant cytoskeletal alterations and lipid peroxidation at 4 hours after H<sub>2</sub>O<sub>2 </sub>treatment, nuclear staining using bisbenzimide (Hoechst 33258) indicated that most cells maintained normal nuclear morphology at this time (Fig. <xref ref-type="fig" rid="F4">4A</xref>, untreated cells; Fig. <xref ref-type="fig" rid="F4">4B</xref>, 4 hours after treatment). Nuclear condensation increased with length of H<sub>2</sub>O<sub>2 </sub>exposure, which was clearly evident at 12 hours after H<sub>2</sub>O<sub>2 </sub>treatment (Fig <xref ref-type="fig" rid="F4">4C</xref>, arrows), and even more prominent at 16 hours after treatment (Fig. <xref ref-type="fig" rid="F4">4D</xref>). These results suggest that H<sub>2</sub>O<sub>2</sub>treatment caused apoptosis in RPE. Nuclear condensation appeared to start at the edge of the culture (relatively lower density area, Fig. <xref ref-type="fig" rid="F4">4C</xref>, arrows) and spread to the center part of the culture (higher density, Fig. <xref ref-type="fig" rid="F4">4D</xref>) over time. This phenomenon is consistent with the viability assay in which higher density cultures were more resistant to oxidative stress (Fig. <xref ref-type="fig" rid="F1">1C</xref>).</p>
        <fig position="float" id="F4">
          <label>Figure 4</label>
          <caption>
            <p>H<sub>2</sub>O<sub>2 </sub>induced nuclear condensation in ARPE-19 cells. ARPE-19 cells were treated with 1.5 mM H<sub>2</sub>O<sub>2 </sub>for various periods of time, and then processed for nuclear staining. Fig. <xref ref-type="fig" rid="F4">4A</xref>: untreated cells; Fig. <xref ref-type="fig" rid="F4">4B</xref>: 4-hour; Fig. <xref ref-type="fig" rid="F4">4C</xref>: 12-hour; Fig. <xref ref-type="fig" rid="F4">4D</xref>: 16-hour after treatment. Fig. <xref ref-type="fig" rid="F4">4E</xref>: Cells were pretreated with 1 μM 15d-PGJ<sub>2 </sub>overnight, followed by 1.5 mM H<sub>2</sub>O<sub>2 </sub>for 16 hours (without 15d-PGJ<sub>2</sub>). See text for detailed description of the results. Scale bar in Fig. <xref ref-type="fig" rid="F4">4E</xref>: 100 μm.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-5-4"/>
        </fig>
      </sec>
      <sec>
        <title>Effect of oxidative stress on PPARγ protein expression</title>
        <p>During rod outer segment ingestion, there is a generation of H<sub>2</sub>O<sub>2 </sub>[<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>] and an up-regulation of PPARγ mRNA expression [<xref ref-type="bibr" rid="B24">24</xref>] in RPE, experiments were performed to determine if H<sub>2</sub>O<sub>2 </sub>could induce PPARγ protein expression over the control levels. ARPE-19 cells were treated with various concentrations (0.5, 1, 1.5, 2 mM) of H<sub>2</sub>O<sub>2 </sub>for 24 hours and processed for Western blot analysis. Results indicated a slight induction of PPARγ protein levels in some experiments. This induction, however, was not apparent in other experiments (Results not shown). Densitometry analyses from a total of six independent experiments indicated that treatment of these cells with 0.5, 1, 1.5 or 2 mM H<sub>2</sub>O<sub>2 </sub>for 24 hours caused an alteration of band intensity to 76%, 108%, 113% or 104% of controls, respectively. There was no significant change of PPARγ protein level after 30-min or 12-hour H<sub>2</sub>O<sub>2 </sub>treatment, either (results not shown). A separate set of experiments also indicated that treatment of primary human RPE cells with 1 mM H<sub>2</sub>O<sub>2 </sub>for 24 hours did not induce PPARγ protein expression over the control levels (results not shown).</p>
      </sec>
      <sec>
        <title>Prevention of oxidative stress induced cytotoxicity by PPARγ agonists</title>
        <p>Even though H<sub>2</sub>O<sub>2 </sub>did not increase PPARγ protein expression significantly as indicated in the previous study, experiments were performed to determine whether PPARγ agonists could activate the existing PPARγ thus preventing H<sub>2</sub>O<sub>2 </sub>induced cytotoxicity in RPE cells. Cells were pretreated with the PPARγ agonist 15d-PGJ<sub>2 </sub>overnight followed by H<sub>2</sub>O<sub>2 </sub>for one day (without 15d-PGJ<sub>2</sub>) and processed for the MTT viability assay. Results indicated that 15d-PGJ<sub>2 </sub>prevented H<sub>2</sub>O<sub>2 </sub>induced cytotoxicity in primary human RPE cultures in a dose-dependent manner (Fig. <xref ref-type="fig" rid="F5">5A</xref>). Subsequent experiments with ARPE-19 cells also indicated this saving effect. While H<sub>2</sub>O<sub>2 </sub>at 1.3 mM, 1.4 mM or 1.5 mM lowered the ARPE-19 viability to 64%, 46% or 28% of control, respectively; pretreatment of these cells with 1 μM 15d-PGJ<sub>2 </sub>raised the viabilities to 95%, 84% or 68% of control, respectively (Fig. <xref ref-type="fig" rid="F5">5B</xref>). Cells stained with Hoechst 33258 indicated that 15d-PGJ<sub>2 </sub>prevented H<sub>2</sub>O<sub>2 </sub>induced nuclear condensation (Fig. <xref ref-type="fig" rid="F4">4E</xref>; compare this with Fig. <xref ref-type="fig" rid="F4">4D</xref>). The other PPARγ agonists, ciglitazone [<xref ref-type="bibr" rid="B30">30</xref>], azelaoyl PAF [<xref ref-type="bibr" rid="B31">31</xref>] and LY171883 [<xref ref-type="bibr" rid="B32">32</xref>], however, were not effective (tested between 1–10 μM, 3 independent experiments for each agent, results not shown). The PPARα agonist WY14643 had some saving effect at a high concentration (40 μM), however, the difference was not statistically significant (results not shown).</p>
        <fig position="float" id="F5">
          <label>Figure 5</label>
          <caption>
            <p>Prevention of H<sub>2</sub>O<sub>2 </sub>induced cytotoxicity by 15d-PGJ<sub>2 </sub>in RPE cells. Fig. <xref ref-type="fig" rid="F5">5A</xref>: Primary RPE cells were pretreated with various concentrations of 15d-PGJ<sub>2 </sub>overnight, followed by 1.3 mM or 1.4 mM H<sub>2</sub>O<sub>2 </sub>for 1 day (without 15d-PGJ<sub>2</sub>), then processed for the MTT viability assay. Fig. <xref ref-type="fig" rid="F5">5B</xref>: ARPE-19 cells were pretreated with 1 μM 15d-PGJ<sub>2 </sub>overnight, followed by various concentrations of H<sub>2</sub>O<sub>2 </sub>for 1 day (without 15d-PGJ<sub>2</sub>), then processed for the MTT viability assay. Statistical analyses were performed comparing cells treated with H<sub>2</sub>O<sub>2 </sub>alone versus H<sub>2</sub>O<sub>2 </sub>plus 15d-PGJ<sub>2</sub>.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-5-5"/>
        </fig>
      </sec>
      <sec>
        <title>Activation of ERK by H<sub>2</sub>O<sub>2</sub></title>
        <p>A set of experiments was performed to determine the effects of H<sub>2</sub>O<sub>2 </sub>on ERK activation. ARPE-19 cells were treated with 1.5 mM H<sub>2</sub>O<sub>2 </sub>for 1 hour and processed for immunohistochemical staining using antibodies against phospho-ERK. Untreated cells showed a faint phospho-ERK staining while there was an apparent increase of phospho-ERK staining in the cytoplasm and nuclei in H<sub>2</sub>O<sub>2 </sub>treated cells (Fig. <xref ref-type="fig" rid="F6">6A,6B</xref>). A separate set of cultures was treated with H<sub>2</sub>O<sub>2 </sub>for 30 min and then processed for Western blot analysis. This H<sub>2</sub>O<sub>2 </sub>treatment of the cells caused only a slight alteration in ERK levels but led to a dose-dependent increase of phospho-ERK, with a maximal stimulation observed at 1.5 mM (Fig. <xref ref-type="fig" rid="F6">6C</xref>). Densitometry analyses from 3 independent experiments indicated that 0.5, 1, 1.5 or 2 mM H<sub>2</sub>O<sub>2 </sub>caused an increase of p42ERK (ERK2) phosphorylation to 2.1-, 12.7-, 18.8- or 2.0- fold of control, respectively. Similar treatment caused an increase of p44 ERK (ERK1) phosphorylation to 1.5-, 15.7-, 21.4- or 3.4-fold of control, respectively. The phospho-ERK in H<sub>2</sub>O<sub>2 </sub>treated samples remained higher than control at 24-hour after treatment (results not shown).</p>
        <fig position="float" id="F6">
          <label>Figure 6</label>
          <caption>
            <p>Activation of ERK by H<sub>2</sub>O<sub>2 </sub>treatment. ARPE-19 were treated with 1.5 mM H<sub>2</sub>O<sub>2 </sub>for one hour, then processed for immunohistochemical staining using anti-phospho-ERK antibody. Fig. <xref ref-type="fig" rid="F6">6A</xref>: untreated cells. Scale bar: 50 μm. Fig. <xref ref-type="fig" rid="F6">6B</xref>: H<sub>2</sub>O<sub>2 </sub>treated cells. Fig. <xref ref-type="fig" rid="F6">6C</xref>: ARPE-19 were treated with various concentrations (0.5, 1, 1.5, 2 mM) of H<sub>2</sub>O<sub>2 </sub>for 30 minutes, and then processed for Western blot analysis. Antibodies against ERK and phospho-ERK were used in this study. P: positive controls. This is a representative result from 3 similar experiments.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-5-6"/>
        </fig>
      </sec>
      <sec>
        <title>Effect of ERK inhibition on H<sub>2</sub>O<sub>2 </sub>induced cytotoxicity in ARPE-19</title>
        <p>Since ERK activation appeared to be an early event associated with H<sub>2</sub>O<sub>2 </sub>induced cytotoxicity, experiments were performed to determine if inhibitors of ERK activation could affect the cytotoxicity caused by H<sub>2</sub>O<sub>2</sub>. ARPE-19 cells were pretreated with 10 μM PD98059 (a MEK inhibitor which functions upstream of ERK [<xref ref-type="bibr" rid="B33">33</xref>]) followed by H<sub>2</sub>O<sub>2 </sub>challenge. Results from 3 independent experiments indicated that this agent could prevent low-dose (1–1.2 mM) H<sub>2</sub>O<sub>2 </sub>induced cell death slightly. In contrast, it enhanced high-dose (1.3–1.6 mM) H<sub>2</sub>O<sub>2 </sub>induced cell death. These effects in either case were not remarkable (results not shown). This agent at concentrations higher than 10 μM was toxic to ARPE-19 cells by itself and could enhance H<sub>2</sub>O<sub>2 </sub>toxicity (results not shown).</p>
        <p>In a separate set of experiments, ARPE-19 cells were pretreated with 10 μM AG126 (a protein tyrosine kinase inhibitor [<xref ref-type="bibr" rid="B34">34</xref>]) followed by H<sub>2</sub>O<sub>2 </sub>challenge. The treatment of cells with 1.3 mM, 1.4 mM or 1.5 mM H<sub>2</sub>O<sub>2 </sub>decreased the cellular viability to 66%, 40% or 22% of control, respectively. Pretreatment of cells with AG126 raised the viability to 72% (p &lt; 0.05 compared to H<sub>2</sub>O<sub>2 </sub>treatment only), 63% (p &lt; 0.005) or 35% (p &lt; 0.01) of control, respectively. AG126 at concentrations higher than 10 μM was toxic to ARPE-19 cells by itself and could enhance H<sub>2</sub>O<sub>2 </sub>toxicity (results not shown).</p>
        <p>Both AG126 (10 μM) and 15d-PGJ<sub>2 </sub>(1 μM) could prevent H<sub>2</sub>O<sub>2 </sub>induced cytotoxicity in ARPE-19, a set of experiments was also performed to determine whether these two agents had additive saving effects. While 1.4 mM H<sub>2</sub>O<sub>2 </sub>treatment reduced the viability to ~40% of control, AG126 raised this viability to ~55% of control and 15d-PGJ<sub>2 </sub>raised the viability to 75% of control. A combination of these two agents did not raise the viability above 15d-PGJ<sub>2 </sub>alone (Fig. <xref ref-type="fig" rid="F7">7</xref>).</p>
        <fig position="float" id="F7">
          <label>Figure 7</label>
          <caption>
            <p>Saving of RPE cells by AG126 and 15d-PGJ<sub>2</sub>. ARPE-19 cells were treated with 10 μM AG126, 1 μM 15d-PGJ<sub>2 </sub>or a combination of these two agents overnight, followed by 1.4 mM H<sub>2</sub>O<sub>2 </sub>for 1 day (without testing agents), then processed for the MTT viability assay. *P &lt; 0.05 as compared to H<sub>2</sub>O<sub>2 </sub>alone; **p &lt; 0.001 as compared to H<sub>2</sub>O<sub>2 </sub>alone. There was no statistical difference between H<sub>2</sub>O<sub>2 </sub>+15d-PGJ<sub>2 </sub>and H<sub>2</sub>O<sub>2 </sub>+AG/15d-PGJ<sub>2</sub>.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-5-7"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <sec>
        <title>Cytotoxicity of oxidative stress on RPE</title>
        <p>Results from this study indicated that both primary human RPE cultures and ARPE-19 cells were susceptible to H<sub>2</sub>O<sub>2 </sub>treatment. It is important to point out that H<sub>2</sub>O<sub>2 </sub>showed a very steep dose-response curve in primary RPE cultures under our experimental conditions such that an increase of H<sub>2</sub>O<sub>2 </sub>concentration from 1 mM to 1.2 mM for one-day treatment caused a decrease in viability from ~100% to ~10% of control (Fig. <xref ref-type="fig" rid="F1">1A</xref>). Though the H<sub>2</sub>O<sub>2 </sub>titration curve in ARPE-19 was not as steep as observed in primary RPE, one-day treatment of these cells with 1.8 mM H<sub>2</sub>O<sub>2 </sub>could decrease the cellular viability to ~10% of control while 1 mM H<sub>2</sub>O<sub>2 </sub>did not affect cellular viability (Fig. <xref ref-type="fig" rid="F1">1B</xref>). The sharp dose-response curves demonstrated in this study suggests that it is important to have an effective cellular anti-oxidation mechanism to prevent the build-up of oxidative stress over a critical level. An increase of oxidative stress in RPE is associated with an increase of cellular catalase, metallothionein [<xref ref-type="bibr" rid="B3">3</xref>] and glutathione S-transferase [<xref ref-type="bibr" rid="B35">35</xref>], which should serve as a protective mechanism to decrease the cytotoxicity caused by H<sub>2</sub>O<sub>2 </sub>and other reactive oxygen species. This protective mechanism declines with age because a study analyzing metallothionein levels in RPE of macular region showed a dramatic decrease in aged donors (mean age = 80-yr) as compared to those from younger donors (mean age = 58-yr) [<xref ref-type="bibr" rid="B36">36</xref>]. A separate report concluded that there was also an age-dependent decrease of catalase activity in RPE [<xref ref-type="bibr" rid="B37">37</xref>]. These studies suggest RPE in the elderly are more susceptible to oxidative stress induced damage, which may contribute to age-related RPE dysfunction and vision loss. The oxidative stress induced RPE cytotoxicity can be aggravated by zinc deficiency, as previously reported by Tate et al. [<xref ref-type="bibr" rid="B9">9</xref>].</p>
        <p>Significant morphological changes were observed in RPE cells treated with a cytotoxic concentration of H<sub>2</sub>O<sub>2</sub>. Actin fiber re-organization was noticed as early as 15 minutes after treatment (Fig. <xref ref-type="fig" rid="F2">2</xref>). Those images presented in Fig. <xref ref-type="fig" rid="F2">2D,2E</xref> and <xref ref-type="fig" rid="F2">2F</xref> are three representatives of RPE cells at 4 hr after H<sub>2</sub>O<sub>2 </sub>treatment. The cells shown in 2D and 2F are commonly seen at different locations on the same slide. In Fig. <xref ref-type="fig" rid="F2">2D</xref>, the dense peripheral bands of actin fibers were very prominent in some cells and the high intensity fluorescence caused an impression that the cells were relatively empty. The thickening of dense peripheral bands in this study was in contrast to previous observations in endothelial cells. For example, Zhao and Davis reported that cultured pulmonary endothelial cells treated with H<sub>2</sub>O<sub>2 </sub>underwent a morphological change that was accompanied by an accumulation/increase in stress fibers running across the cells while the dense peripheral bands of most cells were disrupted or eliminated [<xref ref-type="bibr" rid="B38">38</xref>]. Similar observations on endothelial cells were made by Liu and Sundqvist [<xref ref-type="bibr" rid="B39">39</xref>]. The dense peripheral bands are important in cell-cell adhesion, which maintains the structural integrity. While it is apparent that endothelial cells used in those studies and epithelial cells used in this study respond differently to H<sub>2</sub>O<sub>2</sub>, the underlying reason for this difference is currently unknown. One may speculate that RPE cells use this build-in mechanism to defend the oxidative stress that they are constantly exposed to. We currently have no data to support or dismiss this possibility. In Fig. <xref ref-type="fig" rid="F2">2E</xref>, some cultures responded to H<sub>2</sub>O<sub>2 </sub>treatment by a perinuclear distribution of actin fibers. In Fig. <xref ref-type="fig" rid="F2">2F</xref>, we observed microspikes at the periphery of the cells. A detailed study of microspikes by Adams indicated that these structures consist of actin, the actin binding protein, 55 kd/fascin and myosin [<xref ref-type="bibr" rid="B40">40</xref>]. The perinuclear staining and microspikes of cells under oxidative stress in this study are very similar to those observed by Huot et al. in endothelial cells treated with H<sub>2</sub>O<sub>2 </sub>[<xref ref-type="bibr" rid="B41">41</xref>]. The functional significance of these structural changes in RPE after H<sub>2</sub>O<sub>2 </sub>treatment is not clear. There is a possibility that the appearance of microspikes around the cells under stressed conditions is an adapted behavior of the cells in order to attach to the substratum firmly. Prolonged H<sub>2</sub>O<sub>2 </sub>treatment led to cell death with the appearance of condensed nuclei is an indication of apoptosis (Fig. <xref ref-type="fig" rid="F4">4C,4D</xref>). This general finding is consistent with that observed by others [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B12">12</xref>].</p>
        <p>It is of interest to note that cultures with a reduced density are more vulnerable to H<sub>2</sub>O<sub>2 </sub>treatment (Fig. <xref ref-type="fig" rid="F1">1C</xref>). One straightforward explanation for the vulnerability of low-density cultures treated with H<sub>2</sub>O<sub>2 </sub>is that more molecules of H<sub>2</sub>O<sub>2 </sub>per cell were present in these low-density cultures, which caused a lower viability. If this were the case, a mathematic analysis of the H<sub>2</sub>O<sub>2 </sub>molecules per cell should be able to estimate the cytotoxicity in this experimental system. For example, 1.4 mM H<sub>2</sub>O<sub>2 </sub>in a culture plated at a density of 40,000 cells/well should result in a viability close to twice of that generated in 20,000 cells/well and four times of that in 10,000 cells/well. Results from Fig. <xref ref-type="fig" rid="F1">1C</xref> indicated that the viability of each condition above was 94%, 49% or 11%, respectively. It is apparent that H<sub>2</sub>O<sub>2 </sub>killed more cells in cultures of lower density (10,000 cells/well) than expected. Because the result could not always be predicted by a mathematic estimation, there is a possibility that cell-cell contacts and some autocrine/paracrine production in a culture may alter the microenvironment thus determine the cytotoxicity caused by H<sub>2</sub>O<sub>2</sub>. Since cells with lower density are more susceptible to oxidative stress, there is a possibility that a vicious cycle exists such that when an area of RPE loses some of the constituent cells by oxidative stress, the remaining cells will become even more vulnerable to this insult.</p>
      </sec>
      <sec>
        <title>PPARs in RPE</title>
        <p>This study indicated that the PPARγ agonist 15d-PGJ<sub>2 </sub>could prevent H<sub>2</sub>O<sub>2 </sub>induced RPE cell death (Figs. <xref ref-type="fig" rid="F5">5A,5B</xref> and Fig. <xref ref-type="fig" rid="F4">4E</xref>). This suggests that this agent can prevent oxidative stress induced RPE damage. This finding is significant given prior reports that oxidative stress on RPE is an important contributing factor of age-related macular degeneration [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B42">42</xref>]. An earlier report also indicated that PPARγ agonists could prevent laser photocoagulation induced choroidal neovascularization in rat eyes and monkey eyes, which suggests the possible application of these agents on the exudative form of age-related macular degeneration [<xref ref-type="bibr" rid="B43">43</xref>]. It is important to note that the other PPARγ agonists tested in this study (ciglitazone, azelaoyl PAF and LY171883) were ineffective in saving cells under the same experimental conditions. Since three out of four PPARγ agonists tested were ineffective, this raises the possibility that the saving effect of 15d-PGJ<sub>2 </sub>is not through PPARγ activation. In this respect, it should be noted that this agent has been shown to exert some biological effects that are independent of PPARγ activation [<xref ref-type="bibr" rid="B44">44</xref>-<xref ref-type="bibr" rid="B46">46</xref>].</p>
        <p>We have previously shown that 15d-PGJ<sub>2 </sub>can prevent the cytotoxicity of cholesterol oxides, end products of cholesterol under oxidative stress [<xref ref-type="bibr" rid="B27">27</xref>]. Together with results from the current study, this agent may have a general protective effect against oxidative stress itself or against cytotoxic agents generated by oxidative stress. It is important to note that 15d-PGJ<sub>2 </sub>functions as a general inhibitor of immune activities. For example, this agent is a potent inhibitor of microglia, the macrophage-like cells in the central nervous system [<xref ref-type="bibr" rid="B47">47</xref>-<xref ref-type="bibr" rid="B49">49</xref>] and shown to be effective in reducing the symptoms of experimental autoimmune encephalomyelitis (EAE), an animal model for the human disease multiple sclerosis [<xref ref-type="bibr" rid="B50">50</xref>]. Together, these results suggest that this agent may be useful in preventing ocular diseases that result from oxidative stress or inflammation.</p>
      </sec>
      <sec>
        <title>ERK activation and 4-HNE protein adducts formation as a result of oxidative stress</title>
        <p>Oxidative stress is a potent stimulator of the MAP kinase activities [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B51">51</xref>]. Phosphorylation of ERK could be observed within 30–60 minutes after H<sub>2</sub>O<sub>2 </sub>treatment (Fig. <xref ref-type="fig" rid="F6">6</xref>). There are conflicting results in literature regarding whether an increase of ERK phosphorylation is beneficial or detrimental to cell survival. Bhat et al. demonstrated that 5–25 μM PD98059 could prevent H<sub>2</sub>O<sub>2 </sub>induced cell death in an oligodendrocyte cell line [<xref ref-type="bibr" rid="B14">14</xref>]. In contrast, 20 μM PD98059 was shown to enhance cell death caused by H<sub>2</sub>O<sub>2 </sub>treatment in HeLa cells [<xref ref-type="bibr" rid="B15">15</xref>]. This reagent had no significant effect on H<sub>2</sub>O<sub>2 </sub>treated ARPE-19 cells under our experimental conditions. AG126, on the other hand, appeared to reduce the cytotoxicity caused by oxidative stress (Fig. <xref ref-type="fig" rid="F7">7</xref>). While this suggests that inhibition of tyrosine phosphorylation or ERK activation after H<sub>2</sub>O<sub>2 </sub>treatment might be beneficial for the cells, results from PD98059 could not support this statement.</p>
        <p>There is a possibility that the saving effect of AG126 is not related to ERK inhibition. Under the current experimental conditions, AG126 at 10 μM was protective but it enhanced H<sub>2</sub>O<sub>2 </sub>toxicity at 20 μM. These results were consistent with those reported by Sagara et al. [<xref ref-type="bibr" rid="B52">52</xref>]. AG126 belongs to a group of tyrosine kinase inhibitors named tyrphostins. Many of these agents can prevent cellular oxidative stress including that generated by glutamate. There is no correlation between the kinase inhibition and the observed protective effect. Overnight treatment of cells with AG126 can increase cellular glutathione levels. Furthermore, this agent has some anti-oxidant effect based on the Trolox Equivalent Activity Concentration [<xref ref-type="bibr" rid="B52">52</xref>]. Collectively, this may explain the observation that AG126 at 10 μM could partially prevent H<sub>2</sub>O<sub>2 </sub>induced cytotoxicity. This agent can also function as a mitochondria uncoupler, thus it actually enhances H<sub>2</sub>O<sub>2 </sub>cytotoxicity at higher concentrations [<xref ref-type="bibr" rid="B52">52</xref>].</p>
        <p>An accumulation of 4-HNE-conjugated protein has been detected in lesions of aging-related diseases, including Parkinson's disease [<xref ref-type="bibr" rid="B53">53</xref>] and Alzheimer's disease [<xref ref-type="bibr" rid="B54">54</xref>]. It also accumulates in the affected neuronal tissues of experimental animals experiencing brain ischemia [<xref ref-type="bibr" rid="B55">55</xref>,<xref ref-type="bibr" rid="B56">56</xref>] and traumatic spinal cord injury [<xref ref-type="bibr" rid="B57">57</xref>]. 4-HNE can impair synaptosomal membrane proteins, glutamate transport and importantly, mitochondrial functions [<xref ref-type="bibr" rid="B58">58</xref>,<xref ref-type="bibr" rid="B59">59</xref>]. Evidence indicates that 4-HNE increases neuronal susceptibility to oxidative stress [<xref ref-type="bibr" rid="B60">60</xref>] and serves as a mediator of oxidative stress that leads to neuronal apoptosis [<xref ref-type="bibr" rid="B61">61</xref>]. As indicated in the Introduction, 4-HNE has been implicated in some ocular pathological conditions [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>].</p>
        <p>Several laboratories have attempted to document the formation of 4-HNE protein adducts during oxidative stress by Western blot analysis. Uchida et al. first reported oxidative stress caused by t-butylhydroperoxide or iron/ascorbate could lead to 4-HNE protein adducts in hepatocytes [<xref ref-type="bibr" rid="B62">62</xref>]. Further studies by these researchers attempted to identify the common epitope recognized by the 4-HNE antibodies. However, no specific protein was positively identified [<xref ref-type="bibr" rid="B63">63</xref>]. More recently, the formation of 4-HNE protein adducts was also demonstrated by Western blot analysis from the heart [<xref ref-type="bibr" rid="B64">64</xref>], the liver [<xref ref-type="bibr" rid="B65">65</xref>] and the kidney [<xref ref-type="bibr" rid="B66">66</xref>] under oxidative stress. It is important to point out that the patterns of 4-HNE protein adducts, as shown by these Western blot analyses, were different among these studies, probably as a result of tissue specificity. No particular protein was identified as a specific target for 4-HNE adduct formation in these studies. Results from the current study indicate that H<sub>2</sub>O<sub>2 </sub>treatment of RPE could lead to the accumulation of 4-HNE protein adducts in the cytoplasm and the nuclei of these cells (Fig. <xref ref-type="fig" rid="F3">3</xref>). There was a dose-dependent increase of 4-HNE protein adduct after H<sub>2</sub>O<sub>2 </sub>treatment with a maximal intensity of ~7X control at 2 mM H<sub>2</sub>O<sub>2 </sub>(Fig. <xref ref-type="fig" rid="F3">3C</xref>). This may partially contribute to oxidative stress induced ocular disease. Even though ocular tissues, including the retina, contain glutathione S-transferases that can actively detoxify 4-HNE [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B67">67</xref>], adverse events may occur if aging or pathological conditions hinder this normal defense from functioning properly. It warrants further studies to identify those proteins species that are modified by 4-HNE.</p>
      </sec>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>This study demonstrates that oxidative stress induced by H<sub>2</sub>O<sub>2 </sub>could lead to RPE cell death, which is preceded by distinct morphological changes, ERK activation and 4-HNE protein adduct formation. The cell death can be prevented partially by AG126, and the prostaglandin derivative, 15d-PGJ<sub>2. </sub>These agents may be useful pharmacological tools in the future capable of preventing oxidative stress induced RPE cell death in human ocular diseases.</p>
    </sec>
    <sec>
      <title>Competing Interests</title>
      <p>None declared.</p>
    </sec>
    <sec>
      <title>Authors' Contributions</title>
      <p>TKG and JYC were both involved in the experimental design and data collection. Both authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>15d-PGJ<sub>2</sub>, 15-deoxy-delta 12, 14-Prostaglandin J<sub>2</sub>; ERK, Extracellular signal-Regulated Kinase; 4-HNE, 4-hydroxynonenal, MAP kinases, Mitogen-Activated Protein kinases; MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide); PBS, phosphate-buffered saline; PPARs, peroxisome proliferator-activated receptors; RPE, retinal pigment epithelium.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/5/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgments</title>
        <p>This work was supported by funds from Fight For Sight and Research to Prevent Blindness. Primary human RPE cell cultures were prepared from specimens provided by the Arkansas Lions Eye Bank &amp; Laboratory. Support by the Pat &amp; Williard Walker Eye Research Center is greatly appreciated.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rozanowska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jarvis-Evans</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Korytowski</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Boulton</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Sarna</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species</article-title>
          <source>J Biol Chem</source>
          <year>1995</year>
          <volume>270</volume>
          <fpage>18825</fpage>
          <lpage>18830</lpage>
          <pub-id pub-id-type="pmid">7642534</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.270.32.18825</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miceli</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Liles</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Newsome</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis</article-title>
          <source>Exp Cell Res</source>
          <year>1994</year>
          <volume>214</volume>
          <fpage>242</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="pmid">8082727</pub-id>
          <pub-id pub-id-type="doi">10.1006/excr.1994.1254</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tate</surname>
              <given-names>D.J., Jr.</given-names>
            </name>
            <name>
              <surname>Miceli</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Newsome</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1995</year>
          <volume>36</volume>
          <fpage>1271</fpage>
          <lpage>1279</lpage>
          <pub-id pub-id-type="pmid">7775104</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sternberg</surname>
              <given-names>P., Jr.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>Oxidative damage and protection of the RPE</article-title>
          <source>Prog Retin Eye Res</source>
          <year>2000</year>
          <volume>19</volume>
          <fpage>205</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="pmid">10674708</pub-id>
          <pub-id pub-id-type="doi">10.1016/S1350-9462(99)00009-9</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Winkler</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Boulton</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Gottsch</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Sternberg</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Oxidative damage and age-related macular degeneration</article-title>
          <source>Mol Vis</source>
          <year>1999</year>
          <volume>5</volume>
          <fpage>32</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">10562656</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wills</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Weng</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hellmich</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Buchheit</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Godley</surname>
              <given-names>BF</given-names>
            </name>
          </person-group>
          <article-title>Chloride channel expression in cultured human fetal RPE cells: response to oxidative stress</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>4247</fpage>
          <lpage>4255</lpage>
          <pub-id pub-id-type="pmid">11095622</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jahngen-Hodge</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Obin</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Shang</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Nowell</surname>
              <given-names>T.R., Jr.</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Abasi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Blumberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress</article-title>
          <source>J Biol Chem</source>
          <year>1997</year>
          <volume>272</volume>
          <fpage>28218</fpage>
          <lpage>28226</lpage>
          <pub-id pub-id-type="pmid">9353272</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.272.45.28218</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Morse</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Goldkorn</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Ceramide: a potential mediator of apoptosis in human retinal pigment epithelial cells</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>247</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="pmid">11133876</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tate</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Miceli</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Newsome</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Zinc protects against oxidative damage in cultured human retinal pigment epithelial cells</article-title>
          <source>Free Radic Biol Med</source>
          <year>1999</year>
          <volume>26</volume>
          <fpage>704</fpage>
          <lpage>713</lpage>
          <pub-id pub-id-type="pmid">10218660</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0891-5849(98)00253-6</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ballinger</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Van Houten</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Conklin</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Godley</surname>
              <given-names>BF</given-names>
            </name>
          </person-group>
          <article-title>Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells</article-title>
          <source>Exp Eye Res</source>
          <year>1999</year>
          <volume>68</volume>
          <fpage>765</fpage>
          <lpage>772</lpage>
          <pub-id pub-id-type="pmid">10375440</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.1998.0661</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Verna</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Holman</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>VC</given-names>
            </name>
            <name>
              <surname>Hoh</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>UVA-induced oxidative damage in retinal pigment epithelial cells after H2O2 or sparfloxacin exposure</article-title>
          <source>Cell Biol Toxicol</source>
          <year>2000</year>
          <volume>16</volume>
          <fpage>303</fpage>
          <lpage>312</lpage>
          <pub-id pub-id-type="pmid">11201054</pub-id>
          <pub-id pub-id-type="doi">10.1023/A:1026798314217</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jin</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Hurst</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Godley</surname>
              <given-names>BF</given-names>
            </name>
          </person-group>
          <article-title>Hydrogen peroxide stimulates apoptosis in cultured human retinal pigment epithelial cells</article-title>
          <source>Curr Eye Res</source>
          <year>2001</year>
          <volume>22</volume>
          <fpage>165</fpage>
          <lpage>173</lpage>
          <pub-id pub-id-type="pmid">11462152</pub-id>
          <pub-id pub-id-type="doi">10.1076/ceyr.22.3.165.5517</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dalle-Donne</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Milzani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Di Simplicio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Colombo</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself</article-title>
          <source>Free Radic Biol Med</source>
          <year>2001</year>
          <volume>31</volume>
          <fpage>1624</fpage>
          <lpage>1632</lpage>
          <pub-id pub-id-type="pmid">11744337</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0891-5849(01)00749-3</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhat</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal- regulated kinase in hydrogen peroxide-induced cell death</article-title>
          <source>J Neurochem</source>
          <year>1999</year>
          <volume>72</volume>
          <fpage>112</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="pmid">9886061</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1471-4159.1999.0720112.x</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Martindale</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Holbrook</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>The cellular response to oxidative stress: influences of mitogen- activated protein kinase signalling pathways on cell survival</article-title>
          <source>Biochem J</source>
          <year>1998</year>
          <volume>333</volume>
          <fpage>291</fpage>
          <lpage>300</lpage>
          <pub-id pub-id-type="pmid">9657968</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keller</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Mattson</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system</article-title>
          <source>Rev Neurosci</source>
          <year>1998</year>
          <volume>9</volume>
          <fpage>105</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="pmid">9711902</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Verdejo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Marco</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Renau-Piqueras</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pinazo-Duran</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Lipid peroxidation in proliferative vitreoretinopathies</article-title>
          <source>Eye</source>
          <year>1999</year>
          <volume>13</volume>
          <fpage>183</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">10450379</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Kuijk</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>4-Hydroxynonenal interaction with rhodopsin</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1997</year>
          <volume>230</volume>
          <fpage>275</fpage>
          <lpage>279</lpage>
          <pub-id pub-id-type="pmid">9016765</pub-id>
          <pub-id pub-id-type="doi">10.1006/bbrc.1996.5942</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ansari</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Role of lipid aldehydes in cataractogenesis: 4-hydroxynonenal-induced cataract</article-title>
          <source>Biochem Mol Med</source>
          <year>1996</year>
          <volume>58</volume>
          <fpage>25</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">8809342</pub-id>
          <pub-id pub-id-type="doi">10.1006/bmme.1996.0028</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Srivastata</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Awasthi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bhatnagar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Awasthi</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Ansari</surname>
              <given-names>NH</given-names>
            </name>
          </person-group>
          <article-title>Attenuation of 4-hydroxynonenal-induced cataractogenesis in rat lens by butylated hydroxytoluene</article-title>
          <source>Curr Eye Res</source>
          <year>1996</year>
          <volume>15</volume>
          <fpage>749</fpage>
          <lpage>754</lpage>
          <pub-id pub-id-type="pmid">8670783</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kersten</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Desvergne</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wahli</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Roles of PPARs in health and disease</article-title>
          <source>Nature</source>
          <year>2000</year>
          <volume>405</volume>
          <fpage>421</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="pmid">10839530</pub-id>
          <pub-id pub-id-type="doi">10.1038/35013000</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corton</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Stauber</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators</article-title>
          <source>Annu Rev Pharmacol Toxicol</source>
          <year>2000</year>
          <volume>40</volume>
          <fpage>491</fpage>
          <lpage>518</lpage>
          <pub-id pub-id-type="pmid">10836145</pub-id>
          <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.40.1.491</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bishop-Bailey</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Peroxisome proliferator-activated receptors in the cardiovascular system</article-title>
          <source>Br J Pharmacol</source>
          <year>2000</year>
          <volume>129</volume>
          <fpage>823</fpage>
          <lpage>834</lpage>
          <pub-id pub-id-type="pmid">10696077</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ershov</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Bazan</surname>
              <given-names>NG</given-names>
            </name>
          </person-group>
          <article-title>Photoreceptor phagocytosis selectively activates PPARgamma expression in retinal pigment epithelial cells</article-title>
          <source>J Neurosci Res</source>
          <year>2000</year>
          <volume>60</volume>
          <fpage>328</fpage>
          <lpage>337</lpage>
          <pub-id pub-id-type="pmid">10797535</pub-id>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(20000501)60:3&lt;328::AID-JNR7&gt;3.0.CO;2-5</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunn</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Aotaki-Keen</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Putkey</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>Hjelmeland</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>ARPE-19, a human retinal pigment epithelial cell line with differentiated properties</article-title>
          <source>Exp Eye Res</source>
          <year>1996</year>
          <volume>62</volume>
          <fpage>155</fpage>
          <lpage>169</lpage>
          <pub-id pub-id-type="pmid">8698076</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.1996.0020</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunn</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Marmorstein</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Bonilha</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Rodriguez-Boulan</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Giordano</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hjelmeland</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Use of the ARPE-19 cell line as a model of RPE polarity: basolateral secretion of FGF5</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1998</year>
          <volume>39</volume>
          <fpage>2744</fpage>
          <lpage>2749</lpage>
          <pub-id pub-id-type="pmid">9856785</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Peroxisome proliferator-activated receptor agoinsts prevent 25-OH-cholesterol induced c-jun activation and cell death</article-title>
          <source>BMC Pharmacol</source>
          <year>2001</year>
          <volume>1</volume>
          <fpage>10</fpage>
          <pub-id pub-id-type="pmid">11737865</pub-id>
          <pub-id pub-id-type="doi">10.1186/1471-2210-1-10</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carter</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Parham</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Chambers</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Cytoskeletal reorganization induced by retinoic acid treatment of human endometrial adenocarcinoma (RL95-2) cells is correlated with alterations in protein kinase C-alpha</article-title>
          <source>Pathobiology</source>
          <year>1998</year>
          <volume>66</volume>
          <fpage>284</fpage>
          <lpage>292</lpage>
          <pub-id pub-id-type="pmid">9769475</pub-id>
          <pub-id pub-id-type="doi">10.1159/000028035</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gelfman</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Matsunaga</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Alizadeh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morse</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Handa</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Hjelmeland</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Density-dependent expression of FGF-2 in response to oxidative stress in RPE cells in vitro</article-title>
          <source>Curr Eye Res</source>
          <year>2001</year>
          <volume>23</volume>
          <fpage>226</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="pmid">11803485</pub-id>
          <pub-id pub-id-type="doi">10.1076/ceyr.23.3.226.5467</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Willson</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Cobb</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Cowan</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Wiethe</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Correa</surname>
              <given-names>ID</given-names>
            </name>
            <name>
              <surname>Prakash</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Kliewer</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Lehmann</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones</article-title>
          <source>J Med Chem</source>
          <year>1996</year>
          <volume>39</volume>
          <fpage>665</fpage>
          <lpage>668</lpage>
          <pub-id pub-id-type="pmid">8576907</pub-id>
          <pub-id pub-id-type="doi">10.1021/jm950395a</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Pontsler</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Marathe</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Hinshaw</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Prestwich</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Hilaire</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Prescott</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Zimmerman</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>McIntyre</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>16015</fpage>
          <lpage>16023</lpage>
          <pub-id pub-id-type="pmid">11279149</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.M100878200</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kliewer</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Forman</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Blumberg</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ong</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Borgmeyer</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Mangelsdorf</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Umesono</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Differential expression and activation of a family of murine peroxisome proliferator-activated receptors</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1994</year>
          <volume>91</volume>
          <fpage>7355</fpage>
          <lpage>7359</lpage>
          <pub-id pub-id-type="pmid">8041794</pub-id>
        </citation>
      </ref>
      <ref id="B33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sawada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Decker</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Saltiel</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor</article-title>
          <source>J Biol Chem</source>
          <year>1995</year>
          <volume>270</volume>
          <fpage>13585</fpage>
          <lpage>13588</lpage>
          <pub-id pub-id-type="pmid">7775407</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.270.36.21040</pub-id>
        </citation>
      </ref>
      <ref id="B34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levitzki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gazit</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Tyrosine kinase inhibition: an approach to drug development</article-title>
          <source>Science</source>
          <year>1995</year>
          <volume>267</volume>
          <fpage>1782</fpage>
          <lpage>1788</lpage>
          <pub-id pub-id-type="pmid">7892601</pub-id>
        </citation>
      </ref>
      <ref id="B35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singhal</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Godley</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Chandra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pandya</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Saini</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Awasthi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Awasthi</surname>
              <given-names>YC</given-names>
            </name>
          </person-group>
          <article-title>Induction of glutathione S-transferase hGST 5.8 is an early response to oxidative stress in RPE cells</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1999</year>
          <volume>40</volume>
          <fpage>2652</fpage>
          <lpage>2659</lpage>
          <pub-id pub-id-type="pmid">10509662</pub-id>
        </citation>
      </ref>
      <ref id="B36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tate</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Newsome</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Oliver</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>Metallothionein shows an age-related decrease in human macular retinal pigment epithelium</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1993</year>
          <volume>34</volume>
          <fpage>2348</fpage>
          <lpage>2351</lpage>
          <pub-id pub-id-type="pmid">8505216</pub-id>
        </citation>
      </ref>
      <ref id="B37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liles</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Newsome</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Oliver</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>Antioxidant enzymes in the aging human retinal pigment epithelium</article-title>
          <source>Arch Ophthalmol</source>
          <year>1991</year>
          <volume>109</volume>
          <fpage>1285</fpage>
          <lpage>1288</lpage>
          <pub-id pub-id-type="pmid">1929958</pub-id>
        </citation>
      </ref>
      <ref id="B38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>HW</given-names>
            </name>
          </person-group>
          <article-title>Hydrogen peroxide-induced cytoskeletal rearrangement in cultured pulmonary endothelial cells</article-title>
          <source>J Cell Physiol</source>
          <year>1998</year>
          <volume>174</volume>
          <fpage>370</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="pmid">9462699</pub-id>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-4652(199803)174:3&lt;370::AID-JCP11&gt;3.0.CO;2-D</pub-id>
        </citation>
      </ref>
      <ref id="B39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Sundqvist</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide and cGMP regulate endothelial permeability and F-actin distribution in hydrogen peroxide-treated endothelial cells</article-title>
          <source>Exp Cell Res</source>
          <year>1997</year>
          <volume>235</volume>
          <fpage>238</fpage>
          <lpage>244</lpage>
          <pub-id pub-id-type="pmid">9281373</pub-id>
          <pub-id pub-id-type="doi">10.1006/excr.1997.3675</pub-id>
        </citation>
      </ref>
      <ref id="B40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adams</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Formation of stable microspikes containing actin and the 55 kDa actin bundling protein, fascin, is a consequence of cell adhesion to thrombospondin-1: implications for the anti-adhesive activities of thrombospondin-1</article-title>
          <source>J Cell Sci</source>
          <year>1995</year>
          <volume>108 ( Pt 5)</volume>
          <fpage>1977</fpage>
          <lpage>1990</lpage>
          <pub-id pub-id-type="pmid">7657718</pub-id>
        </citation>
      </ref>
      <ref id="B41">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huot</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Houle</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rousseau</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Deschesnes</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Landry</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis</article-title>
          <source>J Cell Biol</source>
          <year>1998</year>
          <volume>143</volume>
          <fpage>1361</fpage>
          <lpage>1373</lpage>
          <pub-id pub-id-type="pmid">9832563</pub-id>
          <pub-id pub-id-type="doi">10.1083/jcb.143.5.1361</pub-id>
        </citation>
      </ref>
      <ref id="B42">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>O'Connell</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Bressler</surname>
              <given-names>NM</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Regillo CD, Brown GC and Flynn HW Jr</surname>
            </name>
          </person-group>
          <article-title>Age-related macular degeneration</article-title>
          <source>Vitreoretinal disease: The essentials</source>
          <year>1999</year>
          <publisher-name>New York, Thieme Medical Publishers, Inc.</publisher-name>
          <fpage>213</fpage>
          <lpage>240</lpage>
        </citation>
      </ref>
      <ref id="B43">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hangai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ishibashi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>XP</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hsueh</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Law</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Hinton</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>2309</fpage>
          <lpage>2317</lpage>
          <pub-id pub-id-type="pmid">10892878</pub-id>
        </citation>
      </ref>
      <ref id="B44">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vaidya</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Somers</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Detmers</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Bansal</surname>
              <given-names>VS</given-names>
            </name>
          </person-group>
          <article-title>15-Deoxy-Delta12,1412,14-prostaglandin J2 inhibits the beta2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor gamma ligation</article-title>
          <source>J Immunol</source>
          <year>1999</year>
          <volume>163</volume>
          <fpage>6187</fpage>
          <lpage>6192</lpage>
          <pub-id pub-id-type="pmid">10570310</pub-id>
        </citation>
      </ref>
      <ref id="B45">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ward</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dransfield</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Farrow</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Haslett</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism</article-title>
          <source>J Immunol</source>
          <year>2002</year>
          <volume>168</volume>
          <fpage>6232</fpage>
          <lpage>6243</lpage>
          <pub-id pub-id-type="pmid">12055237</pub-id>
        </citation>
      </ref>
      <ref id="B46">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jozkowicz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dulak</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Prager</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nanobashvili</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nigisch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Winter</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Weigel</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Huk</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner</article-title>
          <source>Prostaglandins Other Lipid Mediat</source>
          <year>2001</year>
          <volume>66</volume>
          <fpage>165</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="pmid">11577781</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0090-6980(01)00155-1</pub-id>
        </citation>
      </ref>
      <ref id="B47">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bernardo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Levi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Minghetti</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Role of the peroxisome proliferator-activated receptor-gamma (PPAR- gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions</article-title>
          <source>Eur J Neurosci</source>
          <year>2000</year>
          <volume>12</volume>
          <fpage>2215</fpage>
          <lpage>2223</lpage>
          <pub-id pub-id-type="pmid">10947800</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1460-9568.2000.00110.x</pub-id>
        </citation>
      </ref>
      <ref id="B48">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petrova</surname>
              <given-names>TV</given-names>
            </name>
            <name>
              <surname>Akama</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Van Eldik</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <article-title>Cyclopentenone prostaglandins suppress activation of microglia: down- regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14- prostaglandin J2</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1999</year>
          <volume>96</volume>
          <fpage>4668</fpage>
          <lpage>4673</lpage>
          <pub-id pub-id-type="pmid">10200320</pub-id>
          <pub-id pub-id-type="doi">10.1073/pnas.96.8.4668</pub-id>
        </citation>
      </ref>
      <ref id="B49">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drew</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Chavis</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells</article-title>
          <source>J Neuroimmunol</source>
          <year>2001</year>
          <volume>115</volume>
          <fpage>28</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">11282151</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0165-5728(01)00267-3</pub-id>
        </citation>
      </ref>
      <ref id="B50">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diab</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Hussain</surname>
              <given-names>RZ</given-names>
            </name>
            <name>
              <surname>Phanavanh</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lovett-Racke</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Drew</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Racke</surname>
              <given-names>MK</given-names>
            </name>
          </person-group>
          <article-title>Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis</article-title>
          <source>J Immunol</source>
          <year>2002</year>
          <volume>168</volume>
          <fpage>2508</fpage>
          <lpage>2515</lpage>
          <pub-id pub-id-type="pmid">11859145</pub-id>
        </citation>
      </ref>
      <ref id="B51">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshizumi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Haendeler</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Berk</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>11706</fpage>
          <lpage>11712</lpage>
          <pub-id pub-id-type="pmid">10766791</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.275.16.11706</pub-id>
        </citation>
      </ref>
      <ref id="B52">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sagara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ishige</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Maher</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Tyrphostins protect neuronal cells from oxidative stress</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>36204</fpage>
          <lpage>36215</lpage>
          <pub-id pub-id-type="pmid">12121989</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.M203895200</pub-id>
        </citation>
      </ref>
      <ref id="B53">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoritaka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hattori</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stadtman</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1996</year>
          <volume>93</volume>
          <fpage>2696</fpage>
          <lpage>2701</lpage>
          <pub-id pub-id-type="pmid">8610103</pub-id>
          <pub-id pub-id-type="doi">10.1073/pnas.93.7.2696</pub-id>
        </citation>
      </ref>
      <ref id="B54">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takeda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Avila</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nunomura</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Siedlak</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sayre</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification</article-title>
          <source>J Neurochem</source>
          <year>2000</year>
          <volume>75</volume>
          <fpage>1234</fpage>
          <lpage>1241</lpage>
          <pub-id pub-id-type="pmid">10936206</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.0751234.x</pub-id>
        </citation>
      </ref>
      <ref id="B55">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Urabe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamasaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hattori</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yoshikawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Accumulation of 4-hydroxynonenal-modified proteins in hippocampal CA1 pyramidal neurons precedes delayed neuronal damage in the gerbil brain</article-title>
          <source>Neuroscience</source>
          <year>2000</year>
          <volume>100</volume>
          <fpage>241</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="pmid">11008164</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0306-4522(00)00264-5</pub-id>
        </citation>
      </ref>
      <ref id="B56">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshino</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hattori</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Urabe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Postischemic accumulation of lipid peroxidation products in the rat brain: immunohistochemical detection of 4-hydroxy-2-nonenal modified proteins</article-title>
          <source>Brain Res</source>
          <year>1997</year>
          <volume>767</volume>
          <fpage>81</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="pmid">9365018</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0006-8993(97)00616-1</pub-id>
        </citation>
      </ref>
      <ref id="B57">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Springer</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Azbill</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Mark</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Begley</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Waeg</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mattson</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>4-hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake</article-title>
          <source>J Neurochem</source>
          <year>1997</year>
          <volume>68</volume>
          <fpage>2469</fpage>
          <lpage>2476</lpage>
          <pub-id pub-id-type="pmid">9166741</pub-id>
        </citation>
      </ref>
      <ref id="B58">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keller</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Mark</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Bruce</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Blanc</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rothstein</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Waeg</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mattson</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes</article-title>
          <source>Neuroscience</source>
          <year>1997</year>
          <volume>80</volume>
          <fpage>685</fpage>
          <lpage>696</lpage>
          <pub-id pub-id-type="pmid">9276486</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0306-4522(97)00065-1</pub-id>
        </citation>
      </ref>
      <ref id="B59">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Subramaniam</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Roediger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mattson</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Keller</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Waeg</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Butterfield</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins</article-title>
          <source>J Neurochem</source>
          <year>1997</year>
          <volume>69</volume>
          <fpage>1161</fpage>
          <lpage>1169</lpage>
          <pub-id pub-id-type="pmid">9282939</pub-id>
        </citation>
      </ref>
      <ref id="B60">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keller</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Hanni</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Markesbery</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>4-hydroxynonenal increases neuronal susceptibility to oxidative stress</article-title>
          <source>J Neurosci Res</source>
          <year>1999</year>
          <volume>58</volume>
          <fpage>823</fpage>
          <lpage>830</lpage>
          <pub-id pub-id-type="pmid">10583913</pub-id>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19991215)58:6&lt;823::AID-JNR9&gt;3.3.CO;2-K</pub-id>
        </citation>
      </ref>
      <ref id="B61">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kruman</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bruce-Keller</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Bredesen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Waeg</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mattson</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis</article-title>
          <source>J Neurosci</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>5089</fpage>
          <lpage>5100</lpage>
          <pub-id pub-id-type="pmid">9185546</pub-id>
        </citation>
      </ref>
      <ref id="B62">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uchida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Szweda</surname>
              <given-names>LI</given-names>
            </name>
            <name>
              <surname>Chae</surname>
              <given-names>HZ</given-names>
            </name>
            <name>
              <surname>Stadtman</surname>
              <given-names>ER</given-names>
            </name>
          </person-group>
          <article-title>Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1993</year>
          <volume>90</volume>
          <fpage>8742</fpage>
          <lpage>8746</lpage>
          <pub-id pub-id-type="pmid">8378358</pub-id>
        </citation>
      </ref>
      <ref id="B63">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uchida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Itakura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kawakishi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hiai</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Toyokuni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stadtman</surname>
              <given-names>ER</given-names>
            </name>
          </person-group>
          <article-title>Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies</article-title>
          <source>Arch Biochem Biophys</source>
          <year>1995</year>
          <volume>324</volume>
          <fpage>241</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="pmid">8554315</pub-id>
          <pub-id pub-id-type="doi">10.1006/abbi.1995.0036</pub-id>
        </citation>
      </ref>
      <ref id="B64">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eaton</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hearse</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Shattock</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart</article-title>
          <source>Am J Physiol</source>
          <year>1999</year>
          <volume>276</volume>
          <fpage>H935</fpage>
          <lpage>NaN</lpage>
          <pub-id pub-id-type="pmid">10070077</pub-id>
        </citation>
      </ref>
      <ref id="B65">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Hinson</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Mayeux</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Oxidant stress in rat liver after lipopolysaccharide administration: effect of inducible nitric-oxide synthase inhibition</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2000</year>
          <volume>293</volume>
          <fpage>968</fpage>
          <lpage>972</lpage>
          <pub-id pub-id-type="pmid">10869399</pub-id>
        </citation>
      </ref>
      <ref id="B66">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walker</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>York</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Imam</surname>
              <given-names>SZ</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Muldrew</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Mayeux</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress and reactive nitrogen species generation during renal ischemia</article-title>
          <source>Toxicol Sci</source>
          <year>2001</year>
          <volume>63</volume>
          <fpage>143</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="pmid">11509754</pub-id>
          <pub-id pub-id-type="doi">10.1093/toxsci/63.1.143</pub-id>
        </citation>
      </ref>
      <ref id="B67">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singhal</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Awasthi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Zimniak</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ansari</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Awasthi</surname>
              <given-names>YC</given-names>
            </name>
          </person-group>
          <article-title>Novel human ocular glutathione S-transferases with high activity toward 4-hydroxynonenal</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1995</year>
          <volume>36</volume>
          <fpage>142</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="pmid">7822141</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:155649</identifier><datestamp>2003-05-17</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">155649</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-3-6</article-id>
      <article-id pub-id-type="pmid">12702216</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-3-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Clinical and surgical data of affected members of a classic CFEOM 1 family</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Magli</surname>
            <given-names>Adriano</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>magli@cds.unina.it</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>de Berardinis</surname>
            <given-names>Teresa</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>debera@libero.it</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>D'Esposito</surname>
            <given-names>Fabiana</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>magli@cds.unina.it</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Gagliardi</surname>
            <given-names>Vincenzo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>gagliardicav@tin.it</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Dipartimento di Scienze Oftalmologiche Facoltà di Medicina e Chirurgia Università degli Studi di Napoli "Federico II"</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>4</month>
        <year>2003</year>
      </pub-date>
      <volume>3</volume>
      <fpage>6</fpage>
      <lpage>6</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/6"/>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>12</month>
          <year>2002</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>4</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2003 Magli et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Magli et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Congenital fibiosis of the extraocular muscles (CFEOM1) refers to a group of congenital eye movement disorders that are characterized by non-progressive restrictive ophthalmoplegia. We present clinical and surgical data on affected members of a classic CFEOM1 family.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>Ten members of a fifteen-member, three-generation Italian family affected by classic CFEOM participated in this study. Each affected family member underwent ophthalmologic (corrected visual acuity, pupillary function, anterior segment and fundus examination), orthoptic (cover test, cover-uncover test, prism alternate cover test), and preoperative examinations. Eight of the ten affected members had surgery and underwent postoperative examinations. Surgical procedures are listed.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>All affected members were born with varying degrees of bilateral ptosis and ophthalmoplegia with both eyes fixed in a hypotropic position (classic CFEOM). The affected members clinical data prior to surgery, surgery procedures and postoperative outcomes are presented. On 14 operated eyes to correct ptosis there was an improvement in 12 eyes. In addition, the head position improved in all patients.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Surgery is effective at improving ptosis in the majority of patients with classic CFEOM. However, the surgical approach should be individualized to each patient, as inherited CFEOM exhibits variable expressivity and the clinical features may differ markedly between affected individuals, even within the same family.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>congenital fibrosis</kwd>
        <kwd>extraocular muscles</kwd>
        <kwd>CFEOM</kwd>
        <kwd>ptosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Congenital fibrosis of the extraocular muscles (CFEOM) refers to a group of congenital eye movement disorders that are characterized by non-progressive restrictive ophthalmoplegia. An early description of CFEOM was given by Baumgarten in 1840[<xref ref-type="bibr" rid="B1">1</xref>] and Heuck is credited with the first report of a familial occurrence in 1879[<xref ref-type="bibr" rid="B2">2</xref>]. Affected individuals are born with their eyes fixed in an abnormal position, are unable to move them normally, and often develop a compensatory chin-up position to see. CFEOM is often associated with ptosis and depending on the subtype, can affect one or both eyes. Table <xref ref-type="table" rid="T1">1</xref> lists the general clinical features of CFEOM as classified by the Authors. Individuals with classic CFEOM are born with ptosis and their eyes in a hypotropic position which they are unable to elevate above the midline. In familial cases, affected family members may present with similar clinical phenotypes, or exhibit a range of clinical severity [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. If left untreated, CFEOM can result in amblyopia, if binocular vision is lost, and the patient may become a strict monofixator.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Clinical Features of CFEOM.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="left">Clinical Feature</td>
              <td align="left">Frequency Observed</td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Restrictive Ophthalmoplegia (positive forced duction tests)</td>
              <td align="left">Required</td>
            </tr>
            <tr>
              <td align="left">Congenital</td>
              <td align="left">Required</td>
            </tr>
            <tr>
              <td align="left">Non-progressive</td>
              <td align="left">Required</td>
            </tr>
            <tr>
              <td align="left">Inelasticity and decreased contractility of one or more extraocular muscles</td>
              <td align="left">Required</td>
            </tr>
            <tr>
              <td align="left">Ptosis, unilateral or bilateral</td>
              <td align="left">Very Common</td>
            </tr>
            <tr>
              <td align="left">Downward deviation of eyes and retroflexion of head</td>
              <td align="left">Very Common</td>
            </tr>
            <tr>
              <td align="left">Normal pupillary function</td>
              <td align="left">Very Common</td>
            </tr>
            <tr>
              <td align="left">Inexpressive Facies</td>
              <td align="left">Very Common</td>
            </tr>
            <tr>
              <td align="left">Reduced visual acuity</td>
              <td align="left">Common</td>
            </tr>
            <tr>
              <td align="left">Astigmatism</td>
              <td align="left">Common</td>
            </tr>
            <tr>
              <td align="left">Nystagmus</td>
              <td align="left">Common</td>
            </tr>
            <tr>
              <td align="left">Inelastic and fragile conjunctiva</td>
              <td align="left">Common</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>The CFEOM conditions were traditionally classified based on clinical differences and are referred to in the literature by many names including: congenital fibrosis of the extraocular muscles [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B11">11</xref>]; general fibrosis syndrome[<xref ref-type="bibr" rid="B5">5</xref>] ; congenital static familial ophthalmoplegia [<xref ref-type="bibr" rid="B12">12</xref>]; familial musculofascial anomaly [<xref ref-type="bibr" rid="B13">13</xref>] ; familial opthalmoplegia with co-contraction [<xref ref-type="bibr" rid="B14">14</xref>]; congenital external ophthalmoplegia[<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>] ; and hereditary congenital external ophthalmoplegia [<xref ref-type="bibr" rid="B17">17</xref>]. As the genetic basis of these disorders became known, however, their classification changed to one combining both genetic etiology and clinical presentation. Therefore, clinical entities that have the same underlying genetic cause, regardless of clinical variations, are being grouped first by genetic aetiology and then by clinical differences [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>].</p>
      <p>Three genetic loci for CFEOM have been identified (CFEOM1–3) [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B28">28</xref>]</p>
      <p>While the aetiology of CFEOM is not fully understood, there is evidence of a neurological rather than myopathic basis. A neuropathologic examination of an individual exhibiting a classic CFEOM phenotype whose disease gene maps to the CFEOM1 locus revealed an absence of the superior division of the third cranial nerve and corresponding oculomotor subnuclei [<xref ref-type="bibr" rid="B11">11</xref>], suggesting a primary neuropathic aetiology with secondary myopathic changes, rather than a primary myopathic aetiology.</p>
      <p>This finding was similar to postmortem findings showing an absence of the abducens nucleus and abducens nerve in individuals with isolated Duane syndrome, another congenital non-progressive ophthalmoplegia [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. Furthermore, Gottlob described a patient with CFEOM and elevation of one eye during tooth brushing. This is the first of aberrant regeneration between the nerve to the superior rectus and the trigeminal nerve in a patient with CFEOM, and further supports a primary developmental abnormality of the cranial nerves in CFEOM [<xref ref-type="bibr" rid="B31">31</xref>].</p>
      <p>Treatment for CFEOM is primarily surgical and aimed at the elimination or improvement of an unacceptable head position, the reduction of ptosis, and/or the elimination or reduction of significant misalignment of the eyes [<xref ref-type="bibr" rid="B32">32</xref>]. Unfortunately, nothing can be done to correct the absence of eye movements. Apt and Axelrod [<xref ref-type="bibr" rid="B33">33</xref>] demonstrated that satisfactory cosmesis can be obtained with appropriate extraocular muscle surgery, that amblyopia can be successfully treated when recognized early, and that uncomfortable head position can be relieved with proper alignement of the eyes.</p>
      <p>They used a strict sequence of surgical steps when the eyes are fixed in the down and out position, beginning with vertical, then horizontal muscle surgery, and finally, eyelid surgery. In case of recurrence of any appreciable degree of deviation, they performed reexploration, lysis of adhesions, and additional appropriate eye muscle surgery. Because the rectus muscle procedures often cause a change in relative eyelid position, blepharoptosis surgery is done last. Houtman [<xref ref-type="bibr" rid="B17">17</xref>] treated thirteen individuals affected by CFEOM by a recession or a disinsertion of the inferior rectus muscle and a frontalis suspension procedure in one stage. Boergen [<xref ref-type="bibr" rid="B34">34</xref>] reported a large series of CFEOM patients in whom an aggressive surgical approach led to good clinical results. Ferrer [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>] proposed "maximal surgery" at the first procedure: unsutured tenomyectomy (9–10 mm) of the inferior rectus, exeresis of the lower-half fascias, recession of the conjunctiva; tenectomy of the superior oblique; and, when not absent, resection of the superior rectus. Despite this aggressive surgery, he has not experienced overcorrections to date. Three to four months later, he corrected ptosis, and, if it existed, the horizontal deviation; this simplified rational approach has been predictably efficient in his experience. Although treatment of these patients is difficult, visual rehabilitation can be achieved [<xref ref-type="bibr" rid="B37">37</xref>]. This is accomplished with occlusion for amblyopia and spectacle correction of refractive errors and anisometropia. The goal of strabismus surgery is to release muscle restriction and to align the eye as closely as possible to straight in primary position. Binocular vision is rarely attained post surgery, even with a good surgical result, and repeat surgery is often necessary if a significant amount of residual deviation gradually develops after surgical intervention [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. We present clinical and, if surgery was done, surgical data on ten affected members of a classic CFEOM1 family.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Pedigree</title>
        <p>The family (3 generations) was identified in the ophthalmological clinic of the University of Naples "Federico II". The ten affected family members each underwent ophthalmologic (corrected visual acuity, examination of pupillary function, anterior segment and fundus), orthoptic (cover test, cover-uncover test, prism alternate cover test), and preoperative examinations.</p>
        <p>To classify the degree of ptosis in our patients the amount of cornea left "covered" by the palpebrae was measured [<xref ref-type="bibr" rid="B38">38</xref>]. A baseline measurement of 2 mm for the non-ptosis state was calculated. Using this baseline measurements, the degree of ptosis was quantified as follows: Absence of ptosis:2 mm of cornea "covered"; Ist degree ptosis:4 mm of cornea "covered"; II degree ptosis: 5–6 mm of cornea "covered"; III degree ptosis: &gt;6 mm of cornea "covered".</p>
        <p>The amount of ptosis was measured without frontalis innervation, and during this process the frontalis muscle was immobilized using the hands, and the eyebrow was kept in the normal position. The type of surgery performed to correct ptosis depended on the level of the patient's eyelid levator function. Levator function was assessed by measuring the palpebral excursion [<xref ref-type="bibr" rid="B39">39</xref>]. This was done by doing a measurement from the point in the extreme down gaze to the point in the extreme upgaze. The levator muscle function (mm) was quantified as follows: 10–15 mm: excellent; 8 mm: good; 5–7 mm: sufficient; &lt;4 mm: poor.</p>
        <p>All affected members who had surgery (eight of the ten) also underwent postoperative examinations.</p>
        <p>Prior to surgery we found that an evaluation of the function of the frontalis muscle is recommended because some varieties of complete congenital ophthalmoplegia involve the mimetic frontal muscles. In addition, the function of the lacrimal tears and sensitivity of the cornea should be tested. To avoid post surgical negative reactions (corneal exposure)treatment with artificial tears in the form of hydroxymethylcellulose, or polyvinylpyrrolidine alkaline eye drops and with simple ointement at night, is recommended after surgery.</p>
      </sec>
      <sec>
        <title>Surgical Treatment</title>
        <p>Eight of the ten affected members had surgery. Surgical procedures are listed in <xref ref-type="supplementary-material" rid="S1">Additional File 1</xref>.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <p>Ten members of a fifteen-member, three-generation Italian family who are affected by classic CFEOM participated in this study (figure <xref ref-type="fig" rid="F1">1</xref>, figure <xref ref-type="fig" rid="F2">2</xref>). All affected members were born with bilateral ptosis and varying degrees of ophthalmoplegia with both eyes fixed in a hypotropic position. None were able to elevate either eye above the horizontal midline. All affected members presented with a compensatory chin up position and head turn prior to surgical intervention.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>F.Family pedigree</p>
        </caption>
        <graphic xlink:href="1471-2415-3-6-1"/>
      </fig>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>Seven members of the family affected by CFEOM1 Top: From the left : III:1 after the last operation III:2 after the last operation II:2 after the last operation II:4 after the last operation III:7 before surgery Bottom: III:5 before surgery III:4 before surgery</p>
        </caption>
        <graphic xlink:href="1471-2415-3-6-2"/>
      </fig>
      <p>Examination of pupillary function, anterior segment and fundus were normal in all ten affected members. Eight of the ten affected members underwent strabismus and ptosis surgery. Forced duction testing done during surgery of these individuals was positive, showing a restriction of eye movement. The affected family members' clinical presentations prior to surgery, surgical procedures performed and postoperative outcomes are shown in <xref ref-type="supplementary-material" rid="S1">Additional File 1</xref>.</p>
      <sec>
        <title>Case descriptions(the age of the patient shown for the year 2000)</title>
        <p><bold>Case I</bold>: 1 is a 66 year old man who was born with asymmetric ptosis (1<sup>st </sup>degree in the right eye and 3<sup>rd </sup>degree in the left eye), bilateral ophthalmoplegia with complete restriction of up-gaze and marked restriction of down-gaze. He has not had any surgery. He has esotropia of +30 prism dioptres, corrected visual acuity of 6/8 in right eye and 6/12 in left eye, and simple hypermetropic astigmatism. The levator function is absent in the left eye and sufficient (6 mm) in the right eye.</p>
        <p><bold>Case II</bold>: 2 is a 41 year old woman who was born with marked symmetric ptosis (3rd degree), bilateral ophthalmoplegia with complete restriction of up-gaze and marked restriction of down-gaze. She had exotropia of -30 prism dioptres, corrected visual acuity of 6/8 (RE) and 6/7 (LE), and simple hypermetropic astigmatism. The levator function was sufficient (5 mm) in both eyes. She had surgery in 1967 at age 8 years (Both eyes: recession Inferior Rectus Muscle(IRM)5 mm, resection Superior Rectus Muscle(SRM) 6 mm, eyelid levator resection 10 mm by skin approach) and in 1968 at age 9 years (RE: superior oblique tenotomy; LE: recession Lateral Rectus Muscle(LRM) 5 mm, resection MRM(Medial Rectus Muscle) 9 mm). Postoperative results showed an improvement in degree of ptosis (now mild) in both eyes, and exotropia changed from -30 prism dioptres prior to surgery to -10 prism dioptres. The patient was operated on all recti muscles, but did not have an anterior segmenti ischemia.</p>
        <p><bold>Case II</bold>: 4 is a 38 year old man who was born with marked symmetric ptosis (3rd degree), bilateral ophthalmoplegia with complete restriction of up-gaze and very marked restriction of down-gaze. He had esotropia of +20 prism dioptres, corrected visual acuity of 6/60 (RE) and 6/8 (LE), and simple myopic astigmatism. His levator function was poor (4 mm) in both eyes. He had surgery in 1967 at age 5 years (Both eyes: recession IRM 6 mm, resection SRM 6 mm), in 1968 at age 6 years (Both eyes: recession MRM 5 mm, superior oblique tenotomy) and in 1969 at age 7 years (Both eyes: eyelid levator resection 14 mm by skin approach). Postoperative results showed mild ptosis in both eyes, and a consecutive exotropia (-10 prism dioptres) in the right eye.</p>
        <p><bold>Case III</bold>: 1 is a 21 year old man who was born with marked symmetric ptosis of 2nd degree, bilateral ophthalmoplegia with complete restriction of up-gaze, very marked restriction of down-gaze and exophoria-tropia OD. His corrected visual acuity was 6/20 (RE) and 6/8 (LE), and a simple hypermetropic astigmatism was present. His levator function was absent in both eyes. He had surgery in 1984 at age 5 years (both eyes: recession IRM 6 mm., conjunctival recession of 5 mm. LE: resection SRM 7 mm. RE: resection SRM 6 mm.) and 1986 at age 7 years (both eyes: suspension from frontalis muscle with autologous fascia lata). Postoperative results showed 1<sup>st </sup>degree ptosis and exophoria-tropia OD.</p>
        <p><bold>Case III</bold>: 2 is a 20 year old woman who was born with very marked symmetric ptosis (3rd degree), and bilateral ophthalmoplegia with complete restriction of up- and down-gaze. She had esotropia of + 25 prism dioptres and horizontal manifest-latent nystagmus. Her corrected visual acuity was 6/30 in both eyes and a simple myopic astigmatism was present. Her levator function was absent in both eyes. She had surgery in 1986 at age 6 years (both eyes: suspension from frontalis with autologous fascia lata, recession IRM 6 mm, recession of conjunctive 6 mm), in 1987 at age 7 years (RE : suspension from frontalis with autologous fascia lata, LE: recession MRM 8 mm) and in 1988 at age 8 years (both eyes: entropion correction). Postoperative results showed mild ptosis in both eyes (1st degrees), and the left eye showed consecutive exotropia (-10 prism dioptres).</p>
        <p><bold>Case III</bold>: 3 is a 15 year old girl who was born with very marked bilateral ptosis (3<sup>rd </sup>degree), and bilateral ophthalmoplegia with an inability to move her eyes above the midline. She had exotropia of -30 prism dioptres (V alphabetical pattern), corrected visual acuity of 6/8 in both eyes and hypermetropic astigmatism. Her levator function was sufficient (6 mm) in both eyes. She had surgery in 1989 at age 4 years (both eyes: levator resection 8 mm by conjunctival approach) and in 1996 at age 11 years (both eyes: recession IRM 5 mm, conjunctival recession 4 mm; RE: recession LRM 8 mm and up displacement LRM 5 mm; LE: recession LRM 5 mm and up displacement LRM 5 mm). Postoperative results showed 1<sup>st </sup>degree ptosis and exotropia was reduced from -30 to -5 prism dioptres in the RE.</p>
        <p><bold>Case III</bold>: 4 is a 13 year old girl who was born with very marked bilateral ptosis (3<sup>rd </sup>degree) and bilateral ophthalmoplegia with complete restriction of both up- and down-gaze. She had exotropia of -20 prism dioptres (V alphabetical pattern), corrected visual acuity of 6/30 in both eyes and a myopic astigmatism. Her levator function was absent in both eyes. She had surgery in 1995 at age 8 years (both eyes: resection SRM 8 mm) and in1997 at age 10 years (both eyes: suspension from frontalis with autologous fascia lata, recession LRM 4, up displacement LRM 6 mm). Postoperative results showed that ptosis was a slightly improved after surgery (2<sup>nd </sup>degree) only in the left eye, and strabismus was unchanged.</p>
        <p><bold>Case III</bold>: 5 is a 10 year old girl who was born with a very marked symmetric ptosis (3rd degree) and bilateral ophthalmoplegia with complete restriction of all eye movement. She had esotropia of +20 prism dioptres, corrected visual acuity of 6/8 in both eyes and a hypermetropic astigmatism. Her levator function was absent in both eyes. She had surgery in 1995 at age 4 years (both eyes: recession IRM and conjunctive), in 1996 at age 5 years (both eyes: resection RSM 6 mm) and in 1997 at age 6 years (both eyes: suspension from frontalis with autologous fascia lata; LE: Up transposition muscular belly MRM 7 mm; Up transposition muscular belly LRM 7 mm). Postoperative results showed 2<sup>nd </sup>degree ptosis in the right eye, but ptosis in the left eye and vertical and horizontal strabismus were unchanged.</p>
        <p><bold>Case III</bold>: 7 is an 8 year old boy who was born with a very marked symmetric ptosis (3rd degree), and bilateral ophthalmopegia with complete restriction of up- and down-gaze. He had exotropia of -30 prism dioptres, corrected visual acuity of 6/30 in both eyes and a hypermetropic astigmatism. His levator function was absent in both eyes. He had surgery in 1998 at age 6 years (both eyes: recession IRM 5 mm, recession of conjunctive and recession LRM 7 mm), in 1999 at age 7 years (both eyes: resection SRM 3 mm) and in 2000 at age 8 years (RE: resection MRM 6 mm). Postoperative results showed that a consecutive esotropia (+10 prism dioptres) was present in the left eye. The patient has not yet been operated for ptosis.</p>
        <p><bold>Case III</bold>: 8 is a two year old girl who was born with symmetric moderate ptosis (2nd degree) and ophthalmoplegia with complete restriction of up-gaze and moderate restriction of down-gaze. Her levator function was sufficient (6 mm). She has not yet had surgery.</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>The surgical management performed on individuals with CFEOM in this study can be summarized as follows[<xref ref-type="bibr" rid="B40">40</xref>]: an Inferior Recti Muscles recession was generally performed (II:2, II:4, III:1, III:2, III:3, III:5, III:7). If this was not possible because of muscle contractures, surgery was performed directly on the Superior Recti Muscles (III:4).</p>
      <p>The shallow inferior fornix was then corrected by means of a 4–5 mm conjuctival recession (III:1, III:2, III:3, III:5, III:7). Shortening of the inferior fornix, which is caused by the congenital downward rotation, is corrected by elevation of the eyeballs. This in turn corrected the anomalous head position. The elevation was then reinforced, whenever possible, by means of a SRM resection (II:2, II:4, III:1, III:4, III:5). If the SRM presented as a thin fibrous cord adhering to the sclera, surgery was not possible. If this was the case, to straighten the eye, the SRM was replaced with a portion of the superior oblique muscle which was resected and anchored to the sclera (III:7). If horizontal strabismus was present (esotropia or exotropia), surgery was performed on medial and lateral rectus muscles to reduce horizontal strabismus(II:2, II:4, III:2, III:3, III:4, III:5, III:7).</p>
      <p>The type of surgery performed to correct ptosis depended on the level of the patient's eyelid levator function. The level of levator function in our patients was rated as sufficient, poor or absent. When the level of levator function was sufficient or poor (a measurement of approximately 4–5 mm), a resection of levator palpebrae by skin approach was done (II:2, II:4), or, in one case (III:3), with a levator function of approximately 6 mm, a resection of the levator palpebral by conjunctival approach was performed. When the levator function was absent (a measurement of &lt; 4 mm), a suspension to the frontalis muscle was done (III:1, III:2, III:4, III:5).</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>Surgery on vertical muscles, associated with ptosis surgery, resulted in improvements in head position in all patients, with 3 of them (II 2, III 3 and III 7) achieving a normal head position. We obtained this result with a moderate amount of strabismus surgery for both vertical and horizontal deviation; we did not perform multiple supra-maximal surgeries and believe that different results achieved with different surgical approaches reflects mostly on the fact that CFEOM clinical features are variable.</p>
      <p>On 14 operated eyes (7 patients) to correct ptosis, we had an improvement in 12 eyes, while 2 cases (III: 4 RE; III: 5 LE) exhibited no improvement. This is even when a suspension from frontalis by autologous fascia lata was performed. Careful attempts to avoid overcorrection of ptosis have prevented corneal exposure problems in all operated patients. The post-operative status of cornea is good in all operated patients. Even so, treatment with artificial tears in the form of hydroxymethylcellulose or polyvinylpyrrolidine alkaline eye drops and with simple ointement at night was recommended after ptosis surgery for six months in all patients.</p>
      <p>In some cases (III:4, III:5), in spite of sugery performed on the vertical muscles and to correct ptosis, satisfactory results were not achieved. Unfortunately, this is a common outcome when these surgeries are performed on individuals with CFEOM and is related to the condition rather than any errors in how the surgeries were done. As the clinical features of the CFEOM are often variable, even in the same family, the surgical approach should be individualized to optimise success.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/6/prepub"/>
      </p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="S1">
        <caption>
          <title>Additional File 1</title>
        </caption>
        <media xlink:href="1471-2415-3-6-S1.doc" mimetype="application" mime-subtype="msword">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>We thank the family members for their kind cooperation and Dr E.C. Engle for critical advice. Special thanks to Ms. N. McIntosh for critical review and for translation of the manuscript.</p>
        <p>Written consent was obtained from the patient or their relative for publication of the patient's details.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baumgarten</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Erfahrungen uber den Strabismus und die Muskeldurchschneidung am Auge in physiologisch-pathologischer und therapeutischer Beziehung</article-title>
          <source>Monatsschr Med Augenheilkd Chir</source>
          <year>1840</year>
          <volume>3</volume>
          <fpage>474</fpage>
          <lpage>499</lpage>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heuck</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Uber angeborenen verebten Beweglichkeitsdefekte der Augen</article-title>
          <source>Klin Monatsbl Augeneilk</source>
          <year>1879</year>
          <volume>17</volume>
          <fpage>253</fpage>
          <lpage>278</lpage>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Magli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Greco</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>D'Esposito</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Genetica della oftalmoplegia congenita esterna</article-title>
          <source>Atti LVIII Congresso SOI Roma</source>
          <year>1977</year>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mollica</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Li Volti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Incorpora</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tita</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Tomarchio</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Moro</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Variabilité intrafamiliale de l'ophtalmoplegie externe congenitale. Etude d'une famille sicilienne</article-title>
          <source>J Génét Hum</source>
          <year>1980</year>
          <volume>28</volume>
          <fpage>23</fpage>
          <lpage>30</lpage>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hiatt</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Halle</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>General fibrosis syndrome</article-title>
          <source>Ann Ophthalmol</source>
          <year>1983</year>
          <volume>15</volume>
          <fpage>1103</fpage>
          <lpage>1109</lpage>
          <pub-id pub-id-type="pmid">6660689</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abeloos</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Cordonnier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Van Nechel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Van Bogaert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gérard</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Van Regemoorter</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Fibrose Congénitale des muscles oculaires: un diagnostic pour plusieurs tableaux cliniques</article-title>
          <source>Bull Soc Belge Ophtalmol</source>
          <year>1990</year>
          <volume>239</volume>
          <fpage>61</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">2133536</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laughlin</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Congenital fibrosis of the extraocular muscles. A report of six cases</article-title>
          <source>Am J Ophthalmol</source>
          <year>1956</year>
          <volume>41</volume>
          <fpage>432</fpage>
          <lpage>438</lpage>
          <pub-id pub-id-type="pmid">13302348</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>McKusick</surname>
              <given-names>VA</given-names>
            </name>
          </person-group>
          <article-title>Mendelian inheritance in man: catalogs of autosomal dominant, autosomal recessive, and X-linked phenotypes</article-title>
          <source>Baltimore: The Johns Hopkins University Press</source>
          <year>1990</year>
          <edition>9</edition>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engle</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Kunkel</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Specht</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Beggs</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Mapping a gene for congenital fibrosis of the extraocular muscles to the centromeric region of chromosome 12</article-title>
          <source>Nat Genet</source>
          <year>1994</year>
          <volume>7</volume>
          <fpage>69</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="pmid">8075644</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engle</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Marondel</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Houtman</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>de Vries</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Loewenstein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lazar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Kucherlapati</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Beggs</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Congenital fibrosis of the extraocular muscles (autosomal dominant congenital external ophthalmoplegia): genetic homogeneity, linkage refinement, and physical mapping on chromosome 12</article-title>
          <source>Am J Hum Genet</source>
          <year>1995</year>
          <volume>57</volume>
          <fpage>1086</fpage>
          <lpage>1094</lpage>
          <pub-id pub-id-type="pmid">7485159</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engle</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Goumnerov</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>McKeown</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Schatz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Johns</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Beggs</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles</article-title>
          <source>Ann Neurol</source>
          <year>1997</year>
          <volume>41</volume>
          <fpage>314</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="pmid">9066352</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lees</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Congenital static familial ophthalmoplegia</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1960</year>
          <volume>23</volume>
          <fpage>46</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="pmid">14415239</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Catford</surname>
              <given-names>GV</given-names>
            </name>
          </person-group>
          <article-title>A familial musculo-fascial anomaly</article-title>
          <source>Trans Ophtalmol Soc UK</source>
          <year>1966</year>
          <volume>86</volume>
          <fpage>19</fpage>
          <lpage>36</lpage>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cibis</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Kies</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lawwill</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Varghese</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Electromyography in congenital familial ophthalmoplegia</article-title>
          <source>Strabismus</source>
          <year>1984</year>
          <volume>2</volume>
          <fpage>379</fpage>
          <lpage>389</lpage>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Magli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Santoro</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Perretti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>D'Esposito</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Caruso</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Francois J, Maione M</surname>
            </name>
          </person-group>
          <article-title>Electromyographic and enzymatic studies on families with external congenital ophthalmoplegia</article-title>
          <source>Reprinted from Paediatric Ophthalmology</source>
          <year>1982</year>
          <volume>19</volume>
          <publisher-name>John Wiley &amp; Sons and Cortina Verona</publisher-name>
          <fpage>371</fpage>
          <lpage>374</lpage>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Black</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Perveen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hatchwell</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Reck</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Clayton-Smith</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Locus heterogeneity in autosomal dominant congenital external ophthalmoplegia</article-title>
          <source>J Med Genet</source>
          <year>1998</year>
          <volume>35</volume>
          <fpage>985</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">9863593</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Houtman</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>van Weerden</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>de Vries</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hoogenraad</surname>
              <given-names>TU</given-names>
            </name>
          </person-group>
          <article-title>Hereditary congenital external ophthalmoplegia</article-title>
          <source>Ophthalmologica</source>
          <year>1986</year>
          <volume>193</volume>
          <fpage>207</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="pmid">3587876</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engle</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>Applications of molecular genetics to the understanding of congenital ocular motility disorders</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2002</year>
          <volume>956</volume>
          <fpage>55</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">11960793</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engle</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>The molecular basis of the congenital fibrosis syndromes</article-title>
          <source>Strabismus</source>
          <year>2002</year>
          <volume>10</volume>
          <fpage>125</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="pmid">12221491</pub-id>
          <pub-id pub-id-type="doi">10.1076/stra.10.2.125.8142</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lorenz</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Genetics of isolated and syndromic strabismus: facts and perspectives</article-title>
          <source>Strabismus</source>
          <year>2002</year>
          <volume>10</volume>
          <fpage>147</fpage>
          <lpage>156</lpage>
          <pub-id pub-id-type="pmid">12221494</pub-id>
          <pub-id pub-id-type="doi">10.1076/stra.10.2.147.8133</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zwaan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mullaney</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Jabak</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Al-Awad</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Beggs</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Engle</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>Congenital fibrosis of the extraocular muscles type 2 (CFEOM2), an inherited exotropic strabismus fixus, maps to distal 11q13</article-title>
          <source>Am J Hum Genet</source>
          <year>1998</year>
          <volume>63</volume>
          <fpage>517</fpage>
          <lpage>525</lpage>
          <pub-id pub-id-type="pmid">9683611</pub-id>
          <pub-id pub-id-type="doi">10.1086/301980</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Doherty</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Macy</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dykeman</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Melanson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Engle</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>CFEOM3: a new extraocular congenital fibrosis syndrome that maps to 16q24.2-q24.3</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1999</year>
          <volume>40</volume>
          <fpage>1687</fpage>
          <lpage>1694</lpage>
          <pub-id pub-id-type="pmid">10393037</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Traboulsi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mousawi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Khamis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Engle</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Evidence of genetic heterogeneity in autosomal recessive Congenital Fibrosis of the Extraocular Muscles (CFEOM)</article-title>
          <source>Am J Ophthalmol</source>
          <year>2000</year>
          <volume>129</volume>
          <fpage>658</fpage>
          <lpage>662</lpage>
          <pub-id pub-id-type="pmid">10844060</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0002-9394(99)00467-5</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fain</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sener</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Sellek</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Awad</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Zwaan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mullaney</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Bosley</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Engle</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>Homozygous mutations in ARIX (PHOX2A) result in congenital fibrosis of the extraocular muscles type 2</article-title>
          <source>Nat Genet</source>
          <year>2001</year>
          <volume>29</volume>
          <fpage>315</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">11600883</pub-id>
          <pub-id pub-id-type="doi">10.1038/ng744</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sener</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Turgut</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Akarsu</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Engle</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>New clinical variation of a fibrosis syndrome in a Turkish family maps to the CFEOM1 locus on chromosome 12</article-title>
          <source>Arch Ophthalmol</source>
          <year>2000</year>
          <volume>118</volume>
          <fpage>1090</fpage>
          <lpage>1097</lpage>
          <pub-id pub-id-type="pmid">10922204</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>D'Esposito</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Magli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>de Berardinis</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bhattacharya</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Oftalmoplegia congenita esterna: conferma della presenza di un locus genetico sul cromosoma 12</article-title>
          <source>IX Meeting of the International Society for Genetic Eye Diseases, Siena</source>
          <year>1992</year>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engle</surname>
              <given-names>Ec</given-names>
            </name>
            <name>
              <surname>McIntosh</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>O'Keefe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Letson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>London</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ballard</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ruttum</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Monte</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Magli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>de Berardinis</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>CFEOM 1, the classic familial form of congenital fibrosis of the extraocular muscles, is genetically heterogeneous but does not result from mutations in ARIX</article-title>
          <source>BMC Genet</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>3</fpage>
          <pub-id pub-id-type="pmid">11882252</pub-id>
          <pub-id pub-id-type="doi">10.1186/1471-2156-3-3</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Venkatesh</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Pillai</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Raghunath</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Prakash</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Vathsala</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pericak-Vance</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Clinical phenotype and linkage analysis of the congenital fibrosis of the extraocular muscles in an Indian family</article-title>
          <source>Mol Vis</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>294</fpage>
          <lpage>297</lpage>
          <pub-id pub-id-type="pmid">12181522</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hotchkiss</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>WG</given-names>
            </name>
          </person-group>
          <article-title>Bilateral Duane's retraction syndrome: A clinical-pathological case report</article-title>
          <source>Arch Ophthalmol</source>
          <year>1980</year>
          <volume>98</volume>
          <fpage>870</fpage>
          <lpage>874</lpage>
          <pub-id pub-id-type="pmid">7378011</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Kiel</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>AW</given-names>
            </name>
          </person-group>
          <article-title>Unilateral Duane's retraction syndrome (type 1)</article-title>
          <source>Arch Ophthalmol</source>
          <year>1982</year>
          <volume>100</volume>
          <fpage>1468</fpage>
          <lpage>1472</lpage>
          <pub-id pub-id-type="pmid">7115176</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gottlob</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Engle</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Elevation of one eye during tooth brushing</article-title>
          <source>Am J Ophthalmol</source>
          <year>2002</year>
          <volume>134</volume>
          <fpage>459</fpage>
          <pub-id pub-id-type="pmid">12208268</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0002-9394(02)01540-4</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Traboulsi</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Jaafar</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Kattan</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Parks</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Congenital fibrosis of the extraocular muscles: Report of 24 cases illustrating the clinical spectrum and surgical management</article-title>
          <source>Am Orthop J</source>
          <year>1993</year>
          <volume>43</volume>
          <fpage>45</fpage>
          <lpage>53</lpage>
        </citation>
      </ref>
      <ref id="B33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Apt</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Axelord</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title>Generalized fibrosis of the extraocular muscles</article-title>
          <source>Am J Ophtalmol</source>
          <year>1978</year>
          <volume>85</volume>
          <fpage>822</fpage>
          <lpage>829</lpage>
        </citation>
      </ref>
      <ref id="B34">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Boergen</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Proceedings of 18th European Strabismological Association, ed</article-title>
          <source>Kaufman</source>
          <year>1989</year>
          <fpage>55</fpage>
          <lpage>59</lpage>
        </citation>
      </ref>
      <ref id="B35">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrer</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>General Fibrosis Syndrome</article-title>
          <source>Second Congress of the International Strabismological Association Paris: Diffus Générale de Librairie</source>
          <year>1976</year>
          <fpage>352</fpage>
          <lpage>361</lpage>
        </citation>
      </ref>
      <ref id="B36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrer</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Letters to Editor:Congenital Fibrosis of the Extraocular Muscles</article-title>
          <source>Ophthalmology</source>
          <year>1996</year>
          <volume>63</volume>
          <fpage>1517</fpage>
          <lpage>1518</lpage>
          <pub-id pub-id-type="pmid">8874417</pub-id>
        </citation>
      </ref>
      <ref id="B37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hertle</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Katowitz</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Farber</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Congenital unilateral fibrosis, blepharoptosis, and enophthalmos syndrome</article-title>
          <source>Ophthalmology</source>
          <year>1992</year>
          <volume>99</volume>
          <fpage>347</fpage>
          <lpage>355</lpage>
          <pub-id pub-id-type="pmid">1565446</pub-id>
        </citation>
      </ref>
      <ref id="B38">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Kanski</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Oftalmologia clinica</article-title>
          <source>USES Edizioni Scientifiche Firenze</source>
          <year>1989</year>
          <fpage>20</fpage>
          <lpage>21</lpage>
        </citation>
      </ref>
      <ref id="B39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Magli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>de Berardinis</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gagliardi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pignalosa</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Classificazione, valutazione e trattamento delle blefaroptosi in età pediatrica</article-title>
          <source>Boll Ocul</source>
          <year>1998</year>
          <volume>77</volume>
          <fpage>183</fpage>
          <lpage>193</lpage>
        </citation>
      </ref>
      <ref id="B40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D'Esposito</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bonavolontà</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Magli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aurilia</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Ptosis correction in the context of the treatment of external congenital ophthalmoplegia</article-title>
          <source>Ophthalmic Plast Reconstr Surg</source>
          <year>1989</year>
          <volume>5</volume>
          <fpage>176</fpage>
          <lpage>181</lpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:166276</identifier><datestamp>2003-07-26</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">166276</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-3-7</article-id>
      <article-id pub-id-type="pmid">12841852</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-3-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Congenital cystic eye with multiple dermal appendages: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" equal-contrib="yes" corresp="yes" contrib-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>Pankaj</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>itsdrpankaj@hotmail.com</email>
        </contrib>
        <contrib id="A2" equal-contrib="yes" contrib-type="author">
          <name>
            <surname>Malik</surname>
            <given-names>Krishna Pal Singh</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>malikkps@rediffmail.com</email>
        </contrib>
        <contrib id="A3" equal-contrib="yes" contrib-type="author">
          <name>
            <surname>Goel</surname>
            <given-names>Ruchi</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>gruchi1@rediffmail.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Senior Resident, Department of Ophthalmology Vardhman Mahavir Medical College New Delhi 110029 India</aff>
      <aff id="I2"><label>2</label>Consultant and Head, Department of Ophthalmology Vardhman Mahavir Medical College New Delhi 110029 India</aff>
      <aff id="I3"><label>3</label>Senior Resident, Department of Ophthalmology Vardhman Mahavir Medical College New Delhi 110029 India</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>3</day>
        <month>7</month>
        <year>2003</year>
      </pub-date>
      <volume>3</volume>
      <fpage>7</fpage>
      <lpage>7</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/7"/>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>2</month>
          <year>2003</year>
        </date>
        <date date-type="accepted">
          <day>3</day>
          <month>7</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2003 Gupta et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Gupta et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>A partial or complete failure in the involution of the primary optic vesicle resulting in the formation of a cyst is an extremely rare anomaly known as congenital cystic eye. The primary optic vesicle is formed but instead of the anterior part of the vesicle involuting to lie in apposition with the posterior part, a cyst persists at birth and replaces the eye.</p>
        </sec>
        <sec>
          <title>Case Presentation</title>
          <p>We report a case of congenital cystic eye associated with multiple dermal appendages in a 1-day-old female child. This condition presented at birth as a large orbital mass in the left orbit that bulged forwards and stretched the eyelids. No globe or any other ocular structures were identified in the orbit. Multiple dermal appendages were present in the adjacent part of the face below the left orbit and on the upper part of the neck.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Congenital cystic eye is an extremely rare condition and with only 28 previous cases reported in the literature. We present the second case of congenital cystic eye with multiple dermal appendages of the face and neck.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>A partial or complete failure in the involution of the primary optic vesicle resulting in the formation of a cyst is an extremely rare anomaly. The primary optic vesicle is formed but instead of the anterior part of the vesicle involuting to lie in apposition with the posterior part, a cyst persists at birth and replaces the eye. The size of the cyst is variable. The condition has also been called anophthalmos with cyst in the literature. The term congenital cystic eye was coined by Mann [<xref ref-type="bibr" rid="B1">1</xref>] to describe a case of this rare ocular malformation. The failure in invagination of the primary optic vesicle occurs between the 2 mm and 7 mm stage of fetal development [<xref ref-type="bibr" rid="B2">2</xref>]. The exact aetiology of congenital cystic eye remains unknown. We in this study present a 1-day-old infant with congenital cystic eye associated with multiple skin tags.</p>
    </sec>
    <sec>
      <title>Case Presentation</title>
      <sec>
        <title>Case Report</title>
        <p>A 1-day-old female child presented with a large mass in the left orbital region and multiple skin appendages on the face and upper part of neck on the left side. The child was born to nonconsangineous parents and was the product of a full term vaginal delivery. The pregnancy and labour were uncomplicated. The baby had a birth weight of 2.7 kg. The baby had normal reflexes for age and had no respiratory distress.</p>
        <p>Examination disclosed a large erythematous mass that virtually filled the entire left orbit (fig. <xref ref-type="fig" rid="F1">1</xref>). The lower eyelid was obscured by the swelling, the upper eyelid was stretched, and the eyebrow was also displaced upwards. The skin of the eyelids was normal. The mass was soft, cystic in consistency, translucent, nontender, nonpulsatile, nonreducible and the size of the mass was not related to crying. Examination disclosed no identifiable globe. The right eye was normal. The patient also had multiple dermal appendages on the face inferotemporal to the left orbit (fig. <xref ref-type="fig" rid="F1">1</xref>) in addition to 1 appendage present just anterior to the tragus of the ear and an appendage present on the upper part of the neck. The appendages measured 5–10 mm in size, were nontender and were covered by normal skin.</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p>Clinical photograph of the patient showing the large mass in the left orbit stretching the upper eyelid along with multiple dermal appendages on the face.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-7-1"/>
        </fig>
        <p>The laboratory workup was unremarkable. Roentgenograms of the skull disclosed symmetrical enlargement of the left orbit with a soft tissue shadow. The intracranial features were normal and no radiologic evidence of encephalocoele or meningocoele was present. Computed tomography of the head and orbits disclosed a mass in the left orbit that was predominantly hypodense and cystic. The left orbit was larger in size than the right orbit. No identifiable globe, optic nerve, extraocular muscles or any other orbital structure were present (fig. <xref ref-type="fig" rid="F2">2</xref>). The intracranial cavity was normal with normally developed brain parenchyma, corpus callosum and ventricles. Based upon the above findings, a diagnosis of congenital cystic eye was made.</p>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p>CT scan of the orbits of the same patient showing the large cystic mass in the left orbit. The right eye appears normal.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-7-2"/>
        </fig>
        <p>The patient underwent surgery at the age of 14 days. An anterior orbitotomy approach was used to excise the orbital mass while preserving the eyelids. The cystic mass was removed in toto and measured 4 × 3 × 3.5 cm in size. An orbital implant was also placed in the orbit keeping the future orbital growth in mind. The facial appendages were also excised along with the orbital mass. No identifiable ocular structures or optic stalk were present. The posterior most part of the mass was firm while the majority of the mass was cystic in nature. Histologic examination disclosed multilocular cyst with an outer wall of fibrous tissue and an inner wall of disorganized neural tissue. No ocular structure could be made out. Absence of optic stalk was also confirmed. Examination of the facial dermal appendages disclosed normal epidermal and dermal elements. No cartilaginous or bony structures were present in the appendages.</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Cystic orbital lesions account for approximately 10–30% of all nonthyroid orbital lesions [<xref ref-type="bibr" rid="B3">3</xref>]. Congenital cystic eye is the rarest cystic orbital lesion. Duke-Elder reviewed the literature from 1880–1960 and found only 16 cases that he believed represented congenital cystic eye. Since his review, 12 additional cases have reported in the English literature [<xref ref-type="bibr" rid="B3">3</xref>]. Congenital cystic eye is thought to result from noninvagination of the primary optic nerve vesicle between the 2 mm and 7 mm stages of the embryonic development, and ectodermal elements do not develop into the future eye structures. The orbit thus contains a cyst instead of an eye. The cyst is usually completely filled by proliferating glial tissue. In contrast, a discontinuation in development between the 7 mm and 14 mm stage of embryonic development leads to formation of the more common coloboma.</p>
      <p>Although the exact aetiology of congenital cystic eye is not known, the frequent presence of inflammatory cells in the cyst suggests an inflammatory cause [<xref ref-type="bibr" rid="B2">2</xref>]. No hereditary tendencies have been noted. No abnormalities during pregnancy or perinatal period have been described. The ectodermal elements are not able to develop into the future eye structures. The orbit thus contains a cyst instead of an eye. The cyst is usually completely filled by proliferating glial tissue. Congenital cystic eye is usually unilateral, however 2 cases of bilateral congenital cystic eyes have been reported [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Although the fellow eye in cases of unilateral cystic eye is usually normal, a case of micropthalmia with cyst [<xref ref-type="bibr" rid="B6">6</xref>] and persistent hyperplastic primary vitreous [<xref ref-type="bibr" rid="B7">7</xref>] each have been reported in the literature.</p>
      <p>Congenital cystic eye needs to be differentiated from micropthalmia with cyst. Micropthalmia with cyst develops from incomplete closure of the fetal cleft that results in a cyst attached to the sclera [<xref ref-type="bibr" rid="B8">8</xref>]. The eyes are micropthalmic and frequently have uveal, retinal and lens colobomas. The cysts with micropthalmia are usually located in the inferior orbit and cause the lower eyelid to bulge. In contrast, congenital cystic eye usually causes bulging of the upper eyelid.</p>
      <p>The cyst associated with congenital cystic eye may vary in size and may have an attached stalk. The patency of the stalk, if present, is associated with the size of the cyst. If the stalk is patent, the size of the cyst remains small due to communication of the cyst with the cranial cavity as described by Hevelston and coworkers in a case report [<xref ref-type="bibr" rid="B9">9</xref>]. No stalk was identified in the present case. The cysts are usually single but multiple cysts have been reported by Pillai and coworkers [<xref ref-type="bibr" rid="B10">10</xref>]. Congenital cystic eye may be associated with normal or abnormal extraocular muscles although no extraocular muscles were present in the case described in this report. Although the eyelids are usually normally developed, eyelid abnormalities have been reported. Rice and coworkers [<xref ref-type="bibr" rid="B11">11</xref>] reported a case of congenital cystic eye with accessory limb of the lower eyelid. The accessory limb of the lower eyelid was attached to the maxilla with a bony joint with cartilages. The limb itself contained striated muscle, fat, areolar tissue and skin and had 2 nipple-like and 1 finger-like projections from its surface. Dollfus and coworkers [<xref ref-type="bibr" rid="B12">12</xref>] reported a case of congenital cystic eye associated with skin tags. The skin tags were 3 in number and were present near the inner canthus and at the root of nose. Pasquale and coworkers [<xref ref-type="bibr" rid="B7">7</xref>] presented a case of congenital cystic eye that was associated with multiple periocular dermal appendages that were present at the lateral aspect of the left upper eyelid. The patient described in this report had multiple dermal appendages that were similar to the ones reported by Pasquale and coworkers. However, the appendages were more numerous and were present on the face and upper part of the neck. This case thus represents the second case of congenital cystic eye associated with multiple dermal appendages.</p>
      <p>Other nonocular abnormalities have also been reported in association with congenital cystic eye. These include facial clefting, saddle nose, nostril malformation, choanal atresia, malformation of the sphenoid bone, multiple punched out lesions of the face and scalp, agenesis of the corpus callosum, basal encephalocoele, midbrain deformities, microphallus with hydrocoele, hypoconvex fingernails on short stubby fingers and bifid thumb [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. The case reported here was associated with no such systemic abnormality.</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>Congenital cystic eye is usually evident at birth and has a varied presentation. A high degree of suspicion and knowledge about the varied presentations of this condition, and coordinated efforts by Ophthalmologists and Pediatricians are needed for its early recognition and appropriate treatment.</p>
    </sec>
    <sec>
      <title>List of abbreviations</title>
      <p>CT scan – Computed Tomography scan.</p>
    </sec>
    <sec>
      <title>Competing Interests</title>
      <p>None declared.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>All authors have contributed to this case presentation equally.</p>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>Clinical photograph of the cyst after surgical excision.</p>
        </caption>
        <graphic xlink:href="1471-2415-3-7-3"/>
      </fig>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/7/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>Written consent was obtained from the patient's relatives for publication of the patient's details.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mann</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>A case of congenital cystic eye</article-title>
          <source>Trans Ophthalmol Soc Aust</source>
          <year>1939</year>
          <volume>1</volume>
          <fpage>120</fpage>
          <lpage>4</lpage>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Duke-Elder</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Duke-Elder S</surname>
            </name>
          </person-group>
          <article-title>Normal and abnormal development: congenital deformities</article-title>
          <source>System of Ophthalmology</source>
          <year>1963</year>
          <volume>III</volume>
          <publisher-name>London Henry Kimpton</publisher-name>
          <fpage>451</fpage>
          <lpage>3</lpage>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayashi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Repka</surname>
              <given-names>MX</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Iliff</surname>
              <given-names>NT</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Congenital cystic eye: Report of two cases and review of literature</article-title>
          <source>Surv Ophthalmol</source>
          <year>1999</year>
          <volume>44</volume>
          <fpage>173</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">10541156</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0039-6257(99)00084-3</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldberg</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Farber</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Bullock</surname>
              <given-names>JD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Bilateral congenital ocular cysts</article-title>
          <source>Ophthalmic Paediatr Genet</source>
          <year>1991</year>
          <volume>12</volume>
          <fpage>31</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">1881653</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sacks</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Lindenberg</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Efferent nerve fibres in the anterior visual pathways in bilateral congenital cystic eyeballs</article-title>
          <source>Am J Ophthalmol</source>
          <year>1969</year>
          <volume>68</volume>
          <fpage>691</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">4186527</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waring</surname>
              <given-names>GO</given-names>
              <suffix>III</suffix>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Clinicopathologic correlation of micropthalmos with cyst</article-title>
          <source>Am J Ophthalmol</source>
          <year>1976</year>
          <volume>82</volume>
          <fpage>714</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">826159</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pasquale</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Romayananda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kubacki</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congenital cystic eye with multiple ocular and intracranial anomalies</article-title>
          <source>Arch Ophthalmol</source>
          <year>1991</year>
          <volume>109</volume>
          <fpage>985</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">2064582</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Mann</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <source>Developmental abnormalities of the eye</source>
          <year>1957</year>
          <edition>second</edition>
          <publisher-name>Philadelphia, JB Lippincott</publisher-name>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hevelston</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Malone</surname>
              <given-names>E</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Lashmet</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Congenital cystic eye</article-title>
          <source>Arch Ophthalmol</source>
          <year>1970</year>
          <volume>84</volume>
          <fpage>622</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">4991284</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pillai</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Rema</surname>
              <given-names/>
            </name>
            <name>
              <surname>Sambasivan</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Congenital cystic eye – A case report with CT scan</article-title>
          <source>Ind J Ophthalmol</source>
          <year>1987</year>
          <volume>35</volume>
          <fpage>88</fpage>
          <lpage>91</lpage>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rice</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Minwalla</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Wania</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Case of congenital cystic eye and accessory limb of the lower eyelid</article-title>
          <source>Br J Ophthalmol</source>
          <year>1966</year>
          <volume>50</volume>
          <fpage>409</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">5911141</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dollfus</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Marx</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Langlois</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congenital cystic eyeball</article-title>
          <source>Am J Ophthalmol</source>
          <year>1968</year>
          <volume>66</volume>
          <fpage>504</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">5676359</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:169184</identifier><datestamp>2003-08-06</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">169184</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-3-8</article-id>
      <article-id pub-id-type="pmid">12859794</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-3-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Study Protocol</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Tehran Eye Study: research design and eye examination protocol</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Hashemi</surname>
            <given-names>Hassan</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>hhashemi@noorvision.com</email>
        </contrib>
        <contrib id="A2" corresp="yes" contrib-type="author">
          <name>
            <surname>Fotouhi</surname>
            <given-names>Akbar</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>afotouhi@sina.tums.ac.ir</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Mohammad</surname>
            <given-names>Kazem</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>mohamadk@sina.tums.ac.ir</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Farabi Eye Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</aff>
      <aff id="I2"><label>2</label>Noor Vision Correction Center, Tehran, Iran</aff>
      <aff id="I3"><label>3</label>Epidemiology and Biostatistics Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>7</month>
        <year>2003</year>
      </pub-date>
      <volume>3</volume>
      <fpage>8</fpage>
      <lpage>8</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/8"/>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>1</month>
          <year>2003</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>7</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2003 Hashemi et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Hashemi et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Visual impairment has a profound impact on society. The majority of visually impaired people live in developing countries, and since most disorders leading to visual impairment are preventable or curable, their control is a priority in these countries. Considering the complicated epidemiology of visual impairment and the wide variety of factors involved, region specific intervention strategies are required for every community. Therefore, providing appropriate data is one of the first steps in these communities, as it is in Iran. The objectives of this study are to describe the prevalence and causes of visual impairment in the population of Tehran city; the prevalence of refractive errors, lens opacity, ocular hypertension, and color blindness in this population, and also the familial aggregation of refractive errors, lens opacity, ocular hypertension, and color blindness within the study sample.</p>
        </sec>
        <sec>
          <title>Methods Design</title>
          <p>Through a population-based, cross-sectional study, a total of 5300 Tehran citizens will be selected from 160 clusters using a stratified cluster random sampling strategy. The eligible people will be enumerated through a door-to-door household survey in the selected clusters and will be invited. All participants will be transferred to a clinic for measurements of uncorrected, best corrected and presenting visual acuity; manifest, subjective and cycloplegic refraction; color vision test; Goldmann applanation tonometry; examination of the external eye, anterior segment, media, and fundus; and an interview about demographic characteristics and history of eye diseases, eye trauma, diabetes mellitus, high blood pressure, and ophthalmologic cares. The study design and eye examination protocol are described.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>We expect that findings from the TES will show the status of visual problems and their causes in the community. This study can highlight the people who should be targeted by visual impairment prevention programs.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Visual impairment is a global public health problem. Worldwide, an estimated 45 million people are blind, and an additional 135 million have severe visual impairment. [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>] The prevalence of blindness in developing countries is 10–40 times higher than in developed countries, and close to three quarters of the world's blindness is either curable or preventable. The majority of blind people on earth reside in the developing nations of Africa, Asia, and Latin America. [<xref ref-type="bibr" rid="B3">3</xref>] There are several studies on the prevalence of visual impairment in the world [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B35">35</xref>] and Eastern Mediterranean countries. [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B31">31</xref>-<xref ref-type="bibr" rid="B33">33</xref>] Population-based data on frequency and causes of visual impairment are useful for identifying needs for treatment and rehabilitation services, planning and implementing blindness prevention programs, and determining research priorities for different populations.</p>
      <p>There are very few published studies concerning this issue in the Iranian population. [<xref ref-type="bibr" rid="B36">36</xref>] Iran's National Health Survey provides data on visual impairment in this country. [<xref ref-type="bibr" rid="B37">37</xref>] These data, based on self-reporting, have some limitations. The goal of the present project is to describe the prevalence and causes of visual impairment in the population of Tehran city.</p>
      <sec>
        <title>Specific Objectives</title>
        <p>To determine the prevalence of visual impairment (low vision and blindness) in Tehran population.</p>
        <p>To evaluate the determinants of visual impairment within the study sample.</p>
        <p>To determine the prevalence of refractive errors, lens opacity, ocular hypertension and color blindness in Tehran population.</p>
        <p>To describe the familial aggregation of refractive errors, lens opacity, ocular hypertension, and color blindness within the study sample.</p>
      </sec>
    </sec>
    <sec>
      <title>Methods/Design</title>
      <p>The Tehran Eye Study has been designed as a cross-sectional survey in the population of the urban area of Tehran city.</p>
      <sec>
        <title>Population and sampling strategy</title>
        <sec>
          <title>Tehran population</title>
          <p>The Tehran region, which is a part of Tehran province, includes the cities of Tehran, Karaj, Savejbolagh, Shahryar, Shemiran, Rey, Eslamshahr and Varamin. On account of common borders and due to close economic and social links, this area is called "the Tehran region". These various cities became a collective entity in 1966, and their links have become more intensified since 1976. The 1996 census recorded Tehran region's population as 9.4 million, 6.8 million of which belonged to Tehran city alone.</p>
          <p>The sampling frame is considered the population of the urban area of Tehran city. Table <xref ref-type="table" rid="T1">1</xref> shows the distribution of Tehran population and families in the 22 municipal districts according to the 1996 census. It is estimated that the present total population in this area is nearly 7.5 million, but there is no evidence suggesting any change in the distribution. So we will distribute our clusters on the basis of the population size of each district in 1996.</p>
          <table-wrap position="float" id="T1">
            <label>Table 1</label>
            <caption>
              <p>Distribution of Tehran population in the 22 municipal districts (1996 census).</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <td/>
                  <td align="center" colspan="2">
                    <bold>Family</bold>
                  </td>
                  <td align="center" colspan="2">
                    <bold>Population</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="1">
                    <hr/>
                  </td>
                  <td colspan="2">
                    <hr/>
                  </td>
                  <td colspan="2">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="left">
                    <bold>District</bold>
                  </td>
                  <td align="right">
                    <bold>Number</bold>
                  </td>
                  <td align="right">
                    <bold>Percent</bold>
                  </td>
                  <td align="right">
                    <bold>Number</bold>
                  </td>
                  <td align="right">
                    <bold>Percent</bold>
                  </td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">1</td>
                  <td align="right">66,142</td>
                  <td align="right">3.98</td>
                  <td align="right">249,676</td>
                  <td align="right">3.69</td>
                </tr>
                <tr>
                  <td align="left">2</td>
                  <td align="right">120,333</td>
                  <td align="right">7.25</td>
                  <td align="right">458,089</td>
                  <td align="right">6.78</td>
                </tr>
                <tr>
                  <td align="left">3</td>
                  <td align="right">71,746</td>
                  <td align="right">4.32</td>
                  <td align="right">259,019</td>
                  <td align="right">3.83</td>
                </tr>
                <tr>
                  <td align="left">4</td>
                  <td align="right">155,214</td>
                  <td align="right">9.35</td>
                  <td align="right">663,166</td>
                  <td align="right">9.81</td>
                </tr>
                <tr>
                  <td align="left">5</td>
                  <td align="right">105,186</td>
                  <td align="right">9.34</td>
                  <td align="right">427,995</td>
                  <td align="right">6.33</td>
                </tr>
                <tr>
                  <td align="left">6</td>
                  <td align="right">60,063</td>
                  <td align="right">3.62</td>
                  <td align="right">220,331</td>
                  <td align="right">3.26</td>
                </tr>
                <tr>
                  <td align="left">7</td>
                  <td align="right">81,657</td>
                  <td align="right">4.92</td>
                  <td align="right">300,212</td>
                  <td align="right">4.44</td>
                </tr>
                <tr>
                  <td align="left">8</td>
                  <td align="right">89,103</td>
                  <td align="right">5.37</td>
                  <td align="right">336,474</td>
                  <td align="right">4.98</td>
                </tr>
                <tr>
                  <td align="left">9</td>
                  <td align="right">42,847</td>
                  <td align="right">2.58</td>
                  <td align="right">173,482</td>
                  <td align="right">2.57</td>
                </tr>
                <tr>
                  <td align="left">10</td>
                  <td align="right">75,064</td>
                  <td align="right">4.52</td>
                  <td align="right">282,308</td>
                  <td align="right">4.18</td>
                </tr>
                <tr>
                  <td align="left">11</td>
                  <td align="right">59,065</td>
                  <td align="right">3.56</td>
                  <td align="right">225,840</td>
                  <td align="right">3.34</td>
                </tr>
                <tr>
                  <td align="left">12</td>
                  <td align="right">48,579</td>
                  <td align="right">2.92</td>
                  <td align="right">189,625</td>
                  <td align="right">2.81</td>
                </tr>
                <tr>
                  <td align="left">13</td>
                  <td align="right">61,062</td>
                  <td align="right">3.68</td>
                  <td align="right">245,142</td>
                  <td align="right">3.63</td>
                </tr>
                <tr>
                  <td align="left">14</td>
                  <td align="right">98,140</td>
                  <td align="right">5.91</td>
                  <td align="right">394,611</td>
                  <td align="right">5.84</td>
                </tr>
                <tr>
                  <td align="left">15</td>
                  <td align="right">142,236</td>
                  <td align="right">8.57</td>
                  <td align="right">622,517</td>
                  <td align="right">9.21</td>
                </tr>
                <tr>
                  <td align="left">16</td>
                  <td align="right">71,269</td>
                  <td align="right">4.29</td>
                  <td align="right">298,410</td>
                  <td align="right">4.42</td>
                </tr>
                <tr>
                  <td align="left">17</td>
                  <td align="right">66,711</td>
                  <td align="right">4.02</td>
                  <td align="right">287,367</td>
                  <td align="right">4.25</td>
                </tr>
                <tr>
                  <td align="left">18</td>
                  <td align="right">64,241</td>
                  <td align="right">3.87</td>
                  <td align="right">296,243</td>
                  <td align="right">4.38</td>
                </tr>
                <tr>
                  <td align="left">19</td>
                  <td align="right">47,381</td>
                  <td align="right">2.85</td>
                  <td align="right">227,389</td>
                  <td align="right">3.36</td>
                </tr>
                <tr>
                  <td align="left">20</td>
                  <td align="right">80,835</td>
                  <td align="right">4.87</td>
                  <td align="right">356,079</td>
                  <td align="right">5.27</td>
                </tr>
                <tr>
                  <td align="left">21</td>
                  <td align="right">40,746</td>
                  <td align="right">2.45</td>
                  <td align="right">188,890</td>
                  <td align="right">2.79</td>
                </tr>
                <tr>
                  <td align="left">22</td>
                  <td align="right">12,599</td>
                  <td align="right">0.76</td>
                  <td align="right">56,020</td>
                  <td align="right">0.83</td>
                </tr>
                <tr>
                  <td align="left">Total</td>
                  <td align="right">1,660,219</td>
                  <td align="right">100</td>
                  <td align="right">6,758,845</td>
                  <td align="right">100</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec>
          <title>Number of Households in Tehran City</title>
          <p>Census 1996 statistics showed that there were 1,660,219 households in Tehran city. Table <xref ref-type="table" rid="T1">1</xref> presents the number of households within each district of Tehran city. Households averaged 4.3 people in 1996.</p>
        </sec>
        <sec>
          <title>Sample Size</title>
          <p>For sample size calculation, the objective we have considered is to estimate the prevalence of variables with proportions as little as 0.02 (P). On this assumption, for a 95% confidence interval (Z<sub>1-α/2 </sub>= 1.96) and precision of 0.005 (d), the sample size is calculated as follows:</p>
          <p>
            <inline-graphic xlink:href="1471-2415-3-8-i1.gif"/>
          </p>
          <p>Considering a design effect of 1.5 and a response rate of 85%, total sample size is calculated by the following equation:</p>
          <p>n = 3010 × 1.5 × 1/0.85 ≈ 5300.</p>
        </sec>
        <sec>
          <title>Sampling Plan</title>
          <p>This study follows a stratified cluster sampling strategy with proportional allocation within strata. The target population is all urban non-institutionalized citizens, of all ages, who reside in Tehran city in the year 2002. The stratification of the sample according to the 22 municipal districts of Tehran city is incorporated in the sampling process. Proportional to the number of households in the 22 districts (table <xref ref-type="table" rid="T1">1</xref>), the appropriate number of clusters is assigned to each district (table <xref ref-type="table" rid="T2">2</xref>). A total of 160 clusters are randomly selected based on blocks enumeration of the national census of 1996 by the Iranian Statistics Center. The decision about the number of clusters is based on total sample size; mean household members; and logistical facilities for subject enumeration, transport, and examination. For each cluster, a team of 2 interviewers (one male and one female) approaches the index household, which is specified through the aforementioned random selection of clusters, and continues the enumeration in 10 neighbor households in a systematic manner by proceeding round in a clock-wise direction. If more than one household inhabits a building, one will be randomly selected. They introduce themselves by presenting their identification cards. Then they describe the project to the present members of the households. At the end, all household members (people who have lived together in a housing unit for 6 months or more over the past year) are invited for a complete eye examination at Noor Vision Correction Center. They receive an invitation card in which the date and time of visit are clarified. The household members are informed that they will be transported to the clinic by the project staff. The enumeration teams approach clusters on Mondays and Tuesdays, and participants are examined on Thursdays and Fridays (formal weekend in Iran). Nine clusters are covered, and nearly 240 participants are visited weekly.</p>
          <table-wrap position="float" id="T2">
            <label>Table 2</label>
            <caption>
              <p>Number of clusters in the 22 municipal districts of Tehran.</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <td align="left">
                    <bold>District</bold>
                  </td>
                  <td align="left">
                    <bold>Number of clusters</bold>
                  </td>
                  <td align="left">
                    <bold>District</bold>
                  </td>
                  <td align="left">
                    <bold>Number of clusters</bold>
                  </td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">1</td>
                  <td align="center">6</td>
                  <td align="left">12</td>
                  <td align="center">5</td>
                </tr>
                <tr>
                  <td align="left">2</td>
                  <td align="center">12</td>
                  <td align="left">13</td>
                  <td align="center">6</td>
                </tr>
                <tr>
                  <td align="left">3</td>
                  <td align="center">7</td>
                  <td align="left">14</td>
                  <td align="center">9</td>
                </tr>
                <tr>
                  <td align="left">4</td>
                  <td align="center">15</td>
                  <td align="left">15</td>
                  <td align="center">14</td>
                </tr>
                <tr>
                  <td align="left">5</td>
                  <td align="center">10</td>
                  <td align="left">16</td>
                  <td align="center">7</td>
                </tr>
                <tr>
                  <td align="left">6</td>
                  <td align="center">6</td>
                  <td align="left">17</td>
                  <td align="center">6</td>
                </tr>
                <tr>
                  <td align="left">7</td>
                  <td align="center">8</td>
                  <td align="left">18</td>
                  <td align="center">6</td>
                </tr>
                <tr>
                  <td align="left">8</td>
                  <td align="center">9</td>
                  <td align="left">19</td>
                  <td align="center">4</td>
                </tr>
                <tr>
                  <td align="left">9</td>
                  <td align="center">4</td>
                  <td align="left">20</td>
                  <td align="center">8</td>
                </tr>
                <tr>
                  <td align="left">10</td>
                  <td align="center">7</td>
                  <td align="left">21</td>
                  <td align="center">4</td>
                </tr>
                <tr>
                  <td align="left">11</td>
                  <td align="center">6</td>
                  <td align="left">22</td>
                  <td align="center">1</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec>
          <title>Non-response</title>
          <p>Enumerated subjects who do not attend the examination process following the initial invitation will be contacted twice in subsequent weeks. Those who fail to appear even after the third invitation will be considered non-respondent.</p>
        </sec>
      </sec>
      <sec>
        <title>Examination Protocol</title>
        <p>The examination protocol includes lensometry; uncorrected, best corrected and presenting visual acuity measurements; manifest, subjective and cycloplegic refraction; color vision test; Goldmann applanation tonometry; examination of the external eye, anterior segment, media, and fundus; and an interview about demographic characteristics, history of eye diseases, eye trauma, diabetes mellitus, high blood pressure, and ophthalmologic cares (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p>Examination process flowchart. UCVA = uncorrected visual acuity; BCVA = best-corrected visual acuity; VA = visual acuity; IOP = intraocular pressure.</p>
          </caption>
          <graphic xlink:href="1471-2415-3-8-1"/>
        </fig>
        <sec>
          <title>Visual Acuity and Refraction</title>
          <p>An optometrist determines the visual acuity by using a NIDEK chart projector (CP – 670 20/10–20/400; Nidek Co, Gamagori, Japan) with tumbling E letters at a distance of 4 meters. Best spectacle corrected and uncorrected visual acuity tests are performed separately for each eye (one eye at a time). Presenting visual acuity is measured with the participant's habitual distance correction. Lensometry is performed by an optometrist for those who use glasses. Visual acuity is recorded as the smallest line in which the patient can read the four letters correctly. If the person is unable to read the largest E letters in the chart (20/400 E letters) at 4 meters, then finger counting is done at 1 meter. The examiner stands one meter in front of the participant and asks if the participant can see his/her hand. The examiner slowly waves his/her hand and asks the participant if he/she can see what the hand is doing. If the participant is able to see the examiners hand moving, "hand motion" is recorded on the exam form. If the participant cannot see the examiner's hand, a penlight is held in front of the participant's eye and he/she is asked if he/she can tell when the light is on. If the participant can correctly identify when the light is on, "light perception" is recorded on the exam form. If the participant is unable to see the light, "no light perception" is recorded. Care will be taken to ensure that the unexamined eye is adequately covered with the palm or cloth and not pressed.</p>
          <p>Refraction is done on all participants of five years of age and over using a Topcon automated refractometer (Topcon KR 8000, Topcon Corporation, Tokyo, Japan) by an optometrist. The optometrists act according to the instruction manual of Topcon KR 8000. Results from autorefraction are used as a starting point for a full subjective and manifest refraction. If autorefraction is not possible (especially due to a media opacity) manual manifest and subjective refraction is attempted. On the judgment of an ophthalmologist, if there is no contraindication, cycloplegic refraction is done. In this case, cyclopentolate 1%, 2 drops are instilled 30 and 25 minutes before refraction. The participants are warned about the symptoms of cyclopentolate.</p>
        </sec>
        <sec>
          <title>Color vision test</title>
          <p>Using Farnsworth D-15 test, an optometrist tests color vision in all participants of at least 7 years of age. The Farnsworth D-15 test consists of 15 colored papers selected from the hue circle mounted in plastic caps. The participant is given the tray and allowed 2 minutes to arrange the hue in serial order according to their colors.</p>
        </sec>
        <sec>
          <title>Eye Examination</title>
          <p>Eyelid, globe, and anterior segment examination is performed at the first ophthalmologic visit. Presence of globe is recorded. In order to assess defective eyelid closure, the participant is asked to close the eyes. In cases of lagophthalmos, ectropion, loss of lid margin, etc, the lid may not come into apposition. Then the condition is specified.</p>
          <p>For all participants of five years of age and over, a slitlamp examination is done (Topcon slitlamp, Topcon Corporation, Tokyo, Japan). The participant is seated comfortably at the slitlamp with his/her chin firmly on the chin rest and forehead against the headrest. The examiner then examines the anterior segment of each eye adjusting the beam width, magnification, and beam angle to achieve the best view of all the structures in the anterior segment. In viewing the cornea, the presence of arcus and the amount of involvement, any corneal scars, lesions, or abnormalities are recorded. The sclera, conjunctiva, and iris are all inspected for the presence of any lesions and abnormalities. The presence of pinguecula and pyterigia are recorded. A pyterigium is distinguished from a pingueculum if it crosses the limbus.</p>
        </sec>
        <sec>
          <title>Iris color determination</title>
          <p>Iris color is determined by viewing the participant's iris with the pupil undilated using a penlight. The color is compared to a color standards developed on the basis of the standards used in Beaver Dam Eye Study. Although the choices on the form are "gray or blue", "yellow or green", "light brown", "medium brown" and "dark", the amount of pigment in the iris is taken into account rather than the actual color. When an iris has more than one color, the grade is assigned based on the color which is 50% or more.</p>
        </sec>
        <sec>
          <title>Intraocular pressure</title>
          <p>The intraocular pressure (IOP) is measured using a Goldmann applanation tonometer. A drop of tetracain is instilled in each eye of the participant and tear is stained with fluorescein. The tonometer is swung into place on the slitlamp, the blue filter put into place, and the beam width opened to its fullest height. The beam angle should be about 45–60 degrees to the side of the tonometer and should illuminate the end of the prism head. The examiner should be aware of possible contact of the tonometer with the lids, lashes, or beard; all of which may cause a "high" reading. If IOP is &gt;30 mmHg, it is rechecked after dilation. If IOP is &gt;40 mmHg, the ophthalmologist prescribes appropriate treatment for the participant and informs him / her about the disease. Time of IOP measurement is recorded. The participant is asked whether he or she is currently taking medication for glaucoma. If the answer is affirmative, the drug is recorded.</p>
        </sec>
        <sec>
          <title>Angle assessment</title>
          <p>The angle of the anterior chamber is evaluated to determine the risk of occlusion upon dilation. The examiner assesses the angle by viewing it nasally and temporally with a narrow beam directed at an angle of about 45 degrees. If the ophthalmologist feels the chamber angle to be occludable, dilating drops are not administered. When the examiner is in doubt, another examiner will be consulted. If the chamber does not appear occludable, dilating drops are administered following the intraocular pressure test.</p>
        </sec>
        <sec>
          <title>Clinical lens opacities grading</title>
          <p>The ophthalmologist grades cortical and posterior subcapsular opacities, nuclear opalescence and color by visual comparison with a standard photograph (the Lens Opacities Classification System III, LOCS III) [<xref ref-type="bibr" rid="B38">38</xref>] through the biomicroscopic ophthalmic exam by a Topcon slitlamp (Topcon Corporation, Tokyo, Japan).</p>
        </sec>
        <sec>
          <title>Direct and Indirect ophthalmoscopy</title>
          <p>All participants of five years of age and over undergo a retinal exam first using direct ophthalmoscopy followed by indirect ophthalmoscopy. The retina is examined systematically to ensure that no lesions are passed over. The examiner inspects the optic disc assessing disc size, color, vascularity, and degree of cupping. The retinal exam proceeds systematically, not overlooking any lesions or abnormalities such as congenital anomalies, signs of early age-related maculopathy, retinitis pigmentosa, vascular retinopathy, Drusen, retinal detachment, and different types of diabetic retinopathy, which are recorded on the exam form if present.</p>
        </sec>
      </sec>
      <sec>
        <title>Definitions</title>
        <sec>
          <title>Visual impairment</title>
          <p>The 10<sup>th </sup>edition of the International Classification of Diseases (ICD10) defines visual impairment as a visual acuity of less than 6/18 (20/60, 0.3) in the better eye with the best correction. [<xref ref-type="bibr" rid="B39">39</xref>] Visual impairment is categorized to blindness and low vision. Blindness is a visual acuity of less than 3/60 (20/400, 0.05) in the better eye with the best correction. Low vision is defined as a best corrected visual acuity of less than 6/18 (20/60, 0.3) but not less than 3/60 (20/400, 0.05) in the better eye. The cause of visual impairment is identified by an ophthalmologist. Using the best judgment, the ophthalmologist will determine one cause for each eye thought to be the principal cause in either eye. When multiple disorders are present, the ophthalmologist attempts to identify the disorder causing the greatest limitation of vision. If there are any other contributory causes, the ophthalmologist specifies that as a second cause. In cases with different causes of visual reduction in the patient's two eyes, the diagnosis in the less affected eye is used. Cataract is considered the main cause of severe low vision if the fundus is obscured by lens changes, or if no evident fundus abnormalities are observed in eyes with significant cataract. Regarding the results of exams, the ophthalmologist specifies whether the participant needs any action and specifies the type of needed action.</p>
        </sec>
      </sec>
      <sec>
        <title>Observers Training and quality assurance</title>
        <p>All observers (including enumerators, optometrists and ophthalmologists) take part in a comprehensive training course, which has been developed for conducting the protocol. The course includes a full spectrum of education to ensure that all investigators have a broad based knowledge of the study process, study purposes, data forms, and technical skills needed to conduct the protocol in a scientifically sound manner. All staff must complete the training course prior to getting involved in the study. The program director and manager directly supervise the staff training process.</p>
        <p>All observers receive regular quality control visits from the project manager who checks their performance. In addition, the data are reviewed periodically, and feedback is given to the observers weekly.</p>
        <sec>
          <title>Pilot and reliability study</title>
          <p>In order to assess the protocol, sampling process, participants' transport, data forms, equipment, and interobserver agreement, a pilot study is done one month before starting the study. The pilot study is done on 3 clusters in different districts outside those selected for the main study. To determine the reliability coefficient for visual acuity and refraction, the procedures are repeated twice by two series of observers. The agreement rates are calculated.</p>
        </sec>
      </sec>
      <sec>
        <title>Humanity and ethics</title>
        <p>The study is approved by the Research and Ethics Committee of Noor Vision Correction Center and Ethics Committee of the National Research Center for Medical Sciences. All subjects included in this study will be informed about the project and the procedures in their native language before being enrolled. They will be informed that their participation is entirely voluntary and they may decide to withdraw from the study at any time. The participants' agreement for examination will be obtained verbally. The confidentiality of all study participants will be protected in accordance with a good epidemiological practice.</p>
      </sec>
      <sec>
        <title>Data handling and statistical analysis</title>
        <sec>
          <title>Data entry</title>
          <p>During the enumeration process, as data on each household is completed, a supervisor will do a quick check to see that all data is collected properly. Similarly, during the eye examination at the clinic, as each person completes the eye exam, the supervisor checks all data forms to ensure that all relevant data has been collected. Missing data and mistakes are rectified after consulting the concerned person.</p>
        </sec>
        <sec>
          <title>Data editing</title>
          <p>During data entry, the forms will be checked for completeness and consistency by the data entry software. If the forms are not filled in completely, the concerned person will be consulted to fill in the missing data or clarify an inconsistent data. All changes and coding will be made in ink by crossing out the original data and recording the new data beside it. It will be signed and dated by the person making the changes. Overwriting will be avoided.</p>
        </sec>
        <sec>
          <title>Statistical analysis</title>
          <p>In calculating standard errors and the 95% confidence interval for categorical and continuous variables, the cluster sampling design is taken into account and adjusted for. [<xref ref-type="bibr" rid="B40">40</xref>] In addition to descriptive analyses, odds ratios are calculated with multivariate logistic regression in order to control potential confounding variables, and account for cluster design effects.</p>
          <p>A familial association of qualitative variables may be assessed by an odds ratio (OR) [<xref ref-type="bibr" rid="B41">41</xref>] that, for any pair j and k of individuals in a family, is defined as the odds of person j having an outcome given person k has the same outcome divided by the odds of person j having the outcome given person k does not. To adjust for possible confounding variables, we will use the second-order generalized estimating equations (GEE2) approach to logistic regression that simultaneously models the risk of a person having myopia and the familial associations. [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>] In order to assess the degree of familial association for quantitative variables (e.g., spherical equivalent and cylindrical power) we computed Pearson correlation coefficients for all possible pairs of siblings. All analyses will be done using STATA statistical software, version 6.0 (STATA Corporation, TX).</p>
        </sec>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>This study protocol describes the study design and eye examination of a cross-sectional population-based study in Tehran population. We expect that findings from the TES will show the status of visual problems and their causes in the community. This study will highlight the people who should be targeted by intervention programs for prevention of visual impairment.</p>
    </sec>
    <sec>
      <title>List of abbreviations used</title>
      <p>VA = visual acuity</p>
      <p>UCVA = uncorrected visual acuity</p>
      <p>BCVA = best corrected visual acuity</p>
      <p>IOP = intraocular pressure</p>
      <p>ICD10 = The International Classification of Diseases, 10<sup>th </sup>edition</p>
      <p>LOCS III = The Lens Opacities Classification System III</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>None declared.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>HH, the director of the project, participated in the design of the study and the examination protocol, and he will supervise the examination process. AF, the manager of the project, participated in the design of the study and will coordinate the study. He drafted the manuscript and will participate in the statistical analyses. KM participated in the design of the study and will participate in the statistical analyses. All authors have read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/8/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>Special thanks are given to Dr Ronald Klein, the Beaver Dam Eye Study; Dr Rupert Bourne, the National Blindness and Low Vision Prevalence Survey of Bangladesh; Dr Leon Ellwein and Dr Praveen K Nirmalan, the Tirunelveli eye survey; Dr Montserrat Martin-Baranera, Survey of blindness in Bioko, Equatorial Guinea, all who kindly have provided us the protocols and data forms of their studies. We also thank Dr Kamran Hojat Jalali and Dr Azam Alimardani for their helps in preparation of the eye examination protocol.</p>
        <p>This project is supported in part by Noor Vision Correction Center, and a grant from the Iranian National Research Center for Medical Sciences. The selection of clusters is done based on blocks enumeration of the national census of 1996 by the Iranian Statistics Center.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thylefors</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>A mission for vision</article-title>
          <source>Lancet</source>
          <year>1999</year>
          <volume>354</volume>
          <fpage>SIV44</fpage>
          <pub-id pub-id-type="pmid">10691457</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thylefors</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Negrel</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Pararajasegaram</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dadzie</surname>
              <given-names>KY</given-names>
            </name>
          </person-group>
          <article-title>Global data on blindness</article-title>
          <source>Bull World Health Organ</source>
          <year>1995</year>
          <volume>73</volume>
          <fpage>115</fpage>
          <lpage>121</lpage>
          <pub-id pub-id-type="pmid">7704921</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tabbara</surname>
              <given-names>KF</given-names>
            </name>
          </person-group>
          <article-title>Blindness in the eastern Mediterranean countries</article-title>
          <source>Br J Ophthalmol</source>
          <year>2001</year>
          <volume>85</volume>
          <fpage>771</fpage>
          <lpage>777</lpage>
          <pub-id pub-id-type="pmid">11423445</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.85.7.771</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>BEK</given-names>
            </name>
            <name>
              <surname>Linton</surname>
              <given-names>KLP</given-names>
            </name>
            <name>
              <surname>De Mets</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>The Beaver Dam Eye Study: visual acuity</article-title>
          <source>Ophthalmology</source>
          <year>1991</year>
          <volume>98</volume>
          <fpage>1310</fpage>
          <lpage>1315</lpage>
          <pub-id pub-id-type="pmid">1923372</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Attebo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study</article-title>
          <source>Ophthalmology</source>
          <year>1996</year>
          <volume>103</volume>
          <fpage>357</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="pmid">8600410</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rahmani</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Tielsch</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gottsch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Quigley</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Javitt</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey</article-title>
          <source>Ophthalmology</source>
          <year>1996</year>
          <volume>103</volume>
          <fpage>1721</fpage>
          <lpage>1726</lpage>
          <pub-id pub-id-type="pmid">8942862</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mansour</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Kassak</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chaya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hourani</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sibai</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alameddine</surname>
              <given-names>MN</given-names>
            </name>
          </person-group>
          <article-title>National survey of blindness and low vision in Lebanon</article-title>
          <source>Br J Ophthalmol</source>
          <year>1997</year>
          <volume>81</volume>
          <fpage>905</fpage>
          <lpage>906</lpage>
          <pub-id pub-id-type="pmid">9486035</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubin</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Munoz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bandeen-Roche</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zeger</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schein</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Fried</surname>
              <given-names>LP</given-names>
            </name>
          </person-group>
          <article-title>A comprehensive of visual impairment in a population of older assessment The SEE Study. Salisbury Eye Evaluation Project. Americans</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1997</year>
          <volume>38</volume>
          <fpage>557</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="pmid">9071208</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Livingston</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Stanislavsky</surname>
              <given-names>YL</given-names>
            </name>
            <name>
              <surname>McCarty</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Visual impairment in Australia: distance visual acuity, near vision, and visual field findings of the Melbourne Visual Impairment Project</article-title>
          <source>Am J Ophthalmol</source>
          <year>1997</year>
          <volume>123</volume>
          <fpage>328</fpage>
          <lpage>337</lpage>
          <pub-id pub-id-type="pmid">9063242</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klaver</surname>
              <given-names>CCW</given-names>
            </name>
            <name>
              <surname>Wolfs</surname>
              <given-names>RCW</given-names>
            </name>
            <name>
              <surname>Vingerling</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Hofman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>de Jong</surname>
              <given-names>PT</given-names>
            </name>
          </person-group>
          <article-title>Age-specific prevalence and causes of blindness and visual impairment in an older population: The Rotterdam Study</article-title>
          <source>Arch Ophthalmol</source>
          <year>1998</year>
          <volume>116</volume>
          <fpage>653</fpage>
          <lpage>658</lpage>
          <pub-id pub-id-type="pmid">9596502</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Gomez-Marin</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>BL</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of uncorrected binocular distance visual acuity in Hispanic and non-Hispanic adults</article-title>
          <source>Ophthalmology</source>
          <year>1998</year>
          <volume>105</volume>
          <fpage>552</fpage>
          <lpage>560</lpage>
          <pub-id pub-id-type="pmid">9499790</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(98)93042-1</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sui</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ellwein</surname>
              <given-names>LB</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of blindness and cataract surgery in Shunyi county, China</article-title>
          <source>Am J Ophthalmol</source>
          <year>1998</year>
          <volume>126</volume>
          <fpage>506</fpage>
          <lpage>514</lpage>
          <pub-id pub-id-type="pmid">9780095</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0002-9394(98)00275-X</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pokharel</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Regmi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Shrestha</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Negrel</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Ellwein</surname>
              <given-names>LB</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of blindness and cataract surgery in Nepal</article-title>
          <source>Br J Ophthalmol</source>
          <year>1998</year>
          <volume>82</volume>
          <fpage>600</fpage>
          <lpage>605</lpage>
          <pub-id pub-id-type="pmid">9797657</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Munier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gunning</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>O'Keefe</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Causes of blindness in the adult population of the Republic of Ireland</article-title>
          <source>Br J Ophthalmol</source>
          <year>1998</year>
          <volume>82</volume>
          <fpage>630</fpage>
          <lpage>633</lpage>
          <pub-id pub-id-type="pmid">9797662</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>See</surname>
              <given-names>JLS</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>TY</given-names>
            </name>
            <name>
              <surname>Yeo</surname>
              <given-names>KT</given-names>
            </name>
          </person-group>
          <article-title>Trends in the Pattern of Blindness and Major Ocular Diseases in Singapore and Asia</article-title>
          <source>Ann Acad Med Singapore</source>
          <year>1998</year>
          <volume>27</volume>
          <fpage>540</fpage>
          <lpage>546</lpage>
          <pub-id pub-id-type="pmid">9791663</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>He</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Munoz</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Ellwein</surname>
              <given-names>LB</given-names>
            </name>
          </person-group>
          <article-title>A survey of blindness and cataract surgery in Doumen County, China</article-title>
          <source>Ophthalmology</source>
          <year>1999</year>
          <volume>106</volume>
          <fpage>1602</fpage>
          <lpage>1608</lpage>
          <pub-id pub-id-type="pmid">10442910</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(99)90460-8</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weih</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>VanNewkirk</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>McCarty</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Age-specific causes of bilateral visual impairment</article-title>
          <source>Arch Ophthalmol</source>
          <year>2000</year>
          <volume>118</volume>
          <fpage>264</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="pmid">10676793</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van der Pols</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Bates</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>McGraw</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Reacher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Prentice</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Finch</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Visual acuity measurements in a national sample of British elderly people</article-title>
          <source>Br J Ophthalmol</source>
          <year>2000</year>
          <volume>84</volume>
          <fpage>165</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="pmid">10655192</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.84.2.165</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murthy</surname>
              <given-names>GVS</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ellwein</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Munoz</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Bachani</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dada</surname>
              <given-names>VK</given-names>
            </name>
          </person-group>
          <article-title>A population-based eye survey of older adults in a rural district of Rajasthan</article-title>
          <source>Ophthalmology</source>
          <year>2001</year>
          <volume>108</volume>
          <fpage>679</fpage>
          <lpage>685</lpage>
          <pub-id pub-id-type="pmid">11297483</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(00)00579-0</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>VanNewkirk</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Weih</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>McCarty</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Cause-specific Prevalence of Bilateral Visual Impairment in Victoria, Australia</article-title>
          <source>Ophthalmology</source>
          <year>2001</year>
          <volume>108</volume>
          <fpage>960</fpage>
          <lpage>967</lpage>
          <pub-id pub-id-type="pmid">11320028</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(01)00554-1</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hyman</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Connell</surname>
              <given-names>AMS</given-names>
            </name>
            <name>
              <surname>Schachat</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nemesure</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hennis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leske</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Prevalence and Causes of Visual Impairment in the Barbados Eye Study</article-title>
          <source>Ophthalmology</source>
          <year>2001</year>
          <volume>108</volume>
          <fpage>1751</fpage>
          <lpage>1756</lpage>
          <pub-id pub-id-type="pmid">11581045</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(01)00590-5</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buch</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Vinding</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>NV</given-names>
            </name>
          </person-group>
          <article-title>Prevalence and Causes of Visual Impairment According to World Health Organization and United States Criteria in an Aged, Urban Scandinavian Population, The Copenhagen City Eye Study</article-title>
          <source>Ophthalmology</source>
          <year>2001</year>
          <volume>108</volume>
          <fpage>2347</fpage>
          <lpage>2357</lpage>
          <pub-id pub-id-type="pmid">11733284</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(01)00823-5</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Michon</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Ellwein</surname>
              <given-names>LB</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of visual impairment, blindness, and cataract surgery in the Hong Kong elderly</article-title>
          <source>Br J Ophthalmol</source>
          <year>2002</year>
          <volume>86</volume>
          <fpage>133</fpage>
          <lpage>139</lpage>
          <pub-id pub-id-type="pmid">11815334</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.86.2.133</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moser</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Martin-Baranera</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vega</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Survey of blindness and visual impairment in Bioko, Equatorial Guinea</article-title>
          <source>Br J Ophthalmol</source>
          <year>2002</year>
          <volume>86</volume>
          <fpage>257</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="pmid">11864876</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.86.3.257</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dandona</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dandona</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Srinivas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Giridhar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Prasad</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Vilas</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>McCarty</surname>
              <given-names/>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>GN</given-names>
            </name>
          </person-group>
          <article-title>Moderate visual impairment in India: the Andhra Pradesh Eye Disease Study</article-title>
          <source>Br J Ophthalmol</source>
          <year>2002</year>
          <volume>86</volume>
          <fpage>373</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="pmid">11914201</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.86.4.373</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Munoz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Blindness and visual impairment in the Americas and the Caribbean</article-title>
          <source>Br J Ophthalmol</source>
          <year>2002</year>
          <volume>86</volume>
          <fpage>498</fpage>
          <lpage>504</lpage>
          <pub-id pub-id-type="pmid">11973241</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.86.5.498</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nirmalan</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Thulasiraj</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Maneksha</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Rahmathullah</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ramakrishnan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Padmavathi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Munoz</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Ellwein</surname>
              <given-names>LB</given-names>
            </name>
          </person-group>
          <article-title>A population based eye survey of older adults in Tirunelveli district of south India: blindness, cataract surgery, and visual outcomes</article-title>
          <source>Br J Ophthalmol</source>
          <year>2002</year>
          <volume>86</volume>
          <fpage>505</fpage>
          <lpage>512</lpage>
          <pub-id pub-id-type="pmid">11973242</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.86.5.505</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kocur</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Resnikoff</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Visual impairment and blindness in Europe and their prevention</article-title>
          <source>Br J Ophthalmol</source>
          <year>2002</year>
          <volume>86</volume>
          <fpage>716</fpage>
          <lpage>722</lpage>
          <pub-id pub-id-type="pmid">12084735</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.86.7.716</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evans</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Wormald</surname>
              <given-names>RPL</given-names>
            </name>
            <name>
              <surname>Siu-Woon Ng</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stirling</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Smeeth</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Breeze</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bulpitt</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tulloch</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community</article-title>
          <source>Br J Ophthalmol</source>
          <year>2002</year>
          <volume>86</volume>
          <fpage>795</fpage>
          <lpage>800</lpage>
          <pub-id pub-id-type="pmid">12084753</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.86.7.795</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zainal</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ismail</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Ropilah</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Elias</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Arumugam</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Alias</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fathilah</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>TO</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Goh</surname>
              <given-names>PP</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of blindness and low vision in Malaysian population: results from the National Eye Survey 1996</article-title>
          <source>Br J Ophthalmol</source>
          <year>2002</year>
          <volume>86</volume>
          <fpage>951</fpage>
          <lpage>956</lpage>
          <pub-id pub-id-type="pmid">12185113</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.86.9.951</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khandekar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mohammed</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Negrel</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Al Riyami</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The prevalence and causes of blindness in the Sultanate of Oman: the Oman Eye Study (OES)</article-title>
          <source>Br J Ophthalmol</source>
          <year>2002</year>
          <volume>86</volume>
          <fpage>957</fpage>
          <lpage>962</lpage>
          <pub-id pub-id-type="pmid">12185115</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.86.9.957</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amansakhatov</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Volokhovskaya</surname>
              <given-names>ZP</given-names>
            </name>
            <name>
              <surname>Afanasyeva</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Limburg</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Cataract blindness in Turkmenistan: results of a national survey</article-title>
          <source>Br J Ophthalmol</source>
          <year>2002</year>
          <volume>86</volume>
          <fpage>1207</fpage>
          <lpage>1210</lpage>
          <pub-id pub-id-type="pmid">12386068</pub-id>
          <pub-id pub-id-type="doi">10.1136/bjo.86.11.1207</pub-id>
        </citation>
      </ref>
      <ref id="B33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Munoz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Broman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Quigley</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Causes of Blindness and Visual Impairment in a Population-based Sample of U. S. Hispanics</article-title>
          <source>Ophthalmology</source>
          <year>2002</year>
          <volume>109</volume>
          <fpage>737</fpage>
          <lpage>743</lpage>
          <pub-id pub-id-type="pmid">11927431</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(01)01008-9</pub-id>
        </citation>
      </ref>
      <ref id="B34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bourne</surname>
              <given-names>RRA</given-names>
            </name>
            <name>
              <surname>Dineen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Noorul Hug</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>The national blindness and low vision prevalence of Bangladesh: research design, eye examination methodology and results of pilot study</article-title>
          <source>Ophthalmic Epidemiol</source>
          <year>2002</year>
          <volume>9</volume>
          <fpage>119</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">11821977</pub-id>
          <pub-id pub-id-type="doi">10.1076/opep.9.2.119.1520</pub-id>
        </citation>
      </ref>
      <ref id="B35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thulasiraj</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Rahmathulla</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Saraswati</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Selvaraj</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ellwein</surname>
              <given-names>LB</given-names>
            </name>
          </person-group>
          <article-title>The Sivaganga Eye Survey: I. Blindness and cataract surgery</article-title>
          <source>Ophthalmic Epidemiol</source>
          <year>2002</year>
          <volume>9</volume>
          <fpage>299</fpage>
          <lpage>312</lpage>
          <pub-id pub-id-type="pmid">12528915</pub-id>
          <pub-id pub-id-type="doi">10.1076/opep.9.5.299.10334</pub-id>
        </citation>
      </ref>
      <ref id="B36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mohammad</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Joghatai</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Syiadati</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rahgozar</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A national survey of visual disturbances In Iran</article-title>
          <source>J Medical Council of IRI</source>
          <year>2001</year>
          <volume>19</volume>
          <fpage>203</fpage>
          <lpage>209</lpage>
        </citation>
      </ref>
      <ref id="B37">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Noorbala</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Mohammad</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>National Health Survey of Iran</article-title>
          <source>The National Research Center for Medical Sciences</source>
          <year>2001</year>
        </citation>
      </ref>
      <ref id="B38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chylack</surname>
              <given-names>LT</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Wolfe</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Singer</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Leske</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Bullimore</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>IL</given-names>
            </name>
            <name>
              <surname>Friend</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>SY</given-names>
            </name>
          </person-group>
          <article-title>The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group</article-title>
          <source>Arch Ophthalmol</source>
          <year>1993</year>
          <volume>111</volume>
          <fpage>831</fpage>
          <lpage>836</lpage>
          <pub-id pub-id-type="pmid">8512486</pub-id>
        </citation>
      </ref>
      <ref id="B39">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>World Health</surname>
              <given-names>Organization</given-names>
            </name>
          </person-group>
          <article-title>International Statistical Classification of Diseases and Related Health Problems</article-title>
          <source>Geneva</source>
          <year>1992</year>
        </citation>
      </ref>
      <ref id="B40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bennett</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Woods</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Liyanage</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>A simplified method for cluster sample surveys of health in developing countries</article-title>
          <source>World Health Statistics Quarterly</source>
          <year>1991</year>
          <volume>44</volume>
          <fpage>98</fpage>
          <lpage>106</lpage>
        </citation>
      </ref>
      <ref id="B41">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liang</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Beaty</surname>
              <given-names>TH</given-names>
            </name>
          </person-group>
          <article-title>Measuring familial aggregation by using odds-ratio regression models</article-title>
          <source>Genet Epidemiol</source>
          <year>1991</year>
          <volume>8</volume>
          <fpage>361</fpage>
          <lpage>370</lpage>
          <pub-id pub-id-type="pmid">1806405</pub-id>
        </citation>
      </ref>
      <ref id="B42">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qaqish</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>KY</given-names>
            </name>
          </person-group>
          <article-title>Marginal models for correlated binary responses with multiple classes and multiple levels of nesting</article-title>
          <source>Biometrics</source>
          <year>1992</year>
          <volume>48</volume>
          <fpage>939</fpage>
          <lpage>950</lpage>
          <pub-id pub-id-type="pmid">1420848</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:183851</identifier><datestamp>2003-08-27</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">183851</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-3-9</article-id>
      <article-id pub-id-type="pmid">12885300</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-3-9</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Longitudinal study on visual outcome and spectacle use after intracapsular cataract extraction in Northern India</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>Sanjeev K</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>comoph@ndfvsnl.net.in</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Murthy</surname>
            <given-names>GVS</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>comoph@ndfvsnl.net.in</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Sharma</surname>
            <given-names>Namrata</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>namrata103@hotmail.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Community Ophthalmology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India</aff>
      <aff id="I2"><label>2</label>Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>7</month>
        <year>2003</year>
      </pub-date>
      <volume>3</volume>
      <fpage>9</fpage>
      <lpage>9</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/9"/>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>9</month>
          <year>2002</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>7</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2003 Gupta et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Gupta et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>More than 3 million cataract extractions are undertaken in India annually. Almost 60% of these operations are intracapsular Cataract Extractions. The subsequent optical correction is provided by aphakic spectacles. The aim of this study is to assess visual outcome and perceived benefits of post-operative use of aphakic spectacles.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>One hundred and sixty-seven persons who had undergone intracapsular cataract extraction and had been given best corrected aphakic spectacles were evaluated one year following prescription of the best corrected aphakic spectacles. Out of these, 82.6% were re-examined in this interview-based longitudinal study.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>The mean age of the male participants was 65.95 years and that of females was 71.26 years. 81.2% of the participants were using the provided spectacles. There was no significant association between the spectacle use and gender of the participant. The commonest reason stated by the respondents, for the non-use of the spectacles was 'poor vision'. 61.7% of the current users of provided spectacles had a visual acuity of 6/18 or better. 91.1% of the current users were very satisfied with the spectacles. All the current users could now manage personal activities and the spectacles had facilitated independent mobility. There was no difference in the level of satisfaction between mono-aphakics and bi-aphakics. Among the satisfied users, the modal spherical power was +10 D followed by + 11 D. About one-third of these required a cylindrical correction.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Following intracapsular cataract extraction, provision of the best correction after cataract surgery is desirable to obtain an optimal visual outcome.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Cataract</kwd>
        <kwd>Cataract surgery</kwd>
        <kwd>spectacles</kwd>
        <kwd>aphakia</kwd>
        <kwd>India</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>An estimated 38 million individuals are blind worldwide, who cannot count fingers at a distance of 3 meters with the better eye and with the best possible correction [<xref ref-type="bibr" rid="B1">1</xref>]. India accounts for more than 6 million of the above estimate. Cataract alone is responsible for 80% of the blindness in India [<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>More than 3 million cataract extractions are being undertaken in the country annually. Almost 60% of these operations are intracapsular cataract extractions (ICCE) performed in temporary eye camps in rural and peri-urban areas, where the population is unable to have access to fixed eye care facilities [<xref ref-type="bibr" rid="B3">3</xref>]. The subsequent optical correction is provided by the use of aphakic spectacles which may be given as standard power of +10 to + 12 Dioptres or the exact prescription of the same may be given.</p>
      <p>There is paucity of studies on the actual outcome of intracapsular cataract extraction, especially on a long-term basis. Most of the available literature on spectacle use relates to the use of the standard aphakic spectacles rather than the use of best-corrected spectacles.</p>
      <p>Hence we undertook this study to evaluate the visual outcome and the perceived benefits following the use of best-corrected aphakic spectacles after intracapsular cataract extraction.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>In this preliminary study, which was undertaken one year ago, the best corrected aphakic spectacles after refraction had been provided to 167 patients who had been operated by intracapsular cataract extraction earlier. These patients had undergone intracapsular cataract extraction four years prior to the study either at an eye camp or at a base hospital in the rural areas and urban slums of north India and were selected randomly. The best-corrected aphakic spectacles had been given to them in place of the standard aphakic spectacles, which were dispensed following intracapsular cataract extraction. The cohort was spread over ten villages in District Faridabad of the Haryana State and the urban slums of Delhi.</p>
      <p>The inclusion criteria for being recruited to the study were: the patient was operated by intracapsular cataract extraction either at any eye camp or at a base hospital within the past four years and the best corrected visual acuity of the patient was 6/60 or better. The cut off point of 6/60 was taken as per the definition of blindness in our national program. Further this would eliminate causes other than uncorrected aphakia, which may be responsible for diminution of vision such as glaucoma, dense central corneal opacities, complications of cataract extraction and posterior segment pathology. Both bilateral and unilateral aphakes were included in the study.</p>
      <p>The present study was conducted in four steps: Step I – Identification and training of the personnel, pre-testing of the questionnaire and preparation of the list of the participants. Step II – Domiciliary visits to identify the patients and announce the time schedule. Step III – Clinical examination, patient interview and data analysis. Step IV – Distribution of the spectacles.</p>
      <p>The database prepared in the preliminary study conducted one year ago was used to identify the patients who had been prescribed best-corrected aphakic spectacles. The participants were contacted through domiciliary visits. A pre-tested semi-open-ended questionnaire schedule was administered (Appendix 1). This type of questionnaire, called an interview schedule was necessary, as most of the participants of the study were illiterate. The investigator himself (SKG) filled the questionnaire. Care was taken not to ask any leading questions. The spectacle frames were examined for any cracks or repairs and the lenses were checked for any scratches. Information pertaining to the use of provided spectacles, their perceived benefits and level of confirmed beneficiary satisfaction was elicited. Refraction was carried out by a trained optometrist with an experience of conducting more than 25000 refractions in camps organized by the base hospitals. The optometrist confirmed the power of the provided spectacles with the use of a lensometer. The visual outcome was assessed for each eye using Snellen's E-chart placed at a distance of 6 meters, as most of the participants were illiterate.</p>
      <sec>
        <title>Data analysis</title>
        <p>The data was analyzed using EPI INFO package, version 6.0. The questionnaire was prepared in the EPED menu of EPI INFO. The coding of the questionnaire was done in the first step of the study itself.</p>
        <p>The participants who did not have spectacles or who needed a change were prescribed and distributed new spectacles.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <p>For the purpose of this manuscript the best corrected spectacles, which had been given to the participants, one year ago would be referred to as the provided spectacles. Of the 167 patients who were provided spectacles, 25 were lost to follow-up (13 females and 12 males) and four claimed that they had not received the aphakic spectacles, and were excluded from further analysis (Table <xref ref-type="table" rid="T1">1</xref>). Thus, numbers of patients examined for this study were 138 (82.6%) of the original 167 recruited to the study. Reasons for loss of follow-up included 5 deaths, 5 migrations, and 11 out-of-station and 3 bedridden (terminally ill) patients. The 11 participants who were out-of-station were scattered over 6 villages.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Visual acuity of eyes of participants who were using the provided spectacles and had no change in current prescription</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td/>
              <td align="left" colspan="2">
                <bold>Current visual acuity</bold>
              </td>
              <td align="left">
                <bold>Total</bold>
              </td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">
                <bold>Visual acuity one year ago</bold>
              </td>
              <td align="left">
                <bold>6/18 or better</bold>
              </td>
              <td align="left">
                <bold>Less than 6/18</bold>
              </td>
              <td/>
            </tr>
            <tr>
              <td colspan="4">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left">6/18 or better</td>
              <td align="left">87</td>
              <td align="left">2</td>
              <td align="left">89</td>
            </tr>
            <tr>
              <td align="left">Less than 6/18</td>
              <td align="left">0</td>
              <td align="left">52</td>
              <td align="left">52</td>
            </tr>
            <tr>
              <td align="left">Total</td>
              <td align="left">87</td>
              <td align="left">54</td>
              <td align="left">141</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <sec>
        <title>Demographic features</title>
        <p>Out of a total of 138 participants, there were 57 males (41.3%) and 81 females (58.7%). One hundred and twenty four participants out of 138 (89.8%) were aged more than 60 years. The mean age of the males was 65.9 years and that of females was 71.3 years.</p>
      </sec>
      <sec>
        <title>Visual outcome</title>
        <p>Out of the 138 participants who were followed, 37 were bi-aphakic and the remaining 101 were mono-aphakic. The 138 participants thus contributed to a total of 175 operated eyes. The mean duration since intracapsular cataract extraction of the first eye was 32.0 ± 24.9 months and that of the second eye was 20.4 ± 13.1 months. Of the 138 participants who were examined and interviewed 113 were using the provided spectacles and 25 participants were no longer using the provided spectacles. The 113 participants who were currently using the provided spectacles contributed to 141 operated eyes. Amongst the 141 eyes, 7 eyes had deterioration in the visual acuity by one line on the Snellen's chart during the follow up period whereas the remaining 134 did not show any change in the visual acuity. Of these 141 operated eyes, 87 (61.7%) eyes had a visual acuity of 6/18 or better on both the occasions i.e. one year ago and during the present study, two eyes who had a visual acuity of 6/18 or better one year ago now had a visual acuity of less than 6/18 and 52 eyes had a visual acuity of less than 6/18 on both the occasions i.e. one year ago and during the present study. However, refraction of each eye confirmed that none of the 138 participants required a change in the spectacle power at the time of follow up.</p>
        <p>The 25 participants who were not using the provided spectacles contributed to 34 operated eyes in the study. Out of these 34 eyes, all the 17 eyes which had a best-corrected vision of 6/18 or better one year ago still had a visual acuity of 6/18 or better. Of the remaining 17 eyes, three eyes of two participants had a current visual acuity of less than 3/60 as one of the participants had developed bilateral retinal detachment and the second had developed a dense central corneal opacity during the previous year.</p>
      </sec>
      <sec>
        <title>Spectacle use and perceived benefits</title>
        <p>Of the 113 patients who were using the provided spectacles, 112 (99.1%) were using them all the time and only one patient was using them occasionally. The 25 patients discontinued the use of the provided spectacles sometime during the one-year follow-up period. Twenty-two of these 25 patients had replaced them with other spectacles and the remaining three did not replace them and had uncorrected aphakia. There was no significant association between gender and the use of provided spectacles (χ<sup>2 </sup>= 0.14: p = 0.71) (Table <xref ref-type="table" rid="T2">2</xref>).</p>
        <table-wrap position="float" id="T2">
          <label>Table 2</label>
          <caption>
            <p>Distribution of spectacle use with respect to sex</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td/>
                <td align="left">
                  <bold>Using provided spectacles</bold>
                </td>
                <td align="left">
                  <bold>Not using provided spectacles</bold>
                </td>
                <td align="left">
                  <bold>Total</bold>
                </td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Male</td>
                <td align="left">48 (84.3)</td>
                <td align="left">9 (15.7)</td>
                <td align="left">57 (100)</td>
              </tr>
              <tr>
                <td align="left">Female</td>
                <td align="left">65 (80.2)</td>
                <td align="left">16 (19.8)</td>
                <td align="left">81 (100)</td>
              </tr>
              <tr>
                <td align="left">Total</td>
                <td align="left">113</td>
                <td align="left">25</td>
                <td align="left">138</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>The most common reason stated for the non-use of the provided spectacles by the respondents was 'poor vision' (Table <xref ref-type="table" rid="T3">3</xref>). Other reasons included were breakage of the spectacle pairs, dizziness due to spectacles, an ability to see better with the unoperated fellow eye (which had immature cataract) and loss of spectacles. The duration of use of the provided spectacles was less than one month in 17 (68%) of these 25 patients who discontinued them because of 'poor vision' or 'dizziness'. The remaining 8 patients discontinued the use after 2–10 months.</p>
        <table-wrap position="float" id="T3">
          <label>Table 3</label>
          <caption>
            <p>Level of satisfaction after cataract surgery</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td align="left">
                  <bold>Level of satisfaction</bold>
                </td>
                <td align="left">
                  <bold>Using provided spectacles</bold>
                </td>
                <td align="left">
                  <bold>Using other spectacles</bold>
                </td>
                <td align="left">
                  <bold>Not using any spectacles</bold>
                </td>
                <td align="left">
                  <bold>Total*</bold>
                </td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Very satisfied</td>
                <td align="left">103 (91.1)</td>
                <td align="left">17 (77.3)</td>
                <td align="left">2 (66.7)</td>
                <td align="left">122 [88.4 (81.9–93.2)]</td>
              </tr>
              <tr>
                <td align="left">Marginally satisfied</td>
                <td align="left">9 (8.0)</td>
                <td align="left">2 (9.1)</td>
                <td align="left">0</td>
                <td align="left">11 [8.0 (4.1–13.8)]</td>
              </tr>
              <tr>
                <td align="left">Not satisfied</td>
                <td align="left">1 (0.9)</td>
                <td align="left">2 (9.1)</td>
                <td align="left">1 (33.3)</td>
                <td align="left">4 [2.9 (0.8–7.3)]</td>
              </tr>
              <tr>
                <td align="left">Unhappy as vision worsened</td>
                <td align="left">0</td>
                <td align="left">1 (4.5)</td>
                <td align="left">0</td>
                <td align="left">1 [0.7 (0.02–4.0)]</td>
              </tr>
              <tr>
                <td align="left">Total</td>
                <td align="left">113 (100.0)</td>
                <td align="left">22 (100.0)</td>
                <td align="left">3 (100.0)</td>
                <td align="left">138 [100.0]</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>*Figures in parenthesis are percentages</p>
          </table-wrap-foot>
        </table-wrap>
        <p>Out of a total of 135 spectacles examined by the investigator, 122 (90.4%) spectacles in current use were in good condition, 11 (8.2%) had scratches on their lenses and one each had a broken lens or frame.</p>
        <p>Out of 113 participants who were using the provided spectacles, 91.1%(103/113) stated that they were 'very satisfied' with the results of cataract surgery (Table <xref ref-type="table" rid="T4">4</xref>). This percentage was much higher as compared to the 77.3% participants (17/22) who were using their own spectacles. 8.0% (9/113) of the users of provided spectacles and 9.1% (2/22) of those using their own spectacles were 'marginally satisfied'.</p>
        <table-wrap position="float" id="T4">
          <label>Table 4</label>
          <caption>
            <p>Perceived benefits from the use of aphakic spectacles</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td align="left">
                  <bold>Perceived benefit</bold>
                </td>
                <td align="left">
                  <bold>Using provided spectacles n = 113</bold>
                </td>
                <td align="left">
                  <bold>Using other spectacles N = 25</bold>
                </td>
                <td align="left">
                  <bold>Total* n = 138</bold>
                </td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Can manage all personal activities</td>
                <td align="left">113 (100)</td>
                <td align="left">19 (76)</td>
                <td align="left">132 [95.7 (90.8–98.4)]</td>
              </tr>
              <tr>
                <td align="left">Has facilitated independent mobility</td>
                <td align="left">113 (100)</td>
                <td align="left">18 (72)</td>
                <td align="left">131 [95.0 (89.8–97.9)]</td>
              </tr>
              <tr>
                <td align="left">Can recognize family members and cattle clearly</td>
                <td align="left">102 (90.3)</td>
                <td align="left">17 (68)</td>
                <td align="left">119 [86.2(79.3–91.5)]</td>
              </tr>
              <tr>
                <td align="left">Has improved economic potential</td>
                <td align="left">5 (4.4)</td>
                <td align="left">0</td>
                <td align="left">5 [3.6 (1.2–8.3)]</td>
              </tr>
              <tr>
                <td align="left">Surroundings better visible but hazy</td>
                <td align="left">1 (0.9)</td>
                <td align="left">1 (4)</td>
                <td align="left">2 [1.4 (0.2–5.1)]</td>
              </tr>
              <tr>
                <td align="left">Has not helped in any fashion</td>
                <td align="left">0</td>
                <td align="left">5 (20)</td>
                <td align="left">5 [3.6 (1.2–8.3)]</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>*Figures in parentheses are percentages</p>
          </table-wrap-foot>
        </table-wrap>
        <p>Of the three subjects who were not using any spectacles at present, two were very satisfied with the cataract surgery till their spectacles were lost or broken. The third was no satisfied, as vision did not improve. He did not use the spectacles as he could see better with the fellow eye, which had am immature cataract.</p>
        <p>When asked about the comparative effect of the provided spectacles on vision, vis-à-vis the standard spectacles they were using before the commencement of the preliminary study, 81.2% (112/138) stated that the provided spectacles had greatly improved their vision. However 3.6% (5/138) maintained a slight improvement, 2.9% (4/138) found no difference, another 2.9% (4/138) felt it had slightly worsened their vision, 6.5% (9/138) found that their vision had been greatly worsened, and 2.9% (4/138) were unable to offer an opinion.</p>
        <p>A comparison between the level of satisfaction between the mono-aphakics and the bi-aphakics did not reveal any difference. 88.5% (77/87) of the mono-aphakics and 88.2% (45/51) of the bi-aphakics were 'very satisfied'. This could be because majority of the mono-aphakics probably had cataract in the other eye, of sufficient density to cause a significant impairment of vision.</p>
        <p>An inquiry into the perceived benefits from the use of aphakic spectacles revealed that most (95.7% -132/138) participants could now manage all personal activities, 95.0% (131/138) felt that it had facilitated independent mobility and 86.2%(119/138) stated that they could now recognize their family members and cattle clearly (Table <xref ref-type="table" rid="T5">5</xref>). Only 5 participants (3.6%) felt that it had helped in improving their economic potential. However, 1.4% (2/138) found that the surroundings were visible better but hazy and 3.6% (5/138) felt it had not helped them in any fashion.</p>
        <table-wrap position="float" id="T5">
          <label>Table 5</label>
          <caption>
            <p>Distribution of spherical and cylindrical power in the provided spectacles which were still being used</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td align="left">
                  <bold>Spherical Power (+D)</bold>
                </td>
                <td align="left">
                  <bold>Cylindrical Power (+D)</bold>
                </td>
                <td align="left">
                  <bold>Number of eyes</bold>
                </td>
                <td align="left">
                  <bold>%</bold>
                </td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">10.00</td>
                <td align="left">No cylinder</td>
                <td align="left">34</td>
                <td align="left">24.1</td>
              </tr>
              <tr>
                <td align="left">11.00</td>
                <td align="left">No cylinder</td>
                <td align="left">27</td>
                <td align="left">19.2</td>
              </tr>
              <tr>
                <td align="left">10.00</td>
                <td align="left">With cylinder</td>
                <td align="left">26</td>
                <td align="left">18.5</td>
              </tr>
              <tr>
                <td align="left">11.00</td>
                <td align="left">With cylinder</td>
                <td align="left">13</td>
                <td align="left">9.2</td>
              </tr>
              <tr>
                <td align="left">9.00</td>
                <td align="left">No cylinder</td>
                <td align="left">11</td>
                <td align="left">7.8</td>
              </tr>
              <tr>
                <td align="left">12.00</td>
                <td align="left">No cylinder</td>
                <td align="left">9</td>
                <td align="left">6.4</td>
              </tr>
              <tr>
                <td align="left" colspan="2">Others (each in less than 5 eyes</td>
                <td align="left">21</td>
                <td align="left">14.8</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Total</bold>
                </td>
                <td/>
                <td align="left">
                  <bold>141</bold>
                </td>
                <td align="left">
                  <bold>100.0</bold>
                </td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>The percentages of the perceived benefits were higher among those still using the provided spectacles than those who had replaced them (Table <xref ref-type="table" rid="T5">5</xref>). All the participants using the provided spectacles could now manage all personal activities and claimed that the spectacles had facilitated independent mobility. 90.3% (102/113) stated that they could now recognize family members and cattle clearly. The corresponding percentages among those who had replaced the provided spectacles were 76%, 72% and 68% respectively. However none of the participants using the provided spectacles stated that it had not helped them in any fashion as compared to 20% (5/25) of those who were using other spectacles.</p>
        <p>All the spectacles were examined with a lensometer. This confirmed that all the participants who claimed that they were using the provided spectacles were indeed using them. And the others were indeed, using some other spectacle pairs purchased by them.</p>
        <p>An analysis of the spherical power of the corrective lenses for the eyes of those who were still using the provided spectacles revealed that, though +10D is still the modal power (42.6% -60/141), a spherical correction of +11D is not far behind accounting for more than over a quarter (28.4% -40/141) of the eyes (Table 6). Thus the two together account for 71.1% (100/141) of the participants' eyes. The range of the spherical powers was +7.50 D to +16.00 D. This has far-reaching implications as currently, most of the patients undergoing intracapsular cataract extraction in India are being provided standard + 10D spherical correction with no cylindrical correction or refraction.</p>
        <p>A perusal of the cylindrical correction among the same 113 participants (141 eyes) who were still using the provided spectacles found that 36.2% (51/141) eyes required a cylindrical correction as well. The modal cylindrical powers were +2.00 D (47.0% -24/51) and +1.00 D (43.1% -22/51). The range was +1.00 D to +3.00 D (Table 7).</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Intracapsular cataract extraction has been the commonest mode adopted in eye camps in India. Intracapsular cataract extraction has been thought to be appropriate in terms of technology and is cost-effective in terms of time, resources and manpower, for use in developing countries with limited resources [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>].</p>
      <p>With the advent of the technologically superior extracapsular cataract extraction with posterior chamber intraocular lens implantation (ECCE + IOL), there has been a lot of pressure to change this modality in developing nations because of the better visual outcome with this procedure [<xref ref-type="bibr" rid="B6">6</xref>]. Eventually, extracapsular cataract extraction with lens implant may replace intracapsular cataract extraction with aphakic spectacle correction. However, in a vast and developing country like India, with its huge backlog of unoperated cataract patients and their predominant rural habitat, this is likely to take a substantial time.</p>
      <p>It is also important to consider the visual needs of the population and their level of satisfaction with intracapsular cataract extraction before deciding on whether this modality should be discontinued.</p>
      <p>Very few studies are available on the actual outcome of intracapsular cataract extraction, especially on a long-term basis [<xref ref-type="bibr" rid="B7">7</xref>]. Most of the available literature on spectacle use relates to the use of the standard aphakic spectacles.</p>
      <p>The vast majority of the participants (81.2%) were still using the best-corrected aphakic spectacles, which were provided to them one year ago. All but one of the 113 participants was satisfied with them. This figure compares favorably with the satisfaction rate of 70% with the standard aphakic spectacles as has been demonstrated in earlier studies from northern India [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. The frequency of the use of the best corrected spectacles was much higher (91.1%) amongst the participants using the provided spectacles as compared to those using the spectacles purchased by them (77.3%). However, it is conceivable that those using 'other spectacles' were doing so because they were perhaps not satisfied with the provided spectacles. Another study in India also found a high incidence of spectacle use [<xref ref-type="bibr" rid="B2">2</xref>], although a follow-up study in Nepal documented that only half of the operated patients were actually using the aphakic correction [<xref ref-type="bibr" rid="B10">10</xref>].</p>
      <p>Quality control in the selection of the aphakic spectacles is very important. The spectacles in the current study were provided of sheet acetate frames and white English lenses. Breakage of the spectacles and their subsequent non-replacement is considered to be one of the disadvantages in ICCE. In the present study, with good quality spectacles, only 4.3% of the participants reported breakage after one-year use. However, the condition of the spectacles was found to be good in 90.4% of the participants.</p>
      <p>All the participants who were using the provided spectacles stated that they could now manage all personal activities and that the spectacles had facilitated independent mobility. However, only a small proportion was actually rehabilitated economically. The above results with the general satisfaction of the majority of the participants adds credence to the view that excellent vision for improving economic potential is not a felt need of the rural population in developing country like ours. Improved mobility, ability to undertake personal activities and recognition of family members, friends and cattle are more important in the context of rural India. This can be adequately achieved by aphakic correction with spherical and cylindrical refraction in most cases.</p>
      <p>Amongst the users of the provided spectacles who were satisfied, 61.7% of the eyes had a visual acuity of 6/18 or better. We have earlier reported a lower percentage (44.7%) of satisfaction rates for visual acuity of 6/18 of better with the use of standard aphakic spectacles in a socio-epidemiological assessment after camp-based intracapsular cataract extraction in villages and peri-urban areas in north India [<xref ref-type="bibr" rid="B9">9</xref>]. In the present study, when asked about the comparative effect of the provided spectacles on vision, vis-à-vis the spectacles they were using before that, 81.2% of the participants stated that the provided spectacles had greatly improved their vision. Thus, it appears that the aphakic spectacles after complete spherical and cylindrical correction provide a better visual outcome than the standard +10D spherical correction.</p>
      <p>However, there are a few sources of bias in our study. We have excluded the patients who have a visual acuity of &lt; 6/60 some of which may occur due to results of the complications of surgery. Further, it is also possible that the 11 patients who were out station (and hence we were unable to assess their visual acuity) were perhaps more mobile due to a better visual acuity. Although care was taken not to ask leading questions, the possibility that participants out of their natural politeness may have exaggerated their satisfaction to please the interviewer, cannot be ruled out. The historical comparison within each participant's experience may also introduce a bias. A randomized controlled trial is required to address this issue.</p>
      <p>Nevertheless, our study suggests that the distribution of standard +10D spherical spectacles is inadequate, in terms of provision of best vision to the acceptors of intracapsular cataract surgery. The wide range of powers accepted by the participants necessitates proper refraction at six weeks post-operatively and provision of good quality spectacles of correct power. However, this would require another visit by the patient to the campsite for receiving the best-corrected aphakic spectacles and will also incur additional costs. It is likely that a patient who has come twice before, once for the surgery and the second time for removal of sutures will be willing to come again if he knows that the new pair of spectacles will provide him with better vision than the standard +10D spherical spectacles which are dispensed at the time of suture removal, 4–6 weeks operatively.</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>Thus we concluded from the study that following intracapsular cataract extraction, the provision of the best correction after cataract surgery is desirable to obtain an optimal visual outcome.</p>
    </sec>
    <sec>
      <title>Competing Interests</title>
      <p>None declared.</p>
    </sec>
    <sec>
      <title>Authors' Contributions</title>
      <p>Sanjeev K. Gupta : Instituting of the study, Collection of data, Data Compilation</p>
      <p>G.V.S. Murthy : Data compilation and data analysis</p>
      <p>Namrata Sharma: Data analysis and preparation of manuscript</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/9/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thylefors</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Negrel</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Pararajasegaram</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dadzie</surname>
              <given-names>KY</given-names>
            </name>
          </person-group>
          <article-title>Global data on blindness</article-title>
          <source>Bulletin World Health Org</source>
          <year>1995</year>
          <volume>73</volume>
          <fpage>115</fpage>
          <lpage>121</lpage>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <collab>World Health Organisation</collab>
          </person-group>
          <article-title>Available data on blindness. WHO Programme for the Prevention of Blindness</article-title>
          <year>1994</year>
          <comment>WHO/PBL/94.38</comment>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Mohan</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Jose R</surname>
            </name>
          </person-group>
          <article-title>Survey of blindness in India 1986–89 – results at a glance: All India estimates</article-title>
          <source>Present status of the National Programme for Control of Blindness (NPCB). Ophthalmology Section, DGHS, Ministry of Health and Family Welfare, Government of India, New Delhi</source>
          <year>1992</year>
          <fpage>81</fpage>
          <lpage>100</lpage>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwab</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Cost effective cataract surgery in developing nations</article-title>
          <source>Ophthalmic Surg</source>
          <year>1987</year>
          <volume>18</volume>
          <fpage>307</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="pmid">3108739</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwab</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Whitfield</surname>
              <given-names/>
            </name>
          </person-group>
          <article-title>Appropriate ophthalmic surgical technology in developing nations</article-title>
          <source>Ophthalmic Surg</source>
          <year>1982</year>
          <volume>13</volume>
          <fpage>991</fpage>
          <lpage>993</lpage>
          <pub-id pub-id-type="pmid">7162768</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Audit of results of cataract surgery</article-title>
          <source>Community Eye Health</source>
          <year>1992</year>
          <volume>10</volume>
          <fpage>1</fpage>
          <lpage>2</lpage>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reidy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mehra</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Minassian</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mahashabde</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Outcome of cataract surgery in Central India: a longitudinal follow-up study</article-title>
          <source>Br J Ophthalmol</source>
          <year>1991</year>
          <volume>75</volume>
          <fpage>102</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">1995036</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murthy</surname>
              <given-names>GVS</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>A community based evaluation of eyesight and spectacle use after intra-capsular cataract extraction in northern India</article-title>
          <source>J Trop Med Hyg</source>
          <year>1995</year>
          <volume>98</volume>
          <fpage>84</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">7714941</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murthy</surname>
              <given-names>GVS</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Talwar</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Assessment of cataract surgery in rural India: visual acuity outcome</article-title>
          <source>Acta Ophthalmol</source>
          <year>1996</year>
          <volume>74</volume>
          <fpage>60</fpage>
          <lpage>3</lpage>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hogeweg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sapkota</surname>
              <given-names>YD</given-names>
            </name>
            <name>
              <surname>Foster</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Acceptability of aphakic correction: results from Karnali eye camps in Nepal</article-title>
          <source>Acta Ophthalmol</source>
          <year>1992</year>
          <volume>70</volume>
          <fpage>407</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">1636407</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:239861</identifier><datestamp>2003-11-04</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">239861</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-3-10</article-id>
      <article-id pub-id-type="pmid">14529574</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-3-10</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Reviglio</surname>
            <given-names>Victor E</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>victorwilmer@aol.com</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Hakim</surname>
            <given-names>Melinda A</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>mhakim@jhmi.edu</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Jae K</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>navymed@hanmail.net</email>
        </contrib>
        <contrib id="A4" corresp="yes" contrib-type="author">
          <name>
            <surname>O'Brien</surname>
            <given-names>Terrence P</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>tobrien@jhmi.edu</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Ocular Microbiology and Immunology Laboratory, Refractive Surgery Research Laboratory, The Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>10</month>
        <year>2003</year>
      </pub-date>
      <volume>3</volume>
      <fpage>10</fpage>
      <lpage>10</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/10"/>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>4</month>
          <year>2003</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>10</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2003 Reviglio et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Reviglio et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Matrix metalloproteinases play an important role in extracellular matrix deposition and degradation. Based on previous clinical observations of corneal perforations during topical fluoroquinolone treatment, we decided to evaluate the comparative effects of various fluoroquinolone eye drops on the expression of matrix metalloproteinases (MMPs) in cornea.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>Eighty female Lewis rats were divided into two experimental groups: intact and wounded corneal epithelium. Uniform corneal epithelial defects were created in the right eye with application of 75% alcohol in the center of the tissue for 6 seconds. The treatment groups were tested as follows: 1) Tear drops: carboxymethylcellulose sodium 0.5 % (Refresh, Allergan); 2) Ciprofloxacin 0.3% (Ciloxan, Alcon); 3) Ofloxacin 0.3%(Ocuflox, Allergan); 4) Levofloxacin 0.5%(Quixin, Santen). Eye drops were administered 6 times a day for 48 hours. Rats were sacrificed at 48 hours. Immunohistochemical analysis and zymography were conducted using antibodies specific to MMPs-1, 2, 8 and 9.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>MMP-1, MMP-2, MMP-8 and MMP-9 expression were detected at 48 hrs in undebrided corneal epithelium groups treated with the topical fluoroquinolones. No statistical difference was observed in quantitative expression of MMPs among ciprofloxacin 0.3%, ofloxacin 0.3%, levofloxacin 0.5%. When the artificial tear group and the fluoroquinolone groups with corneal epithelial defect were compared, increased expression of MMPs was observed as a result of the wound healing process. However, the fluoroquinolone treated group exhibited high statistically significantly levels of MMPs expression.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Our study provides preliminary evidence that topical application of fluoroquinolone drugs can induce the expression of MMP-1, MMP-2, MMP-8 and MMP-9 in the undebrided corneal epithelium compared to artificial tear eye drops.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Fluoroquinolones</kwd>
        <kwd>Levofloxacin</kwd>
        <kwd>Ciprofloxacin</kwd>
        <kwd>Ofloxacin</kwd>
        <kwd>Matrix metalloproteinases</kwd>
        <kwd>Cornea</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Since their introduction in the United States over a decade ago, the quinolone antibacterial agents have become a mainstay in the treatment of serious bacterial infections. The fluoroquinolones are known for their extremely broad spectrum of antibacterial activity.[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>] They exert a bactericidal effect by inhibiting bacterial DNA synthesis through interference with the enzymes DNA gyrase and topoisomerase IV. The structural differences of the fluorinated carboxyquinolones commercially available, for topical ophthalmic use, alter their potency as well as their pharmacological profiles. To be clinically useful, antibiotics should be effective with minimal adverse effects. Although fluoroquinolones have been shown to be highly effective antibacterial agents, several clinical studies have reported a fluoroquinolone-induced tendinopathy with bone and articular damage associated with alterations in collagen deposition and chondrocyte function after systematic fluoroquinolone administration. [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>] Topical fluoroquinolone antibiotics are frequently administered prophylactically in post-surgical care and represent a therapeutic option in the treatment of infectious conjunctivitis and keratitis.[<xref ref-type="bibr" rid="B2">2</xref>] These are generally well tolerated and compare favorably with other topical antibiotics in terms of efficacy. However, it is interesting to note that most of the commercial fluoroquinolone ophthalmic solutions contain very low concentrations of the preservatives benzalkonium chloride or edetate disodium (Ciloxan at 0.006%, Ocuflox at 0.05 mg and Quixin at 0.005%) in their formulations. As it is known, much of the reported toxicity has been associated with the presence of certain preservatives in high concentrations (close to 0.1%) which is not the case with the current fluoroquinolone formulations studied. [<xref ref-type="bibr" rid="B6">6</xref>]<italic>In vivo </italic>animal and <italic>in vitro </italic>studies have also demonstrated that fluoroquinolone agents may adversely affect wound healing by exerting cytotoxic effects on corneal epithelial cells and keratocytes; however, the exact mechanism of fluoroquinolone toxicity is still unknown. [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B10">10</xref>]</p>
      <p>A recent study reported an increased incidence of ulcerative keratolysis with corneal perforation after topical fluoroquinolone treatment for microbial keratitis.[<xref ref-type="bibr" rid="B11">11</xref>] These findings led us to investigate the role of various commercially available fluoroquinolone eye drop formulations on the physiological remodeling of the corneal extracellular matrix by evaluating matrix metalloproteinase expression in cornea.</p>
      <p>Matrix metalloproteinases (MMPs) are involved in numerous physiological and pathological processes of corneal extracellular matrix remodeling and degradation. [<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B14">14</xref>] The proteolytic properties of these enzymes may play an important role in the unidentified mechanism of ulcerative keratolysis associated with the topical use of fluoroquinolone eye drops. The MMPs can be grouped into different subclasses according to their natural substrates. We focused on two specific groups: collagenases and gelatinases; evaluating the expression of interstitial collagenase (MMP-1) and PMN collagenase (MMP-8), both of which can be secreted by corneal cells and are able to cleave corneal stromal collagens. We assessed the expression of 72-kDa gelatinase A (MMP-2) and 92-kDa gelatinase B (MMP-9) as well. These gelatinases help to degrade the basement membrane and act cooperatively with the collagenases to completely degrade interstitial corneal collagens.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>Eighty female Lewis rats each weighing 250 g were first divided into two experimental groups. Each rat was prepared to produce a debrided corneal epithelium in the right eye and intact corneal epithelium in the left eye. The animals were then randomly divided into four experimental test groups of 20 rats each, as follows: Group 1 received tear drops consisting of carboxymethylcellulose sodium 0.5% (Refresh, Allergan, Irvine, CA); Group 2 received ciprofloxacin 0.3% (Ciloxan, Alcon, Fort Worth, TX); Group 3 was instilled ofloxacin 0.3% (Ocuflox, Allergan, Irvine, CA); finally, group 4 received levofloxacin 0.5%(Quixin, Santen, Napa, CA).</p>
      <p>All of the animals were treated in accordance with the tenets of the Association for Research in Vision and Ophthalmology (ARVO) statement for the use of animals in Ophthalmic and Vision Research.</p>
      <p>Anesthesia was achieved by intramuscular injection of 0.5 ml/kg body weight of a mixture 1:1 of 100 mg/ml ketamine and 20 mg/ml xylazine. Uniform corneal epithelial defects were created in the right eyes with the application of a filter paper disk soaked in 75% ethanol solution in the center of the tissue for 60 seconds. Immediately after the procedure, treated eyes were thoroughly irrigated with balanced salt solution. The left eye served as an intact epithelium control in each rat. Eye drops were instilled six times/day for 48 hours. Rats were sacrificed at 48 hours after initiation of treatment. The corneas from fifty six rats were removed at the scleral ring, embedded in ornithine carbamoyltransferase compound (OCT Tissue-Tek, Miles Inc., Elkhart, USA), and frozen at -80°C. Cryostat sections of 8 μm from all corneas were stained with hematoxylin and eosin, or immunohistochemically using antibodies specific for MMP-1, MMP-2, MMP-8 and MMP-9. We used six rats from each treatment group (n = 24) to perform immunoblotting and zymography studies.</p>
      <sec>
        <title>Immunohistochemistry</title>
        <p>Immunohistochemical staining was performed using an avidin-biotin-peroxidase complex technique. Primary antibodies consisted of polyclonal antibodies recognizing epitopes of both the pro- and active forms of MMP-1 and MMP-8 (Chemicon, Temecula, CA) as well as monoclonal antibodies against MMP-2 and MMP-9 (Oncogene, Cambridge, MA and Chemicon, Temecula, CA respectively). The primary antibodies were applied to the corneal sections and incubated at room temperature for 1 hour. After washing with TBS (20 mM Tris-HCl pH 7.5, 150 mM NaCL), a biotin-labeled secondary antibody, either goat anti-rabbit or horse anti-mouse IgG (Vector Laboratories, Burlingame, CA) was used. Finally, after incubation with the avidin-biotin-peroxidase complex (Vector Laboratories, Burlingame, CA), slides were developed in 3,3' diaminobenzidine and counterstained with 1 % methyl green in methanol. Analysis of immunostaining was performed to determine possible statistical significance between the artificial tear group and the fluoroquinolone treated groups. All samples were stained in parallel to minimize specimen variation and cell staining intensity was graded by a masked observer. A statistical calculation and significant differences in immunostaining between the treated groups and the artificial tear control group were defined as p &lt; 0.05 by Fisher's exact test.</p>
        <p>To quantify the metalloproteinase expression after the application of fluoroquinolone eye drops, the four test groups were analyzed by western-blot and zymography.</p>
      </sec>
      <sec>
        <title>Zymography</title>
        <p>MMP-2 and MMP-9 levels were also assayed by zymography. Debrided (n = 24) and intact rat corneas (n = 24) from the four treatment groups were dissected and trephined (3 mm) at 48 hours and immediately cultivated in a 24-well culture dish with 500 μl of serum-free medium (MEM + minimal essential amino acid + antibiotic/antimycotic) at 37°C, 5% CO<sub>2 </sub>atmosphere for 72 hours. Each and every conditioned media aliquot was subjected to gel electrophoresis (10% SDS polyacrylamide gel containing 1 mg/ml gelatin) under nonreducing conditions. Fifteen microliters of each conditioned medium and zymography sample buffer were combined and incubated at room temperature for 5 minutes. Electrophoresis was carried out at 100 to 150 volts for 2–4 hours. The gels were washed in renaturing buffer (Bio-Rad Laboratories, Hercules, CA) for 30 minutes at room temperature, incubated with development buffer (Bio-Rad) at 37°C for 16 hours, stained for 3 hours with Coomassie Brillant Blue R-250, and destained with three changes (15, 30, 60 minutes) of destain solution (Bio-Rad Laboratories).</p>
      </sec>
      <sec>
        <title>Immunoblot Assays</title>
        <p>The levels of MMP-1 and MMP-8 in the cornea-conditioned culture medium were assessed by Western blot. The blot was probed with polyclonal antibodies against MMP-1 or MMP-8, (Chemicon, CA). Fifteen microliters of conditioned medium was mixed with electrophoresis Laemmli buffer and heated at 90°C for 5 minutes, and then kept on ice. The samples were run on 10% polyacrylamide SDS gel at 100 volts for 2 hours, and transferred to nitrocellulose membranes at 120 volts for 2 hours (Bio-Rad Richmond, CA). The nitrocellulose paper was agitated in blocking buffer at room temperature (PBS, 0.05% Tween 20, 0.5% non-fat dry milk) for 1 hour. The primary antibody (1:5000 dilution) and secondary antibody (1:2000 dilution) incubations were carried out for 1 hour respectively. After three washes with TBS-T (TBS, 0.05% Tween-20), the membranes were incubated in enhanced chemiluminescence solution (Amersham Life Science, Arlington Heights, IL) followed by exposure to chemiluminescence film for 15 seconds.</p>
      </sec>
      <sec>
        <title>Statistical Analysis</title>
        <p>The western blots and zymograms from all treated eyes, each one in duplicate were subjected to densitometry analysis. The statistical analysis was done using one-way ANOVA test, Dunnett's multiple comparison test and Bonferroni test (SPSS, ver. 10.0 for Windows; SPSS Inc., Chicago, IL) and Microstat-Ecosoft Inc. (Indianapolis, Inc.), the values lower than 0.05 was considered statistically significant (fluoroquinolone treated groups compared to artificial tear treated group as control). The quantification of metalloproteinase values of each X-ray film and gel zymograms from all treated eyes were performed by scanning densitometry (Molecular Dynamics, Sunnyvale, CA).</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <p>Using immunohistochemical staining we found positive collagenases MMP-1 and MMP-8 staining in the wounded corneal epithelium of the artificial tear group and the absence of MMP staining in the unwounded eyes of the same group (Table <xref ref-type="table" rid="T1">1</xref>). These results are consistent with an established correlation between the wound healing and extracellular matrix remodeling process and the up-regulation of MMPs. The current artificial tear solution was demonstrated to be innocuous to the corneal tissue and did not have any effect on the expression of corneal metalloproteinases in unwounded corneal epithelium.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Effects of Topical fluoroquinolones on Collagenase-type Metalloproteinases Immunohistochemical detection at 48 Hours</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="left">Type of eye drops</td>
              <td/>
              <td align="left">
                <bold>MMP-1</bold>
              </td>
              <td align="left">
                <bold>MMP-8</bold>
              </td>
            </tr>
            <tr>
              <td align="left">Applied q.i.d.</td>
              <td align="left">Epithelium</td>
              <td/>
              <td/>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">
                <bold>Artificial Tear</bold>
              </td>
              <td align="left">Intact</td>
              <td align="left">0/14</td>
              <td align="left">0/14</td>
            </tr>
            <tr>
              <td/>
              <td align="left">Debrided</td>
              <td align="left">14/14</td>
              <td align="left">13/14</td>
            </tr>
            <tr>
              <td align="left">
                <bold>Ciloxan</bold>
              </td>
              <td align="left">Intact</td>
              <td align="left">14/14 **</td>
              <td align="left">13/14 **</td>
            </tr>
            <tr>
              <td/>
              <td align="left">Debrided</td>
              <td align="left">14/14</td>
              <td align="left">14/14</td>
            </tr>
            <tr>
              <td align="left">
                <bold>Ocuflox</bold>
              </td>
              <td align="left">Intact</td>
              <td align="left">13/14**</td>
              <td align="left">12/14**</td>
            </tr>
            <tr>
              <td/>
              <td align="left">Debrided</td>
              <td align="left">14/14</td>
              <td align="left">14/14</td>
            </tr>
            <tr>
              <td align="left">
                <bold>Quixin</bold>
              </td>
              <td align="left">Intact</td>
              <td align="left">13/14**</td>
              <td align="left">12/14**</td>
            </tr>
            <tr>
              <td/>
              <td align="left">Debrided</td>
              <td align="left">14/14</td>
              <td align="left">14/14</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>Double masked observer determined the total positive immunostained eyes for MMP-1 and MMP-8 in each test group. Immunoreactivity is reported as number of positively immunostained corneas / total number of corneas examined. ** Statistically different when comparing the corresponding fluoroquinolone group to artificial tear. (P &lt; 0.05 using Fisher's exact test analysis).</p>
        </table-wrap-foot>
      </table-wrap>
      <p>We also examined the MMP expression after the application of commercially available fluoroquinolone eye drops. Analysis of immunohistochemical staining disclosed a positive staining for metalloproteinase at corneal epithelium and superficial stroma. Interestingly, the percentage of eyes positively staining for MMP-1 and MMP-8 was not found to be significantly different between unwounded groups treated with each of the commercially available fluoroquinolone eye drops. This result indicates that the fluoroquinolone ophthalmic solutions are the major trigger for the increased expression of these MMPs in the normal corneal epithelium. In previous studies, we also observed MMP-8 expression at the level of the corneal epithelium associated with ulcerative keratolysis. These findings identify a novel source of MMP-8 expression at the corneal epithelial cells as a non-PMN cellular source of this collagenase. Using hematoxylin-eosin stain, the polymorpho nuclear neutrophils (PMNs) were identified on the basis of their characteristic multilobed nucleus and staining pattern. In the current study, the fluoroquinolone treatment causes a non significant increase of PMNs in unwounded corneas compared to the artificial tear group at 48 hours. Figure <xref ref-type="fig" rid="F1">1</xref> illustrates MMP-1 immunostaining primarily in the epithelial cells and occasionally in the superficial stromal keratocytes of intact corneas of the fluoroquinolone treated groups.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Immunolocalization of MMP-1 in intact corneal epithelium at 48 hours is shown for each treatment group. Panel <bold>a</bold>: artificial tears; panel <bold>b</bold>: Ciprofloxacin 0.3%; panel c: Ofloxacin 0.3%; panel <bold>d</bold>: Levofloxacin 0.5%. A photomicrograph of the artificial tear group shows negative corneal staining for MMP-1. However, intense corneal epithelial and superficial stromal expression of MMP-1 was identified in intact corneal epithelium groups treated with fluoroquinolone eye drops (panel's b-d). The presence of MMP-1 was detected mostly in the corneal epithelial cells (arrows). (Immunohistochemistry, ×400 magnification).</p>
        </caption>
        <graphic xlink:href="1471-2415-3-10-1"/>
      </fig>
      <p>To confirm the results illustrated by immunohistochemical staining and to provide a more accurate quantitative analysis, we used western blotting and zymography techniques to study the early MMP expression after fluoroquinolone eye drop treatment. The values of each MMP bands from western blots and zymography studies made in all treated eyes were quantified by densitometry analysis and also studied statistically to indicate any significance between each fluoroquinolone treated groups and the artificial tear group (Figure <xref ref-type="fig" rid="F4">4A</xref> through <xref ref-type="fig" rid="F4">4D</xref>).</p>
      <p>A comparison of topical artificial tear group as control versus groups treated with ciprofloxacin, ofloxacin and levofloxacin on the expression of corneal metalloproteinases was conducted. These studies also disclosed that the application of the present ophthalmic fluoroquinolone solutions (Ciloxan, Ocuflox and Quixin) increases MMP-1, MMP-8 (immunoblots, figure <xref ref-type="fig" rid="F2">2</xref>) and MMP-2, MMP-9 (zymography, figure <xref ref-type="fig" rid="F3">3</xref>) expression in both intact and wounded corneas although the levels of expression may be slightly different among various groups. In accordance with our previous findings, treatment with the artificial tear does not appreciably induce the expression of MMPs in intact corneal epithelium. The MMP up-regulation detected in all groups of wounded eyes presumably resulted from the wound healing process and extracellular matrix remodeling. However, the expression of MMPs in wounded eyes was up-regulated by the topical application of the fluoroquinolone drugs when compared to the artificial tear treated group. The results presented in this study demonstrated a statistically significant difference between fluoroquinolone treated groups (P &lt; 0.0001) versus artificial tear treated group as control in the expression of corneal metalloproteinases.</p>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>A representative western blot of MMP-1 and MMP-8 expression of supernatant samples from control (artificial tear) and the fluoroquinolone test groups. Corneas with debrided (OD) and intact (OS) epithelium were analyzed. 1. MW; 2. Tears OS; 3. Tears OD; 4. Ciprofloxacin OS; 5. Ciprofloxacin OD; 6. Ofloxacin OS; 7. Ofloxacin OD; 8. Levofloxacin OS; 9. Levofloxacin OD The molecular sizes of both MMPs were calculated based on a molecular weight standard and recorded in kilodaltons (kDa). The fluoroquinolone eye drops increased the expression of both metalloproteinases, MMP-1 (42 kDa) and of MMP-8 (64 kDa) in intact corneas; whereas, the expression of these MMPs was negative in the controls treated with artificial tears.</p>
        </caption>
        <graphic xlink:href="1471-2415-3-10-2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>Typical gelatin zymography analyses of gelatinase A (MMP-2) and gelatinase B (MMP-9) expression in artificial tear group rat and in the test groups were performed. Corneal conditioned medium samples from debrided (OD) and intact (OS) corneal epithelium of each group were analyzed. 1. Tears OD; 2. Tears OS; 3. Levofloxacin 0.5% OD; 4. Levofloxacin 0.5% OS; 5. Ciprofloxacin OD; 6. Ciprofloxacin OS; 7. Ofloxacin OD; 8. Ofloxacin OS. MMP-9 (92 kDa) and MMP-2 (72 kDa) expression were up regulated in fluoroquinolone treated corneas and were present at basal level in unwounded corneas receiving artificial tears. Corneal epithelium debridement up regulated the expression of MMP-9 and MMP-2 in all test groups.</p>
        </caption>
        <graphic xlink:href="1471-2415-3-10-3"/>
      </fig>
      <fig position="float" id="F4">
        <label>Figure 4</label>
        <caption>
          <p>Effects of fluoroquinolone eye drops on the corneal rat's metalloproteinases expression. The bands densities of western immunoblots for MMP-1 (A) and MMP-8 (B) and zymograms for MMP-2 (C), MMP-9 (D) were subjected to densitometry analysis, the statistical significance was determined by one-way ANOVA test (values are means, error bars). <italic>P </italic>&lt; 0.05 was considered statistically significant when compared fluoroquinolones groups vs. artificial tear group. Note the highest values of MMPs levels from topical fluoroquinolone groups compared to artificial tear group in unwounded corneas.</p>
        </caption>
        <graphic xlink:href="1471-2415-3-10-4"/>
      </fig>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>Fluoroquinolones are one class of synthetic antibacterial agents, which inhibit the bacterial topoisomerases involved in bacterial DNA replication. Since the 1980s, the U.S. Food and Drug Administration has approved several generations of fluoroquinolones. Recently, levofloxacin 0.5% solution, a third generation fluoroquinolone, was introduced as a commercial eye drop for clinical use in therapy of acute bacterial conjunctivitis. The unique structure of this drug differs from other fluoroquinolones conferring high solubility to potentially allow formulation at higher concentrations. It also extends the Gram-positive spectrum; and enhances the activity against anaerobic microbes while maintaining Gram-negative activity.[<xref ref-type="bibr" rid="B1">1</xref>] Fluoroquinolones are generally well tolerated with minimal side effects when used appropriately.[<xref ref-type="bibr" rid="B15">15</xref>] However, several <italic>in vitro </italic>and <italic>in vivo </italic>studies have demonstrated that both ciprofloxacin and ofloxacin eye drops significantly delay corneal wound healing.[<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B16">16</xref>] In addition, ciprofloxacin hydrochloride 0.3% solution has demonstrated a tendency for precipitation with corneal crystal deposition, mainly in association with the pH dependent solubility of the eye drop formulation.[<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>] The above mentioned studies suggest that the current commercially available topical fluoroquinolone agents, and their accompanying preservatives, have cytotoxic effects on corneal cells.</p>
      <p>The metalloproteinases are potent enzymes that are capable of degrading a wide range of extracellular matrix components. Numerous studies have documented the important role of matrix metalloproteinases in the corneal wound healing process.[<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>] The perturbation of the normal regulation of degradative processes may result in the accelerated breakdown of connective tissues and may lead to conditions such as ulcerative keratolysis. There is increasing experimental and clinical evidence that during corneal injury and inflammation, MMPs play a major role in the proteolytic processes, which can predispose the cornea to perforation.[<xref ref-type="bibr" rid="B21">21</xref>] Thus, this study focuses on evaluating the expression of MMPs after the use of commercially available fluoroquinolone eye drops in order to elucidate a relationship between keratolysis, corneal perforation and the use of ophthalmic fluoroquinolone drugs as reported in previous clinical studies.[<xref ref-type="bibr" rid="B11">11</xref>] The findings in the current study provide the first evidence that some undesirable effects on corneal wound healing from the use of specific fluoroquinolone eye drops (or their use in vulnerable corneal epithelium) may be secondary to the over-expression of the metalloproteinases. Furthermore, the results of our study clearly demonstrate that the commercial fluoroquinolone ophthalmic agents tested stimulate expression of corneal collagenases (MMP-1 and MMP-8) and gelatinases (MMP-2 and MMP-9) in normal eyes compared to a negative expression of MMPs in the artificial tear group. Additional studies are required to confirm the exact cellular origin of MMP-8 expressed in corneal tissue, although it is now recognized that cell types other than PMNs can express this collagenase.</p>
      <p>Recent <italic>in vivo </italic>and <italic>in vitro </italic>studies indicate that the pathologic mechanism with fluoroquinolones may be related to significant increases of matrix-degrading proteolytic activity, inhibitory effects on cell metabolism, as well as the degenerative and ultrastructural cell changes with increased levels and interferences in the regulative pathways of several cytokines. [<xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B26">26</xref>] The clinical significance of these findings revolve around two main questions: how is the expression of these matrix metalloproteinase increased after the application of topical fluoroquinolone eye drops? and how significant are the eye drop preservatives at low concentration in stimulating MMP expression in the cornea? A new generation fluoroquinolone agent, moxifloxacin 0.5% (Vigamox, Alcon Labs, Fort Worth, TX) is commercially formulated without preservatives. Further studies addressing these important questions and explaining the cascade of factors involved in producing this increased expression of MMPs seem warranted. Physicians should be aware of the possible consequences of using fluoroquinolones for both normal and impaired corneal tissue especially with a prophylactic aim. Clinical decisions should balance safety with efficacy especially in the light of studies, such as this one, documenting the potential for corneal cytotoxicity and wound healing impairment after the topical application of commercially available fluoroquinolone drugs.</p>
    </sec>
    <sec>
      <title>Competing Interests</title>
      <p>None declared.</p>
    </sec>
    <sec>
      <title>Authors' Contributions</title>
      <p>Victor E. Reviglio, MD: AB, JY</p>
      <p>Melinda A. Hakim, MD: JY</p>
      <p>Jae K. Song, MD: JY, ES</p>
      <p>Terrence P. O'Brien, MD: FG</p>
      <p>Victor E. Reviglio, Melinda A. Hakim and Jae K. Song carried out animal model, sample preparation, microscopy, immunostaining, zymography and immunoblotting.</p>
      <p>Victor E. Reviglio and Terrence P. O'Brien were both involved in the experimental design, data analysis and preparation of manuscript.</p>
      <p>All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/3/10/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>The authors would like to thanks Dr. Juan C. Muiño for providing the statistical assistance.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Graves</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Henry</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Van Buskirk</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Trousdale</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>In Vitro Susceptibilities of Bacterial Ocular Isolates to Fluoroquinolones</article-title>
          <source>CORNEA</source>
          <year>2001</year>
          <volume>20</volume>
          <fpage>301</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="pmid">11322420</pub-id>
          <pub-id pub-id-type="doi">10.1097/00003226-200104000-00012</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Brien</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Maguire</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Alfonso</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>McDonnell</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy of bacterial keratitis</article-title>
          <source>Arch Ophthalmol</source>
          <year>1995</year>
          <volume>113</volume>
          <fpage>1257</fpage>
          <lpage>1265</lpage>
          <pub-id pub-id-type="pmid">7575256</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrell</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Fluoroquinolone-induced tendinopathy. What do we know?</article-title>
          <source>South Med J</source>
          <year>1999</year>
          <volume>92</volume>
          <fpage>622</fpage>
          <lpage>625</lpage>
          <pub-id pub-id-type="pmid">10372859</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huston</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Achilles tendonitis and tendon rupture due to fluoroquinolone antibiotics (Letter)</article-title>
          <source>N Eng J Med</source>
          <year>1994</year>
          <volume>331</volume>
          <fpage>748</fpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199409153311116</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Redmond</surname>
              <given-names>AO</given-names>
            </name>
          </person-group>
          <article-title>Risk-benefit experience of ciprofloxacin use in pediatric patients in the United Kingdom</article-title>
          <source>Pediatr Infect Dis J</source>
          <year>1997</year>
          <volume>16</volume>
          <fpage>147</fpage>
          <lpage>9</lpage>
          <comment>discussion 160–2</comment>
          <pub-id pub-id-type="pmid">9002126</pub-id>
          <pub-id pub-id-type="doi">10.1097/00006454-199701000-00040</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burstein</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title>Corneal cytotoxicity of topically applied drugs, vehicles and preservatives</article-title>
          <source>Surv Ophthalmol</source>
          <year>1980</year>
          <volume>25</volume>
          <fpage>15</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">6998034</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cutarelli</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Lass</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Lazarus</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Putman</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity</article-title>
          <source>Curr Eye Res</source>
          <year>1991</year>
          <volume>10</volume>
          <fpage>557</fpage>
          <lpage>563</lpage>
          <pub-id pub-id-type="pmid">1893771</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seitz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wee</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>LaBree</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>McDonnell</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>In vitro effects of aminoglycosides and fluoroquinolones on keratocytes</article-title>
          <source>Invest Ophthal Vis Sci</source>
          <year>1996</year>
          <volume>37</volume>
          <fpage>656</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="pmid">8595966</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morlet</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Minassian</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Butcher</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Ofloxacin Study Groups. Risk factors for treatment of suspected microbial keratitis</article-title>
          <source>Br J Ophthalmol</source>
          <year>1999</year>
          <volume>83</volume>
          <fpage>1027</fpage>
          <lpage>1031</lpage>
          <pub-id pub-id-type="pmid">10460769</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bekoe</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Ashraf</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
          <article-title>Effects of ciprofloxacin, ofloxacin and gentamicin on corneal cells and wound healing</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1999</year>
          <volume>40</volume>
          <fpage>S548</fpage>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mallari</surname>
              <given-names>PLT</given-names>
            </name>
            <name>
              <surname>McCarty</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Daniell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis</article-title>
          <source>Am J Ophthalmol</source>
          <year>2001</year>
          <volume>131</volume>
          <fpage>131</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="pmid">11162991</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0002-9394(00)00642-5</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Massova</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kotra</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Fridman</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Matrix metalloproteinases: structures, evolution and diversification</article-title>
          <source>FASEB J</source>
          <year>1998</year>
          <volume>12</volume>
          <fpage>1075</fpage>
          <lpage>1095</lpage>
          <pub-id pub-id-type="pmid">9737711</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fini</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Parks</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Rinehart</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Girard</surname>
              <given-names>MT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury</article-title>
          <source>Am J Pathol</source>
          <year>1996</year>
          <volume>149</volume>
          <fpage>1287</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="pmid">8863676</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ye</surname>
              <given-names>HQ</given-names>
            </name>
            <name>
              <surname>Azar</surname>
              <given-names>DT</given-names>
            </name>
          </person-group>
          <article-title>Statement of gelatinases A and B, and TIMPs 1 and 2 during wound healing</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1998</year>
          <volume>39</volume>
          <fpage>913</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">9579471</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leibowitz</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Antibacterial effectiveness of ciprofloxacin 3% ophthalmic solution in the treatment of bacterial conjunctivitis</article-title>
          <source>Am J Ophthalmol</source>
          <year>1991</year>
          <volume>112</volume>
          <fpage>29S</fpage>
          <lpage>33S</lpage>
          <pub-id pub-id-type="pmid">1928271</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moreira</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>LaBree</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>McDonnell</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Effect of topical fluoroquinolones on corneal re-epithelialization after excimer laser keratectomy</article-title>
          <source>J Cataract Refract Surg</source>
          <year>1997</year>
          <volume>23</volume>
          <fpage>845</fpage>
          <lpage>848</lpage>
          <pub-id pub-id-type="pmid">9292666</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Essepian</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Rajpal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
          <article-title>Tandem scanning confocal microscopic analysis of ciprofloxacin corneal deposits in vivo</article-title>
          <source>Cornea</source>
          <year>1995</year>
          <volume>14</volume>
          <fpage>402</fpage>
          <lpage>407</lpage>
          <pub-id pub-id-type="pmid">7671612</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kanellopoulos</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wittpenn</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Deposition of topical ciprofloxacin to prevent re-epithelialization of corneal defect (Letter)</article-title>
          <source>Am J Ophthalmol</source>
          <year>1994</year>
          <volume>117</volume>
          <fpage>258</fpage>
          <lpage>259</lpage>
          <pub-id pub-id-type="pmid">8116756</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fini</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Yue</surname>
              <given-names>YJT</given-names>
            </name>
            <name>
              <surname>Sugar</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Collagenolytic / gelatinolytic metalloproteinases in normal and keratoconus corneas</article-title>
          <source>Curr Eye Res</source>
          <year>1992</year>
          <volume>11</volume>
          <fpage>849</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">1424728</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Birkedal-Hansen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Bodden</surname>
              <given-names>MK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Matrix metalloproteinases: a review</article-title>
          <source>Crit Rev Oral Biol Med</source>
          <year>1993</year>
          <volume>4</volume>
          <fpage>197</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="pmid">8435466</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Brien</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>QJ</given-names>
            </name>
            <name>
              <surname>Sauerburger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Reviglio</surname>
              <given-names>VE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use</article-title>
          <source>Ophthalmology</source>
          <year>2001</year>
          <volume>108</volume>
          <fpage>656</fpage>
          <lpage>659</lpage>
          <pub-id pub-id-type="pmid">11297478</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(00)00590-X</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Riesbeck</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sigvardsson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leanderson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Forsgren</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Superinduction of cytokine gene transcription by ciprofloxacin</article-title>
          <source>J Immunol</source>
          <volume>153</volume>
          <fpage>343</fpage>
          <lpage>52</lpage>
          <comment>1994 Jul 1</comment>
          <pub-id pub-id-type="pmid">8207247</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>RJ</given-names>
              <suffix>III</suffix>
            </name>
            <name>
              <surname>Attia</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wickiewicz</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Hannafin</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism</article-title>
          <source>Am J Sports Med</source>
          <year>2000</year>
          <volume>28</volume>
          <fpage>364</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">10843129</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shakibaei</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stahlmann</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Ultrastructure of Achilles tendon from rats after treatment with fleroxacin</article-title>
          <source>Arch Toxicol</source>
          <year>2001</year>
          <volume>75</volume>
          <fpage>97</fpage>
          <lpage>102</lpage>
          <pub-id pub-id-type="pmid">11354912</pub-id>
          <pub-id pub-id-type="doi">10.1007/s002040000203</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egerbacher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seiberl</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wolfesberger</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Ciprofloxacin causes Cytoskeletal changes and detachment of human and rat chondrocytes in vitro</article-title>
          <source>Arch Toxicol</source>
          <year>2000</year>
          <volume>73</volume>
          <fpage>557</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">10663387</pub-id>
          <pub-id pub-id-type="doi">10.1007/s002040050008</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Shakibaei</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stahlmann</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Ultrastructural changes induced by the des-F(6)-quinolone garenoxacin (BMS-284756) and two fluoroquinolones in Achilles tendon from immature rats</article-title>
          <source>Arch Toxicol</source>
          <year>2003</year>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:362876</identifier><datestamp>2004-03-11</datestamp><setSpec>bmcopht</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-title>BMC Ophthalmology</journal-title>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">362876</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-4-1</article-id>
      <article-id pub-id-type="pmid">15018630</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-4-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Technical Advance</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Variability of wavefront aberration measurements in small pupil sizes using a clinical Shack-Hartmann aberrometer</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" equal-contrib="yes" corresp="yes" contrib-type="author">
          <name>
            <surname>Ginis</surname>
            <given-names>Harilaos S</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>ginis@med.uoc.gr</email>
        </contrib>
        <contrib id="A2" equal-contrib="yes" contrib-type="author">
          <name>
            <surname>Plainis</surname>
            <given-names>Sotiris</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>plainis@med.uoc.gr</email>
        </contrib>
        <contrib id="A3" equal-contrib="yes" contrib-type="author">
          <name>
            <surname>Pallikaris</surname>
            <given-names>Aristophanis</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>apallik@med.uoc.gr</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Vardinoyiannion Eye Institute of Crete (VEIC), Department of Ophthalmology, School of Medicine, University of Crete, Heraklion, Crete, Greece</aff>
      <pub-date pub-type="collection">
        <year>2004</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>2</month>
        <year>2004</year>
      </pub-date>
      <volume>4</volume>
      <fpage>1</fpage>
      <lpage>1</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/4/1"/>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>10</month>
          <year>2003</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>2</month>
          <year>2004</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2004 Ginis et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2004</copyright-year>
        <copyright-holder>Ginis et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Recently, instruments for the measurement of wavefront aberration in the living human eye have been widely available for clinical applications. Despite the extensive background experience on wavefront sensing for research purposes, the information derived from such instrumentation in a clinical setting should not be considered a priori precise. We report on the variability of such an instrument at two different pupil sizes.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>A clinical aberrometer (COAS Wavefront Scienses, Ltd) based on the Shack-Hartmann principle was employed in this study. Fifty consecutive measurements were perfomed on each right eye of four subjects. We compared the variance of individual Zernike expansion coefficients as determined by the aberrometer with the variance of coefficients calculated using a mathematical method for scaling the expansion coefficients to reconstruct wavefront aberration for a reduced-size pupil.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Wavefront aberration exhibits a marked variance of the order of 0.45 microns near the edge of the pupil whereas the central part appears to be measured more consistently. Dispersion of Zernike expansion coefficients was lower when calculated by the scaling method for a pupil diameter of 3 mm as compared to the one introduced when only the central 3 mm of the Shack – Hartmann image was evaluated. Signal-to-noise ratio was lower for higher order aberrations than for low order coefficients corresponding to the sphero-cylindrical error. For each subject a number of Zernike expansion coefficients was below noise level and should not be considered trustworthy.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Wavefront aberration data used in clinical care should not be extracted from a single measurement, which represents only a static snapshot of a dynamically changing aberration pattern. This observation must be taken into account in order to prevent ambiguous conclusions in clinical practice and especially in refractive surgery.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Since the application of excimer laser technology for the correction of eye's simple refractive errors (i.e. defocus and astigmatism), there has been a considerable debate concerning the visual impact of correcting the higher order monochromatic aberrations of the eye (e.g. spherical aberration, coma and secondary astigmatism), which also degrade retinal image quality [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B4">4</xref>]. Advances in the measurement of the eye's wave aberration have led to the emergence of sophisticated instrumentation for the clinical evaluation of the ocular higher-order aberrations. In general, these devices typically represent the aberrations as a wavefront-error map at the corneal or pupil plane.</p>
      <p>Among other subjective and objective techniques which are now available for measuring ocular aberrations (e.g. the Spatially Resolved Refractometer (SRR)[<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>], the Tscherning aberrometer[<xref ref-type="bibr" rid="B7">7</xref>] and the Retinal ray-tracing[<xref ref-type="bibr" rid="B8">8</xref>], Shack-Hartmann based instruments [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>] have become the most widely adopted. Aberrometry is rapidly making its way into the clinic and has already been applied in measuring aberrations of normal[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>] or clinically abnormal eyes (eg dry, keratoconic) [<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B16">16</xref>], eyes undergone refractive surgery [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B20">20</xref>], as well as <italic>in situ </italic>aberration structures of soft and RGP contact lenses [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>] and intraocular lenses (IOLs)[<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>].</p>
      <p>Recently, the clinical measurement of higher-order aberrations has become important for patient care. There is currently a major ongoing effort to refine laser refractive surgery, with the aim to eliminate higher order aberrations. In principle, wavefront aberration is measured using devices such as the Hartmann-Shack wavefront sensor. This information is then fed to a computer that generates the excimer laser's scanning pattern to allow simple refractive errors as well as higher order aberrations to be corrected. Preliminary results are still tentative as no clinically significant difference between conventional and wavefront-guided ablations has been demonstrated[<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B27">27</xref>].</p>
      <p>Moreover, there have been studies using state-of-the-art aberrometers to evaluate the refractive state[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B28">28</xref>] and the accommodative response[<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>] of the human eye. Therefore, an obvious requirement of each of these devices is accuracy and repeatability of the measurement of the low order (sphero-cylindrical error) as well as the higher-order aberrations of the eye. Several studies have addressed the accuracy and the repeatability of static measurements of wavefront aberration[<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. These studies have shown that, although there is some variation arising from a combination of misalignment errors and small drifts in the measuring equipment, these are well beyond the clinicians' normal operation range. However, the use of a single measurement of the wavefront error in the planning of a custom correction is not recommended[<xref ref-type="bibr" rid="B32">32</xref>].</p>
      <p>In this study, we used a clinical aberrometer to evaluate the variability of low and higher order aberrations at different pupil sizes, since no standard pupil has been established for reporting ocular aberrations. Morever, we compared the variance of individual Zernike coefficients as determined by the aberrometer with the variance of coefficients calculated with a matrix method that reconstructs a new set of expansion coefficients appropriate for any reduced-size pupil.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Subjects</title>
        <p>Four right eyes of four subjects aged between 23 and 33 years (mean age: 29.2 years) were tested. One subject was emmetropic (AP: plano), two were low myopes (SP: -2.00 / -0.25 × 30, HG: -1.75 / -1.25 × 86), and one was an intermediate myope (OL: -4.75 / -0.25 × 10). None of the subjects had any ocular pathology or had undergone any kind of refractive surgery. Subjects were familiarised with the measurements. Prior to data collection, institutional research board approval was obtained.</p>
      </sec>
      <sec>
        <title>Instrumentation</title>
        <p>The monochromatic aberration function of the eye was measured using the Complete Ophthalmic Analysis System (COAS, Wavefront Sciences Ltd), which is based on the Shack-Hartmann principle as described elsewhere[<xref ref-type="bibr" rid="B9">9</xref>]. COAS also provides a real time display of the pupil image, which is used to objectively measure pupil size to the nearest 0.1 mm. COAS uses an 840 nm infrared super-luminescent diode as the light source and utilises a square lenslet array of 33 × 44 (a total of 1452 lenslets). The diameter of each lenslet is 144 μm. According to the manufacturers the pupil magnification factor is about 0.685, which means that the lenslet array samples the exiting wavefront every 210 μm in the pupil plane. This allows approximately 600 sample points within a 6.0 mm diameter pupil (150 sample point within a 3.0 mm diameter pupil), providing very high resolution sampling of the aberration. The software allows continuous recording of Shack – Hartmann images and pupil size with an exposure time of about 130 ms for each frame capture, i.e. a temporal frequency of 7.7 Hz. The data extracted from COAS, consist of a set of Zernike coefficients (up to 4<sup>th </sup>order) in Malacara format, that quantify the type and the magnitude of aberrations present. The ordering of Zernike coefficients was transposed to the format recommended by the Optical Society of America (OSA)[<xref ref-type="bibr" rid="B33">33</xref>].</p>
      </sec>
      <sec>
        <title>Procedure</title>
        <p>All measurements were performed on natural pupils without the use of any dilating or cycloplegic drug. Room illuminance was set at mesopic light levels. Large pupil analysis was based on the full pupil, which, at these lighting conditions, varied for each subject (ranged between 4.5 and 7.1 mm). The subject positioned his head on the chin rest and fixated on the centre of a circular grid. The operator manually aligned the subject's pupil centre with the optical axis of the device by means of six dots (that lie on a circle concentric with the pupil) displayed on a video monitor. This ensured that subject's line-of-sight was coaxial with the instrument's optical axis. A series of fifty consecutive measurements (total recording time 6.5 sec) for each eye were taken for the full pupil without re-alignment. Subjects were asked to blink prior to the measurement. In addition to subjects, we measured the wave aberration of an artificial eye supplied by the manufacturer as a test object.</p>
      </sec>
      <sec>
        <title>Data analysis</title>
        <p>Data analysis was performed using MATLAB (V 5.2, The Mathworks, Inc Natick, MA) mathematical software. The Zernike expansion coefficients derived from the wave inclination data for the full pupil, were initially transposed to the OSA format and then corrected for chromatic aberration (from 840 to 550 nm) (see Appendix A).</p>
        <p>The corrected coefficients were "scaled" to a smaller pupil diameter (3 mm) using two different techniques: (i) the "direct" technique (the standard employed by COAS software), which re-calculated Zernike expansion coefficients (up to 4<sup>th </sup>order) after discarding the Shack-Hartmann image outside the 3 mm zone (ii) the "scaling" technique, which uses a matrix method to reconstruct a new set of Zernike coefficients that describe a wavefront aberration corresponding to the central 3 mm of the pupil using all available raw data. To achieve this, we used formulas developed by Schwiegerling[<xref ref-type="bibr" rid="B34">34</xref>] implemented in a MATLAB file, as previously described by Campbell[<xref ref-type="bibr" rid="B35">35</xref>].</p>
        <p>Figure <xref ref-type="fig" rid="F1">1</xref> depicts wavefront difference map of the central 3 mm of the full-size pupil and the calculated central 3 mm as obtained by the "direct" and the "scaling" methods. It is evident that the difference map for the "scaling" method is practically zero for every point of the entrance pupil. In contrast, the "direct" method produces a map that does not correspond closely to the initial data. Apparently, the calculated Zernike polynomial coefficients are different when peripheral data points are discarded.</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p><bold>Difference maps. </bold>Wavefront aberration difference maps between the central 3 mm pupil of the full-size pupil and the re-calculated central 3 mm as obtained by the "scaling" (left) and "direct" (right) methods. The vertical colour bar on the right shows corresponding wavefront aberration error in micrometers.</p>
          </caption>
          <graphic xlink:href="1471-2415-4-1-1"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Variance of the wave aberration data for the full-size pupil</title>
        <p>Prior to the presentation of the results for the scaled pupils it is of interest to report on the variance of the raw wavefront aberration data (50 measurements) for the full-size pupil of each subject. Figure <xref ref-type="fig" rid="F2">2</xref> illustrates the spatial distribution of the standard deviation of the measured wavefront aberration as a function of pupil position.</p>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p><bold>Colour patterns of wavefront aberration at full-size pupils. </bold>Colour patterns of the standard deviation of the wavefront error as a function of horizontal (x) and vertical (y) pupil position for the full-size pupils of the four subjects tested. Map size is 150 × 150 pixels.</p>
          </caption>
          <graphic xlink:href="1471-2415-4-1-2"/>
        </fig>
        <p>It is obvious that wavefront aberration variance at peripheral points of the pupil and especially near the edge of the pupil, is increased. Reasonably, this effect is more pronounced for subjects OL and SP having larger pupil diameters.</p>
      </sec>
      <sec>
        <title>Comparison of the two scaling methods</title>
        <p>Figure <xref ref-type="fig" rid="F3">3</xref> shows the variation with time of Zernike expansion coefficients C<sub>2</sub><sup>0 </sup>and C<sub>4</sub><sup>0</sup>, determined for a pupil diameter of 3 mm. The upper graphs correspond to fifty consecutive measurements made on an artificial eye. There is little doubt that discarding peripheral pupil data points in the "direct" method does not affect the variance of the low order coefficient, C<sub>2</sub><sup>0</sup>. However, it does introduce noise to the value determined for the higher order coefficient, C<sub>4</sub><sup>0</sup>. On the other hand, the "scaling" method produces minimal noise in both coefficients. It is noteworthy that noise introduced by the direct method is not observed in the coefficients corresponding to the large pupil.</p>
        <fig position="float" id="F3">
          <label>Figure 3</label>
          <caption>
            <p><bold>Variation of aberration coefficients C<sub>2</sub><sup>0 </sup>and C<sub>4</sub><sup>0 </sup>with time. </bold>Variation of wavefront aberration coefficient C<sub>2</sub><sup>0 </sup>(left) and C<sub>4</sub><sup>0 </sup>(right) with time for a 3 mm pupil as calculated by the direct (filled symbols) and scaling (open symbols) methods. Data from an artificial eye (upper graphs) and two subjects are shown. The dotted lines are least-square regression coefficients. Note, that the scaling of y axis is different for the artificial eye.</p>
          </caption>
          <graphic xlink:href="1471-2415-4-1-3"/>
        </fig>
        <p>The two lower graphs depict similar plots for two of the subjects tested. The variance for the C<sub>2</sub><sup>0 </sup>is much higher in this case, as would be expected due to the dynamic nature of the human eye. Moreover, note that there is no difference between the two methods, which also supports the above statement. For the 4<sup>th </sup>order term, the "scaling" method improves substantially the dispersion of the coefficient. Similar improvement in the variability of all higher order aberration coefficients is observed when the scaling method is applied for the calculation at 3 mm pupil.</p>
        <p>Another point worth mentioning is that a drift in the value of the C<sub>4</sub><sup>0 </sup>with time indicated by the direct method (see subject SP) may be ambiguous, as this is not the case when the scaling method is used. Moreover, there is no evidence of change of any aberration coefficient with time, as no statistically significant correlation can be established. This implies that during time period of the recordings (6.5 sec) needed to capture the fifty measurements, subjects maintained fixation and wavefront changes related to the tear film quality as well as accommodation state did not interfere significantly with the estimated dispersion.</p>
        <p>Figures <xref ref-type="fig" rid="F4">4a</xref> and <xref ref-type="fig" rid="F4">4b</xref> show frequency histograms of the spherical aberration coefficient (C<sub>4</sub><sup>0</sup>) and the higher-order RMS error for all subjects tested. It is clear from these data that the dispersion of the values is wider when the direct method is used, where as the scaling method calculates coefficients with higher variability. Furthermore, there is an obvious difference in the mean value, with a trend of the direct method to overestimate the amount of the wavefront error.</p>
        <fig position="float" id="F4">
          <label>Figure 4</label>
          <caption>
            <p><bold>Frequency histograms of C<sub>4</sub><sup>0 </sup>and higher-order RMS error. </bold>(a) Frequency histograms of the spherical aberration coefficient, C<sub>4</sub><sup>0 </sup>for all subjects tested. Comparison between results derived from the direct (upper) and scaling (lower) methods for a 3 mm pupil. Bin width is 0.001. (b) Frequency histograms of the higher-order RMS error for all subjects tested. Comparison between results derived from the direct (upper) and scaling (lower) methods for a 3 mm pupil. Bin width is 0.0025.</p>
          </caption>
          <graphic xlink:href="1471-2415-4-1-4"/>
        </fig>
      </sec>
      <sec>
        <title>Impact of error on different aberration terms and radial orders</title>
        <p>Figure <xref ref-type="fig" rid="F5">5</xref> presents signal-to-noise (S/N) ratio charts (mean / SD) for different radial orders of the wavefront aberration for all subjects tested. High S/N values imply high variability of the measured order of aberration. For example, subject's HG 2<sup>nd </sup>order terms are measured to have a value about thirty times higher than their standard deviation (noise level), whereas the magnitude of the 4<sup>th </sup>order terms is only five times higher than the standard deviation. There are three points to note from these data. First, the signal-to-noise ratios are much higher for the 2nd order compared to the higher-order coefficients for all the subjects. Second, there is some substantial variation between subjects for the 2<sup>nd </sup>order coefficients, while this is not the case for the higher order terms. This is mainly due to the fact that the amount of the sphero-cylindrical error (determining the 2<sup>nd </sup>order terms) varies between the subjects, while there is little variation in the magnitude of 3<sup>rd </sup>and 4<sup>th </sup>order coefficients. Third, the scaling method improves the signal-to-noise ratio in all cases, but this is more profound in the higher-order terms, as also displayed in figure <xref ref-type="fig" rid="F3">3</xref>.</p>
        <fig position="float" id="F5">
          <label>Figure 5</label>
          <caption>
            <p><bold>Signal-to-noise ratios for different radial order. </bold>Signal-to-noise ratios (mean / SD) for different radial orders of the wavefront aberration at 3 mm pupil as calculated by the direct and scaling methods. Data for all subjects are shown.</p>
          </caption>
          <graphic xlink:href="1471-2415-4-1-5"/>
        </fig>
        <p>The improvement of S/N for each expansion coefficient is depicted in figure <xref ref-type="fig" rid="F6">6</xref>, which uses the standard graph that describes the radial and angular modes of the Zernike polynomial expansion. Determination of coefficients having values smaller than two times the noise level, (S/N &lt; 2) are below the detection limit, regarded imprecise and are therefore displayed by red color. This graph corresponds to measurements of subject OL. We derived similar results for the other subjects.</p>
        <fig position="float" id="F6">
          <label>Figure 6</label>
          <caption>
            <p><bold>Signal-to-noise ratio for individual Zernike coefficients. </bold>Signal-to-noise (S/N) ratio in the standard pyramidical layout of Zernike expansion coefficients for one subject (OL) as calculated by the two methods. Green colours show high S/N ratio, red colours show low S/N ratio.</p>
          </caption>
          <graphic xlink:href="1471-2415-4-1-6"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>The aim of this study was to use a Shack-Hartmann clinical aberrometer (COAS, Wavefront Sciences Ltd) to evaluate the variability of low- and higher-order aberration measurement of the eye. Using the wave aberration polynomial determined for a full-size pupil we compared the Zernike expansion coefficients for a smaller, 3 mm pupil derived by two methods: first, by re-calculating the wave aberration coefficients to the reduced sampled points corresponding to that pupil ("direct" method), and, second, by using a matrix method to reconstruct a new set of coefficients appropriate for the reduced pupil ("scaling" method) (see figure <xref ref-type="fig" rid="F1">1</xref>).</p>
      <p>Our results suggest that, for full-size pupil, the efficiency of the measurements varies across x and y pupil position: where the wavefront is larger, measurement variance is higher, especially near the margins of the pupil, where increased standard deviation results to higher wave-aberration error. Some of this increased variance may have been due to poorer image quality in parts of the Shack-Hartmann images[<xref ref-type="bibr" rid="B36">36</xref>]. Also, it may be partially attributed to the fact that saccadic movements, during the time required for data collection, lead to alignment errors that continuously change the set of sensor elements contributing to wavefront sensing. Although such displacements in respect to the optical axis of the instrument cannot justify significant fluctuations of the wavefront aberration[<xref ref-type="bibr" rid="B37">37</xref>], we cannot exclude the possibility that the algorithm employed in COAS software may generate the increased noise in periphery during wavefront expansion, since pupil translation magnitude (~100 μm) is comparable to lenslet array spacing (as magnified by the conjugating optics) in the particular instrument.</p>
      <p>The increased standard deviation of wavefront aberration at the periphery has implications in calculating wavefront-guided ablation patterns. An error of 0.45 μm in the measured wavefront aberration at the periphery of the treatment zone may lead to a substantial error in the calculated shot pattern depending on the laser beam delivery (scanning) method as well as beam parameters and compensation for corneal curvature[<xref ref-type="bibr" rid="B38">38</xref>].</p>
      <p>As pupil becomes smaller, the magnitude of wavefront aberrations decreases. At 3 mm pupil, the "direct" method (employed by COAS) induces considerable variance in the measurement of higher-order aberration coefficients attributed to inherent fitting error. This results from the small number of sensor elements involved in the wavefront inclination measurement. Moreover, there is a clear shift in the magnitude of each coefficient to higher values, which may lead to inaccurate determination of higher-order terms. In contrast, the "scaling" method produces coefficients of higher variability, and this is not surprising since it allows the use of the information from a larger set of sensor elements, reducing instrument noise.</p>
      <p>On the other hand, second-order terms, and especially C<sub>2</sub><sup>0</sup>, are measured with higher variability (see figure <xref ref-type="fig" rid="F5">5</xref>), and this is an interesting feature as the coefficients C<sub>2</sub><sup>0</sup>, C<sub>2</sub><sup>-2</sup>, C<sub>2</sub><sup>+2 </sup>can be used in the calculation of the conventional sphero-cylindrical correction[<xref ref-type="bibr" rid="B33">33</xref>]. This observation, in conjuction with the high accuracy of the refraction estimated objectively from wavefront aberration data when small (~3 mm) pupils are used[<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>], is of considerable importance, as this means that the COAS clinical aberrometer may be used as a reliable and accurate autorefractor. However, care must be taken when large pupils are tested, as the objective estimation of refractive error may lead to ambiguous results, due to the influence of higher-order aberrations on the determination of correction[<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>].</p>
      <p>Another finding is that the variability of C<sub>2</sub><sup>0 </sup>(corresponding to defocus) improves only slightly when the "scaling" method is used. This probably occurs because the defocus term is mostly contained in the Shack-Hartmann spots at the centre of pupil. In contrast, spherical aberration, for example, depends on the 4<sup>th </sup>power of pupil radius, which means that most of the information is outside the central 3 mm and what is measured with a small pupil is mostly noise. Another reason may be the fact that the variance in C<sub>2</sub><sup>0 </sup>is not related to the inherent noise of the instrument itself, but to the dynamic characteristics of the human visual system, such as accommodation micro-fluctuations[<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>], tear film changes[<xref ref-type="bibr" rid="B44">44</xref>], and eye movements leading to alignment errors[<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B45">45</xref>].</p>
      <p>Although instruments based on the Shack – Hartmann sensor have been extensively validated for experimental work[<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B40">40</xref>], our results indicate that special care should be taken when measurement of aberration is used in clinical applications, such as refractive surgery, either decision making or outcome evaluation. The diversity of the measured values of various coefficients suggest that a number of measurements should be taken and averaged for each subject in order to calculate coefficients of higher efficiency[<xref ref-type="bibr" rid="B32">32</xref>]. This is of major importance in customized laser surgery, where aberration data are used to correct higher-order aberrations for the potential enhancement of visual performance [<xref ref-type="bibr" rid="B46">46</xref>-<xref ref-type="bibr" rid="B48">48</xref>].</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>Wavefront aberration of the eye, as derived from Shack-Hartmann images is determined with a certain degree of accuracy that varies considerably with pupil position. Zernike expansion coefficients are determined with less accuracy when re-calculated at "cropped" pupils with the use of the algorithm employed in COAS. This study shows that these errors attributed to the reduced number of sensor elements could be, at least partially, overcome using an appropriate algorithm that calculates the aberration coefficients for smaller pupils based on full-size pupil set of data. Moreover, micro – fluctuations observed in the C<sub>2</sub><sup>0 </sup>corresponding to defocus, are probably inherent characteristics of the eye and therefore show no improvement when the algorithm is applied.</p>
      <p>Consequently, it must be emphasised that wavefront aberration data used in clinical care should not be extracted from a single measurement, which represents only a static snapshot of a dynamically changing aberration pattern.</p>
    </sec>
    <sec>
      <title>Appendix A</title>
      <sec>
        <title>Correcting Zernike coefficients for chromatic aberration</title>
        <p>All Zernike coefficients, except the coefficient of defocus (C<sub>2</sub><sup>0</sup>), were adjusted to appropriate values for 550 nm, using a chromatic correction factor, K (equation 1):</p>
        <p>K = (n<sub>1</sub>-1)/(n<sub>2</sub>-1)     (1)</p>
        <p>Where n<sub>1 </sub>and n<sub>2 </sub>are the refractive index values for 550 nm and 840 nm, respondingly. These were calculated using equation 2[<xref ref-type="bibr" rid="B49">49</xref>], where the wavelength λ is written in nm.</p>
        <p>n<sub>λ </sub>= 1.320535 - (4.685/ (λ - 214.102))     (2)</p>
        <p>The C<sub>2</sub><sup>0 </sup>was corrected for wavelength, using equations (3) and (4). This is necessary because infrared light used for measurements is not reflected from the photoreceptors plane, where the subjective focal plane lies, but passes through to deeper layers and is reflected from the choroid[<xref ref-type="bibr" rid="B50">50</xref>]. Equation (3) calculates the spherical equivalent power corrected at 550 nm (S<sub>550</sub>), assuming that the 840-nm light is reflected from a plane 0.125 mm posterior to the retina of a 60D model eye (with a focal length of 16.667 mm). Equation (4) is used to derive C<sub>2</sub><sup>0 </sup>(in OSA format) from the spherical equivalent (S) for a specific pupil diameter (d) at each wavelength.</p>
        <p>
          <inline-graphic xlink:href="1471-2415-4-1-i1.gif"/>
        </p>
        <p>
          <inline-graphic xlink:href="1471-2415-4-1-i2.gif"/>
        </p>
      </sec>
    </sec>
    <sec>
      <title>Competing interests (medicine)</title>
      <p>None declared.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>HG participated in data analysis, manuscript preparation and study design. SP carried out measurements, performed data analysis and participated in manuscript and figure preparation. AP performed wavefront measurements, implemented the MATLAB code, participated in figure preparation and created the attached computer program. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/4/1/prepub"/>
      </p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="S1">
        <caption>
          <title>Additional File 1</title>
          <p>This zip file containes two MATLAB (v 5.2) files used for Zernike coefficient scaling to different pupil sizes. To run these files, MATLAB needs to be installed. This was tested for versions 5.2 for Macintosh and 6.1 for windows. Instructions for use as well as author credits are included in the files.</p>
        </caption>
        <media xlink:href="1471-2415-4-1-S1.zip" mimetype="application" mime-subtype="x-zip-compressed">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S2">
        <caption>
          <title>Additional File 2</title>
          <p>This zip file contains three files that form a Windows utility (an executable) used for Zernike coefficient scaling. Instructions for use, as well as author credits and a disclaimer, are included in the files.</p>
        </caption>
        <media xlink:href="1471-2415-4-1-S2.zip" mimetype="application" mime-subtype="x-zip-compressed">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>This work was supported by the EU, through the Research Training Network "Adaptive optics for retinal imaging and improved vision" under contract number HPRN-CT-2002-00301. Authors would like to thank Oleksandr Lutsenko for his involvement in data acquisition and Professor Ioannis Pallikaris for his valuable comments.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ivanoff</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>About the spherical aberration of the eye</article-title>
          <source>Journal of the Optical Society of America</source>
          <year>1956</year>
          <volume>46</volume>
          <fpage>901</fpage>
          <lpage>903</lpage>
          <pub-id pub-id-type="pmid">13367938</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jenkins</surname>
              <given-names>TCA</given-names>
            </name>
          </person-group>
          <article-title>Aberrations of the human eye and their effects on vision: Part I</article-title>
          <source>British Journal of Physiological Optics</source>
          <year>1963</year>
          <volume>20</volume>
          <fpage>59</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">14042743</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Charman</surname>
              <given-names>WN</given-names>
            </name>
          </person-group>
          <article-title>The retinal image in the human eye</article-title>
          <source>Progress in Retinal and Eye Research</source>
          <year>1983</year>
          <volume>2</volume>
          <fpage>1</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1016/0278-4327(83)90002-0</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
           